data_2kds_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kds _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.998 0.427 . . . . 4.7199999999999998 110.66 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -72.43 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.081 -1.012 . . . . 2.8900000000000001 108.972 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 79.91 37.72 21.63 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.722 -1.237 . . . . 1.47 111.187 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.1 ptt-85 -146.75 -177.93 5.91 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 120.92 -1.341 . . . . 4.0999999999999996 108.789 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.4 mt -107.34 142.39 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.719 1.247 . . . . 1.95 112.213 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 p -113.43 155.47 25.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.785 -1.552 . . . . 1.1899999999999999 113.225 -175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.7 138.82 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 114.975 -1.011 . . . . 1.6200000000000001 108.591 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.65 ' HB3' ' O ' ' A' ' 18' ' ' ALA . 63.1 tttm -86.16 126.93 34.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 118.682 -2.511 . . . . 3.52 110.826 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.71 126.61 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.62 -1.232 . . . . 2.21 111.498 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 51.9 tttp -170.94 172.42 5.54 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 105.221 -2.141 . . . . 2.8500000000000001 105.221 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -86.1 178.23 49.44 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.167 -1.973 . . . . 2.4100000000000001 108.167 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 17' ' ' GLU . 40.9 ttm180 40.07 99.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.942 . . . . 5.4100000000000001 111.291 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 33.3 109.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 113.441 0.904 . . . . 3.1299999999999999 113.441 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -171.75 16.37 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.958 0 O-C-N 121.338 -0.851 . . . . 2.3199999999999998 110.387 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.05 110.53 4.03 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 107.564 -2.214 . . . . 1.53 107.564 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -142.57 139.47 31.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.123 -1.436 . . . . 1.8999999999999999 107.123 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.554 ' NZ ' ' OG1' ' A' ' 42' ' ' THR . 1.3 pttm -94.28 138.62 32.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.325 -1.484 . . . . 3.6400000000000001 109.787 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.2 p -142.1 157.96 44.29 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.531 -0.868 . . . . 0.78000000000000003 111.274 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -104.06 134.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.113 -1.81 . . . . 1.1200000000000001 106.113 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.9 mt -96.89 133.71 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.032 -1.043 . . . . 1.3300000000000001 110.371 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 17.1 m -151.94 69.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.457 -1.697 . . . . 1.73 113.594 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.6 t0 171.19 152.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.737 -1.227 . . . . 1.5600000000000001 109.991 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.5 mt -117.66 127.57 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 103.038 -2.949 . . . . 2.5299999999999998 103.038 171.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 29' ' ' ASP . 20.9 mm -99.75 -111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.017 -1.677 . . . . 1.47 111.853 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 91.6 m-20 -62.71 -41.36 99.1 Favored 'General case' 0 C--O 1.201 -1.452 0 O-C-N 121.695 -0.628 . . . . 2.3999999999999999 110.157 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.582 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 89.9 m-20 164.34 -50.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 C-N-CA 124.833 1.253 . . . . 2.5499999999999998 109.353 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -95.07 4.85 53.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 2.1299999999999999 111.922 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.84 147.22 42.33 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.068 -1.02 . . . . 2.4900000000000002 110.337 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.98 162.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.676 -0.49 . . . . 1.2 109.676 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.605 ' CD1' HH21 ' A' ' 46' ' ' ARG . 8.2 tt -97.4 132.48 43.07 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 119.361 -0.936 . . . . 1.6799999999999999 108.643 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.71 150.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.777 -0.769 . . . . 1.1699999999999999 110.556 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 7.0 t -144.03 155.12 43.88 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.974 -0.69 . . . . 1.3100000000000001 112.15 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -152.55 169.08 31.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.132 -1.987 . . . . 0.83999999999999997 108.132 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' CG ' ' HZ1' ' A' ' 21' ' ' LYS . 36.9 Cg_endo -70.39 110.35 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 CA-C-N 118.938 1.369 . . . . 1.1799999999999999 109.322 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -58.82 -39.5 81.36 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.057 -1.027 . . . . 3.9700000000000002 111.202 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.26 -40.22 96.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.941 -1.099 . . . . 2.27 112.47 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.87 -77.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.419 -0.801 . . . . 2.71 112.874 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.554 ' OG1' ' NZ ' ' A' ' 21' ' ' LYS . 33.4 m -61.89 -35.06 77.24 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.729 -1.232 . . . . 1.75 109.492 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.54 -10.97 56.47 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.653 -0.654 . . . . 1.28 111.797 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -91.1 128.33 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 119.93 1.865 . . . . 1.6799999999999999 108.15 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' O ' ' OG1' ' A' ' 36' ' ' THR . 16.5 tttt -95.33 -75.57 0.52 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.332 1.063 . . . . 3.98 110.66 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.605 HH21 ' CD1' ' A' ' 34' ' ' LEU . 65.2 ttt180 -148.7 125.44 11.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.301 -1.37 . . . . 3.3500000000000001 107.301 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -157.23 164.34 37.82 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 119.969 -1.707 . . . . 3.6699999999999999 109.489 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -105.25 141.1 37.37 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.43 -0.793 . . . . 3.4700000000000002 109.528 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -133.8 143.6 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 2.2599999999999998 110.052 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 48.6 t-20 -80.87 154.24 27.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.669 0.747 . . . . 2.6899999999999999 111.243 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 93.1 mt -58.36 -23.84 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.638 -0.664 . . . . 2.1000000000000001 109.728 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.6 mt -53.26 -29.87 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 1.8 108.94 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -117.43 91.7 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.553 -1.647 . . . . 2.27 106.553 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.4 tp -113.82 130.38 56.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.684 -0.635 . . . . 2.1400000000000001 110.548 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -137.81 90.33 14.41 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 106.864 -1.532 . . . . 2.2799999999999998 106.864 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.26 148.13 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.629 1.553 . . . . 0.81000000000000005 113.926 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 p -119.73 163.81 16.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.491 -0.929 . . . . 1.1799999999999999 108.491 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.599 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 55.3 p30 -75.4 125.82 29.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.282 -1.747 . . . . 2.5699999999999998 106.282 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 24.5 mttt -162.14 -173.03 3.46 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.083 1.42 . . . . 3.3399999999999999 112.704 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' GLY . 25.3 tttt -81.48 150.88 28.08 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.722 -1.581 . . . . 5.6799999999999997 111.231 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 tt -120.6 120.16 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.503 0.668 . . . . 5.2400000000000002 110.628 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -179.6 87.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 117.62 -1.181 . . . . 2.1400000000000001 112.208 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -115.15 138.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 CA-C-N 123.543 2.883 . . . . 2.3300000000000001 108.112 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.569 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.7 mt-30 -60.76 -41.28 95.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 115.166 -2.614 . . . . 3.1800000000000002 106.282 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 59.3 tttt 114.11 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.139 -1.059 . . . . 3.8599999999999999 108.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 119.849 -1.782 . . . . 0.72999999999999998 111.539 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.76 144.8 17.23 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.201 -1.764 . . . . 1.3100000000000001 112.225 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 52.8 p -69.89 167.02 18.26 Favored 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 108.152 -1.055 . . . . 1.0600000000000001 108.152 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 93.0 m-20 -59.56 -47.35 85.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 119.585 -1.947 . . . . 2.02 112.088 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -41.1 98.3 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 117.003 -1.879 . . . . 2.2999999999999998 108.022 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.8 -35.72 82.0 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.134 -1.061 . . . . 1.96 108.134 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 68' ' ' SER . 79.5 t -65.39 -42.82 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 1.1599999999999999 110.094 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.68 -42.92 98.06 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.908 -1.117 . . . . 1.3100000000000001 110.09 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -59.44 -38.19 80.08 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.182 -1.007 . . . . 2.7400000000000002 109.072 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 11.8 mtpt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.882 -0.511 . . . . 3.1200000000000001 110.169 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 88.4 mt -57.48 -37.68 73.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.662 -1.273 . . . . 1.98 108.641 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 97.1 mt-10 -58.65 -33.08 69.68 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 118.307 -1.357 . . . . 1.7 108.179 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.02 -35.68 75.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.145 -2.168 . . . . 2.29 105.145 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 m -70.01 -21.88 63.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.014 -0.539 . . . . 1.78 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 77' ' ' GLU . 74.4 m-20 66.83 46.7 1.62 Allowed 'General case' 0 N--CA 1.519 3.011 0 CA-C-O 122.229 1.014 . . . . 2.1099999999999999 112.481 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.456 ' CD1' ' O ' ' A' ' 76' ' ' LEU . 6.2 mp -65.52 -27.51 68.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.357 -0.838 . . . . 3.0 111.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.0 m -42.62 -33.59 0.74 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.965 -1.084 . . . . 3.1099999999999999 111.29 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -157.66 -21.17 0.09 Allowed 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.009 -1.682 . . . . 3.5299999999999998 110.952 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -60.59 -42.33 96.49 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 117.73 -1.588 . . . . 3.5299999999999998 107.076 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' NZ ' ' A' ' 59' ' ' LYS . 62.3 mtt -94.82 -125.3 0.11 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.627 -1.624 . . . . 2.96 114.178 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 52.99 31.42 10.96 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.631 -1.248 . . . . 2.04 107.631 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 116.347 1.981 . . . . 2.6899999999999999 116.347 -174.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 6' ' ' VAL . 95.9 mt-10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.063 -0.347 . . . . 4.7199999999999998 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.642 ' O ' ' O ' ' A' ' 5' ' ' GLU . 7.2 m -43.19 -149.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.269 1.033 . . . . 2.8900000000000001 112.585 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.81 66.4 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 106.721 -2.551 . . . . 1.47 106.721 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 57' ' ' THR . 71.1 mtp180 -128.74 170.43 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.431 -0.952 . . . . 4.0999999999999996 108.431 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 57' ' ' THR . 82.8 mt -93.99 145.41 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.021 -1.05 . . . . 1.95 108.845 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.0 p -122.44 155.66 35.66 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.9 -1.045 . . . . 1.1899999999999999 112.643 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 41.0 t -127.31 139.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 CA-C-N 115.625 -0.716 . . . . 1.6200000000000001 110.158 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 18' ' ' ALA . 22.7 tptm -81.1 137.52 35.97 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 118.03 -2.919 . . . . 3.52 111.685 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.61 100.42 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 122.58 1.181 . . . . 2.21 109.476 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.569 ' NZ ' ' CE1' ' A' ' 53' ' ' HIS . 31.6 mttm -157.02 169.08 25.63 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.153 -1.795 . . . . 2.8500000000000001 106.153 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -82.84 178.83 53.15 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 117.353 -2.356 . . . . 2.4100000000000001 107.305 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 15' ' ' GLY . 59.3 ttt85 49.35 106.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.172 -1.193 . . . . 5.4100000000000001 111.01 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 48.33 53.55 11.73 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.996 0.903 . . . . 3.1299999999999999 110.74 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 12' ' ' LYS . . . -67.88 -15.3 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.538 -1.351 . . . . 2.3199999999999998 110.781 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.45 94.91 1.9 Allowed Glycine 0 C--N 1.285 -2.284 0 O-C-N 120.718 -1.239 . . . . 1.53 114.374 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -136.35 134.32 37.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.62 -1.992 . . . . 1.8999999999999999 105.62 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.576 ' NZ ' ' H ' ' A' ' 86' ' ' LYS . 1.7 ptpt -100.53 136.84 39.78 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.622 -1.299 . . . . 3.6400000000000001 111.455 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.2 p -137.5 159.57 41.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.772 0.796 . . . . 0.78000000000000003 111.199 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.12 136.27 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.056 -1.461 . . . . 1.1200000000000001 107.056 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.37 133.69 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.117 -0.989 . . . . 1.3300000000000001 109.912 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.607 ' CG1' ' HZ3' ' A' ' 75' ' ' LYS . 1.1 m -149.18 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.884 -1.126 . . . . 1.73 111.668 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 54.3 t0 172.14 137.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 1.5600000000000001 109.183 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.5 mt -118.78 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 104.177 -2.527 . . . . 2.5299999999999998 104.177 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -97.05 -79.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.053 -1.03 . . . . 1.47 110.843 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 44.1 t0 -106.03 179.0 4.4 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.135 0.969 . . . . 2.3999999999999999 108.871 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 91.8 m-20 -54.8 -38.51 67.39 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 118.969 -1.093 . . . . 2.5499999999999998 108.81 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.54 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 33.6 p-10 -112.11 5.15 18.42 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 115.685 1.735 . . . . 2.1299999999999999 115.685 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 89.3 m-85 -112.64 138.94 48.7 Favored 'General case' 0 N--CA 1.528 3.455 0 CA-C-N 121.696 2.044 . . . . 2.4900000000000002 113.78 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 m -130.8 162.78 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 115.727 -0.67 . . . . 1.2 109.899 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -100.28 135.61 41.44 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.272 -0.893 . . . . 1.6799999999999999 108.829 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -126.75 150.5 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.613 -0.835 . . . . 1.1699999999999999 110.541 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -146.89 153.09 39.72 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.648 -0.821 . . . . 1.3100000000000001 112.015 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.7 29.82 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.571 -2.212 . . . . 0.83999999999999997 107.571 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.88 108.06 0.86 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 CA-C-N 119.156 1.478 . . . . 1.1799999999999999 110.594 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -58.6 -39.21 79.79 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.174 0.988 . . . . 3.9700000000000002 109.592 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -38.99 93.25 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.43 -0.794 . . . . 2.27 112.251 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mm -96.24 -78.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.028 . . . . 2.71 113.39 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -32.94 74.4 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.999 0.904 . . . . 1.75 108.605 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.12 56.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 111.438 -0.665 . . . . 1.28 111.438 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.37 148.94 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.8 1.8 . . . . 1.6799999999999999 109.912 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -92.69 -131.18 0.13 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.524 -1.287 . . . . 3.98 107.524 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -139.86 122.32 16.15 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 103.982 -2.599 . . . . 3.3500000000000001 103.982 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -159.64 165.83 31.91 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 117.467 -1.693 . . . . 3.6699999999999999 110.576 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -93.12 139.12 30.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.274 -0.891 . . . . 3.4700000000000002 108.695 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.04 153.48 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.96 -1.087 . . . . 2.2599999999999998 110.304 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -86.3 167.7 14.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.955 0.883 . . . . 2.6899999999999999 111.611 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 51' ' ' ILE . 98.4 mt -58.15 -24.84 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 115.999 -0.546 . . . . 2.1000000000000001 110.234 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.7 mt -55.23 -30.87 60.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.207 -1.034 . . . . 1.8 108.207 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 98.7 m-70 -116.04 88.53 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.508 -1.293 . . . . 2.27 107.508 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.6 tp -118.91 129.67 55.31 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.285 -0.635 . . . . 2.1400000000000001 109.285 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -143.14 90.41 7.4 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 106.368 -1.715 . . . . 2.2799999999999998 106.368 176.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -90.22 153.54 4.64 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 121.557 1.504 . . . . 0.81000000000000005 114.322 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.538 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 63.5 p -111.68 166.71 10.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.333 -1.728 . . . . 1.1799999999999999 106.333 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HA ' HH21 ' A' ' 8' ' ' ARG . 88.4 m-20 -84.21 11.49 8.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.047 -1.033 . . . . 2.5699999999999998 110.664 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . 0.317 44.6 tttm -91.34 124.6 35.65 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.185 -0.947 . . . . 3.3399999999999999 111.389 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -133.57 119.04 18.97 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 118.596 -1.242 . . . . 5.6799999999999997 111.382 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.8 pt -128.5 157.12 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.872 -1.158 . . . . 5.2400000000000002 107.872 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -86.13 128.37 34.87 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 122.891 1.329 . . . . 2.1400000000000001 111.928 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.78 164.07 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 115.11 -0.95 . . . . 2.3300000000000001 109.933 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -96.39 139.98 31.71 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.842 -1.17 . . . . 3.1800000000000002 107.842 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -67.24 138.87 57.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 116.056 -0.52 . . . . 3.8599999999999999 111.064 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.8 21.43 61.55 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.52 -1.324 . . . . 0.72999999999999998 112.998 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.04 21.74 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 120.294 2.047 . . . . 1.3100000000000001 111.389 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -71.2 166.27 21.87 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.696 -1.594 . . . . 1.0600000000000001 106.696 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 53.0 p30 -60.65 -40.55 92.45 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 116.328 -2.149 . . . . 2.02 110.683 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 97.1 mt-10 -63.23 -39.31 94.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 119.517 -1.989 . . . . 2.2999999999999998 107.731 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.73 -35.71 81.93 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.773 -1.171 . . . . 1.96 108.09 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.09 -43.52 97.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.436 -1.306 . . . . 1.1599999999999999 107.881 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.74 -44.25 97.27 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.014 -1.074 . . . . 1.3100000000000001 109.428 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.48 -42.32 96.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.371 -1.456 . . . . 2.7400000000000002 108.315 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.607 ' HZ3' ' CG1' ' A' ' 25' ' ' VAL . 10.1 mtmp? -62.63 -34.93 78.04 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.507 -0.877 . . . . 3.1200000000000001 109.588 176.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.661 ' O ' ' OG ' ' A' ' 79' ' ' SER . 38.1 tp -59.24 -40.5 86.11 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.735 -1.186 . . . . 1.98 108.392 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.543 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -62.42 -34.38 76.64 Favored 'General case' 0 C--N 1.281 -2.373 0 O-C-N 120.175 -1.578 . . . . 1.7 108.135 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.68 -36.97 77.52 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 105.589 -2.004 . . . . 2.29 105.589 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.661 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 95.8 p -71.11 -18.25 62.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.397 -1.705 . . . . 1.78 106.397 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 20.2 m120 61.6 35.02 17.45 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.123 -0.944 . . . . 2.1099999999999999 111.065 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 81' ' ' LEU . 8.4 mp -74.55 -29.54 61.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.831 -0.543 . . . . 3.0 112.395 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 43.5 m -50.52 -33.09 20.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.122 -0.986 . . . . 3.1099999999999999 110.856 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -147.42 -28.35 0.36 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 118.342 -1.343 . . . . 3.5299999999999998 112.727 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -61.88 -48.57 79.89 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 114.94 -2.704 . . . . 3.5299999999999998 105.606 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 62.2 mtt -88.09 -135.92 0.09 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.378 -1.737 . . . . 2.96 111.355 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.576 ' H ' ' NZ ' ' A' ' 21' ' ' LYS . 27.8 mtpt 62.81 29.67 16.67 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.521 -1.659 . . . . 2.04 106.521 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-N 116.103 -0.498 . . . . 2.6899999999999999 112.112 -179.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.578 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 95.2 mt-10 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.281 -0.637 . . . . 4.7199999999999998 109.281 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.48 178.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.394 -1.335 . . . . 2.8900000000000001 107.394 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 89.77 18.14 52.24 Favored Glycine 0 C--O 1.199 -2.042 0 C-N-CA 119.116 -1.516 . . . . 1.47 111.27 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 28.3 ptt-85 -137.53 176.02 9.08 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.147 -1.207 . . . . 4.0999999999999996 108.275 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 57' ' ' THR . 81.3 mt -104.81 146.98 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 123.171 1.462 . . . . 1.95 111.641 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.47 155.72 29.21 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 112.959 -1.928 . . . . 1.1899999999999999 111.515 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 43.5 t -127.02 135.4 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 CA-C-N 115.437 -0.801 . . . . 1.6200000000000001 111.144 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -87.96 139.05 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.296 -2.753 . . . . 3.52 110.189 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.32 120.12 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 118.834 -1.146 . . . . 2.21 110.659 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.628 ' NZ ' ' CE1' ' A' ' 53' ' ' HIS . 93.1 mttt -161.09 170.55 20.22 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.739 -1.578 . . . . 2.8500000000000001 106.739 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.9 -178.63 51.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 106.142 -2.783 . . . . 2.4100000000000001 106.142 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' O ' ' O ' ' A' ' 17' ' ' GLU . 84.7 mtt180 38.38 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 119.37 1.585 . . . . 5.4100000000000001 111.332 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 35.27 110.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.905 0.86 . . . . 3.1299999999999999 112.673 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.58 16.6 0.07 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.919 -1.113 . . . . 2.3199999999999998 111.167 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.22 98.21 2.39 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.18 -1.968 . . . . 1.53 108.18 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -144.42 137.29 26.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.149 -1.207 . . . . 1.8999999999999999 109.221 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -103.36 139.36 38.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 3.6400000000000001 109.418 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.5 p -131.24 157.69 42.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.839 -1.144 . . . . 0.78000000000000003 109.147 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.17 135.18 44.33 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 N-CA-C 106.556 -1.646 . . . . 1.1200000000000001 106.556 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.73 130.03 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.41 -0.916 . . . . 1.3300000000000001 110.086 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -142.28 68.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.158 -1.417 . . . . 1.73 111.729 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 55.1 t0 164.97 148.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.116 -0.99 . . . . 1.5600000000000001 108.542 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.1 tt -121.74 117.67 53.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.253 -2.499 . . . . 2.5299999999999998 104.253 170.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.5 mt -97.64 -80.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.879 1.323 . . . . 1.47 109.653 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -106.18 161.26 14.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.105 -1.407 . . . . 2.3999999999999999 107.845 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.14 -38.1 67.8 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 118.683 -1.207 . . . . 2.5499999999999998 109.592 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -96.25 0.3 50.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.357 . . . . 2.1299999999999999 113.651 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -121.31 145.03 48.29 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.994 1.27 . . . . 2.4900000000000002 113.091 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.91 161.98 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.926 -0.484 . . . . 1.2 110.064 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 tt -101.36 133.9 45.25 Favored 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 108.122 -1.066 . . . . 1.6799999999999999 108.122 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.51 149.61 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.246 -0.909 . . . . 1.1699999999999999 110.8 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -143.22 151.4 40.56 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.083 -1.047 . . . . 1.3100000000000001 111.922 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.53 164.38 37.25 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.039 -2.025 . . . . 0.83999999999999997 108.039 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -65.79 124.57 12.92 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-N 120.578 2.189 . . . . 1.1799999999999999 109.56 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -60.37 -43.57 96.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.372 -1.455 . . . . 3.9700000000000002 111.267 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.33 -37.43 87.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 2.27 113.729 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.425 HD13 ' HZ1' ' A' ' 86' ' ' LYS . 85.2 mt -94.86 -71.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 114.751 1.389 . . . . 2.71 114.751 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.5 m -70.17 -35.53 74.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.41 1.1 . . . . 1.75 109.635 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -18.17 47.03 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-N 115.136 -0.938 . . . . 1.28 112.316 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -92.26 124.04 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 CA-C-N 120.31 2.055 . . . . 1.6799999999999999 107.582 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -88.98 -79.55 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.237 -1.764 . . . . 3.98 106.237 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -152.54 118.65 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.555 -1.276 . . . . 3.3500000000000001 107.555 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -156.13 163.17 39.96 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.353 -1.467 . . . . 3.6699999999999999 109.838 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -95.39 138.21 33.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.147 -0.971 . . . . 3.4700000000000002 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.64 150.62 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.6 -1.312 . . . . 2.2599999999999998 110.908 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.515 HD22 ' CD1' ' A' ' 52' ' ' LEU . 43.7 p-10 -86.07 172.72 10.39 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.731 0.777 . . . . 2.6899999999999999 111.646 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 51' ' ' ILE . 90.3 mt -57.04 -29.04 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.742 -0.599 . . . . 2.1000000000000001 110.769 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.515 ' CD1' HD22 ' A' ' 50' ' ' ASN . 77.4 mt -53.71 -29.03 37.36 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.124 -0.985 . . . . 1.8 109.083 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.628 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 61.8 m170 -115.96 88.61 2.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.257 -1.757 . . . . 2.27 106.257 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.8 tp -123.93 129.16 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 2.1400000000000001 109.334 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 3.1 tp10 -152.37 94.89 3.18 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 107.584 -1.265 . . . . 2.2799999999999998 107.584 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -87.97 153.81 7.16 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 121.46 1.44 . . . . 0.81000000000000005 112.541 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 50.5 p -116.92 163.95 15.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.415 -0.958 . . . . 1.1799999999999999 108.415 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 49.8 p30 -88.98 39.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.511 -0.743 . . . . 2.5699999999999998 111.468 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -84.3 -166.65 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.007 -1.058 . . . . 3.3399999999999999 111.805 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' ' O ' ' A' ' 7' ' ' GLY . 22.9 tttt -82.75 154.27 24.86 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.037 0.935 . . . . 5.6799999999999997 108.988 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.42 117.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.987 -0.685 . . . . 5.2400000000000002 109.77 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -173.39 85.94 0.05 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.983 -1.073 . . . . 2.1400000000000001 113.464 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.59 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -131.59 159.32 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 120.23 -1.544 . . . . 2.3300000000000001 109.153 176.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.1 mt-30 -63.41 -44.93 93.24 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 116.455 -2.098 . . . . 3.1800000000000002 108.848 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 3.0 ttmp? 99.85 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 108.085 -1.08 . . . . 3.8599999999999999 108.085 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 11.41 63.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.8 -1.72 . . . . 0.72999999999999998 108.8 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.523 ' CB ' ' NZ ' ' A' ' 75' ' ' LYS . . . -56.98 149.44 18.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.662 -0.905 . . . . 1.3100000000000001 112.36 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.4 p -65.23 164.4 13.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.661 -1.237 . . . . 1.0600000000000001 107.661 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.58 -42.48 88.13 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.161 -1.587 . . . . 2.02 111.371 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.96 -39.56 95.03 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 117.269 -1.772 . . . . 2.2999999999999998 108.747 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.9 -36.3 83.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.603 -0.839 . . . . 1.96 108.898 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.57 -42.81 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 1.1599999999999999 109.844 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.16 -42.23 98.19 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.986 -1.086 . . . . 1.3100000000000001 109.791 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.49 -43.39 97.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 2.7400000000000002 110.176 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.523 ' NZ ' ' CB ' ' A' ' 67' ' ' ALA . 37.5 mtmm -60.87 -31.67 71.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.763 -0.586 . . . . 3.1200000000000001 110.637 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.657 ' O ' ' OG ' ' A' ' 79' ' ' SER . 36.4 tp -54.83 -37.48 66.21 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.623 -0.88 . . . . 1.98 108.623 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.51 -31.32 67.78 Favored 'General case' 0 C--N 1.277 -2.568 0 O-C-N 120.407 -1.433 . . . . 1.7 109.183 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.08 -35.64 69.63 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.305 -1.739 . . . . 2.29 106.305 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 57.6 p -66.57 -19.74 65.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.538 -1.282 . . . . 1.78 107.538 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 60.5 37.44 19.68 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 106.904 -1.517 . . . . 2.1099999999999999 106.904 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' THR . 13.9 tp -68.35 -30.42 69.37 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.454 -1.703 . . . . 3.0 111.413 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 38.9 m -43.28 -35.66 1.55 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.291 -0.881 . . . . 3.1099999999999999 110.537 -175.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.79 -23.62 0.11 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.556 -1.658 . . . . 3.5299999999999998 112.219 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -60.65 -48.01 83.67 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 116.404 -2.118 . . . . 3.5299999999999998 107.417 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.55 ' O ' ' N ' ' A' ' 87' ' ' GLU . 84.7 mtp -84.25 -122.92 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 112.192 -2.276 . . . . 2.96 112.951 -174.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HZ1' HD13 ' A' ' 41' ' ' ILE . 25.9 mttm 46.13 14.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.466 -0.939 . . . . 2.04 108.466 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.1 mt-10 . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 114.375 1.25 . . . . 2.6899999999999999 114.375 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.709 ' H ' HH11 ' A' ' 8' ' ' ARG . 95.4 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 122.024 0.916 . . . . 4.7199999999999998 110.492 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.05 175.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.561 -0.904 . . . . 2.8900000000000001 108.561 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 8' ' ' ARG . . . 75.55 -118.8 5.6 Favored Glycine 0 C--N 1.29 -2.023 0 C-N-CA 119.491 -1.338 . . . . 1.47 110.272 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.709 HH11 ' H ' ' A' ' 5' ' ' GLU . 39.5 mtp180 39.8 -171.43 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.894 0 O-C-N 121.507 -0.996 . . . . 4.0999999999999996 109.933 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.403 HG22 ' OG1' ' A' ' 57' ' ' THR . 16.0 tt -118.09 147.95 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 106.277 -1.749 . . . . 1.95 106.277 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 4.7 p -128.01 159.8 33.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.058 0.932 . . . . 1.1899999999999999 111.95 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.16 145.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.961 -1.126 . . . . 1.6200000000000001 107.961 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -89.95 137.16 32.57 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 119.516 -1.99 . . . . 3.52 109.512 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.96 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.254 -1.378 . . . . 2.21 111.754 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -165.76 160.17 16.89 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.144 -2.169 . . . . 2.8500000000000001 105.144 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.89 178.94 51.17 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 117.667 -2.206 . . . . 2.4100000000000001 109.095 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' GLU . 95.0 mtt-85 45.13 94.63 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.618 -0.931 . . . . 5.4100000000000001 110.097 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 41.59 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.719 0.771 . . . . 3.1299999999999999 112.877 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 178.6 8.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.376 -0.827 . . . . 2.3199999999999998 111.725 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.95 115.1 4.69 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 107.618 -2.193 . . . . 1.53 107.618 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -152.48 149.21 28.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.086 -1.243 . . . . 1.8999999999999999 107.862 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.93 141.77 28.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 3.6400000000000001 110.516 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.0 p -139.57 158.8 43.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.78000000000000003 110.313 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.01 135.68 52.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.476 -1.305 . . . . 1.1200000000000001 107.476 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 7' ' ' GLY . 64.9 mt -94.49 133.78 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 C-N-CA 118.211 -1.395 . . . . 1.3300000000000001 110.966 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.59 76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 118.442 -1.303 . . . . 1.73 111.422 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 47.1 t0 169.79 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.273 -1.517 . . . . 1.5600000000000001 108.371 172.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 69.9 mt -119.44 121.88 67.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 103.411 -2.811 . . . . 2.5299999999999998 103.411 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.9 mt -109.63 -38.82 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.941 -1.1 . . . . 1.47 109.927 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -164.69 173.93 11.32 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.962 -1.496 . . . . 2.3999999999999999 106.962 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.93 -39.26 77.58 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.763 -1.175 . . . . 2.5499999999999998 112.336 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -99.83 1.6 43.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.338 -1.476 . . . . 2.1299999999999999 114.811 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -121.77 142.87 49.77 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.121 1.328 . . . . 2.4900000000000002 111.814 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.7 162.42 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.44 -0.788 . . . . 1.2 109.411 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.32 133.05 46.5 Favored 'General case' 0 N--CA 1.52 3.027 0 C-N-CA 118.894 -1.122 . . . . 1.6799999999999999 109.163 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 144.49 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.017 -1.073 . . . . 1.1699999999999999 109.747 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 6.4 t -145.38 155.51 43.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.771 0.796 . . . . 1.3100000000000001 112.293 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -155.34 164.51 32.01 Favored Glycine 0 N--CA 1.501 3.005 0 N-CA-C 107.168 -2.373 . . . . 0.83999999999999997 107.168 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.71 115.6 3.02 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 119.145 1.472 . . . . 1.1799999999999999 110.064 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.89 -34.9 72.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.76 0.79 . . . . 3.9700000000000002 110.55 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.97 -40.96 99.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.635 -0.666 . . . . 2.27 112.683 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.6 mt -98.03 -78.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 2.71 112.767 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 m -61.34 -35.9 78.69 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.913 -1.117 . . . . 1.75 109.459 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.72 -3.82 57.64 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.658 -0.782 . . . . 1.28 112.112 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.5 m -90.73 131.68 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.497 -2.038 . . . . 1.6799999999999999 105.497 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . 8.0 ttpm? -94.15 -78.23 0.44 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.492 -1.283 . . . . 3.98 110.331 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -152.66 126.18 8.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.027 -1.842 . . . . 3.3500000000000001 106.027 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -155.01 165.82 35.53 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.189 -1.569 . . . . 3.6699999999999999 110.08 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -113.21 138.45 49.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.381 -0.824 . . . . 3.4700000000000002 109.601 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 m -132.23 151.73 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 118.727 -1.189 . . . . 2.2599999999999998 110.592 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.55 ' OD1' ' CE2' ' A' ' 32' ' ' PHE . 31.5 m-20 -87.3 163.25 16.94 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.268 -0.878 . . . . 2.6899999999999999 108.717 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.3 mt -57.56 -24.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.02 -1.05 . . . . 2.1000000000000001 111.062 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -55.2 -35.93 65.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.345 -1.472 . . . . 1.8 108.556 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -114.66 87.17 2.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.204 -1.036 . . . . 2.27 108.204 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.3 tp -128.5 127.85 43.23 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.655 -0.868 . . . . 2.1400000000000001 108.655 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.34 87.09 39.19 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 107.314 -1.365 . . . . 2.2799999999999998 107.314 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -92.17 147.95 3.04 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.107 1.872 . . . . 0.81000000000000005 114.744 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 14.7 p -101.87 172.32 7.0 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.459 -1.312 . . . . 1.1799999999999999 107.459 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 50.3 p30 -83.1 16.37 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.088 0.947 . . . . 2.5699999999999998 108.909 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HZ3' ' CA ' ' A' ' 79' ' ' SER 0.346 66.4 tttt -87.53 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.779 -0.823 . . . . 3.3399999999999999 108.779 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' CE ' ' OE1' ' A' ' 5' ' ' GLU . 62.7 tttm -133.19 120.72 21.53 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.986 -1.086 . . . . 5.6799999999999997 110.525 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -118.56 141.8 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.556 -1.646 . . . . 5.2400000000000002 106.556 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.3 p30 -88.23 128.24 35.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.459 -1.4 . . . . 2.1400000000000001 110.43 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.566 ' H ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -126.73 162.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.348 -0.845 . . . . 2.3300000000000001 109.756 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -70.88 -107.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.092 -1.043 . . . . 3.1800000000000002 108.308 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -177.35 119.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.802 -1.187 . . . . 3.8599999999999999 109.663 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.88 20.61 70.23 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.227 -1.463 . . . . 0.72999999999999998 110.855 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' CB ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.56 147.19 6.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.981 -1.305 . . . . 1.3100000000000001 111.316 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 p -66.64 163.37 19.06 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 107.737 -1.208 . . . . 1.0600000000000001 107.737 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.9 -44.03 86.51 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 117.339 -1.744 . . . . 2.02 110.502 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.29 -39.58 94.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.092 -1.843 . . . . 2.2999999999999998 109.404 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.87 -36.71 80.75 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.176 -1.01 . . . . 1.96 109.103 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 73.0 t -62.56 -41.63 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.591 -0.693 . . . . 1.1599999999999999 110.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.65 -39.42 80.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.519 -0.872 . . . . 1.3100000000000001 109.36 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.42 -40.79 87.86 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.221 -0.992 . . . . 2.7400000000000002 111.217 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.421 ' HZ2' ' CB ' ' A' ' 67' ' ' ALA . 7.7 mptt -60.51 -32.64 71.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.715 -1.241 . . . . 3.1200000000000001 111.975 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' O ' ' OG ' ' A' ' 79' ' ' SER . 6.7 mp -58.62 -37.49 75.99 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 120.32 -1.488 . . . . 1.98 108.931 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 78.0 mm-40 -57.26 -32.67 66.83 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 116.957 -1.897 . . . . 1.7 107.353 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.98 -33.97 76.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.147 -1.797 . . . . 2.29 106.147 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 60.6 p -65.61 -26.92 68.05 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 105.74 -1.948 . . . . 1.78 105.74 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.9 m120 61.66 38.59 15.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.472 -1.677 . . . . 2.1099999999999999 106.472 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.16 -29.56 67.61 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.059 -1.428 . . . . 3.0 108.609 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 m -42.55 -34.46 0.86 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.133 -0.94 . . . . 3.1099999999999999 111.365 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -156.35 -14.91 0.1 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 117.949 -1.501 . . . . 3.5299999999999998 111.818 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -61.49 -41.96 98.07 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 116.41 -2.116 . . . . 3.5299999999999998 105.967 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 75.3 mtp -109.39 -120.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.958 -1.019 . . . . 2.96 112.76 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 90.5 mttt 57.74 33.36 23.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.53 -0.545 . . . . 2.04 109.53 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.297 -1.682 0 C-N-CA 118.677 -1.209 . . . . 2.6899999999999999 109.067 178.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.831 ' H ' HH21 ' A' ' 8' ' ' ARG . 97.0 mt-10 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.791 -0.818 . . . . 4.7199999999999998 108.791 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 5' ' ' GLU . 57.4 t 111.12 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 106.782 -1.562 . . . . 2.8900000000000001 106.782 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.435 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 89.42 9.33 67.06 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.366 -1.397 . . . . 1.47 110.398 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.831 HH21 ' H ' ' A' ' 5' ' ' GLU . 8.6 ptp180 -98.55 179.39 4.71 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.75 -1.441 . . . . 4.0999999999999996 111.365 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.0 mt -106.68 138.5 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.082 -2.192 . . . . 1.95 105.082 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 p -123.65 158.52 31.36 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.201 1.001 . . . . 1.1899999999999999 113.128 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.36 137.0 52.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.933 -1.506 . . . . 1.6200000000000001 106.933 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.67 145.82 24.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 119.109 -2.245 . . . . 3.52 109.927 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 8.2 p -128.22 86.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 123.014 1.388 . . . . 2.21 112.664 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -139.06 144.14 38.66 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.615 -1.994 . . . . 2.8500000000000001 105.615 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 179.65 53.06 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 117.795 -2.145 . . . . 2.4100000000000001 109.373 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' GLU . 31.8 ttp180 53.2 91.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.799 -1.186 . . . . 5.4100000000000001 107.799 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 84.3 tt0 45.1 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 120.99 0.424 . . . . 3.1299999999999999 111.004 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 155.61 62.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 122.031 -0.418 . . . . 2.3199999999999998 111.419 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.53 76.62 0.22 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 118.154 -1.974 . . . . 1.53 109.024 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 42' ' ' THR . 83.0 p -142.28 167.1 22.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.833 -0.804 . . . . 1.8999999999999999 110.017 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.9 152.56 22.34 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.806 1.289 . . . . 3.6400000000000001 111.375 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 1.6 p -141.69 160.41 40.24 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.56 -1.2 . . . . 0.78000000000000003 110.056 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.45 129.29 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 105.657 -1.979 . . . . 1.1200000000000001 105.657 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -92.9 134.14 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.695 -1.253 . . . . 1.3300000000000001 112.271 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -148.84 77.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.173 -1.411 . . . . 1.73 113.009 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 51.8 t0 169.08 148.75 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.361 -1.462 . . . . 1.5600000000000001 110.051 172.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.545 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.9 tt -124.44 133.24 69.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 103.923 -2.621 . . . . 2.5299999999999998 103.923 171.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.627 ' CG2' ' H ' ' A' ' 29' ' ' ASP . 21.5 mm -104.89 -122.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.271 -1.518 . . . . 1.47 110.423 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.627 ' H ' ' CG2' ' A' ' 28' ' ' ILE . 92.2 m-20 -61.69 -41.45 97.59 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 120.369 -0.532 . . . . 2.3999999999999999 109.738 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 86.9 m-20 170.01 -58.47 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.559 1.143 . . . . 2.5499999999999998 109.711 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -88.75 3.88 49.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.06 -1.025 . . . . 2.1299999999999999 113.174 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' CD1' ' OD1' ' A' ' 50' ' ' ASN . 90.1 m-85 -110.94 144.29 40.25 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.094 -1.076 . . . . 2.4900000000000002 108.094 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.06 161.11 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.235 -0.915 . . . . 1.2 108.883 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 tt -106.82 131.96 53.32 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 118.698 -1.201 . . . . 1.6799999999999999 108.974 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.47 150.99 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 119.378 -0.929 . . . . 1.1699999999999999 109.847 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -145.65 150.99 37.33 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.961 -1.096 . . . . 1.3100000000000001 111.023 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -160.18 164.61 34.45 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.854 -2.099 . . . . 0.83999999999999997 107.854 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' O ' ' OG1' ' A' ' 42' ' ' THR . 30.3 Cg_endo -69.11 101.46 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 CA-C-N 119.093 1.447 . . . . 1.1799999999999999 109.874 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.32 -38.76 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 3.9700000000000002 109.111 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.65 -36.55 67.18 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.681 -0.69 . . . . 2.27 110.755 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.9 mm -110.13 -40.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 119.065 -1.054 . . . . 2.71 111.1 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 38' ' ' PRO . 29.8 p -84.89 -31.29 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.225 -0.922 . . . . 1.75 112.292 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.98 -10.64 68.03 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.933 -1.267 . . . . 1.28 109.933 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.541 ' CB ' HH12 ' A' ' 47' ' ' ARG . 9.8 m -103.0 128.46 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.913 -1.345 . . . . 1.6799999999999999 107.972 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.711 ' H ' HH22 ' A' ' 47' ' ' ARG . 56.4 tttp -95.58 -81.59 0.4 Allowed 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.432 -1.307 . . . . 3.98 109.516 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 58.3 ttt85 -153.55 120.69 5.77 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.765 -1.198 . . . . 3.3500000000000001 107.765 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.711 HH22 ' H ' ' A' ' 45' ' ' LYS . 9.4 ptp85 -156.86 168.45 27.41 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.709 -1.244 . . . . 3.6699999999999999 109.999 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -110.76 140.42 45.18 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.429 -0.952 . . . . 3.4700000000000002 108.429 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.8 t -123.71 137.67 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 121.914 0.864 . . . . 2.2599999999999998 112.069 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' OD1' ' CD1' ' A' ' 32' ' ' PHE . 36.3 m-20 -78.69 156.15 29.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.589 -1.263 . . . . 2.6899999999999999 107.589 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.406 ' O ' ' CD2' ' A' ' 54' ' ' LEU . 28.5 mm -56.5 -27.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.495 -1.378 . . . . 2.1000000000000001 109.301 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -54.23 -34.17 60.04 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 120.411 -1.431 . . . . 1.8 108.586 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -115.72 93.29 4.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.198 -0.939 . . . . 2.27 108.958 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' OE1' ' A' ' 55' ' ' GLU . 1.7 pp -135.78 129.96 33.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.13 -1.606 . . . . 2.1400000000000001 110.898 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -130.18 86.81 53.0 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 104.995 -2.224 . . . . 2.2799999999999998 104.995 174.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.52 157.41 3.61 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.283 2.655 . . . . 0.81000000000000005 115.647 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.519 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 30.3 p -106.67 165.32 11.39 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.458 -0.942 . . . . 1.1799999999999999 108.458 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -84.67 15.46 3.82 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.944 0.878 . . . . 2.5699999999999998 108.849 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 45.8 mttp -88.53 141.91 28.14 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.19 -1.041 . . . . 3.3399999999999999 108.19 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -135.69 129.21 32.35 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 5.6799999999999997 110.545 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 7' ' ' GLY . 20.4 tt -125.18 148.03 29.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.925 -1.509 . . . . 5.2400000000000002 106.925 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -84.86 119.95 25.91 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.472 -1.392 . . . . 2.1400000000000001 108.281 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.14 158.32 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.567 0.699 . . . . 2.3300000000000001 111.848 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -86.76 0.35 54.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.732 . . . . 3.1800000000000002 110.699 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 mttt 54.89 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.966 -1.084 . . . . 3.8599999999999999 111.357 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.08 65.4 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.972 -1.109 . . . . 0.72999999999999998 111.396 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.04 149.56 5.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.582 -1.54 . . . . 1.3100000000000001 110.235 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -65.56 159.13 25.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 1.0600000000000001 108.751 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.474 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 91.7 m-20 -57.12 -40.47 77.15 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.055 -1.028 . . . . 2.02 111.898 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.6 mp0 -63.03 -39.35 94.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 117.18 -1.808 . . . . 2.2999999999999998 110.279 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.09 -38.15 82.02 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.685 -1.259 . . . . 1.96 109.357 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.24 -42.55 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.728 -0.608 . . . . 1.1599999999999999 111.421 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -60.66 -42.27 96.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.009 -1.477 . . . . 1.3100000000000001 109.763 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -60.98 -44.82 96.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 117.536 -1.665 . . . . 2.7400000000000002 108.853 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.427 ' CB ' ' HZ2' ' A' ' 75' ' ' LYS . 7.8 ttpm? -60.3 -36.26 77.47 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.514 -0.741 . . . . 3.1200000000000001 111.347 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.83 -40.06 66.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.578 -0.849 . . . . 1.98 108.783 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 80' ' ' ASN . 96.9 mt-10 -57.1 -33.68 67.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 117.843 -1.543 . . . . 1.7 107.732 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.42 -34.08 70.39 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.042 -1.466 . . . . 2.29 107.042 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -61.56 -26.2 67.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.509 -1.663 . . . . 1.78 106.509 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' GLU . 16.5 m120 71.63 43.85 0.55 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 122.684 1.231 . . . . 2.1099999999999999 112.715 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -71.13 -22.37 62.08 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.277 -1.329 . . . . 3.0 109.517 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.479 ' C ' ' HZ2' ' A' ' 86' ' ' LYS . 39.9 m -41.76 -37.8 1.31 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.785 -0.572 . . . . 3.1099999999999999 109.774 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -168.82 -11.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.536 -1.353 . . . . 3.5299999999999998 110.05 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -60.61 -44.05 96.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 123.559 1.647 . . . . 3.5299999999999998 106.673 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.1 -127.09 0.16 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.836 -1.984 . . . . 2.96 111.548 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 81' ' ' LEU . 23.5 mttt 52.72 21.76 2.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.74 -0.6 . . . . 2.04 112.155 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.489 1.514 0 C-N-CA 117.547 -1.661 . . . . 2.6899999999999999 108.325 178.011 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 18.0 pt-20 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.256 -1.016 . . . . 4.7199999999999998 108.256 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.8 m -62.6 155.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.938 -1.134 . . . . 2.8900000000000001 107.938 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 23.68 26.55 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.116 -1.516 . . . . 1.47 112.309 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 31.8 ptt-85 -123.62 170.59 10.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.173 -1.192 . . . . 4.0999999999999996 110.842 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.482 ' O ' ' CG2' ' A' ' 57' ' ' THR . 13.9 mm -101.21 141.01 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.649 0.738 . . . . 1.95 109.713 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.595 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.56 156.02 28.8 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.817 1.294 . . . . 1.1899999999999999 112.631 -176.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.446 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 42.0 t -120.65 138.32 51.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 106.536 -1.653 . . . . 1.6200000000000001 106.536 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' ALA . 24.0 tttt -82.71 134.82 35.13 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 117.732 -3.105 . . . . 3.52 110.227 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 8.9 p -109.84 82.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.037 -1.065 . . . . 2.21 108.893 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 38.3 mtpt -155.66 164.84 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.498 -1.667 . . . . 2.8500000000000001 106.498 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.5 165.82 43.0 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 116.908 -2.568 . . . . 2.4100000000000001 107.045 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.587 ' O ' ' O ' ' A' ' 15' ' ' GLY . 93.1 mtt-85 55.73 134.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.087 -1.079 . . . . 5.4100000000000001 108.087 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 48.75 20.4 0.33 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.615 -1.624 . . . . 3.1299999999999999 106.615 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 16' ' ' ARG . . . -56.97 -46.31 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.773 -1.103 . . . . 2.3199999999999998 108.838 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.36 103.65 3.07 Favored Glycine 0 C--N 1.284 -2.307 0 N-CA-C 110.458 -1.057 . . . . 1.53 110.458 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 42' ' ' THR . 36.2 t -147.49 135.5 21.31 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.278 -1.379 . . . . 1.8999999999999999 107.278 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.03 139.64 30.32 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.658 -1.217 . . . . 3.6400000000000001 107.838 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -130.1 140.71 50.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.12 -0.632 . . . . 0.78000000000000003 110.457 -177.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.32 135.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.566 -2.383 . . . . 1.1200000000000001 104.566 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.14 132.29 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 119.246 -0.982 . . . . 1.3300000000000001 110.826 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -151.43 72.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 118.409 -1.316 . . . . 1.73 111.693 175.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.8 t0 170.12 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.549 -1.345 . . . . 1.5600000000000001 110.476 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.6 mt -120.51 127.74 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 104.345 -2.465 . . . . 2.5299999999999998 104.345 171.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -100.37 -104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 121.309 1.868 . . . . 1.47 110.988 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 56.1 t0 -64.19 -42.37 96.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.026 -1.046 . . . . 2.3999999999999999 109.249 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.652 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 49.9 p30 164.0 -46.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.812 0.845 . . . . 2.5499999999999998 109.291 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.652 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 79.7 m-20 -96.09 4.62 52.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.974 -1.079 . . . . 2.1299999999999999 111.56 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -112.17 141.0 46.41 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.352 -0.842 . . . . 2.4900000000000002 109.994 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.98 161.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.858 -0.526 . . . . 1.2 109.962 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -100.9 132.45 46.29 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.69 -0.855 . . . . 1.6799999999999999 108.69 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.12 151.46 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 C-N-CA 119.234 -0.986 . . . . 1.1699999999999999 110.564 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -146.01 152.59 39.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 1.3100000000000001 111.104 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.0 154.38 25.14 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.692 -1.763 . . . . 0.83999999999999997 108.692 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.5 ' O ' ' OG1' ' A' ' 42' ' ' THR . 6.2 Cg_exo -57.64 109.25 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 CA-C-N 119.978 1.889 . . . . 1.1799999999999999 110.081 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.569 ' CE ' ' HZ1' ' A' ' 45' ' ' LYS . 34.9 tttp -56.64 -36.23 69.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.007 -1.058 . . . . 3.9700000000000002 109.472 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.72 -38.58 69.94 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.192 -1.003 . . . . 2.27 109.626 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.32 -38.66 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.206 -0.998 . . . . 2.71 111.533 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' ' OG ' ' A' ' 20' ' ' SER . 80.6 p -81.19 -33.95 32.63 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.93 -1.106 . . . . 1.75 110.112 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.65 66.33 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.31 -0.716 . . . . 1.28 111.31 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 37' ' ' GLY . 15.2 m -103.38 133.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.48 -1.6 . . . . 1.6799999999999999 109.832 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.569 ' HZ1' ' CE ' ' A' ' 39' ' ' LYS . 63.5 mttp -86.11 -78.41 0.28 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.787 -1.821 . . . . 3.98 106.98 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -149.79 124.7 9.92 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.749 -2.315 . . . . 3.3500000000000001 104.749 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -155.55 166.38 33.71 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.827 -1.796 . . . . 3.6699999999999999 109.912 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -109.75 141.39 42.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.641 -0.824 . . . . 3.4700000000000002 109.193 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.97 142.8 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 2.2599999999999998 110.366 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.427 ' ND2' ' CD1' ' A' ' 52' ' ' LEU . 42.6 p-10 -86.45 167.33 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.769 . . . . 2.6899999999999999 110.982 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.39 -26.59 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.689 -0.632 . . . . 2.1000000000000001 111.061 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.427 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 66.5 mt -55.06 -33.0 62.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.967 -1.083 . . . . 1.8 110.371 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -121.76 90.43 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.383 -1.34 . . . . 2.27 107.383 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.68 131.89 56.16 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.825 -0.547 . . . . 2.1400000000000001 110.332 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 2.6 tt0 -131.33 89.6 40.63 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 104.707 -2.331 . . . . 2.2799999999999998 104.707 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.88 149.93 7.15 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.495 1.463 . . . . 0.81000000000000005 114.293 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 39.8 p -110.38 165.82 11.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.718 -1.215 . . . . 1.1799999999999999 107.718 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.15 14.33 3.52 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.351 -0.843 . . . . 2.5699999999999998 110.124 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -91.65 125.55 36.42 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.49 -0.756 . . . . 3.3399999999999999 109.743 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -134.88 122.31 21.81 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.444 -0.785 . . . . 5.6799999999999997 110.465 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.71 152.96 37.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.97 -1.122 . . . . 5.2400000000000002 107.97 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 52.6 p30 -83.71 133.09 34.82 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.856 1.313 . . . . 2.1400000000000001 110.406 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.24 158.71 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 115.031 -0.986 . . . . 2.3300000000000001 112.006 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 59.7 tp60 -64.38 -48.95 73.51 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.546 -1.662 . . . . 3.1800000000000002 109.378 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 15.2 ttmm 100.66 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.323 0.965 . . . . 3.8599999999999999 110.781 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.97 63.75 Favored Glycine 0 N--CA 1.506 3.334 0 O-C-N 120.556 -1.34 . . . . 0.72999999999999998 111.784 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.88 152.87 11.94 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.991 -1.299 . . . . 1.3100000000000001 112.832 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.7 p -63.14 167.59 4.89 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 108.284 -1.006 . . . . 1.0600000000000001 108.284 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.61 -45.65 88.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.916 -1.74 . . . . 2.02 112.749 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.32 -40.11 92.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 116.6 -2.04 . . . . 2.2999999999999998 107.844 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.8 -36.07 83.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.844 -1.169 . . . . 1.96 107.844 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 73.2 t -64.79 -42.99 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.579 -0.849 . . . . 1.1599999999999999 109.499 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.88 -41.65 92.02 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.362 -1.335 . . . . 1.3100000000000001 107.619 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.22 -43.34 92.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.844 -1.169 . . . . 2.7400000000000002 107.844 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.07 -34.18 75.79 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.596 -0.69 . . . . 3.1200000000000001 110.754 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.75 -41.19 73.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.475 -1.391 . . . . 1.98 108.473 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -61.6 -33.94 74.78 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 119.297 -0.961 . . . . 1.7 109.063 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -38.48 81.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.212 -2.144 . . . . 2.29 105.212 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.6 m -68.37 -29.4 68.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.338 -1.356 . . . . 1.78 107.338 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 29.1 m120 60.56 38.12 19.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.351 -2.092 . . . . 2.1099999999999999 105.351 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.95 -11.81 24.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.399 -0.819 . . . . 3.0 111.413 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 m -56.91 -39.72 74.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.306 -1.496 . . . . 3.1099999999999999 110.098 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 84' ' ' TYR . 85.5 tt0 -156.09 -11.31 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.403 -1.319 . . . . 3.5299999999999998 112.297 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 83' ' ' GLU . 70.7 t80 -58.7 -47.25 85.2 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 114.411 -2.915 . . . . 3.5299999999999998 105.609 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.418 ' HG2' ' H ' ' A' ' 87' ' ' GLU . 48.7 ttm -90.73 -110.91 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.336 0.589 . . . . 2.96 112.034 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HZ2' ' CB ' ' A' ' 83' ' ' GLU . 10.4 mtmt 60.91 37.38 18.41 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.726 -1.213 . . . . 2.04 107.726 -175.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 85' ' ' MET . 97.5 mt-10 . . . . . 0 N--CA 1.495 1.806 0 C-N-CA 119.83 -0.748 . . . . 2.6899999999999999 111.286 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HB2' ' HE ' ' A' ' 8' ' ' ARG . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 107.679 -1.23 . . . . 4.7199999999999998 107.679 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.56 154.85 35.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.383 -2.08 . . . . 2.8900000000000001 105.383 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . 90.26 8.81 65.99 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.517 -2.233 . . . . 1.47 107.517 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 79.7 mtt180 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.977 -0.612 . . . . 4.0999999999999996 109.503 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' CG2' ' A' ' 57' ' ' THR . 24.9 mm -108.03 135.31 47.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.311 -2.107 . . . . 1.95 105.311 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.536 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -127.92 155.89 43.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.07 -1.019 . . . . 1.1899999999999999 113.107 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.56 138.02 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 115.701 -0.681 . . . . 1.6200000000000001 109.827 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -85.71 130.81 34.46 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 118.74 -2.475 . . . . 3.52 109.817 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -121.19 123.03 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 117.992 -1.483 . . . . 2.21 112.622 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.679 ' HZ2' ' CG ' ' A' ' 53' ' ' HIS . 49.8 mttm -146.29 153.52 40.65 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.475 -1.306 . . . . 2.8500000000000001 107.475 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 16' ' ' ARG . . . -86.75 102.84 2.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.226 -2.349 . . . . 2.4100000000000001 107.226 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 38.5 ttm180 118.44 124.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.936 -1.505 . . . . 5.4100000000000001 106.936 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 18' ' ' ALA . 77.6 mm-40 73.06 -86.26 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 107.528 -1.286 . . . . 3.1299999999999999 107.528 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 8.19 113.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.07 0.938 . . . . 2.3199999999999998 111.962 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.85 80.21 0.05 OUTLIER Glycine 0 C--N 1.292 -1.914 0 N-CA-C 103.66 -3.776 . . . . 1.53 103.66 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 p -162.67 150.55 13.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 117.849 -1.54 . . . . 1.8999999999999999 110.839 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -114.59 147.84 38.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.362 -0.607 . . . . 3.6400000000000001 109.362 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 3.8 p -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.551 -0.718 . . . . 0.78000000000000003 110.387 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -103.93 136.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 105.874 -1.899 . . . . 1.1200000000000001 105.874 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -94.43 129.25 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 123.642 1.687 . . . . 1.3300000000000001 111.847 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.597 ' CG1' ' H ' ' A' ' 26' ' ' ASP . 2.6 t -105.18 -151.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 112.61 -2.086 . . . . 1.73 109.332 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.597 ' H ' ' CG1' ' A' ' 25' ' ' VAL 0.272 36.3 t0 -67.4 163.49 20.72 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.733 -0.667 . . . . 1.5600000000000001 110.625 -172.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.3 tt -113.82 125.42 71.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 122.429 1.109 . . . . 2.5299999999999998 110.103 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -74.26 -37.45 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.934 0.873 . . . . 1.47 110.671 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -159.62 167.78 27.64 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.637 -0.875 . . . . 2.3999999999999999 108.637 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.14 -37.99 72.86 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.013 -1.075 . . . . 2.5499999999999998 108.615 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -80.45 -31.43 37.46 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.099 -1.0 . . . . 2.1299999999999999 112.464 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -113.27 143.25 44.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.514 -0.741 . . . . 2.4900000000000002 112.71 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.42 156.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.562 -0.532 . . . . 1.2 109.562 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tt -100.04 125.54 46.12 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 105.743 -1.947 . . . . 1.6799999999999999 105.743 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.27 155.47 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 120.812 -1.18 . . . . 1.1699999999999999 110.965 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -142.47 155.09 45.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.261 -0.899 . . . . 1.3100000000000001 110.966 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.89 163.7 29.43 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.013 -2.035 . . . . 0.83999999999999997 108.013 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.13 111.5 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.532 1.666 . . . . 1.1799999999999999 110.05 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -58.66 -39.35 80.37 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.252 -0.905 . . . . 3.9700000000000002 110.843 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.36 -39.78 94.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.415 0.895 . . . . 2.27 113.415 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 mm -96.22 -76.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.037 . . . . 2.71 112.309 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -62.4 -34.87 77.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.667 -0.645 . . . . 1.75 110.311 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.95 -4.41 57.53 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.874 -0.89 . . . . 1.28 110.874 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 m -89.07 126.51 42.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.187 -2.153 . . . . 1.6799999999999999 105.187 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -94.04 -78.86 0.43 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.676 -1.265 . . . . 3.98 110.241 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.637 HH12 ' CG2' ' A' ' 72' ' ' VAL . 56.3 ttt85 -150.8 124.25 8.97 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.658 -1.979 . . . . 3.3500000000000001 105.658 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.62 163.18 40.61 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 117.438 -1.705 . . . . 3.6699999999999999 110.846 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -98.29 138.97 34.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.223 -1.029 . . . . 3.4700000000000002 108.223 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.92 140.14 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-N 119.915 1.234 . . . . 2.2599999999999998 109.817 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.543 ' ND2' ' CD1' ' A' ' 52' ' ' LEU . 44.0 p-10 -90.55 168.02 12.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.812 -0.555 . . . . 2.6899999999999999 110.57 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.53 -27.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.246 -0.909 . . . . 2.1000000000000001 110.549 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.543 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 73.0 mt -52.18 -33.2 39.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.8 109.666 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.679 ' CG ' ' HZ2' ' A' ' 14' ' ' LYS . 77.6 m80 -134.36 88.29 2.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.206 -1.405 . . . . 2.27 107.206 174.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.1 tp -124.49 132.24 53.48 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.648 -0.501 . . . . 2.1400000000000001 109.648 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.49 89.0 32.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.481 -2.044 . . . . 2.2799999999999998 105.481 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.59 156.47 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.014 1.809 . . . . 0.81000000000000005 112.701 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 49.1 p -111.71 168.19 9.76 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.881 0.848 . . . . 1.1799999999999999 108.748 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -81.95 18.44 1.32 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.794 0.807 . . . . 2.5699999999999998 109.392 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 49.2 mttt -91.19 140.33 29.9 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 121.698 0.761 . . . . 3.3399999999999999 112.386 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -136.87 122.62 19.9 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.942 -0.703 . . . . 5.6799999999999997 109.472 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 71.7 mt -120.35 145.38 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.576 -0.898 . . . . 5.2400000000000002 108.576 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -85.39 126.37 33.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.306 -1.497 . . . . 2.1400000000000001 110.698 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.601 ' H ' ' CD1' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -127.45 164.0 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 115.02 -0.991 . . . . 2.3300000000000001 111.137 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 65' ' ' LYS . 95.6 mm-40 -84.27 1.49 44.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.763 -1.21 . . . . 3.1800000000000002 109.679 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 64' ' ' GLN . 99.4 mttt 53.03 124.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.566 0.698 . . . . 3.8599999999999999 112.07 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.04 70.63 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.574 -1.298 . . . . 0.72999999999999998 110.183 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.08 146.64 14.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.015 -1.285 . . . . 1.3100000000000001 111.824 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 72' ' ' VAL . 56.0 p -67.16 164.4 18.16 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.878 -1.156 . . . . 1.0600000000000001 107.878 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.28 -47.34 86.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.355 -1.465 . . . . 2.02 110.601 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -39.23 90.49 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.629 -1.628 . . . . 2.2999999999999998 106.876 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.72 -38.44 91.0 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.369 -0.832 . . . . 1.96 109.1 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.637 ' CG2' HH12 ' A' ' 46' ' ' ARG . 73.6 t -64.7 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.298 1.047 . . . . 1.1599999999999999 109.697 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.8 -42.23 98.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.32 -1.352 . . . . 1.3100000000000001 110.006 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -62.63 -42.89 99.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.998 -1.064 . . . . 2.7400000000000002 112.821 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -67.9 -27.53 66.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.902 -1.124 . . . . 3.1200000000000001 109.593 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 53.9 tp -55.32 -39.33 69.83 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.326 -0.95 . . . . 1.98 108.75 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -29.37 66.83 Favored 'General case' 0 C--N 1.282 -2.328 0 O-C-N 121.043 -1.036 . . . . 1.7 109.349 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.51 -32.64 51.26 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.101 -0.999 . . . . 2.29 110.046 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.1 m -77.82 3.73 13.58 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 119.995 -1.691 . . . . 1.78 111.267 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 64.92 44.74 3.42 Favored 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 122.27 1.034 . . . . 2.1099999999999999 112.485 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' CD1' ' SD ' ' A' ' 85' ' ' MET . 2.1 mm? -66.3 -24.95 66.63 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.484 -0.78 . . . . 3.0 110.398 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 m -42.51 -36.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.974 -1.079 . . . . 3.1099999999999999 110.903 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -161.67 -18.83 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 119.574 -1.954 . . . . 3.5299999999999998 111.029 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -60.49 -43.62 96.8 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 123.518 1.628 . . . . 3.5299999999999998 108.049 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 81' ' ' LEU . 62.8 mtt -95.58 -123.95 0.11 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 112.91 -1.95 . . . . 2.96 111.972 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 81' ' ' LEU . 14.8 mttm 56.45 29.53 15.46 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.867 0.691 . . . . 2.04 112.867 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 120.467 -1.396 . . . . 2.6899999999999999 110.865 179.415 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 6' ' ' VAL . 95.3 mt-10 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 109.916 -0.401 . . . . 4.7199999999999998 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.501 ' CB ' ' O ' ' A' ' 5' ' ' GLU . 3.1 t 94.95 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 CA-C-O 121.15 0.5 . . . . 2.8900000000000001 111.162 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 83.26 27.83 38.76 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.172 -0.955 . . . . 1.47 110.991 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -149.01 -177.98 6.11 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.935 -1.333 . . . . 4.0999999999999996 109.572 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 9' ' ' ILE . 97.6 mt -99.78 140.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 124.031 1.872 . . . . 1.95 113.883 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.4 p -121.4 156.34 32.89 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.049 -2.341 . . . . 1.1899999999999999 109.119 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 42.5 t -124.77 136.29 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 108.668 -0.864 . . . . 1.6200000000000001 108.668 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.565 ' CE ' HH21 ' A' ' 47' ' ' ARG . 36.2 mttp -91.17 125.49 35.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 118.987 -2.321 . . . . 3.52 110.851 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.2 124.29 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.635 -1.226 . . . . 2.21 109.583 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.423 ' H ' ' HB1' ' A' ' 18' ' ' ALA . 24.0 mttm -146.66 156.14 42.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.532 -1.285 . . . . 2.8500000000000001 107.532 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 16' ' ' ARG . . . -85.43 176.62 49.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 103.934 -3.666 . . . . 2.4100000000000001 103.934 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 15' ' ' GLY . 37.0 mtm180 27.32 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.57 0 CA-C-N 120.049 1.924 . . . . 5.4100000000000001 109.343 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 41.3 tp10 93.17 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 106.621 -1.622 . . . . 3.1299999999999999 106.621 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 156.67 104.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.97 -0.456 . . . . 2.3199999999999998 110.479 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.79 76.68 0.05 OUTLIER Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.634 -1.746 . . . . 1.53 110.645 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -155.64 135.8 13.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.394 -1.65 . . . . 1.8999999999999999 109.928 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.35 145.83 26.3 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.409 -0.96 . . . . 3.6400000000000001 108.409 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.1 p -134.61 162.58 31.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.346 0.593 . . . . 0.78000000000000003 110.447 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.18 135.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.349 -2.093 . . . . 1.1200000000000001 105.349 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.31 132.17 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.694 -1.254 . . . . 1.3300000000000001 110.37 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -143.78 70.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 C-N-CA 118.991 -1.084 . . . . 1.73 111.355 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 20.2 t70 165.83 148.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.505 -1.372 . . . . 1.5600000000000001 109.582 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.98 115.45 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 103.815 -2.661 . . . . 2.5299999999999998 103.815 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.3 mt -97.03 -81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 1.47 111.029 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -108.96 171.83 7.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.735 -1.12 . . . . 2.3999999999999999 108.982 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' C ' HD21 ' A' ' 31' ' ' ASN . 92.3 m-20 -55.62 -40.19 71.78 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 118.497 -1.281 . . . . 2.5499999999999998 109.51 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 31' ' ' ASN . 2.7 m120 -102.51 -0.96 31.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.635 -1.291 . . . . 2.1299999999999999 113.82 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.04 141.14 48.99 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 120.935 1.698 . . . . 2.4900000000000002 114.087 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.25 161.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD22 ' HE ' ' A' ' 46' ' ' ARG . 8.4 tt -99.46 136.04 39.98 Favored 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 108.215 -1.032 . . . . 1.6799999999999999 108.215 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.09 150.43 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.258 -0.977 . . . . 1.1699999999999999 111.944 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -143.07 155.05 44.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.472 0.654 . . . . 1.3100000000000001 111.804 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.77 167.08 32.58 Favored Glycine 0 N--CA 1.506 3.361 0 N-CA-C 108.047 -2.021 . . . . 0.83999999999999997 108.047 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.62 124.48 15.53 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 CA-C-N 119.037 1.418 . . . . 1.1799999999999999 110.357 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.451 ' HZ3' ' CD ' ' A' ' 45' ' ' LYS . 23.5 mttt -60.51 -43.23 97.31 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.225 1.012 . . . . 3.9700000000000002 110.869 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.87 -40.67 91.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.526 0.936 . . . . 2.27 113.526 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CD1' ' NZ ' ' A' ' 86' ' ' LYS . 81.6 mt -96.09 -76.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.325 -0.95 . . . . 2.71 113.145 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 m -60.15 -36.6 77.89 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.354 -1.466 . . . . 1.75 109.035 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -6.65 63.46 Favored Glycine 0 C--N 1.293 -1.826 0 N-CA-C 110.249 -1.14 . . . . 1.28 110.249 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 m -91.64 131.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 119.267 1.533 . . . . 1.6799999999999999 107.684 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CD ' ' HZ3' ' A' ' 39' ' ' LYS . 35.7 ttmt -89.16 -78.25 0.36 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.76 -1.176 . . . . 3.98 109.51 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HE ' HD22 ' A' ' 34' ' ' LEU . 55.9 ttt180 -151.92 124.02 8.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 105.009 -2.219 . . . . 3.3500000000000001 105.009 177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.565 HH21 ' CE ' ' A' ' 12' ' ' LYS . 38.1 ptt180 -158.8 166.96 30.7 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 119.385 -2.072 . . . . 3.6699999999999999 110.191 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -96.23 143.38 27.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.112 -0.992 . . . . 3.4700000000000002 111.435 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.93 143.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.595 -0.891 . . . . 2.2599999999999998 108.595 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' ND2' ' CD1' ' A' ' 52' ' ' LEU . 41.7 p-10 -91.85 164.14 13.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.145 -0.972 . . . . 2.6899999999999999 111.768 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.38 -24.75 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 115.814 -0.63 . . . . 2.1000000000000001 111.341 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.446 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 60.9 mt -54.79 -31.4 58.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.954 -1.091 . . . . 1.8 109.557 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -118.15 92.33 3.8 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.09 -1.819 . . . . 2.27 106.09 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.1 tt -113.93 129.53 56.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.138 0.494 . . . . 2.1400000000000001 109.722 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -140.84 93.87 8.25 Favored Pre-proline 0 N--CA 1.502 2.162 0 N-CA-C 107.743 -1.206 . . . . 2.2799999999999998 107.743 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.23 147.46 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.692 1.595 . . . . 0.81000000000000005 114.307 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 p -120.26 161.86 20.39 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.823 -1.177 . . . . 1.1799999999999999 107.823 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 54.6 p30 -78.66 135.61 37.25 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.334 -1.728 . . . . 2.5699999999999998 106.334 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.699 ' HG2' ' H ' ' A' ' 60' ' ' LYS . 40.3 tttm -171.61 -174.57 1.41 Allowed 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 117.298 -1.761 . . . . 3.3399999999999999 109.504 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.699 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 15.7 tttp -82.78 153.1 25.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.767 -1.197 . . . . 5.6799999999999997 107.767 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.4 pt -138.0 82.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 114.609 1.337 . . . . 5.2400000000000002 114.609 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -146.77 91.75 2.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.96 -1.087 . . . . 2.1400000000000001 112.13 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.65 162.64 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.728 0.775 . . . . 2.3300000000000001 109.364 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -72.32 -121.02 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.26 -2.126 . . . . 3.1800000000000002 105.26 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -173.78 131.45 0.43 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.84 -1.163 . . . . 3.8599999999999999 108.834 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.52 17.8 70.12 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.555 -1.783 . . . . 0.72999999999999998 110.178 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.16 144.94 22.54 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.685 -1.48 . . . . 1.3100000000000001 111.715 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 72' ' ' VAL . 52.5 p -68.45 169.22 11.2 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 107.175 -1.417 . . . . 1.0600000000000001 107.175 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 91.6 m-20 -59.15 -47.69 84.37 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.181 -2.199 . . . . 2.02 111.18 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.45 -41.79 98.65 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 116.936 -1.906 . . . . 2.2999999999999998 108.332 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.91 -35.93 82.75 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.266 -0.974 . . . . 1.96 108.403 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' SER . 78.4 t -62.17 -40.12 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.73 0.776 . . . . 1.1599999999999999 109.041 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 99.4 mttt -59.53 -40.66 87.93 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.701 -1.2 . . . . 1.3100000000000001 108.775 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -60.31 -43.13 96.64 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 117.491 -1.684 . . . . 2.7400000000000002 109.222 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.52 78.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.082 -1.011 . . . . 3.1200000000000001 109.956 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.18 -42.98 87.23 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.956 . . . . 1.98 110.245 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.19 -31.15 68.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.183 -0.948 . . . . 1.7 108.715 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -52.57 -32.37 40.75 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.281 -1.748 . . . . 2.29 106.281 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.3 m -62.9 -18.41 62.98 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.783 -0.573 . . . . 1.78 111.668 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 70.4 50.35 0.4 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-O 123.257 1.503 . . . . 2.1099999999999999 110.505 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.4 -28.22 69.1 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.544 -1.662 . . . . 3.0 112.362 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.354 -1.466 . . . . 3.1099999999999999 112.988 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.39 -18.2 0.11 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 119.411 -2.055 . . . . 3.5299999999999998 110.343 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.99 -38.58 86.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.699 1.238 . . . . 3.5299999999999998 107.837 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.06 -125.95 0.22 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.477 -1.238 . . . . 2.96 111.004 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' NZ ' ' CD1' ' A' ' 41' ' ' ILE . 33.1 mttm 54.27 26.42 6.8 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.12 1.368 . . . . 2.04 114.369 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 . . . . . 0 N--CA 1.512 2.634 0 O-C-N 119.394 -2.066 . . . . 2.6899999999999999 110.502 179.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 8' ' ' ARG . 94.6 mt-10 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 4.7199999999999998 108.565 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.7 t -100.39 142.69 15.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.549 -1.278 . . . . 2.8900000000000001 107.549 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.4 62.64 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.492 -1.38 . . . . 1.47 110.329 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 5' ' ' GLU . 95.1 mtt180 -89.92 177.2 6.54 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.33 -1.1 . . . . 4.0999999999999996 110.786 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.9 137.34 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 106.569 -1.641 . . . . 1.95 106.569 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.8 p -127.79 158.62 37.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.515 -0.741 . . . . 1.1899999999999999 110.441 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.08 132.22 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.467 -1.679 . . . . 1.6200000000000001 106.467 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -93.4 119.59 32.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.861 -1.774 . . . . 3.52 112.84 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.08 128.99 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.493 -1.299 . . . . 2.21 107.493 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.463 ' H ' ' HB1' ' A' ' 18' ' ' ALA . 19.0 pttp -143.85 175.82 9.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.833 -0.803 . . . . 2.8500000000000001 108.833 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -81.14 143.19 23.79 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.383 -1.865 . . . . 2.4100000000000001 108.77 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 33.6 ttm180 49.6 87.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.19 -1.411 . . . . 5.4100000000000001 107.19 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 48.9 tp10 112.62 152.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 105.92 -1.882 . . . . 3.1299999999999999 105.92 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 155.95 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 112.662 0.616 . . . . 2.3199999999999998 112.662 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.83 84.21 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.81 -1.662 . . . . 1.53 110.591 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -161.42 147.62 14.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.276 . . . . 1.8999999999999999 108.798 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.592 ' NZ ' ' CE ' ' A' ' 85' ' ' MET . 97.1 mttt -96.63 147.77 23.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.161 -0.962 . . . . 3.6400000000000001 108.707 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 4.9 p -143.93 162.81 35.18 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.228 -0.92 . . . . 0.78000000000000003 110.396 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.5 t -114.7 135.03 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 105.911 -1.885 . . . . 1.1200000000000001 105.911 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 66.5 mt -91.29 134.83 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.693 -1.203 . . . . 1.3300000000000001 110.066 -175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 24' ' ' ILE . 13.1 m -156.78 76.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.464 1.653 . . . . 1.73 115.464 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 54.2 t0 171.63 150.89 0.05 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.094 -1.004 . . . . 1.5600000000000001 109.249 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 26.4 mm -119.22 129.67 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.494 -2.039 . . . . 2.5299999999999998 105.494 171.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.622 ' CG2' ' H ' ' A' ' 29' ' ' ASP . 88.6 mt -121.55 -117.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.816 -1.178 . . . . 1.47 109.552 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.622 ' H ' ' CG2' ' A' ' 28' ' ' ILE . 52.4 t0 -58.22 -35.23 71.37 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.082 -1.451 . . . . 2.3999999999999999 107.082 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 91.9 m-20 121.98 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.119 -1.808 . . . . 2.5499999999999998 106.119 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.59 4.7 53.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.437 -1.32 . . . . 2.1299999999999999 107.437 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.69 148.48 52.48 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.541 -0.754 . . . . 2.4900000000000002 109.736 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.29 161.11 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 108.12 -1.067 . . . . 1.2 108.12 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.66 129.71 52.78 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 117.844 -1.542 . . . . 1.6799999999999999 107.807 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 m -125.7 154.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 118.815 -1.154 . . . . 1.1699999999999999 110.708 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 10.5 t -140.61 156.88 46.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 1.3100000000000001 112.109 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.47 163.54 31.65 Favored Glycine 0 N--CA 1.507 3.371 0 N-CA-C 107.523 -2.231 . . . . 0.83999999999999997 107.523 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.24 122.82 12.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 CA-C-N 119.506 1.653 . . . . 1.1799999999999999 110.78 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.6 -40.43 87.46 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.817 -0.552 . . . . 3.9700000000000002 111.715 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.28 -43.11 95.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.15 1.167 . . . . 2.27 114.15 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mm -96.5 -71.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.32 -1.487 . . . . 2.71 114.016 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.462 ' CG2' ' H ' ' A' ' 21' ' ' LYS . 31.5 m -56.34 -37.06 69.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.723 -0.671 . . . . 1.75 111.002 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.83 7.52 47.45 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.31 -1.424 . . . . 1.28 110.03 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.08 162.62 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 105.527 -2.027 . . . . 1.6799999999999999 105.527 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.528 ' O ' ' OG1' ' A' ' 36' ' ' THR . 54.1 tttp -139.16 -69.92 0.42 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.989 -1.115 . . . . 3.98 107.989 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -146.16 124.63 12.39 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.544 -1.28 . . . . 3.3500000000000001 107.544 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -155.17 168.06 28.29 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.876 -1.14 . . . . 3.6699999999999999 109.543 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -116.62 143.6 45.42 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.662 -1.236 . . . . 3.4700000000000002 107.662 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.48 140.12 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.379 1.085 . . . . 2.2599999999999998 111.365 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 44.6 t-20 -80.79 163.36 23.53 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.967 -1.015 . . . . 2.6899999999999999 110.321 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 24.1 mm -59.2 -27.33 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 115.917 -0.583 . . . . 2.1000000000000001 110.696 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.0 mt -54.55 -37.9 65.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.934 -1.104 . . . . 1.8 111.369 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.99 89.32 3.0 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.35 -1.34 . . . . 2.27 109.953 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.2 tp -118.83 128.82 54.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.928 -0.768 . . . . 2.1400000000000001 108.928 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -135.26 85.88 31.99 Favored Pre-proline 0 N--CA 1.508 2.443 0 O-C-N 120.542 -1.348 . . . . 2.2799999999999998 108.668 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -96.13 151.69 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.89 2.393 . . . . 0.81000000000000005 115.512 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.501 ' OG1' ' NZ ' ' A' ' 59' ' ' LYS . 19.4 p -112.19 162.0 15.94 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 106.297 -1.742 . . . . 1.1799999999999999 106.297 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.19 98.47 5.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.515 -1.99 . . . . 2.5699999999999998 110.657 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' NZ ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -114.06 -164.63 0.94 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.416 1.103 . . . . 3.3399999999999999 111.137 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -84.58 163.36 19.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.212 -1.774 . . . . 5.6799999999999997 106.212 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.19 123.47 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.688 -1.258 . . . . 5.2400000000000002 109.61 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.464 ' OD2' ' OE1' ' A' ' 78' ' ' GLU . 60.7 t0 -161.63 107.09 1.31 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.73 -0.606 . . . . 2.1400000000000001 110.267 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 135.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.333 -1.728 . . . . 2.3300000000000001 106.333 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.633 ' H ' ' NZ ' ' A' ' 75' ' ' LYS . 60.3 tp60 -64.78 -50.61 66.11 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 115.128 -2.629 . . . . 3.1800000000000002 108.657 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 50.3 tttt 131.2 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 107.268 -1.382 . . . . 3.8599999999999999 107.268 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.18 22.3 59.3 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.712 -1.355 . . . . 0.72999999999999998 109.712 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.66 143.64 24.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.236 . . . . 1.3100000000000001 112.436 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.6 p -71.08 163.91 26.65 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 109.059 -0.719 . . . . 1.0600000000000001 109.059 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -54.97 -43.14 73.21 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.304 -1.498 . . . . 2.02 109.908 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -38.47 87.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 117.401 -1.72 . . . . 2.2999999999999998 108.971 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.24 -37.38 83.43 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.557 -1.257 . . . . 1.96 108.581 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.7 -43.73 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 120.121 -0.632 . . . . 1.1599999999999999 111.371 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.51 -42.05 91.33 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.103 -1.439 . . . . 1.3100000000000001 108.322 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.99 -43.4 91.47 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 117.6 -1.64 . . . . 2.7400000000000002 107.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.633 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 56.5 mtmt -60.26 -32.02 70.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 3.1200000000000001 112.12 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.69 ' O ' ' OG ' ' A' ' 79' ' ' SER . 32.0 tp -52.8 -40.91 63.67 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.043 -1.661 . . . . 1.98 107.441 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -58.57 -34.46 71.08 Favored 'General case' 0 C--N 1.272 -2.776 0 C-N-CA 116.888 -1.925 . . . . 1.7 108.381 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.464 ' OE1' ' OD2' ' A' ' 62' ' ' ASP . 97.6 mt-10 -62.33 -33.47 74.76 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.888 -1.523 . . . . 2.29 106.888 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.69 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 83.7 p -65.34 -26.07 67.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.859 -2.274 . . . . 1.78 104.859 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.0 m120 63.12 42.15 7.47 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.743 0.783 . . . . 2.1099999999999999 109.946 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 34.2 mt -92.11 3.73 54.67 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.685 -0.806 . . . . 3.0 111.35 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 m -46.61 -33.74 4.43 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.912 -1.118 . . . . 3.1099999999999999 110.052 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -164.84 0.26 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.051 -1.031 . . . . 3.5299999999999998 108.648 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -61.42 -43.86 98.14 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 103.176 -2.898 . . . . 3.5299999999999998 103.176 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.592 ' CE ' ' NZ ' ' A' ' 21' ' ' LYS . 85.3 mmm -121.3 -120.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.281 -1.327 . . . . 2.96 110.388 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 36.4 mtpt 64.97 39.45 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.152 -1.385 . . . . 2.04 109.878 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.488 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 19.0 pt-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.471 0.653 . . . . 2.6899999999999999 109.687 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 58.3 mp0 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.931 -0.766 . . . . 4.7199999999999998 108.931 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 169.46 123.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.4 -0.963 . . . . 2.8900000000000001 108.4 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 71.28 24.53 76.86 Favored Glycine 0 N--CA 1.502 3.1 0 C-N-CA 119.499 -1.334 . . . . 1.47 110.016 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 57' ' ' THR . 80.9 mtp180 -117.97 164.61 14.82 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.83 -0.806 . . . . 4.0999999999999996 110.294 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.63 137.94 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 122.358 1.075 . . . . 1.95 109.448 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.85 156.69 27.96 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.994 -1.003 . . . . 1.1899999999999999 111.554 -175.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 t -122.09 134.99 63.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 N-CA-C 105.979 -1.86 . . . . 1.6200000000000001 105.979 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.43 130.05 38.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 119.202 -2.186 . . . . 3.52 111.443 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.89 120.46 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 118.197 -1.401 . . . . 2.21 110.409 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -146.59 152.71 39.36 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.664 -1.606 . . . . 2.8500000000000001 106.664 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -85.29 174.1 48.73 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 105.333 -3.107 . . . . 2.4100000000000001 105.333 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 15' ' ' GLY . 73.0 mtm180 34.68 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 CA-C-N 118.643 1.221 . . . . 5.4100000000000001 107.756 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 82.6 tt0 89.71 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.364 -1.347 . . . . 3.1299999999999999 107.364 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 153.59 106.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.78 0.324 . . . . 2.3199999999999998 110.798 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.89 80.88 0.05 OUTLIER Glycine 0 C--N 1.297 -1.62 0 C-N-CA 118.906 -1.616 . . . . 1.53 109.835 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -156.71 141.76 17.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.399 -1.648 . . . . 1.8999999999999999 110.346 176.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -93.62 148.38 22.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.383 -1.448 . . . . 3.6400000000000001 107.725 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -137.02 142.95 42.5 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.249 -0.907 . . . . 0.78000000000000003 112.634 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.82 137.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.228 -1.767 . . . . 1.1200000000000001 106.228 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.7 mt -100.43 131.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.465 -0.894 . . . . 1.3300000000000001 111.706 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -143.84 72.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.145 -1.022 . . . . 1.73 109.966 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 56.9 t0 168.12 144.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.788 -1.195 . . . . 1.5600000000000001 109.716 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.484 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.2 tt -124.0 124.42 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.331 -2.47 . . . . 2.5299999999999998 104.331 170.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -99.56 -84.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.878 -1.139 . . . . 1.47 112.059 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 59.5 t0 -104.47 8.14 35.55 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.188 -0.671 . . . . 2.3999999999999999 109.188 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 81.4 m-20 90.08 -26.86 0.05 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 124.043 0.937 . . . . 2.5499999999999998 109.759 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 39.3 p-10 -103.09 -3.45 25.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 2.1299999999999999 109.78 177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 95.9 m-85 -119.1 140.39 50.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.958 -1.127 . . . . 2.4900000000000002 107.958 175.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.45 158.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 1.2 109.177 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.53 135.88 44.29 Favored 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.026 -1.07 . . . . 1.6799999999999999 108.333 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.39 149.09 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.034 -1.066 . . . . 1.1699999999999999 109.949 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 6.3 t -142.84 154.04 43.77 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.642 0.735 . . . . 1.3100000000000001 111.236 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -156.54 160.14 30.01 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.698 -2.561 . . . . 0.83999999999999997 106.698 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -60.86 121.81 10.26 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 CA-C-N 120.629 2.215 . . . . 1.1799999999999999 110.017 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -58.88 -36.57 74.86 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.522 1.153 . . . . 3.9700000000000002 108.63 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.51 -38.86 91.58 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.511 -0.768 . . . . 2.27 112.373 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.1 mt -96.5 -81.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.915 -1.116 . . . . 2.71 111.369 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.5 m -63.03 -36.79 84.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.927 . . . . 1.75 111.067 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.73 -7.45 57.62 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 120.509 -0.853 . . . . 1.28 111.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.3 m -91.55 130.72 40.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 120.554 2.177 . . . . 1.6799999999999999 105.929 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 36' ' ' THR . 22.9 tttt -92.38 -75.64 0.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.516 -1.273 . . . . 3.98 109.551 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -149.78 125.84 10.62 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.897 -1.89 . . . . 3.3500000000000001 105.897 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -156.58 165.51 36.08 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 119.714 -1.866 . . . . 3.6699999999999999 110.909 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -106.9 136.04 47.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.289 -0.882 . . . . 3.4700000000000002 111.155 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.88 136.74 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.033 -1.042 . . . . 2.2599999999999998 110.674 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.24 167.62 16.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.331 -0.856 . . . . 2.6899999999999999 109.474 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.5 mt -56.86 -26.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.231 -0.918 . . . . 2.1000000000000001 111.375 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.88 -34.88 68.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.426 -1.421 . . . . 1.8 110.253 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -116.44 87.07 2.61 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.296 -0.962 . . . . 2.27 108.625 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.35 127.59 46.86 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.314 -0.866 . . . . 2.1400000000000001 109.079 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -134.45 88.9 28.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.45 -1.315 . . . . 2.2799999999999998 107.45 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -90.5 148.05 4.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.85 1.7 . . . . 0.81000000000000005 114.866 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 30.4 p -117.1 165.46 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.99 -1.115 . . . . 1.1799999999999999 107.99 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.85 137.0 53.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.264 -1.754 . . . . 2.5699999999999998 106.264 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -172.32 -175.78 1.47 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.024 0.916 . . . . 3.3399999999999999 110.127 -178.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 7' ' ' GLY . 48.7 mmtm -86.61 163.15 17.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.781 -1.192 . . . . 5.6799999999999997 107.781 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 61' ' ' ILE . 31.4 pt -130.89 87.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 123.595 1.664 . . . . 5.2400000000000002 111.823 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.1 p30 -150.68 93.05 1.91 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 113.735 1.013 . . . . 2.1400000000000001 113.735 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.1 pt -121.95 153.41 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.728 -1.233 . . . . 2.3300000000000001 110.432 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 26.3 mt-30 -63.05 -42.34 99.69 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.477 -1.689 . . . . 3.1800000000000002 109.216 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 34.4 mtmt 98.21 90.17 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.448 0.567 . . . . 3.8599999999999999 110.037 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.11 8.47 60.21 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.893 -1.129 . . . . 0.72999999999999998 111.66 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.81 148.47 10.12 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.822 -1.399 . . . . 1.3100000000000001 112.158 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -65.49 165.71 11.65 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.616 -1.253 . . . . 1.0600000000000001 107.616 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -59.33 -45.1 92.3 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 119.798 -1.814 . . . . 2.02 111.484 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.43 -39.72 95.25 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.089 -1.844 . . . . 2.2999999999999998 108.777 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.99 -36.39 83.18 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.903 -1.119 . . . . 1.96 108.353 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.3 -42.59 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.768 . . . . 1.1599999999999999 110.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.07 -41.95 93.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 118.716 -1.194 . . . . 1.3100000000000001 109.666 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -59.23 -41.79 89.5 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 117.484 -1.686 . . . . 2.7400000000000002 107.244 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -62.69 -34.92 78.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.63 -0.669 . . . . 3.1200000000000001 110.704 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 50.3 tp -56.55 -41.38 76.75 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.812 -1.18 . . . . 1.98 108.983 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.27 -30.75 66.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.891 -0.781 . . . . 1.7 108.891 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' OD2' ' A' ' 62' ' ' ASP . 84.5 tt0 -53.62 -34.91 60.13 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.66 -1.237 . . . . 2.29 107.66 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.1 m -65.74 -18.31 65.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 1.78 109.907 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 71.16 51.13 0.28 Allowed 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.932 1.349 . . . . 2.1099999999999999 111.551 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 76' ' ' LEU . 6.5 mp -63.51 -28.59 70.06 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.265 -1.334 . . . . 3.0 112.153 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 39.8 m -44.88 -35.63 2.9 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.577 -1.327 . . . . 3.1099999999999999 110.945 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -153.92 -19.06 0.14 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.046 -1.659 . . . . 3.5299999999999998 110.268 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -61.99 -40.94 97.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.373 -1.454 . . . . 3.5299999999999998 108.034 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . 87.7 mtp -103.65 -122.75 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.85 -1.068 . . . . 2.96 110.976 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.404 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 28.6 mtpt 43.14 16.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.865 -0.522 . . . . 2.04 111.134 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.0 mt-10 . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 118.566 -1.254 . . . . 2.6899999999999999 108.923 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 5' ' ' GLU . 18.7 Cg_endo . . . . . 0 N--CA 1.496 1.629 0 CA-C-O 121.773 0.655 . . . . 3.8300000000000001 111.335 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.55 12.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.873 -0.517 . . . . 4.0700000000000003 111.03 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.75 -39.55 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.065 -1.454 . . . . 5.9500000000000002 107.728 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' PRO . 95.5 mt-10 -127.17 151.3 48.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 115.756 -0.656 . . . . 4.7199999999999998 110.66 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -72.43 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.081 -1.012 . . . . 2.8900000000000001 108.972 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 79.91 37.72 21.63 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.722 -1.237 . . . . 1.47 111.187 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.1 ptt-85 -146.75 -177.93 5.91 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 120.92 -1.341 . . . . 4.0999999999999996 108.789 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.4 mt -107.34 142.39 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.719 1.247 . . . . 1.95 112.213 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.6 p -113.43 155.47 25.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.785 -1.552 . . . . 1.1899999999999999 113.225 -175.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.7 138.82 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 114.975 -1.011 . . . . 1.6200000000000001 108.591 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.65 ' HB3' ' O ' ' A' ' 18' ' ' ALA . 63.1 tttm -86.16 126.93 34.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 118.682 -2.511 . . . . 3.52 110.826 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -118.71 126.61 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.62 -1.232 . . . . 2.21 111.498 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 51.9 tttp -170.94 172.42 5.54 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 105.221 -2.141 . . . . 2.8500000000000001 105.221 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -86.1 178.23 49.44 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.167 -1.973 . . . . 2.4100000000000001 108.167 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 17' ' ' GLU . 40.9 ttm180 40.07 99.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.942 . . . . 5.4100000000000001 111.291 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 33.3 109.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 113.441 0.904 . . . . 3.1299999999999999 113.441 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.65 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -171.75 16.37 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.958 0 O-C-N 121.338 -0.851 . . . . 2.3199999999999998 110.387 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.05 110.53 4.03 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 107.564 -2.214 . . . . 1.53 107.564 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -142.57 139.47 31.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.123 -1.436 . . . . 1.8999999999999999 107.123 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.554 ' NZ ' ' OG1' ' A' ' 42' ' ' THR . 1.3 pttm -94.28 138.62 32.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.325 -1.484 . . . . 3.6400000000000001 109.787 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.2 p -142.1 157.96 44.29 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.531 -0.868 . . . . 0.78000000000000003 111.274 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -104.06 134.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.113 -1.81 . . . . 1.1200000000000001 106.113 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.9 mt -96.89 133.71 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.032 -1.043 . . . . 1.3300000000000001 110.371 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 17.1 m -151.94 69.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.457 -1.697 . . . . 1.73 113.594 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.6 t0 171.19 152.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.737 -1.227 . . . . 1.5600000000000001 109.991 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.5 mt -117.66 127.57 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 103.038 -2.949 . . . . 2.5299999999999998 103.038 171.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 29' ' ' ASP . 20.9 mm -99.75 -111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.017 -1.677 . . . . 1.47 111.853 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 91.6 m-20 -62.71 -41.36 99.1 Favored 'General case' 0 C--O 1.201 -1.452 0 O-C-N 121.695 -0.628 . . . . 2.3999999999999999 110.157 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.582 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 89.9 m-20 164.34 -50.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 C-N-CA 124.833 1.253 . . . . 2.5499999999999998 109.353 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -95.07 4.85 53.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 2.1299999999999999 111.922 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.84 147.22 42.33 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.068 -1.02 . . . . 2.4900000000000002 110.337 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.98 162.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.676 -0.49 . . . . 1.2 109.676 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.605 ' CD1' HH21 ' A' ' 46' ' ' ARG . 8.2 tt -97.4 132.48 43.07 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 119.361 -0.936 . . . . 1.6799999999999999 108.643 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.71 150.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.777 -0.769 . . . . 1.1699999999999999 110.556 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 7.0 t -144.03 155.12 43.88 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.974 -0.69 . . . . 1.3100000000000001 112.15 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -152.55 169.08 31.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.132 -1.987 . . . . 0.83999999999999997 108.132 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' CG ' ' HZ1' ' A' ' 21' ' ' LYS . 36.9 Cg_endo -70.39 110.35 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 CA-C-N 118.938 1.369 . . . . 1.1799999999999999 109.322 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -58.82 -39.5 81.36 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.057 -1.027 . . . . 3.9700000000000002 111.202 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.26 -40.22 96.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.941 -1.099 . . . . 2.27 112.47 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.87 -77.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.419 -0.801 . . . . 2.71 112.874 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.554 ' OG1' ' NZ ' ' A' ' 21' ' ' LYS . 33.4 m -61.89 -35.06 77.24 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.729 -1.232 . . . . 1.75 109.492 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.54 -10.97 56.47 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.653 -0.654 . . . . 1.28 111.797 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -91.1 128.33 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 119.93 1.865 . . . . 1.6799999999999999 108.15 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' O ' ' OG1' ' A' ' 36' ' ' THR . 16.5 tttt -95.33 -75.57 0.52 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.332 1.063 . . . . 3.98 110.66 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.605 HH21 ' CD1' ' A' ' 34' ' ' LEU . 65.2 ttt180 -148.7 125.44 11.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.301 -1.37 . . . . 3.3500000000000001 107.301 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -157.23 164.34 37.82 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 119.969 -1.707 . . . . 3.6699999999999999 109.489 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -105.25 141.1 37.37 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.43 -0.793 . . . . 3.4700000000000002 109.528 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -133.8 143.6 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 2.2599999999999998 110.052 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 48.6 t-20 -80.87 154.24 27.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.669 0.747 . . . . 2.6899999999999999 111.243 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 93.1 mt -58.36 -23.84 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.638 -0.664 . . . . 2.1000000000000001 109.728 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.6 mt -53.26 -29.87 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 1.8 108.94 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -117.43 91.7 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.553 -1.647 . . . . 2.27 106.553 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.4 tp -113.82 130.38 56.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.684 -0.635 . . . . 2.1400000000000001 110.548 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -137.81 90.33 14.41 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 106.864 -1.532 . . . . 2.2799999999999998 106.864 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -90.26 148.13 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.629 1.553 . . . . 0.81000000000000005 113.926 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 p -119.73 163.81 16.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.491 -0.929 . . . . 1.1799999999999999 108.491 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.599 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 55.3 p30 -75.4 125.82 29.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.282 -1.747 . . . . 2.5699999999999998 106.282 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.571 ' CG ' ' O ' ' A' ' 58' ' ' ASP . 24.5 mttt -162.14 -173.03 3.46 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.083 1.42 . . . . 3.3399999999999999 112.704 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' GLY . 25.3 tttt -81.48 150.88 28.08 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.722 -1.581 . . . . 5.6799999999999997 111.231 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 tt -120.6 120.16 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.503 0.668 . . . . 5.2400000000000002 110.628 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -179.6 87.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 117.62 -1.181 . . . . 2.1400000000000001 112.208 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -115.15 138.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 CA-C-N 123.543 2.883 . . . . 2.3300000000000001 108.112 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.569 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.7 mt-30 -60.76 -41.28 95.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 115.166 -2.614 . . . . 3.1800000000000002 106.282 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 59.3 tttt 114.11 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.139 -1.059 . . . . 3.8599999999999999 108.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 119.849 -1.782 . . . . 0.72999999999999998 111.539 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.76 144.8 17.23 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.201 -1.764 . . . . 1.3100000000000001 112.225 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 52.8 p -69.89 167.02 18.26 Favored 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 108.152 -1.055 . . . . 1.0600000000000001 108.152 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 93.0 m-20 -59.56 -47.35 85.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 119.585 -1.947 . . . . 2.02 112.088 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -41.1 98.3 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 117.003 -1.879 . . . . 2.2999999999999998 108.022 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.8 -35.72 82.0 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.134 -1.061 . . . . 1.96 108.134 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 68' ' ' SER . 79.5 t -65.39 -42.82 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 1.1599999999999999 110.094 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.68 -42.92 98.06 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.908 -1.117 . . . . 1.3100000000000001 110.09 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -59.44 -38.19 80.08 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.182 -1.007 . . . . 2.7400000000000002 109.072 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 11.8 mtpt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.882 -0.511 . . . . 3.1200000000000001 110.169 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 88.4 mt -57.48 -37.68 73.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.662 -1.273 . . . . 1.98 108.641 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 97.1 mt-10 -58.65 -33.08 69.68 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 118.307 -1.357 . . . . 1.7 108.179 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.02 -35.68 75.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.145 -2.168 . . . . 2.29 105.145 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 m -70.01 -21.88 63.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.014 -0.539 . . . . 1.78 109.597 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 77' ' ' GLU . 74.4 m-20 66.83 46.7 1.62 Allowed 'General case' 0 N--CA 1.519 3.011 0 CA-C-O 122.229 1.014 . . . . 2.1099999999999999 112.481 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.456 ' CD1' ' O ' ' A' ' 76' ' ' LEU . 6.2 mp -65.52 -27.51 68.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.357 -0.838 . . . . 3.0 111.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.0 m -42.62 -33.59 0.74 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.965 -1.084 . . . . 3.1099999999999999 111.29 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -157.66 -21.17 0.09 Allowed 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.009 -1.682 . . . . 3.5299999999999998 110.952 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -60.59 -42.33 96.49 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 117.73 -1.588 . . . . 3.5299999999999998 107.076 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' NZ ' ' A' ' 59' ' ' LYS . 62.3 mtt -94.82 -125.3 0.11 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.627 -1.624 . . . . 2.96 114.178 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 52.99 31.42 10.96 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.631 -1.248 . . . . 2.04 107.631 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.71 -28.4 69.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 116.347 1.981 . . . . 2.6899999999999999 116.347 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt 61.03 75.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 102.894 -3.002 . . . . 5.4100000000000001 102.894 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 86.7 mt -58.39 -38.52 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 120.045 -0.662 . . . . 3.6699999999999999 110.702 -174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -115.99 140.0 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.546 -1.346 . . . . 4.9500000000000002 107.994 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.08 -33.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.64 -1.245 . . . . 5.9699999999999998 107.64 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -83.14 130.68 35.13 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.017 -1.105 . . . . 7.2400000000000002 108.017 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.4 mmm -172.04 -58.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.657 -1.277 . . . . 9.9399999999999995 112.018 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.27 -67.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.725 1.617 . . . . 8.0800000000000001 115.846 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.3 p -93.38 -5.6 49.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.14 -0.975 . . . . 7.7199999999999998 110.536 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.018 -0.991 . . . . 9.0600000000000005 109.456 -179.015 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.492 1.383 0 CA-C-O 121.576 0.573 . . . . 3.8300000000000001 113.095 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.66 70.12 1.0 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.393 1.092 . . . . 4.0700000000000003 108.646 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.3 mt -113.61 146.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.007 -0.997 . . . . 5.9500000000000002 109.544 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 6' ' ' VAL . 95.9 mt-10 -63.17 155.45 28.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.004 -1.06 . . . . 4.7199999999999998 110.063 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.642 ' O ' ' O ' ' A' ' 5' ' ' GLU . 7.2 m -43.19 -149.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.269 1.033 . . . . 2.8900000000000001 112.585 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.81 66.4 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 106.721 -2.551 . . . . 1.47 106.721 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 57' ' ' THR . 71.1 mtp180 -128.74 170.43 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.431 -0.952 . . . . 4.0999999999999996 108.431 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 57' ' ' THR . 82.8 mt -93.99 145.41 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.021 -1.05 . . . . 1.95 108.845 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.0 p -122.44 155.66 35.66 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.9 -1.045 . . . . 1.1899999999999999 112.643 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 41.0 t -127.31 139.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 CA-C-N 115.625 -0.716 . . . . 1.6200000000000001 110.158 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 18' ' ' ALA . 22.7 tptm -81.1 137.52 35.97 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 118.03 -2.919 . . . . 3.52 111.685 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.61 100.42 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 122.58 1.181 . . . . 2.21 109.476 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.569 ' NZ ' ' CE1' ' A' ' 53' ' ' HIS . 31.6 mttm -157.02 169.08 25.63 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.153 -1.795 . . . . 2.8500000000000001 106.153 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -82.84 178.83 53.15 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 117.353 -2.356 . . . . 2.4100000000000001 107.305 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 15' ' ' GLY . 59.3 ttt85 49.35 106.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.172 -1.193 . . . . 5.4100000000000001 111.01 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 48.33 53.55 11.73 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.996 0.903 . . . . 3.1299999999999999 110.74 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' O ' ' O ' ' A' ' 12' ' ' LYS . . . -67.88 -15.3 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.538 -1.351 . . . . 2.3199999999999998 110.781 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.45 94.91 1.9 Allowed Glycine 0 C--N 1.285 -2.284 0 O-C-N 120.718 -1.239 . . . . 1.53 114.374 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -136.35 134.32 37.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.62 -1.992 . . . . 1.8999999999999999 105.62 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.576 ' NZ ' ' H ' ' A' ' 86' ' ' LYS . 1.7 ptpt -100.53 136.84 39.78 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.622 -1.299 . . . . 3.6400000000000001 111.455 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.2 p -137.5 159.57 41.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.772 0.796 . . . . 0.78000000000000003 111.199 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.1 t -111.12 136.27 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.056 -1.461 . . . . 1.1200000000000001 107.056 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -105.37 133.69 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.117 -0.989 . . . . 1.3300000000000001 109.912 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.607 ' CG1' ' HZ3' ' A' ' 75' ' ' LYS . 1.1 m -149.18 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.884 -1.126 . . . . 1.73 111.668 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 54.3 t0 172.14 137.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 1.5600000000000001 109.183 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.5 mt -118.78 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 104.177 -2.527 . . . . 2.5299999999999998 104.177 171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -97.05 -79.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.053 -1.03 . . . . 1.47 110.843 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 44.1 t0 -106.03 179.0 4.4 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.135 0.969 . . . . 2.3999999999999999 108.871 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 91.8 m-20 -54.8 -38.51 67.39 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 118.969 -1.093 . . . . 2.5499999999999998 108.81 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.54 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 33.6 p-10 -112.11 5.15 18.42 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 115.685 1.735 . . . . 2.1299999999999999 115.685 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 89.3 m-85 -112.64 138.94 48.7 Favored 'General case' 0 N--CA 1.528 3.455 0 CA-C-N 121.696 2.044 . . . . 2.4900000000000002 113.78 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 m -130.8 162.78 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 115.727 -0.67 . . . . 1.2 109.899 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 tt -100.28 135.61 41.44 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.272 -0.893 . . . . 1.6799999999999999 108.829 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.3 m -126.75 150.5 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.613 -0.835 . . . . 1.1699999999999999 110.541 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 t -146.89 153.09 39.72 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.648 -0.821 . . . . 1.3100000000000001 112.015 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.7 29.82 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.571 -2.212 . . . . 0.83999999999999997 107.571 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.88 108.06 0.86 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 CA-C-N 119.156 1.478 . . . . 1.1799999999999999 110.594 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -58.6 -39.21 79.79 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.174 0.988 . . . . 3.9700000000000002 109.592 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -38.99 93.25 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.43 -0.794 . . . . 2.27 112.251 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.8 mm -96.24 -78.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.028 . . . . 2.71 113.39 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -32.94 74.4 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.999 0.904 . . . . 1.75 108.605 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.12 56.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 111.438 -0.665 . . . . 1.28 111.438 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.37 148.94 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.8 1.8 . . . . 1.6799999999999999 109.912 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -92.69 -131.18 0.13 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.524 -1.287 . . . . 3.98 107.524 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -139.86 122.32 16.15 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 103.982 -2.599 . . . . 3.3500000000000001 103.982 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.8 ptt85 -159.64 165.83 31.91 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 117.467 -1.693 . . . . 3.6699999999999999 110.576 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -93.12 139.12 30.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.274 -0.891 . . . . 3.4700000000000002 108.695 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.04 153.48 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.96 -1.087 . . . . 2.2599999999999998 110.304 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -86.3 167.7 14.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.955 0.883 . . . . 2.6899999999999999 111.611 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 51' ' ' ILE . 98.4 mt -58.15 -24.84 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 115.999 -0.546 . . . . 2.1000000000000001 110.234 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.7 mt -55.23 -30.87 60.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.207 -1.034 . . . . 1.8 108.207 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 98.7 m-70 -116.04 88.53 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.508 -1.293 . . . . 2.27 107.508 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.6 tp -118.91 129.67 55.31 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.285 -0.635 . . . . 2.1400000000000001 109.285 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -143.14 90.41 7.4 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 106.368 -1.715 . . . . 2.2799999999999998 106.368 176.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -90.22 153.54 4.64 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 121.557 1.504 . . . . 0.81000000000000005 114.322 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.538 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 63.5 p -111.68 166.71 10.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.333 -1.728 . . . . 1.1799999999999999 106.333 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HA ' HH21 ' A' ' 8' ' ' ARG . 88.4 m-20 -84.21 11.49 8.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.047 -1.033 . . . . 2.5699999999999998 110.664 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . 0.317 44.6 tttm -91.34 124.6 35.65 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.185 -0.947 . . . . 3.3399999999999999 111.389 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -133.57 119.04 18.97 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 118.596 -1.242 . . . . 5.6799999999999997 111.382 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.8 pt -128.5 157.12 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.872 -1.158 . . . . 5.2400000000000002 107.872 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -86.13 128.37 34.87 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 122.891 1.329 . . . . 2.1400000000000001 111.928 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.78 164.07 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 115.11 -0.95 . . . . 2.3300000000000001 109.933 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -96.39 139.98 31.71 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.842 -1.17 . . . . 3.1800000000000002 107.842 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -67.24 138.87 57.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 116.056 -0.52 . . . . 3.8599999999999999 111.064 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.8 21.43 61.55 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.52 -1.324 . . . . 0.72999999999999998 112.998 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.04 21.74 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 120.294 2.047 . . . . 1.3100000000000001 111.389 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -71.2 166.27 21.87 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.696 -1.594 . . . . 1.0600000000000001 106.696 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 53.0 p30 -60.65 -40.55 92.45 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 116.328 -2.149 . . . . 2.02 110.683 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 97.1 mt-10 -63.23 -39.31 94.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 119.517 -1.989 . . . . 2.2999999999999998 107.731 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.73 -35.71 81.93 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.773 -1.171 . . . . 1.96 108.09 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.1 t -64.09 -43.52 97.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.436 -1.306 . . . . 1.1599999999999999 107.881 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.74 -44.25 97.27 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.014 -1.074 . . . . 1.3100000000000001 109.428 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.48 -42.32 96.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.371 -1.456 . . . . 2.7400000000000002 108.315 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.607 ' HZ3' ' CG1' ' A' ' 25' ' ' VAL . 10.1 mtmp? -62.63 -34.93 78.04 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.507 -0.877 . . . . 3.1200000000000001 109.588 176.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.661 ' O ' ' OG ' ' A' ' 79' ' ' SER . 38.1 tp -59.24 -40.5 86.11 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.735 -1.186 . . . . 1.98 108.392 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.543 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -62.42 -34.38 76.64 Favored 'General case' 0 C--N 1.281 -2.373 0 O-C-N 120.175 -1.578 . . . . 1.7 108.135 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.68 -36.97 77.52 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 105.589 -2.004 . . . . 2.29 105.589 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.661 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 95.8 p -71.11 -18.25 62.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.397 -1.705 . . . . 1.78 106.397 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 20.2 m120 61.6 35.02 17.45 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.123 -0.944 . . . . 2.1099999999999999 111.065 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 81' ' ' LEU . 8.4 mp -74.55 -29.54 61.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.831 -0.543 . . . . 3.0 112.395 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 43.5 m -50.52 -33.09 20.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.122 -0.986 . . . . 3.1099999999999999 110.856 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -147.42 -28.35 0.36 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 118.342 -1.343 . . . . 3.5299999999999998 112.727 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -61.88 -48.57 79.89 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 114.94 -2.704 . . . . 3.5299999999999998 105.606 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 62.2 mtt -88.09 -135.92 0.09 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.378 -1.737 . . . . 2.96 111.355 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.576 ' H ' ' NZ ' ' A' ' 21' ' ' LYS . 27.8 mtpt 62.81 29.67 16.67 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.521 -1.659 . . . . 2.04 106.521 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' O ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt-10 -86.78 2.08 50.06 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.103 -0.498 . . . . 2.6899999999999999 112.112 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 87' ' ' GLU . 27.6 mttt 56.86 117.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.562 1.073 . . . . 5.4100000000000001 108.73 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.47 -39.36 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 119.94 -1.725 . . . . 3.6699999999999999 108.708 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -95.45 132.92 40.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.722 -1.214 . . . . 4.9500000000000002 107.722 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.68 128.8 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 5.9699999999999998 110.383 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -129.44 143.32 50.79 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.085 0.945 . . . . 7.2400000000000002 110.714 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.656 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -146.81 -45.58 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.576 -1.268 . . . . 9.9399999999999995 107.576 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.656 ' CD ' ' H ' ' A' ' 93' ' ' MET . 25.5 Cg_exo -63.76 -171.96 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 122.514 2.142 . . . . 8.0800000000000001 110.354 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -59.75 -36.44 76.64 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.0 -1.063 . . . . 7.7199999999999998 109.633 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.003 -1.061 . . . . 9.0600000000000005 109.255 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo . . . . . 0 N--CA 1.49 1.27 0 N-CA-C 112.937 0.322 . . . . 3.8300000000000001 112.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.08 175.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.269 -1.752 . . . . 4.0700000000000003 106.269 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.402 ' CG2' ' NH2' ' A' ' 8' ' ' ARG . 71.4 mt -118.33 125.72 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.77 1.168 . . . . 5.9500000000000002 109.349 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.578 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 95.2 mt-10 -126.93 149.02 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.281 -0.637 . . . . 4.7199999999999998 109.281 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.48 178.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.394 -1.335 . . . . 2.8900000000000001 107.394 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 89.77 18.14 52.24 Favored Glycine 0 C--O 1.199 -2.042 0 C-N-CA 119.116 -1.516 . . . . 1.47 111.27 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 28.3 ptt-85 -137.53 176.02 9.08 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.147 -1.207 . . . . 4.0999999999999996 108.275 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 57' ' ' THR . 81.3 mt -104.81 146.98 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 123.171 1.462 . . . . 1.95 111.641 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.47 155.72 29.21 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 112.959 -1.928 . . . . 1.1899999999999999 111.515 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 43.5 t -127.02 135.4 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 CA-C-N 115.437 -0.801 . . . . 1.6200000000000001 111.144 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -87.96 139.05 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.296 -2.753 . . . . 3.52 110.189 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.32 120.12 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 118.834 -1.146 . . . . 2.21 110.659 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.628 ' NZ ' ' CE1' ' A' ' 53' ' ' HIS . 93.1 mttt -161.09 170.55 20.22 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.739 -1.578 . . . . 2.8500000000000001 106.739 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.9 -178.63 51.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 106.142 -2.783 . . . . 2.4100000000000001 106.142 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' O ' ' O ' ' A' ' 17' ' ' GLU . 84.7 mtt180 38.38 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 119.37 1.585 . . . . 5.4100000000000001 111.332 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 35.27 110.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.905 0.86 . . . . 3.1299999999999999 112.673 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.58 16.6 0.07 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.919 -1.113 . . . . 2.3199999999999998 111.167 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.22 98.21 2.39 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.18 -1.968 . . . . 1.53 108.18 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -144.42 137.29 26.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.149 -1.207 . . . . 1.8999999999999999 109.221 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -103.36 139.36 38.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 3.6400000000000001 109.418 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.5 p -131.24 157.69 42.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.839 -1.144 . . . . 0.78000000000000003 109.147 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.9 t -105.17 135.18 44.33 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 N-CA-C 106.556 -1.646 . . . . 1.1200000000000001 106.556 177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.73 130.03 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.41 -0.916 . . . . 1.3300000000000001 110.086 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -142.28 68.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.158 -1.417 . . . . 1.73 111.729 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 55.1 t0 164.97 148.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.116 -0.99 . . . . 1.5600000000000001 108.542 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.1 tt -121.74 117.67 53.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.253 -2.499 . . . . 2.5299999999999998 104.253 170.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.5 mt -97.64 -80.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.879 1.323 . . . . 1.47 109.653 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -106.18 161.26 14.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.105 -1.407 . . . . 2.3999999999999999 107.845 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.14 -38.1 67.8 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 118.683 -1.207 . . . . 2.5499999999999998 109.592 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -96.25 0.3 50.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.357 . . . . 2.1299999999999999 113.651 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -121.31 145.03 48.29 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.994 1.27 . . . . 2.4900000000000002 113.091 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.91 161.98 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.926 -0.484 . . . . 1.2 110.064 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.0 tt -101.36 133.9 45.25 Favored 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 108.122 -1.066 . . . . 1.6799999999999999 108.122 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.51 149.61 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.246 -0.909 . . . . 1.1699999999999999 110.8 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -143.22 151.4 40.56 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.083 -1.047 . . . . 1.3100000000000001 111.922 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.53 164.38 37.25 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.039 -2.025 . . . . 0.83999999999999997 108.039 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -65.79 124.57 12.92 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-N 120.578 2.189 . . . . 1.1799999999999999 109.56 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -60.37 -43.57 96.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.372 -1.455 . . . . 3.9700000000000002 111.267 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.33 -37.43 87.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 2.27 113.729 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.425 HD13 ' HZ1' ' A' ' 86' ' ' LYS . 85.2 mt -94.86 -71.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 114.751 1.389 . . . . 2.71 114.751 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.5 m -70.17 -35.53 74.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.41 1.1 . . . . 1.75 109.635 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -18.17 47.03 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-N 115.136 -0.938 . . . . 1.28 112.316 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -92.26 124.04 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 CA-C-N 120.31 2.055 . . . . 1.6799999999999999 107.582 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -88.98 -79.55 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.237 -1.764 . . . . 3.98 106.237 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -152.54 118.65 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.555 -1.276 . . . . 3.3500000000000001 107.555 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -156.13 163.17 39.96 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.353 -1.467 . . . . 3.6699999999999999 109.838 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -95.39 138.21 33.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.147 -0.971 . . . . 3.4700000000000002 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.64 150.62 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.6 -1.312 . . . . 2.2599999999999998 110.908 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.515 HD22 ' CD1' ' A' ' 52' ' ' LEU . 43.7 p-10 -86.07 172.72 10.39 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.731 0.777 . . . . 2.6899999999999999 111.646 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 51' ' ' ILE . 90.3 mt -57.04 -29.04 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.742 -0.599 . . . . 2.1000000000000001 110.769 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.515 ' CD1' HD22 ' A' ' 50' ' ' ASN . 77.4 mt -53.71 -29.03 37.36 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.124 -0.985 . . . . 1.8 109.083 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.628 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 61.8 m170 -115.96 88.61 2.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.257 -1.757 . . . . 2.27 106.257 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.8 tp -123.93 129.16 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 2.1400000000000001 109.334 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 3.1 tp10 -152.37 94.89 3.18 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 107.584 -1.265 . . . . 2.2799999999999998 107.584 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -87.97 153.81 7.16 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 121.46 1.44 . . . . 0.81000000000000005 112.541 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 50.5 p -116.92 163.95 15.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.415 -0.958 . . . . 1.1799999999999999 108.415 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 49.8 p30 -88.98 39.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.511 -0.743 . . . . 2.5699999999999998 111.468 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -84.3 -166.65 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.007 -1.058 . . . . 3.3399999999999999 111.805 -176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' ' O ' ' A' ' 7' ' ' GLY . 22.9 tttt -82.75 154.27 24.86 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.037 0.935 . . . . 5.6799999999999997 108.988 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.7 mm -116.42 117.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.987 -0.685 . . . . 5.2400000000000002 109.77 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -173.39 85.94 0.05 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.983 -1.073 . . . . 2.1400000000000001 113.464 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.59 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -131.59 159.32 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 120.23 -1.544 . . . . 2.3300000000000001 109.153 176.005 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.1 mt-30 -63.41 -44.93 93.24 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 116.455 -2.098 . . . . 3.1800000000000002 108.848 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 3.0 ttmp? 99.85 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 108.085 -1.08 . . . . 3.8599999999999999 108.085 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 11.41 63.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.8 -1.72 . . . . 0.72999999999999998 108.8 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' CB ' ' NZ ' ' A' ' 75' ' ' LYS . . . -56.98 149.44 18.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.662 -0.905 . . . . 1.3100000000000001 112.36 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.4 p -65.23 164.4 13.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.661 -1.237 . . . . 1.0600000000000001 107.661 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.58 -42.48 88.13 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.161 -1.587 . . . . 2.02 111.371 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.96 -39.56 95.03 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 117.269 -1.772 . . . . 2.2999999999999998 108.747 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.9 -36.3 83.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.603 -0.839 . . . . 1.96 108.898 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.57 -42.81 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 1.1599999999999999 109.844 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.16 -42.23 98.19 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.986 -1.086 . . . . 1.3100000000000001 109.791 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.49 -43.39 97.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 2.7400000000000002 110.176 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.523 ' NZ ' ' CB ' ' A' ' 67' ' ' ALA . 37.5 mtmm -60.87 -31.67 71.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.763 -0.586 . . . . 3.1200000000000001 110.637 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.657 ' O ' ' OG ' ' A' ' 79' ' ' SER . 36.4 tp -54.83 -37.48 66.21 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.623 -0.88 . . . . 1.98 108.623 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.51 -31.32 67.78 Favored 'General case' 0 C--N 1.277 -2.568 0 O-C-N 120.407 -1.433 . . . . 1.7 109.183 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.08 -35.64 69.63 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.305 -1.739 . . . . 2.29 106.305 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 57.6 p -66.57 -19.74 65.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.538 -1.282 . . . . 1.78 107.538 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 60.5 37.44 19.68 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 106.904 -1.517 . . . . 2.1099999999999999 106.904 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' THR . 13.9 tp -68.35 -30.42 69.37 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.454 -1.703 . . . . 3.0 111.413 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 38.9 m -43.28 -35.66 1.55 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.291 -0.881 . . . . 3.1099999999999999 110.537 -175.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.79 -23.62 0.11 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.556 -1.658 . . . . 3.5299999999999998 112.219 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -60.65 -48.01 83.67 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 116.404 -2.118 . . . . 3.5299999999999998 107.417 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.55 ' O ' ' N ' ' A' ' 87' ' ' GLU . 84.7 mtp -84.25 -122.92 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 112.192 -2.276 . . . . 2.96 112.951 -174.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HZ1' HD13 ' A' ' 41' ' ' ILE . 25.9 mttm 46.13 14.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.466 -0.939 . . . . 2.04 108.466 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' O ' ' O ' ' A' ' 88' ' ' LYS . 97.1 mt-10 -68.31 -24.69 64.87 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.375 1.25 . . . . 2.6899999999999999 114.375 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' O ' ' O ' ' A' ' 87' ' ' GLU . 91.5 mttt 57.08 143.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.139 1.336 . . . . 5.4100000000000001 108.766 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -73.03 -8.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.052 -1.655 . . . . 3.6699999999999999 108.402 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.52 -157.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 4.9500000000000002 109.998 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.01 127.93 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.205 -1.035 . . . . 5.9699999999999998 108.205 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' ' SD ' ' A' ' 93' ' ' MET . 81.9 mtp180 -133.34 134.76 44.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.799 -1.188 . . . . 7.2400000000000002 113.358 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.516 ' SD ' ' O ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -155.83 -51.11 0.01 OUTLIER Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.156 -1.424 . . . . 9.9399999999999995 107.156 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.485 ' CD ' ' H ' ' A' ' 93' ' ' MET . 17.9 Cg_exo -63.89 -22.87 68.68 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.914 1.743 . . . . 8.0800000000000001 111.051 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.3 p -75.05 -24.53 58.26 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.298 0.57 . . . . 7.7199999999999998 109.548 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.961 -1.018 . . . . 9.0600000000000005 109.088 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ALA . 12.4 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 N-CA-C 112.938 0.322 . . . . 3.8300000000000001 112.938 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . 48.38 -171.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.591 -1.263 . . . . 4.0700000000000003 107.591 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.6 mt -115.9 126.02 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.869 -1.144 . . . . 5.9500000000000002 110.442 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.709 ' H ' HH11 ' A' ' 8' ' ' ARG . 95.4 mt-10 -108.8 154.98 21.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.024 0.916 . . . . 4.7199999999999998 110.492 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.05 175.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.561 -0.904 . . . . 2.8900000000000001 108.561 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 8' ' ' ARG . . . 75.55 -118.8 5.6 Favored Glycine 0 C--N 1.29 -2.023 0 C-N-CA 119.491 -1.338 . . . . 1.47 110.272 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.709 HH11 ' H ' ' A' ' 5' ' ' GLU . 39.5 mtp180 39.8 -171.43 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.894 0 O-C-N 121.507 -0.996 . . . . 4.0999999999999996 109.933 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.403 HG22 ' OG1' ' A' ' 57' ' ' THR . 16.0 tt -118.09 147.95 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 106.277 -1.749 . . . . 1.95 106.277 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 4.7 p -128.01 159.8 33.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.058 0.932 . . . . 1.1899999999999999 111.95 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.16 145.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.961 -1.126 . . . . 1.6200000000000001 107.961 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -89.95 137.16 32.57 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 119.516 -1.99 . . . . 3.52 109.512 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.96 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.254 -1.378 . . . . 2.21 111.754 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -165.76 160.17 16.89 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.144 -2.169 . . . . 2.8500000000000001 105.144 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.89 178.94 51.17 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 117.667 -2.206 . . . . 2.4100000000000001 109.095 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' GLU . 95.0 mtt-85 45.13 94.63 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.618 -0.931 . . . . 5.4100000000000001 110.097 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 41.59 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.719 0.771 . . . . 3.1299999999999999 112.877 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 178.6 8.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.376 -0.827 . . . . 2.3199999999999998 111.725 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' H ' ' CD1' ' A' ' 89' ' ' ILE . . . -91.95 115.1 4.69 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 107.618 -2.193 . . . . 1.53 107.618 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -152.48 149.21 28.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.086 -1.243 . . . . 1.8999999999999999 107.862 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -94.93 141.77 28.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 3.6400000000000001 110.516 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.0 p -139.57 158.8 43.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.78000000000000003 110.313 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.01 135.68 52.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.476 -1.305 . . . . 1.1200000000000001 107.476 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 7' ' ' GLY . 64.9 mt -94.49 133.78 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 C-N-CA 118.211 -1.395 . . . . 1.3300000000000001 110.966 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.59 76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 118.442 -1.303 . . . . 1.73 111.422 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 47.1 t0 169.79 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.273 -1.517 . . . . 1.5600000000000001 108.371 172.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 69.9 mt -119.44 121.88 67.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 103.411 -2.811 . . . . 2.5299999999999998 103.411 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.9 mt -109.63 -38.82 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.941 -1.1 . . . . 1.47 109.927 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -164.69 173.93 11.32 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.962 -1.496 . . . . 2.3999999999999999 106.962 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.93 -39.26 77.58 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.763 -1.175 . . . . 2.5499999999999998 112.336 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -99.83 1.6 43.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.338 -1.476 . . . . 2.1299999999999999 114.811 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -121.77 142.87 49.77 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.121 1.328 . . . . 2.4900000000000002 111.814 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.7 162.42 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.44 -0.788 . . . . 1.2 109.411 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.32 133.05 46.5 Favored 'General case' 0 N--CA 1.52 3.027 0 C-N-CA 118.894 -1.122 . . . . 1.6799999999999999 109.163 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.61 144.49 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.017 -1.073 . . . . 1.1699999999999999 109.747 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 6.4 t -145.38 155.51 43.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.771 0.796 . . . . 1.3100000000000001 112.293 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -155.34 164.51 32.01 Favored Glycine 0 N--CA 1.501 3.005 0 N-CA-C 107.168 -2.373 . . . . 0.83999999999999997 107.168 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.71 115.6 3.02 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 119.145 1.472 . . . . 1.1799999999999999 110.064 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.89 -34.9 72.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.76 0.79 . . . . 3.9700000000000002 110.55 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.97 -40.96 99.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.635 -0.666 . . . . 2.27 112.683 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 81.6 mt -98.03 -78.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 2.71 112.767 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 m -61.34 -35.9 78.69 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.913 -1.117 . . . . 1.75 109.459 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.72 -3.82 57.64 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.658 -0.782 . . . . 1.28 112.112 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.5 m -90.73 131.68 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.497 -2.038 . . . . 1.6799999999999999 105.497 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' O ' ' OG1' ' A' ' 36' ' ' THR . 8.0 ttpm? -94.15 -78.23 0.44 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.492 -1.283 . . . . 3.98 110.331 -178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -152.66 126.18 8.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.027 -1.842 . . . . 3.3500000000000001 106.027 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -155.01 165.82 35.53 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.189 -1.569 . . . . 3.6699999999999999 110.08 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -113.21 138.45 49.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.381 -0.824 . . . . 3.4700000000000002 109.601 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 m -132.23 151.73 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 118.727 -1.189 . . . . 2.2599999999999998 110.592 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.55 ' OD1' ' CE2' ' A' ' 32' ' ' PHE . 31.5 m-20 -87.3 163.25 16.94 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.268 -0.878 . . . . 2.6899999999999999 108.717 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.3 mt -57.56 -24.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.02 -1.05 . . . . 2.1000000000000001 111.062 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -55.2 -35.93 65.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.345 -1.472 . . . . 1.8 108.556 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -114.66 87.17 2.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.204 -1.036 . . . . 2.27 108.204 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.3 tp -128.5 127.85 43.23 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.655 -0.868 . . . . 2.1400000000000001 108.655 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.34 87.09 39.19 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 107.314 -1.365 . . . . 2.2799999999999998 107.314 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -92.17 147.95 3.04 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.107 1.872 . . . . 0.81000000000000005 114.744 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 14.7 p -101.87 172.32 7.0 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.459 -1.312 . . . . 1.1799999999999999 107.459 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 50.3 p30 -83.1 16.37 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.088 0.947 . . . . 2.5699999999999998 108.909 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.596 ' HZ3' ' CA ' ' A' ' 79' ' ' SER 0.346 66.4 tttt -87.53 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.779 -0.823 . . . . 3.3399999999999999 108.779 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' CE ' ' OE1' ' A' ' 5' ' ' GLU . 62.7 tttm -133.19 120.72 21.53 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.986 -1.086 . . . . 5.6799999999999997 110.525 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -118.56 141.8 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.556 -1.646 . . . . 5.2400000000000002 106.556 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.3 p30 -88.23 128.24 35.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.459 -1.4 . . . . 2.1400000000000001 110.43 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.566 ' H ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -126.73 162.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.348 -0.845 . . . . 2.3300000000000001 109.756 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -70.88 -107.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.092 -1.043 . . . . 3.1800000000000002 108.308 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -177.35 119.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.802 -1.187 . . . . 3.8599999999999999 109.663 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.88 20.61 70.23 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.227 -1.463 . . . . 0.72999999999999998 110.855 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' CB ' ' HZ2' ' A' ' 75' ' ' LYS . . . -51.56 147.19 6.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.981 -1.305 . . . . 1.3100000000000001 111.316 -177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.0 p -66.64 163.37 19.06 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 107.737 -1.208 . . . . 1.0600000000000001 107.737 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.9 -44.03 86.51 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 117.339 -1.744 . . . . 2.02 110.502 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.29 -39.58 94.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.092 -1.843 . . . . 2.2999999999999998 109.404 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.87 -36.71 80.75 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.176 -1.01 . . . . 1.96 109.103 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.465 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 73.0 t -62.56 -41.63 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.591 -0.693 . . . . 1.1599999999999999 110.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.65 -39.42 80.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.519 -0.872 . . . . 1.3100000000000001 109.36 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.42 -40.79 87.86 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.221 -0.992 . . . . 2.7400000000000002 111.217 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.421 ' HZ2' ' CB ' ' A' ' 67' ' ' ALA . 7.7 mptt -60.51 -32.64 71.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.715 -1.241 . . . . 3.1200000000000001 111.975 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' O ' ' OG ' ' A' ' 79' ' ' SER . 6.7 mp -58.62 -37.49 75.99 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 120.32 -1.488 . . . . 1.98 108.931 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 78.0 mm-40 -57.26 -32.67 66.83 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 116.957 -1.897 . . . . 1.7 107.353 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.98 -33.97 76.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.147 -1.797 . . . . 2.29 106.147 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 60.6 p -65.61 -26.92 68.05 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 105.74 -1.948 . . . . 1.78 105.74 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.9 m120 61.66 38.59 15.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.472 -1.677 . . . . 2.1099999999999999 106.472 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.16 -29.56 67.61 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.059 -1.428 . . . . 3.0 108.609 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 m -42.55 -34.46 0.86 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.133 -0.94 . . . . 3.1099999999999999 111.365 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -156.35 -14.91 0.1 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 117.949 -1.501 . . . . 3.5299999999999998 111.818 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -61.49 -41.96 98.07 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 116.41 -2.116 . . . . 3.5299999999999998 105.967 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 75.3 mtp -109.39 -120.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.958 -1.019 . . . . 2.96 112.76 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 90.5 mttt 57.74 33.36 23.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.53 -0.545 . . . . 2.04 109.53 -176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.483 ' O ' ' CB ' ' A' ' 88' ' ' LYS . 97.1 mt-10 -67.18 -37.65 84.07 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.677 -1.209 . . . . 2.6899999999999999 109.067 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 87' ' ' GLU . 43.5 mtpt 100.43 -137.68 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 106.811 -1.551 . . . . 5.4100000000000001 106.811 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.694 ' CG2' ' H ' ' A' ' 90' ' ' LYS . 13.0 tt -110.39 -108.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.09 -1.448 . . . . 3.6699999999999999 107.09 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.694 ' H ' ' CG2' ' A' ' 89' ' ' ILE . 18.2 mttp -138.3 130.7 28.98 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.366 -0.833 . . . . 4.9500000000000002 110.273 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.7 tt -129.85 129.82 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.866 -1.161 . . . . 5.9699999999999998 107.866 175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -136.41 133.67 36.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.004 1.275 . . . . 7.2400000000000002 113.362 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.437 ' H ' ' HD2' ' A' ' 94' ' ' PRO . 2.8 mtm -157.96 -53.06 0.01 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 106.977 -1.49 . . . . 9.9399999999999995 106.977 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.437 ' HD2' ' H ' ' A' ' 93' ' ' MET . 23.0 Cg_exo -61.12 -22.14 73.76 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.447 1.431 . . . . 8.0800000000000001 110.255 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.9 p -74.58 -24.52 58.91 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.768 -0.827 . . . . 7.7199999999999998 108.768 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.946 -1.026 . . . . 9.0600000000000005 109.274 179.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.494 ' O ' ' C ' ' A' ' 3' ' ' ALA . 10.8 Cg_endo . . . . . 0 N--CA 1.491 1.373 0 CA-C-O 120.548 0.145 . . . . 3.8300000000000001 112.398 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 2' ' ' PRO . . . 37.2 -124.68 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.726 -1.213 . . . . 4.0700000000000003 107.726 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -116.8 115.69 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.724 -1.19 . . . . 5.9500000000000002 108.722 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.831 ' H ' HH21 ' A' ' 8' ' ' ARG . 97.0 mt-10 -73.44 -36.37 65.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 4.7199999999999998 108.791 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 5' ' ' GLU . 57.4 t 111.12 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 106.782 -1.562 . . . . 2.8900000000000001 106.782 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 89.42 9.33 67.06 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.366 -1.397 . . . . 1.47 110.398 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.831 HH21 ' H ' ' A' ' 5' ' ' GLU . 8.6 ptp180 -98.55 179.39 4.71 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.75 -1.441 . . . . 4.0999999999999996 111.365 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.0 mt -106.68 138.5 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.082 -2.192 . . . . 1.95 105.082 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 p -123.65 158.52 31.36 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.201 1.001 . . . . 1.1899999999999999 113.128 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.36 137.0 52.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.933 -1.506 . . . . 1.6200000000000001 106.933 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.67 145.82 24.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 119.109 -2.245 . . . . 3.52 109.927 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.532 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 8.2 p -128.22 86.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 123.014 1.388 . . . . 2.21 112.664 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -139.06 144.14 38.66 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.615 -1.994 . . . . 2.8500000000000001 105.615 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 179.65 53.06 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 117.795 -2.145 . . . . 2.4100000000000001 109.373 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' GLU . 31.8 ttp180 53.2 91.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.799 -1.186 . . . . 5.4100000000000001 107.799 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.532 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 84.3 tt0 45.1 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 120.99 0.424 . . . . 3.1299999999999999 111.004 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 155.61 62.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 122.031 -0.418 . . . . 2.3199999999999998 111.419 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.53 76.62 0.22 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 118.154 -1.974 . . . . 1.53 109.024 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 42' ' ' THR . 83.0 p -142.28 167.1 22.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.833 -0.804 . . . . 1.8999999999999999 110.017 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -86.9 152.56 22.34 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.806 1.289 . . . . 3.6400000000000001 111.375 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 1.6 p -141.69 160.41 40.24 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.56 -1.2 . . . . 0.78000000000000003 110.056 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.45 129.29 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 105.657 -1.979 . . . . 1.1200000000000001 105.657 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -92.9 134.14 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.695 -1.253 . . . . 1.3300000000000001 112.271 -174.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -148.84 77.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.173 -1.411 . . . . 1.73 113.009 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 51.8 t0 169.08 148.75 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.361 -1.462 . . . . 1.5600000000000001 110.051 172.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.545 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.9 tt -124.44 133.24 69.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 103.923 -2.621 . . . . 2.5299999999999998 103.923 171.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.627 ' CG2' ' H ' ' A' ' 29' ' ' ASP . 21.5 mm -104.89 -122.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.271 -1.518 . . . . 1.47 110.423 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.627 ' H ' ' CG2' ' A' ' 28' ' ' ILE . 92.2 m-20 -61.69 -41.45 97.59 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 120.369 -0.532 . . . . 2.3999999999999999 109.738 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 86.9 m-20 170.01 -58.47 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.559 1.143 . . . . 2.5499999999999998 109.711 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -88.75 3.88 49.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.06 -1.025 . . . . 2.1299999999999999 113.174 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' CD1' ' OD1' ' A' ' 50' ' ' ASN . 90.1 m-85 -110.94 144.29 40.25 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.094 -1.076 . . . . 2.4900000000000002 108.094 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.06 161.11 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.235 -0.915 . . . . 1.2 108.883 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.8 tt -106.82 131.96 53.32 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 118.698 -1.201 . . . . 1.6799999999999999 108.974 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.47 150.99 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 119.378 -0.929 . . . . 1.1699999999999999 109.847 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -145.65 150.99 37.33 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.961 -1.096 . . . . 1.3100000000000001 111.023 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -160.18 164.61 34.45 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.854 -2.099 . . . . 0.83999999999999997 107.854 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' O ' ' OG1' ' A' ' 42' ' ' THR . 30.3 Cg_endo -69.11 101.46 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 CA-C-N 119.093 1.447 . . . . 1.1799999999999999 109.874 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.32 -38.76 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 3.9700000000000002 109.111 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.65 -36.55 67.18 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.681 -0.69 . . . . 2.27 110.755 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' O ' ' NZ ' ' A' ' 88' ' ' LYS . 22.9 mm -110.13 -40.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 119.065 -1.054 . . . . 2.71 111.1 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 38' ' ' PRO . 29.8 p -84.89 -31.29 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.225 -0.922 . . . . 1.75 112.292 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.98 -10.64 68.03 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.933 -1.267 . . . . 1.28 109.933 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.541 ' CB ' HH12 ' A' ' 47' ' ' ARG . 9.8 m -103.0 128.46 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.913 -1.345 . . . . 1.6799999999999999 107.972 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.711 ' H ' HH22 ' A' ' 47' ' ' ARG . 56.4 tttp -95.58 -81.59 0.4 Allowed 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.432 -1.307 . . . . 3.98 109.516 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 58.3 ttt85 -153.55 120.69 5.77 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.765 -1.198 . . . . 3.3500000000000001 107.765 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.711 HH22 ' H ' ' A' ' 45' ' ' LYS . 9.4 ptp85 -156.86 168.45 27.41 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.709 -1.244 . . . . 3.6699999999999999 109.999 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -110.76 140.42 45.18 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.429 -0.952 . . . . 3.4700000000000002 108.429 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.8 t -123.71 137.67 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 121.914 0.864 . . . . 2.2599999999999998 112.069 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' OD1' ' CD1' ' A' ' 32' ' ' PHE . 36.3 m-20 -78.69 156.15 29.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.589 -1.263 . . . . 2.6899999999999999 107.589 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.406 ' O ' ' CD2' ' A' ' 54' ' ' LEU . 28.5 mm -56.5 -27.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.495 -1.378 . . . . 2.1000000000000001 109.301 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -54.23 -34.17 60.04 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 120.411 -1.431 . . . . 1.8 108.586 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -115.72 93.29 4.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.198 -0.939 . . . . 2.27 108.958 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.471 ' O ' ' OE1' ' A' ' 55' ' ' GLU . 1.7 pp -135.78 129.96 33.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.13 -1.606 . . . . 2.1400000000000001 110.898 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -130.18 86.81 53.0 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 104.995 -2.224 . . . . 2.2799999999999998 104.995 174.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.52 157.41 3.61 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.283 2.655 . . . . 0.81000000000000005 115.647 -175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.519 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 30.3 p -106.67 165.32 11.39 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.458 -0.942 . . . . 1.1799999999999999 108.458 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -84.67 15.46 3.82 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.944 0.878 . . . . 2.5699999999999998 108.849 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 45.8 mttp -88.53 141.91 28.14 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.19 -1.041 . . . . 3.3399999999999999 108.19 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -135.69 129.21 32.35 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 5.6799999999999997 110.545 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 7' ' ' GLY . 20.4 tt -125.18 148.03 29.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.925 -1.509 . . . . 5.2400000000000002 106.925 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -84.86 119.95 25.91 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.472 -1.392 . . . . 2.1400000000000001 108.281 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.14 158.32 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.567 0.699 . . . . 2.3300000000000001 111.848 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -86.76 0.35 54.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.732 . . . . 3.1800000000000002 110.699 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 mttt 54.89 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.966 -1.084 . . . . 3.8599999999999999 111.357 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.08 65.4 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.972 -1.109 . . . . 0.72999999999999998 111.396 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.04 149.56 5.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.582 -1.54 . . . . 1.3100000000000001 110.235 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -65.56 159.13 25.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 1.0600000000000001 108.751 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.474 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 91.7 m-20 -57.12 -40.47 77.15 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.055 -1.028 . . . . 2.02 111.898 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.6 mp0 -63.03 -39.35 94.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 117.18 -1.808 . . . . 2.2999999999999998 110.279 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.09 -38.15 82.02 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.685 -1.259 . . . . 1.96 109.357 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.24 -42.55 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.728 -0.608 . . . . 1.1599999999999999 111.421 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -60.66 -42.27 96.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.009 -1.477 . . . . 1.3100000000000001 109.763 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -60.98 -44.82 96.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 117.536 -1.665 . . . . 2.7400000000000002 108.853 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' CB ' ' HZ2' ' A' ' 75' ' ' LYS . 7.8 ttpm? -60.3 -36.26 77.47 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.514 -0.741 . . . . 3.1200000000000001 111.347 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -53.83 -40.06 66.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.578 -0.849 . . . . 1.98 108.783 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 80' ' ' ASN . 96.9 mt-10 -57.1 -33.68 67.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 117.843 -1.543 . . . . 1.7 107.732 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.42 -34.08 70.39 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.042 -1.466 . . . . 2.29 107.042 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -61.56 -26.2 67.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.509 -1.663 . . . . 1.78 106.509 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 77' ' ' GLU . 16.5 m120 71.63 43.85 0.55 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 122.684 1.231 . . . . 2.1099999999999999 112.715 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -71.13 -22.37 62.08 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.277 -1.329 . . . . 3.0 109.517 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.479 ' C ' ' HZ2' ' A' ' 86' ' ' LYS . 39.9 m -41.76 -37.8 1.31 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.785 -0.572 . . . . 3.1099999999999999 109.774 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -168.82 -11.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.536 -1.353 . . . . 3.5299999999999998 110.05 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -60.61 -44.05 96.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 123.559 1.647 . . . . 3.5299999999999998 106.673 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.1 -127.09 0.16 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.836 -1.984 . . . . 2.96 111.548 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 81' ' ' LEU . 23.5 mttt 52.72 21.76 2.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.74 -0.6 . . . . 2.04 112.155 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.1 mt-10 -68.17 -38.81 82.46 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 117.547 -1.661 . . . . 2.6899999999999999 108.325 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 41' ' ' ILE . 25.7 mttm 88.74 123.06 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 105.368 -2.086 . . . . 5.4100000000000001 105.368 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 mm -59.02 -42.09 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.495 -1.378 . . . . 3.6699999999999999 112.496 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -123.27 136.07 54.53 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 121.521 1.964 . . . . 4.9500000000000002 109.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 91' ' ' ILE . 42.2 pt -148.43 76.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.312 1.053 . . . . 5.9699999999999998 110.956 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 93' ' ' MET . 30.1 ptt180 -64.12 -39.57 94.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.139 -1.601 . . . . 7.2400000000000002 109.484 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.43 ' N ' ' CG ' ' A' ' 92' ' ' ARG . 39.8 mtt -146.85 88.48 5.95 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.422 -0.799 . . . . 9.9399999999999995 109.452 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.25 -26.71 44.14 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.957 1.104 . . . . 8.0800000000000001 110.235 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -62.36 -37.5 85.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.745 -0.835 . . . . 7.7199999999999998 108.745 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.099 -0.953 . . . . 9.0600000000000005 109.227 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.491 1.327 0 CA-C-O 121.387 0.494 . . . . 3.8300000000000001 112.3 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.79 146.17 42.68 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.881 0.848 . . . . 4.0700000000000003 110.765 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.86 137.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.288 -1.005 . . . . 5.9500000000000002 108.288 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 18.0 pt-20 -166.77 -177.08 3.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.648 -1.282 . . . . 4.7199999999999998 108.256 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.8 m -62.6 155.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.938 -1.134 . . . . 2.8900000000000001 107.938 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 23.68 26.55 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.116 -1.516 . . . . 1.47 112.309 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 31.8 ptt-85 -123.62 170.59 10.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.173 -1.192 . . . . 4.0999999999999996 110.842 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.482 ' O ' ' CG2' ' A' ' 57' ' ' THR . 13.9 mm -101.21 141.01 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.649 0.738 . . . . 1.95 109.713 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.595 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.56 156.02 28.8 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.817 1.294 . . . . 1.1899999999999999 112.631 -176.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.446 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 42.0 t -120.65 138.32 51.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 106.536 -1.653 . . . . 1.6200000000000001 106.536 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' ALA . 24.0 tttt -82.71 134.82 35.13 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 117.732 -3.105 . . . . 3.52 110.227 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 8.9 p -109.84 82.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.037 -1.065 . . . . 2.21 108.893 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 38.3 mtpt -155.66 164.84 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.498 -1.667 . . . . 2.8500000000000001 106.498 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.5 165.82 43.0 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 116.908 -2.568 . . . . 2.4100000000000001 107.045 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.587 ' O ' ' O ' ' A' ' 15' ' ' GLY . 93.1 mtt-85 55.73 134.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.087 -1.079 . . . . 5.4100000000000001 108.087 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 48.75 20.4 0.33 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.615 -1.624 . . . . 3.1299999999999999 106.615 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 16' ' ' ARG . . . -56.97 -46.31 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.773 -1.103 . . . . 2.3199999999999998 108.838 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.36 103.65 3.07 Favored Glycine 0 C--N 1.284 -2.307 0 N-CA-C 110.458 -1.057 . . . . 1.53 110.458 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 42' ' ' THR . 36.2 t -147.49 135.5 21.31 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.278 -1.379 . . . . 1.8999999999999999 107.278 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.03 139.64 30.32 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.658 -1.217 . . . . 3.6400000000000001 107.838 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -130.1 140.71 50.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.12 -0.632 . . . . 0.78000000000000003 110.457 -177.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -103.32 135.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.566 -2.383 . . . . 1.1200000000000001 104.566 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.2 mt -103.14 132.29 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 119.246 -0.982 . . . . 1.3300000000000001 110.826 -175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -151.43 72.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 118.409 -1.316 . . . . 1.73 111.693 175.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.8 t0 170.12 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.549 -1.345 . . . . 1.5600000000000001 110.476 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.6 mt -120.51 127.74 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 104.345 -2.465 . . . . 2.5299999999999998 104.345 171.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -100.37 -104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 121.309 1.868 . . . . 1.47 110.988 -177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 56.1 t0 -64.19 -42.37 96.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.026 -1.046 . . . . 2.3999999999999999 109.249 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.652 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 49.9 p30 164.0 -46.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.812 0.845 . . . . 2.5499999999999998 109.291 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.652 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 79.7 m-20 -96.09 4.62 52.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.974 -1.079 . . . . 2.1299999999999999 111.56 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -112.17 141.0 46.41 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.352 -0.842 . . . . 2.4900000000000002 109.994 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.98 161.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.858 -0.526 . . . . 1.2 109.962 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.9 tt -100.9 132.45 46.29 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.69 -0.855 . . . . 1.6799999999999999 108.69 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -128.12 151.46 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 C-N-CA 119.234 -0.986 . . . . 1.1699999999999999 110.564 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -146.01 152.59 39.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 1.3100000000000001 111.104 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.0 154.38 25.14 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.692 -1.763 . . . . 0.83999999999999997 108.692 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.5 ' O ' ' OG1' ' A' ' 42' ' ' THR . 6.2 Cg_exo -57.64 109.25 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 CA-C-N 119.978 1.889 . . . . 1.1799999999999999 110.081 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.569 ' CE ' ' HZ1' ' A' ' 45' ' ' LYS . 34.9 tttp -56.64 -36.23 69.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.007 -1.058 . . . . 3.9700000000000002 109.472 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.72 -38.58 69.94 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.192 -1.003 . . . . 2.27 109.626 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mm -114.32 -38.66 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.206 -0.998 . . . . 2.71 111.533 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' ' OG ' ' A' ' 20' ' ' SER . 80.6 p -81.19 -33.95 32.63 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.93 -1.106 . . . . 1.75 110.112 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.65 66.33 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.31 -0.716 . . . . 1.28 111.31 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 37' ' ' GLY . 15.2 m -103.38 133.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.48 -1.6 . . . . 1.6799999999999999 109.832 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.569 ' HZ1' ' CE ' ' A' ' 39' ' ' LYS . 63.5 mttp -86.11 -78.41 0.28 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.787 -1.821 . . . . 3.98 106.98 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -149.79 124.7 9.92 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.749 -2.315 . . . . 3.3500000000000001 104.749 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.8 ptt85 -155.55 166.38 33.71 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.827 -1.796 . . . . 3.6699999999999999 109.912 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -109.75 141.39 42.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.641 -0.824 . . . . 3.4700000000000002 109.193 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.97 142.8 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 2.2599999999999998 110.366 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.427 ' ND2' ' CD1' ' A' ' 52' ' ' LEU . 42.6 p-10 -86.45 167.33 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.769 . . . . 2.6899999999999999 110.982 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.39 -26.59 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.689 -0.632 . . . . 2.1000000000000001 111.061 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.427 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 66.5 mt -55.06 -33.0 62.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.967 -1.083 . . . . 1.8 110.371 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -121.76 90.43 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.383 -1.34 . . . . 2.27 107.383 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.68 131.89 56.16 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.825 -0.547 . . . . 2.1400000000000001 110.332 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 2.6 tt0 -131.33 89.6 40.63 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 104.707 -2.331 . . . . 2.2799999999999998 104.707 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -87.88 149.93 7.15 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.495 1.463 . . . . 0.81000000000000005 114.293 -176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 39.8 p -110.38 165.82 11.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.718 -1.215 . . . . 1.1799999999999999 107.718 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.15 14.33 3.52 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.351 -0.843 . . . . 2.5699999999999998 110.124 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -91.65 125.55 36.42 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.49 -0.756 . . . . 3.3399999999999999 109.743 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -134.88 122.31 21.81 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.444 -0.785 . . . . 5.6799999999999997 110.465 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.71 152.96 37.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.97 -1.122 . . . . 5.2400000000000002 107.97 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 52.6 p30 -83.71 133.09 34.82 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.856 1.313 . . . . 2.1400000000000001 110.406 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.7 pt -125.24 158.71 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 115.031 -0.986 . . . . 2.3300000000000001 112.006 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 59.7 tp60 -64.38 -48.95 73.51 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.546 -1.662 . . . . 3.1800000000000002 109.378 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 15.2 ttmm 100.66 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.323 0.965 . . . . 3.8599999999999999 110.781 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.97 63.75 Favored Glycine 0 N--CA 1.506 3.334 0 O-C-N 120.556 -1.34 . . . . 0.72999999999999998 111.784 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.88 152.87 11.94 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.991 -1.299 . . . . 1.3100000000000001 112.832 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.7 p -63.14 167.59 4.89 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 108.284 -1.006 . . . . 1.0600000000000001 108.284 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.61 -45.65 88.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.916 -1.74 . . . . 2.02 112.749 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.32 -40.11 92.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 116.6 -2.04 . . . . 2.2999999999999998 107.844 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.8 -36.07 83.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.844 -1.169 . . . . 1.96 107.844 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 73.2 t -64.79 -42.99 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.579 -0.849 . . . . 1.1599999999999999 109.499 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.88 -41.65 92.02 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.362 -1.335 . . . . 1.3100000000000001 107.619 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.22 -43.34 92.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.844 -1.169 . . . . 2.7400000000000002 107.844 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -62.07 -34.18 75.79 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.596 -0.69 . . . . 3.1200000000000001 110.754 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.75 -41.19 73.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.475 -1.391 . . . . 1.98 108.473 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -61.6 -33.94 74.78 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 119.297 -0.961 . . . . 1.7 109.063 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -38.48 81.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.212 -2.144 . . . . 2.29 105.212 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.6 m -68.37 -29.4 68.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.338 -1.356 . . . . 1.78 107.338 175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 29.1 m120 60.56 38.12 19.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.351 -2.092 . . . . 2.1099999999999999 105.351 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.95 -11.81 24.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.399 -0.819 . . . . 3.0 111.413 -178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 m -56.91 -39.72 74.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.306 -1.496 . . . . 3.1099999999999999 110.098 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 84' ' ' TYR . 85.5 tt0 -156.09 -11.31 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.403 -1.319 . . . . 3.5299999999999998 112.297 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 83' ' ' GLU . 70.7 t80 -58.7 -47.25 85.2 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 114.411 -2.915 . . . . 3.5299999999999998 105.609 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.418 ' HG2' ' H ' ' A' ' 87' ' ' GLU . 48.7 ttm -90.73 -110.91 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.336 0.589 . . . . 2.96 112.034 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HZ2' ' CB ' ' A' ' 83' ' ' GLU . 10.4 mtmt 60.91 37.38 18.41 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.726 -1.213 . . . . 2.04 107.726 -175.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.5 mt-10 -67.57 -37.65 82.95 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.83 -0.748 . . . . 2.6899999999999999 111.286 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 62.0 mttp 85.16 126.46 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 105.768 -1.938 . . . . 5.4100000000000001 105.768 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.8 tt -61.3 -28.91 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.842 -1.543 . . . . 3.6699999999999999 108.797 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -101.38 125.56 48.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.821 -1.548 . . . . 4.9500000000000002 106.821 176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.64 131.73 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.942 -1.099 . . . . 5.9699999999999998 111.055 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.7 mmt-85 -60.16 152.26 24.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 7.2400000000000002 108.792 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -57.04 -48.66 97.06 Favored Pre-proline 0 N--CA 1.489 1.51 0 CA-C-N 116.046 -0.525 . . . . 9.9399999999999995 112.278 -177.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.39 -73.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 CA-C-N 120.457 1.199 . . . . 8.0800000000000001 113.89 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.8 t -142.45 162.08 36.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.098 -1.001 . . . . 7.7199999999999998 109.891 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.048 -0.977 . . . . 9.0600000000000005 108.962 178.575 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.494 1.554 0 CA-C-O 121.545 0.56 . . . . 3.8300000000000001 111.674 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.28 -101.88 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.099 -0.704 . . . . 4.0700000000000003 109.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.52 136.43 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 5.9500000000000002 108.692 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HB2' ' HE ' ' A' ' 8' ' ' ARG . 95.5 mt-10 -131.69 148.15 52.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.679 -1.23 . . . . 4.7199999999999998 107.679 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.56 154.85 35.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.383 -2.08 . . . . 2.8900000000000001 105.383 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . 90.26 8.81 65.99 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.517 -2.233 . . . . 1.47 107.517 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' LYS . 79.7 mtt180 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.977 -0.612 . . . . 4.0999999999999996 109.503 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.471 ' O ' ' CG2' ' A' ' 57' ' ' THR . 24.9 mm -108.03 135.31 47.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.311 -2.107 . . . . 1.95 105.311 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.536 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -127.92 155.89 43.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.07 -1.019 . . . . 1.1899999999999999 113.107 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.56 138.02 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 115.701 -0.681 . . . . 1.6200000000000001 109.827 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -85.71 130.81 34.46 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 118.74 -2.475 . . . . 3.52 109.817 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -121.19 123.03 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 117.992 -1.483 . . . . 2.21 112.622 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.679 ' HZ2' ' CG ' ' A' ' 53' ' ' HIS . 49.8 mttm -146.29 153.52 40.65 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.475 -1.306 . . . . 2.8500000000000001 107.475 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 16' ' ' ARG . . . -86.75 102.84 2.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.226 -2.349 . . . . 2.4100000000000001 107.226 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 38.5 ttm180 118.44 124.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.936 -1.505 . . . . 5.4100000000000001 106.936 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 18' ' ' ALA . 77.6 mm-40 73.06 -86.26 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 107.528 -1.286 . . . . 3.1299999999999999 107.528 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' C ' ' O ' ' A' ' 17' ' ' GLU . . . 8.19 113.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.07 0.938 . . . . 2.3199999999999998 111.962 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.85 80.21 0.05 OUTLIER Glycine 0 C--N 1.292 -1.914 0 N-CA-C 103.66 -3.776 . . . . 1.53 103.66 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.0 p -162.67 150.55 13.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 117.849 -1.54 . . . . 1.8999999999999999 110.839 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 1.2 ptpp? -114.59 147.84 38.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.362 -0.607 . . . . 3.6400000000000001 109.362 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 3.8 p -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.551 -0.718 . . . . 0.78000000000000003 110.387 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.7 t -103.93 136.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 105.874 -1.899 . . . . 1.1200000000000001 105.874 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.6 mt -94.43 129.25 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 123.642 1.687 . . . . 1.3300000000000001 111.847 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.597 ' CG1' ' H ' ' A' ' 26' ' ' ASP . 2.6 t -105.18 -151.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 112.61 -2.086 . . . . 1.73 109.332 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.597 ' H ' ' CG1' ' A' ' 25' ' ' VAL 0.272 36.3 t0 -67.4 163.49 20.72 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.733 -0.667 . . . . 1.5600000000000001 110.625 -172.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.3 tt -113.82 125.42 71.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 122.429 1.109 . . . . 2.5299999999999998 110.103 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -74.26 -37.45 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.934 0.873 . . . . 1.47 110.671 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -159.62 167.78 27.64 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.637 -0.875 . . . . 2.3999999999999999 108.637 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -57.14 -37.99 72.86 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.013 -1.075 . . . . 2.5499999999999998 108.615 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -80.45 -31.43 37.46 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.099 -1.0 . . . . 2.1299999999999999 112.464 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -113.27 143.25 44.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.514 -0.741 . . . . 2.4900000000000002 112.71 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.42 156.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.562 -0.532 . . . . 1.2 109.562 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 tt -100.04 125.54 46.12 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 105.743 -1.947 . . . . 1.6799999999999999 105.743 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.27 155.47 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 120.812 -1.18 . . . . 1.1699999999999999 110.965 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -142.47 155.09 45.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.261 -0.899 . . . . 1.3100000000000001 110.966 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.89 163.7 29.43 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.013 -2.035 . . . . 0.83999999999999997 108.013 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.13 111.5 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.532 1.666 . . . . 1.1799999999999999 110.05 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -58.66 -39.35 80.37 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.252 -0.905 . . . . 3.9700000000000002 110.843 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.36 -39.78 94.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.415 0.895 . . . . 2.27 113.415 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.5 mm -96.22 -76.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.037 . . . . 2.71 112.309 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -62.4 -34.87 77.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.667 -0.645 . . . . 1.75 110.311 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.95 -4.41 57.53 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.874 -0.89 . . . . 1.28 110.874 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 m -89.07 126.51 42.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.187 -2.153 . . . . 1.6799999999999999 105.187 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -94.04 -78.86 0.43 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.676 -1.265 . . . . 3.98 110.241 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.637 HH12 ' CG2' ' A' ' 72' ' ' VAL . 56.3 ttt85 -150.8 124.25 8.97 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.658 -1.979 . . . . 3.3500000000000001 105.658 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.62 163.18 40.61 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 117.438 -1.705 . . . . 3.6699999999999999 110.846 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -98.29 138.97 34.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.223 -1.029 . . . . 3.4700000000000002 108.223 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.92 140.14 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-N 119.915 1.234 . . . . 2.2599999999999998 109.817 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.543 ' ND2' ' CD1' ' A' ' 52' ' ' LEU . 44.0 p-10 -90.55 168.02 12.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.812 -0.555 . . . . 2.6899999999999999 110.57 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.53 -27.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.246 -0.909 . . . . 2.1000000000000001 110.549 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.543 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 73.0 mt -52.18 -33.2 39.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.8 109.666 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.679 ' CG ' ' HZ2' ' A' ' 14' ' ' LYS . 77.6 m80 -134.36 88.29 2.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.206 -1.405 . . . . 2.27 107.206 174.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.1 tp -124.49 132.24 53.48 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.648 -0.501 . . . . 2.1400000000000001 109.648 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.49 89.0 32.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.481 -2.044 . . . . 2.2799999999999998 105.481 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.59 156.47 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.014 1.809 . . . . 0.81000000000000005 112.701 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 9' ' ' ILE . 49.1 p -111.71 168.19 9.76 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.881 0.848 . . . . 1.1799999999999999 108.748 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -81.95 18.44 1.32 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.794 0.807 . . . . 2.5699999999999998 109.392 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 49.2 mttt -91.19 140.33 29.9 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 121.698 0.761 . . . . 3.3399999999999999 112.386 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -136.87 122.62 19.9 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.942 -0.703 . . . . 5.6799999999999997 109.472 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 71.7 mt -120.35 145.38 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.576 -0.898 . . . . 5.2400000000000002 108.576 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -85.39 126.37 33.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.306 -1.497 . . . . 2.1400000000000001 110.698 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.601 ' H ' ' CD1' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -127.45 164.0 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 115.02 -0.991 . . . . 2.3300000000000001 111.137 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 65' ' ' LYS . 95.6 mm-40 -84.27 1.49 44.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.763 -1.21 . . . . 3.1800000000000002 109.679 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 64' ' ' GLN . 99.4 mttt 53.03 124.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.566 0.698 . . . . 3.8599999999999999 112.07 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.04 70.63 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.574 -1.298 . . . . 0.72999999999999998 110.183 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.08 146.64 14.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.015 -1.285 . . . . 1.3100000000000001 111.824 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 72' ' ' VAL . 56.0 p -67.16 164.4 18.16 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.878 -1.156 . . . . 1.0600000000000001 107.878 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.28 -47.34 86.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.355 -1.465 . . . . 2.02 110.601 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -39.23 90.49 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.629 -1.628 . . . . 2.2999999999999998 106.876 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -64.72 -38.44 91.0 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.369 -0.832 . . . . 1.96 109.1 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.637 ' CG2' HH12 ' A' ' 46' ' ' ARG . 73.6 t -64.7 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.298 1.047 . . . . 1.1599999999999999 109.697 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.8 -42.23 98.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.32 -1.352 . . . . 1.3100000000000001 110.006 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -62.63 -42.89 99.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.998 -1.064 . . . . 2.7400000000000002 112.821 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -67.9 -27.53 66.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.902 -1.124 . . . . 3.1200000000000001 109.593 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 53.9 tp -55.32 -39.33 69.83 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.326 -0.95 . . . . 1.98 108.75 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -29.37 66.83 Favored 'General case' 0 C--N 1.282 -2.328 0 O-C-N 121.043 -1.036 . . . . 1.7 109.349 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.51 -32.64 51.26 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.101 -0.999 . . . . 2.29 110.046 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.1 m -77.82 3.73 13.58 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 119.995 -1.691 . . . . 1.78 111.267 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 64.92 44.74 3.42 Favored 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 122.27 1.034 . . . . 2.1099999999999999 112.485 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' CD1' ' SD ' ' A' ' 85' ' ' MET . 2.1 mm? -66.3 -24.95 66.63 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.484 -0.78 . . . . 3.0 110.398 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 m -42.51 -36.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.974 -1.079 . . . . 3.1099999999999999 110.903 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -161.67 -18.83 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 119.574 -1.954 . . . . 3.5299999999999998 111.029 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -60.49 -43.62 96.8 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 123.518 1.628 . . . . 3.5299999999999998 108.049 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 81' ' ' LEU . 62.8 mtt -95.58 -123.95 0.11 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 112.91 -1.95 . . . . 2.96 111.972 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.405 ' NZ ' ' O ' ' A' ' 81' ' ' LEU . 14.8 mttm 56.45 29.53 15.46 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.867 0.691 . . . . 2.04 112.867 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' CG ' ' N ' ' A' ' 88' ' ' LYS . 17.6 pt-20 -150.17 -60.5 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.467 -1.396 . . . . 2.6899999999999999 110.865 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' N ' ' CG ' ' A' ' 87' ' ' GLU . 44.4 tptt 45.69 -124.43 1.21 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.243 -1.536 . . . . 5.4100000000000001 111.289 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.498 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 83.7 mt -119.92 131.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.947 0.879 . . . . 3.6699999999999999 110.306 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -130.92 149.14 52.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.343 1.068 . . . . 4.9500000000000002 111.806 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.31 142.21 21.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.825 -1.176 . . . . 5.9699999999999998 107.825 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -127.18 138.81 53.21 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.121 0.962 . . . . 7.2400000000000002 110.567 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.458 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 2.2 ttt -166.32 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 106.98 -1.489 . . . . 9.9399999999999995 106.98 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 93' ' ' MET . 23.8 Cg_exo -60.09 -28.0 86.07 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.612 1.541 . . . . 8.0800000000000001 111.916 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.4 m -66.88 -38.71 86.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.924 -1.11 . . . . 7.7199999999999998 108.331 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.098 -0.953 . . . . 9.0600000000000005 109.334 -179.607 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 121.537 0.557 . . . . 3.8300000000000001 112.067 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.65 69.88 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.587 -0.695 . . . . 4.0700000000000003 109.633 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.443 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 72.0 mt -110.71 137.2 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.957 1.36 . . . . 5.9500000000000002 112.147 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 6' ' ' VAL . 95.3 mt-10 -112.76 152.44 29.11 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.161 -1.381 . . . . 4.7199999999999998 109.916 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.501 ' CB ' ' O ' ' A' ' 5' ' ' GLU . 3.1 t 94.95 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 CA-C-O 121.15 0.5 . . . . 2.8900000000000001 111.162 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 83.26 27.83 38.76 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.172 -0.955 . . . . 1.47 110.991 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 4' ' ' ILE . 12.7 ptm180 -149.01 -177.98 6.11 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.935 -1.333 . . . . 4.0999999999999996 109.572 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 9' ' ' ILE . 97.6 mt -99.78 140.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 124.031 1.872 . . . . 1.95 113.883 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.4 p -121.4 156.34 32.89 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.049 -2.341 . . . . 1.1899999999999999 109.119 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.42 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 42.5 t -124.77 136.29 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 108.668 -0.864 . . . . 1.6200000000000001 108.668 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.565 ' CE ' HH21 ' A' ' 47' ' ' ARG . 36.2 mttp -91.17 125.49 35.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 118.987 -2.321 . . . . 3.52 110.851 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.2 124.29 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.635 -1.226 . . . . 2.21 109.583 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.423 ' H ' ' HB1' ' A' ' 18' ' ' ALA . 24.0 mttm -146.66 156.14 42.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.532 -1.285 . . . . 2.8500000000000001 107.532 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 16' ' ' ARG . . . -85.43 176.62 49.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 103.934 -3.666 . . . . 2.4100000000000001 103.934 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 15' ' ' GLY . 37.0 mtm180 27.32 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.57 0 CA-C-N 120.049 1.924 . . . . 5.4100000000000001 109.343 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 41.3 tp10 93.17 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 106.621 -1.622 . . . . 3.1299999999999999 106.621 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 156.67 104.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.97 -0.456 . . . . 2.3199999999999998 110.479 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.79 76.68 0.05 OUTLIER Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.634 -1.746 . . . . 1.53 110.645 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.422 ' OG ' ' CE ' ' A' ' 90' ' ' LYS . 3.2 m -155.64 135.8 13.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.394 -1.65 . . . . 1.8999999999999999 109.928 175.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -98.35 145.83 26.3 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.409 -0.96 . . . . 3.6400000000000001 108.409 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.1 p -134.61 162.58 31.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.346 0.593 . . . . 0.78000000000000003 110.447 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.18 135.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.349 -2.093 . . . . 1.1200000000000001 105.349 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.7 mt -97.31 132.17 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.694 -1.254 . . . . 1.3300000000000001 110.37 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -143.78 70.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 C-N-CA 118.991 -1.084 . . . . 1.73 111.355 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 20.2 t70 165.83 148.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.505 -1.372 . . . . 1.5600000000000001 109.582 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.98 115.45 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 103.815 -2.661 . . . . 2.5299999999999998 103.815 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.3 mt -97.03 -81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 1.47 111.029 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -108.96 171.83 7.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.735 -1.12 . . . . 2.3999999999999999 108.982 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' C ' HD21 ' A' ' 31' ' ' ASN . 92.3 m-20 -55.62 -40.19 71.78 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 118.497 -1.281 . . . . 2.5499999999999998 109.51 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 31' ' ' ASN . 2.7 m120 -102.51 -0.96 31.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.635 -1.291 . . . . 2.1299999999999999 113.82 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.04 141.14 48.99 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 120.935 1.698 . . . . 2.4900000000000002 114.087 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.25 161.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 HD22 ' HE ' ' A' ' 46' ' ' ARG . 8.4 tt -99.46 136.04 39.98 Favored 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 108.215 -1.032 . . . . 1.6799999999999999 108.215 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.09 150.43 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.258 -0.977 . . . . 1.1699999999999999 111.944 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 t -143.07 155.05 44.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.472 0.654 . . . . 1.3100000000000001 111.804 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.77 167.08 32.58 Favored Glycine 0 N--CA 1.506 3.361 0 N-CA-C 108.047 -2.021 . . . . 0.83999999999999997 108.047 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.62 124.48 15.53 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 CA-C-N 119.037 1.418 . . . . 1.1799999999999999 110.357 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' HZ3' ' CD ' ' A' ' 45' ' ' LYS . 23.5 mttt -60.51 -43.23 97.31 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.225 1.012 . . . . 3.9700000000000002 110.869 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.87 -40.67 91.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.526 0.936 . . . . 2.27 113.526 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CD1' ' NZ ' ' A' ' 86' ' ' LYS . 81.6 mt -96.09 -76.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.325 -0.95 . . . . 2.71 113.145 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.9 m -60.15 -36.6 77.89 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.354 -1.466 . . . . 1.75 109.035 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -6.65 63.46 Favored Glycine 0 C--N 1.293 -1.826 0 N-CA-C 110.249 -1.14 . . . . 1.28 110.249 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.5 m -91.64 131.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 119.267 1.533 . . . . 1.6799999999999999 107.684 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CD ' ' HZ3' ' A' ' 39' ' ' LYS . 35.7 ttmt -89.16 -78.25 0.36 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.76 -1.176 . . . . 3.98 109.51 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HE ' HD22 ' A' ' 34' ' ' LEU . 55.9 ttt180 -151.92 124.02 8.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 105.009 -2.219 . . . . 3.3500000000000001 105.009 177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.565 HH21 ' CE ' ' A' ' 12' ' ' LYS . 38.1 ptt180 -158.8 166.96 30.7 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 119.385 -2.072 . . . . 3.6699999999999999 110.191 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -96.23 143.38 27.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.112 -0.992 . . . . 3.4700000000000002 111.435 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.93 143.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.595 -0.891 . . . . 2.2599999999999998 108.595 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' ND2' ' CD1' ' A' ' 52' ' ' LEU . 41.7 p-10 -91.85 164.14 13.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.145 -0.972 . . . . 2.6899999999999999 111.768 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.38 -24.75 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 115.814 -0.63 . . . . 2.1000000000000001 111.341 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.446 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 60.9 mt -54.79 -31.4 58.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.954 -1.091 . . . . 1.8 109.557 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -118.15 92.33 3.8 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.09 -1.819 . . . . 2.27 106.09 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.1 tt -113.93 129.53 56.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.138 0.494 . . . . 2.1400000000000001 109.722 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -140.84 93.87 8.25 Favored Pre-proline 0 N--CA 1.502 2.162 0 N-CA-C 107.743 -1.206 . . . . 2.2799999999999998 107.743 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.23 147.46 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.692 1.595 . . . . 0.81000000000000005 114.307 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 p -120.26 161.86 20.39 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.823 -1.177 . . . . 1.1799999999999999 107.823 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' O ' ' OD1' ' A' ' 58' ' ' ASP . 54.6 p30 -78.66 135.61 37.25 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.334 -1.728 . . . . 2.5699999999999998 106.334 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.699 ' HG2' ' H ' ' A' ' 60' ' ' LYS . 40.3 tttm -171.61 -174.57 1.41 Allowed 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 117.298 -1.761 . . . . 3.3399999999999999 109.504 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.699 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 15.7 tttp -82.78 153.1 25.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.767 -1.197 . . . . 5.6799999999999997 107.767 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.4 pt -138.0 82.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 114.609 1.337 . . . . 5.2400000000000002 114.609 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -146.77 91.75 2.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.96 -1.087 . . . . 2.1400000000000001 112.13 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.547 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.65 162.64 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.728 0.775 . . . . 2.3300000000000001 109.364 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -72.32 -121.02 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.26 -2.126 . . . . 3.1800000000000002 105.26 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -173.78 131.45 0.43 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.84 -1.163 . . . . 3.8599999999999999 108.834 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.52 17.8 70.12 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.555 -1.783 . . . . 0.72999999999999998 110.178 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.16 144.94 22.54 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.685 -1.48 . . . . 1.3100000000000001 111.715 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 72' ' ' VAL . 52.5 p -68.45 169.22 11.2 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 107.175 -1.417 . . . . 1.0600000000000001 107.175 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 91.6 m-20 -59.15 -47.69 84.37 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.181 -2.199 . . . . 2.02 111.18 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.45 -41.79 98.65 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 116.936 -1.906 . . . . 2.2999999999999998 108.332 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.91 -35.93 82.75 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.266 -0.974 . . . . 1.96 108.403 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' SER . 78.4 t -62.17 -40.12 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.73 0.776 . . . . 1.1599999999999999 109.041 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 99.4 mttt -59.53 -40.66 87.93 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.701 -1.2 . . . . 1.3100000000000001 108.775 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -60.31 -43.13 96.64 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 117.491 -1.684 . . . . 2.7400000000000002 109.222 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.52 78.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.082 -1.011 . . . . 3.1200000000000001 109.956 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.18 -42.98 87.23 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.956 . . . . 1.98 110.245 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.19 -31.15 68.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.183 -0.948 . . . . 1.7 108.715 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -52.57 -32.37 40.75 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.281 -1.748 . . . . 2.29 106.281 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.3 m -62.9 -18.41 62.98 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.783 -0.573 . . . . 1.78 111.668 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 70.4 50.35 0.4 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-O 123.257 1.503 . . . . 2.1099999999999999 110.505 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.661 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.4 -28.22 69.1 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.544 -1.662 . . . . 3.0 112.362 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.354 -1.466 . . . . 3.1099999999999999 112.988 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.39 -18.2 0.11 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 119.411 -2.055 . . . . 3.5299999999999998 110.343 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.99 -38.58 86.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.699 1.238 . . . . 3.5299999999999998 107.837 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.06 -125.95 0.22 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.477 -1.238 . . . . 2.96 111.004 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' NZ ' ' CD1' ' A' ' 41' ' ' ILE . 33.1 mttm 54.27 26.42 6.8 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.12 1.368 . . . . 2.04 114.369 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -66.0 -38.7 89.14 Favored 'General case' 0 N--CA 1.512 2.634 0 O-C-N 119.394 -2.066 . . . . 2.6899999999999999 110.502 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.505 ' NZ ' ' CD1' ' A' ' 91' ' ' ILE . 23.0 tttt 37.07 60.34 1.01 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.779 0.659 . . . . 5.4100000000000001 112.779 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.514 ' O ' ' O ' ' A' ' 92' ' ' ARG . 86.4 mt -64.64 -34.09 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 119.456 -2.028 . . . . 3.6699999999999999 107.846 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' CE ' ' OG ' ' A' ' 20' ' ' SER . 63.0 mttm -52.47 -29.78 26.52 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.927 -1.488 . . . . 4.9500000000000002 109.773 -173.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.505 ' CD1' ' NZ ' ' A' ' 88' ' ' LYS . 19.7 tt -64.89 -23.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.302 -1.499 . . . . 5.9699999999999998 109.652 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' A' ' 89' ' ' ILE . 98.0 mtt180 -125.92 147.07 49.59 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.37 1.081 . . . . 7.2400000000000002 112.004 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.451 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 1.7 ttm -131.25 -50.64 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.287 -0.87 . . . . 9.9399999999999995 109.242 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' CD ' ' H ' ' A' ' 93' ' ' MET . 21.8 Cg_exo -61.37 -33.12 89.51 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.998 1.035 . . . . 8.0800000000000001 111.257 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.2 m -64.12 -39.37 93.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.726 -0.608 . . . . 7.7199999999999998 109.385 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.989 -1.005 . . . . 9.0600000000000005 109.172 179.478 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo . . . . . 0 N--CA 1.488 1.189 0 CA-C-O 121.809 0.671 . . . . 3.8300000000000001 112.058 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.52 158.33 31.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.045 -1.465 . . . . 4.0700000000000003 107.045 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.04 132.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.705 -1.247 . . . . 5.9500000000000002 108.681 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 8' ' ' ARG . 94.6 mt-10 -149.08 160.51 43.27 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.565 -0.902 . . . . 4.7199999999999998 108.565 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.7 t -100.39 142.69 15.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.549 -1.278 . . . . 2.8900000000000001 107.549 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.83 -3.4 62.64 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.492 -1.38 . . . . 1.47 110.329 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 5' ' ' GLU . 95.1 mtt180 -89.92 177.2 6.54 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.33 -1.1 . . . . 4.0999999999999996 110.786 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.9 mt -95.9 137.34 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 106.569 -1.641 . . . . 1.95 106.569 178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.8 p -127.79 158.62 37.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.515 -0.741 . . . . 1.1899999999999999 110.441 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.08 132.22 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.467 -1.679 . . . . 1.6200000000000001 106.467 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -93.4 119.59 32.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.861 -1.774 . . . . 3.52 112.84 -177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.08 128.99 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.493 -1.299 . . . . 2.21 107.493 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.463 ' H ' ' HB1' ' A' ' 18' ' ' ALA . 19.0 pttp -143.85 175.82 9.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.833 -0.803 . . . . 2.8500000000000001 108.833 178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -81.14 143.19 23.79 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.383 -1.865 . . . . 2.4100000000000001 108.77 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 33.6 ttm180 49.6 87.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.19 -1.411 . . . . 5.4100000000000001 107.19 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 48.9 tp10 112.62 152.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 105.92 -1.882 . . . . 3.1299999999999999 105.92 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 155.95 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 112.662 0.616 . . . . 2.3199999999999998 112.662 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.83 84.21 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.81 -1.662 . . . . 1.53 110.591 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -161.42 147.62 14.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.276 . . . . 1.8999999999999999 108.798 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.592 ' NZ ' ' CE ' ' A' ' 85' ' ' MET . 97.1 mttt -96.63 147.77 23.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.161 -0.962 . . . . 3.6400000000000001 108.707 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 4.9 p -143.93 162.81 35.18 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.228 -0.92 . . . . 0.78000000000000003 110.396 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.5 t -114.7 135.03 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 105.911 -1.885 . . . . 1.1200000000000001 105.911 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.419 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 66.5 mt -91.29 134.83 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.693 -1.203 . . . . 1.3300000000000001 110.066 -175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 24' ' ' ILE . 13.1 m -156.78 76.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.464 1.653 . . . . 1.73 115.464 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 54.2 t0 171.63 150.89 0.05 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.094 -1.004 . . . . 1.5600000000000001 109.249 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 26.4 mm -119.22 129.67 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.494 -2.039 . . . . 2.5299999999999998 105.494 171.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.622 ' CG2' ' H ' ' A' ' 29' ' ' ASP . 88.6 mt -121.55 -117.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.816 -1.178 . . . . 1.47 109.552 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.622 ' H ' ' CG2' ' A' ' 28' ' ' ILE . 52.4 t0 -58.22 -35.23 71.37 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.082 -1.451 . . . . 2.3999999999999999 107.082 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 91.9 m-20 121.98 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.119 -1.808 . . . . 2.5499999999999998 106.119 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.59 4.7 53.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.437 -1.32 . . . . 2.1299999999999999 107.437 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.69 148.48 52.48 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.541 -0.754 . . . . 2.4900000000000002 109.736 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.29 161.11 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 108.12 -1.067 . . . . 1.2 108.12 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.66 129.71 52.78 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 117.844 -1.542 . . . . 1.6799999999999999 107.807 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 m -125.7 154.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 118.815 -1.154 . . . . 1.1699999999999999 110.708 -178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 10.5 t -140.61 156.88 46.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 1.3100000000000001 112.109 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.47 163.54 31.65 Favored Glycine 0 N--CA 1.507 3.371 0 N-CA-C 107.523 -2.231 . . . . 0.83999999999999997 107.523 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.24 122.82 12.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 CA-C-N 119.506 1.653 . . . . 1.1799999999999999 110.78 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.6 -40.43 87.46 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.817 -0.552 . . . . 3.9700000000000002 111.715 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.28 -43.11 95.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.15 1.167 . . . . 2.27 114.15 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 mm -96.5 -71.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.32 -1.487 . . . . 2.71 114.016 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.462 ' CG2' ' H ' ' A' ' 21' ' ' LYS . 31.5 m -56.34 -37.06 69.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.723 -0.671 . . . . 1.75 111.002 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.83 7.52 47.45 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.31 -1.424 . . . . 1.28 110.03 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.08 162.62 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 105.527 -2.027 . . . . 1.6799999999999999 105.527 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.528 ' O ' ' OG1' ' A' ' 36' ' ' THR . 54.1 tttp -139.16 -69.92 0.42 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.989 -1.115 . . . . 3.98 107.989 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -146.16 124.63 12.39 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.544 -1.28 . . . . 3.3500000000000001 107.544 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -155.17 168.06 28.29 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.876 -1.14 . . . . 3.6699999999999999 109.543 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -116.62 143.6 45.42 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.662 -1.236 . . . . 3.4700000000000002 107.662 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.48 140.12 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.379 1.085 . . . . 2.2599999999999998 111.365 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 44.6 t-20 -80.79 163.36 23.53 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.967 -1.015 . . . . 2.6899999999999999 110.321 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 24.1 mm -59.2 -27.33 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 115.917 -0.583 . . . . 2.1000000000000001 110.696 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.0 mt -54.55 -37.9 65.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.934 -1.104 . . . . 1.8 111.369 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.99 89.32 3.0 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.35 -1.34 . . . . 2.27 109.953 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.2 tp -118.83 128.82 54.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.928 -0.768 . . . . 2.1400000000000001 108.928 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -135.26 85.88 31.99 Favored Pre-proline 0 N--CA 1.508 2.443 0 O-C-N 120.542 -1.348 . . . . 2.2799999999999998 108.668 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -96.13 151.69 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.89 2.393 . . . . 0.81000000000000005 115.512 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.501 ' OG1' ' NZ ' ' A' ' 59' ' ' LYS . 19.4 p -112.19 162.0 15.94 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 106.297 -1.742 . . . . 1.1799999999999999 106.297 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.19 98.47 5.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.515 -1.99 . . . . 2.5699999999999998 110.657 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' NZ ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -114.06 -164.63 0.94 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.416 1.103 . . . . 3.3399999999999999 111.137 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -84.58 163.36 19.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.212 -1.774 . . . . 5.6799999999999997 106.212 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.7 tt -121.19 123.47 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.688 -1.258 . . . . 5.2400000000000002 109.61 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.464 ' OD2' ' OE1' ' A' ' 78' ' ' GLU . 60.7 t0 -161.63 107.09 1.31 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.73 -0.606 . . . . 2.1400000000000001 110.267 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.54 135.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.333 -1.728 . . . . 2.3300000000000001 106.333 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.633 ' H ' ' NZ ' ' A' ' 75' ' ' LYS . 60.3 tp60 -64.78 -50.61 66.11 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 115.128 -2.629 . . . . 3.1800000000000002 108.657 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 50.3 tttt 131.2 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 107.268 -1.382 . . . . 3.8599999999999999 107.268 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.18 22.3 59.3 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.712 -1.355 . . . . 0.72999999999999998 109.712 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.66 143.64 24.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.236 . . . . 1.3100000000000001 112.436 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.6 p -71.08 163.91 26.65 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 109.059 -0.719 . . . . 1.0600000000000001 109.059 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -54.97 -43.14 73.21 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.304 -1.498 . . . . 2.02 109.908 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -38.47 87.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 117.401 -1.72 . . . . 2.2999999999999998 108.971 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.24 -37.38 83.43 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.557 -1.257 . . . . 1.96 108.581 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.2 t -63.7 -43.73 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 120.121 -0.632 . . . . 1.1599999999999999 111.371 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.51 -42.05 91.33 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.103 -1.439 . . . . 1.3100000000000001 108.322 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.99 -43.4 91.47 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 117.6 -1.64 . . . . 2.7400000000000002 107.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.633 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 56.5 mtmt -60.26 -32.02 70.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 3.1200000000000001 112.12 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.69 ' O ' ' OG ' ' A' ' 79' ' ' SER . 32.0 tp -52.8 -40.91 63.67 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.043 -1.661 . . . . 1.98 107.441 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -58.57 -34.46 71.08 Favored 'General case' 0 C--N 1.272 -2.776 0 C-N-CA 116.888 -1.925 . . . . 1.7 108.381 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.464 ' OE1' ' OD2' ' A' ' 62' ' ' ASP . 97.6 mt-10 -62.33 -33.47 74.76 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.888 -1.523 . . . . 2.29 106.888 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.69 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 83.7 p -65.34 -26.07 67.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.859 -2.274 . . . . 1.78 104.859 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.0 m120 63.12 42.15 7.47 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.743 0.783 . . . . 2.1099999999999999 109.946 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 34.2 mt -92.11 3.73 54.67 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.685 -0.806 . . . . 3.0 111.35 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 m -46.61 -33.74 4.43 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.912 -1.118 . . . . 3.1099999999999999 110.052 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -164.84 0.26 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.051 -1.031 . . . . 3.5299999999999998 108.648 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -61.42 -43.86 98.14 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 103.176 -2.898 . . . . 3.5299999999999998 103.176 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.592 ' CE ' ' NZ ' ' A' ' 21' ' ' LYS . 85.3 mmm -121.3 -120.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.281 -1.327 . . . . 2.96 110.388 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 36.4 mtpt 64.97 39.45 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.152 -1.385 . . . . 2.04 109.878 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.488 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 19.0 pt-20 -98.28 172.28 7.67 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.471 0.653 . . . . 2.6899999999999999 109.687 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -95.04 128.53 41.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.737 -1.209 . . . . 5.4100000000000001 107.737 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.1 mt -68.36 -39.72 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.358 -1.464 . . . . 3.6699999999999999 113.705 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 18' ' ' ALA . 22.8 mttt -128.71 139.21 52.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.357 1.89 . . . . 4.9500000000000002 109.286 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.8 tt -125.66 134.15 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.572 -0.899 . . . . 5.9699999999999998 108.572 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -126.38 147.22 49.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.87 -1.144 . . . . 7.2400000000000002 109.274 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.43 ' C ' ' SD ' ' A' ' 93' ' ' MET . 2.3 tpt -54.65 -56.15 30.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 C-N-CA 118.96 -1.096 . . . . 9.9399999999999995 110.065 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -60.1 -40.14 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.488 1.21 . . . . 8.0800000000000001 112.119 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -65.72 -39.12 90.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 7.7199999999999998 108.192 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.983 -1.008 . . . . 9.0600000000000005 109.181 179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 121.307 0.461 . . . . 3.8300000000000001 112.513 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.66 -40.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.849 . . . . 4.0700000000000003 109.511 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.66 140.18 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 105.963 -1.866 . . . . 5.9500000000000002 105.963 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 58.3 mp0 -104.18 147.11 27.83 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 120.614 1.552 . . . . 4.7199999999999998 108.931 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 169.46 123.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.4 -0.963 . . . . 2.8900000000000001 108.4 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 71.28 24.53 76.86 Favored Glycine 0 N--CA 1.502 3.1 0 C-N-CA 119.499 -1.334 . . . . 1.47 110.016 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 57' ' ' THR . 80.9 mtp180 -117.97 164.61 14.82 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.83 -0.806 . . . . 4.0999999999999996 110.294 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.63 137.94 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 122.358 1.075 . . . . 1.95 109.448 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.85 156.69 27.96 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.994 -1.003 . . . . 1.1899999999999999 111.554 -175.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 t -122.09 134.99 63.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 N-CA-C 105.979 -1.86 . . . . 1.6200000000000001 105.979 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.43 130.05 38.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 119.202 -2.186 . . . . 3.52 111.443 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.89 120.46 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 118.197 -1.401 . . . . 2.21 110.409 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -146.59 152.71 39.36 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.664 -1.606 . . . . 2.8500000000000001 106.664 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -85.29 174.1 48.73 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 105.333 -3.107 . . . . 2.4100000000000001 105.333 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 15' ' ' GLY . 73.0 mtm180 34.68 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 CA-C-N 118.643 1.221 . . . . 5.4100000000000001 107.756 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.545 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 82.6 tt0 89.71 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.364 -1.347 . . . . 3.1299999999999999 107.364 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . 153.59 106.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.78 0.324 . . . . 2.3199999999999998 110.798 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.89 80.88 0.05 OUTLIER Glycine 0 C--N 1.297 -1.62 0 C-N-CA 118.906 -1.616 . . . . 1.53 109.835 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -156.71 141.76 17.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.399 -1.648 . . . . 1.8999999999999999 110.346 176.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -93.62 148.38 22.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.383 -1.448 . . . . 3.6400000000000001 107.725 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -137.02 142.95 42.5 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.249 -0.907 . . . . 0.78000000000000003 112.634 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.82 137.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.228 -1.767 . . . . 1.1200000000000001 106.228 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.7 mt -100.43 131.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.465 -0.894 . . . . 1.3300000000000001 111.706 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -143.84 72.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.145 -1.022 . . . . 1.73 109.966 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 56.9 t0 168.12 144.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.788 -1.195 . . . . 1.5600000000000001 109.716 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.484 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.2 tt -124.0 124.42 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.331 -2.47 . . . . 2.5299999999999998 104.331 170.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -99.56 -84.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.878 -1.139 . . . . 1.47 112.059 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 59.5 t0 -104.47 8.14 35.55 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.188 -0.671 . . . . 2.3999999999999999 109.188 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 81.4 m-20 90.08 -26.86 0.05 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 124.043 0.937 . . . . 2.5499999999999998 109.759 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 39.3 p-10 -103.09 -3.45 25.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 2.1299999999999999 109.78 177.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 95.9 m-85 -119.1 140.39 50.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.958 -1.127 . . . . 2.4900000000000002 107.958 175.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.45 158.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 1.2 109.177 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.53 135.88 44.29 Favored 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.026 -1.07 . . . . 1.6799999999999999 108.333 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.6 m -126.39 149.09 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.034 -1.066 . . . . 1.1699999999999999 109.949 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 45' ' ' LYS . 6.3 t -142.84 154.04 43.77 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.642 0.735 . . . . 1.3100000000000001 111.236 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -156.54 160.14 30.01 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.698 -2.561 . . . . 0.83999999999999997 106.698 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -60.86 121.81 10.26 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 CA-C-N 120.629 2.215 . . . . 1.1799999999999999 110.017 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -58.88 -36.57 74.86 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.522 1.153 . . . . 3.9700000000000002 108.63 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.51 -38.86 91.58 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.511 -0.768 . . . . 2.27 112.373 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 76.1 mt -96.5 -81.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.915 -1.116 . . . . 2.71 111.369 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.5 m -63.03 -36.79 84.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.927 . . . . 1.75 111.067 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.73 -7.45 57.62 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 120.509 -0.853 . . . . 1.28 111.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.3 m -91.55 130.72 40.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 120.554 2.177 . . . . 1.6799999999999999 105.929 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 36' ' ' THR . 22.9 tttt -92.38 -75.64 0.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.516 -1.273 . . . . 3.98 109.551 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -149.78 125.84 10.62 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.897 -1.89 . . . . 3.3500000000000001 105.897 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -156.58 165.51 36.08 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 119.714 -1.866 . . . . 3.6699999999999999 110.909 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -106.9 136.04 47.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.289 -0.882 . . . . 3.4700000000000002 111.155 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.7 t -124.88 136.74 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.033 -1.042 . . . . 2.2599999999999998 110.674 177.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.24 167.62 16.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.331 -0.856 . . . . 2.6899999999999999 109.474 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.5 mt -56.86 -26.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.231 -0.918 . . . . 2.1000000000000001 111.375 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.88 -34.88 68.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.426 -1.421 . . . . 1.8 110.253 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -116.44 87.07 2.61 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.296 -0.962 . . . . 2.27 108.625 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.35 127.59 46.86 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.314 -0.866 . . . . 2.1400000000000001 109.079 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -134.45 88.9 28.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.45 -1.315 . . . . 2.2799999999999998 107.45 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -90.5 148.05 4.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.85 1.7 . . . . 0.81000000000000005 114.866 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 30.4 p -117.1 165.46 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.99 -1.115 . . . . 1.1799999999999999 107.99 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.85 137.0 53.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.264 -1.754 . . . . 2.5699999999999998 106.264 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -172.32 -175.78 1.47 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.024 0.916 . . . . 3.3399999999999999 110.127 -178.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 7' ' ' GLY . 48.7 mmtm -86.61 163.15 17.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.781 -1.192 . . . . 5.6799999999999997 107.781 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 61' ' ' ILE . 31.4 pt -130.89 87.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 123.595 1.664 . . . . 5.2400000000000002 111.823 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.1 p30 -150.68 93.05 1.91 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 113.735 1.013 . . . . 2.1400000000000001 113.735 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.1 pt -121.95 153.41 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.728 -1.233 . . . . 2.3300000000000001 110.432 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 26.3 mt-30 -63.05 -42.34 99.69 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.477 -1.689 . . . . 3.1800000000000002 109.216 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 34.4 mtmt 98.21 90.17 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.448 0.567 . . . . 3.8599999999999999 110.037 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.11 8.47 60.21 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.893 -1.129 . . . . 0.72999999999999998 111.66 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.81 148.47 10.12 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.822 -1.399 . . . . 1.3100000000000001 112.158 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.7 p -65.49 165.71 11.65 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.616 -1.253 . . . . 1.0600000000000001 107.616 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -59.33 -45.1 92.3 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 119.798 -1.814 . . . . 2.02 111.484 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.43 -39.72 95.25 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.089 -1.844 . . . . 2.2999999999999998 108.777 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.99 -36.39 83.18 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.903 -1.119 . . . . 1.96 108.353 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.3 -42.59 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.768 . . . . 1.1599999999999999 110.654 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.07 -41.95 93.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 118.716 -1.194 . . . . 1.3100000000000001 109.666 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -59.23 -41.79 89.5 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 117.484 -1.686 . . . . 2.7400000000000002 107.244 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -62.69 -34.92 78.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.63 -0.669 . . . . 3.1200000000000001 110.704 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 50.3 tp -56.55 -41.38 76.75 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.812 -1.18 . . . . 1.98 108.983 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.27 -30.75 66.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.891 -0.781 . . . . 1.7 108.891 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' OD2' ' A' ' 62' ' ' ASP . 84.5 tt0 -53.62 -34.91 60.13 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.66 -1.237 . . . . 2.29 107.66 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.1 m -65.74 -18.31 65.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 1.78 109.907 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 71.16 51.13 0.28 Allowed 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.932 1.349 . . . . 2.1099999999999999 111.551 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 76' ' ' LEU . 6.5 mp -63.51 -28.59 70.06 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.265 -1.334 . . . . 3.0 112.153 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 39.8 m -44.88 -35.63 2.9 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.577 -1.327 . . . . 3.1099999999999999 110.945 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -153.92 -19.06 0.14 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.046 -1.659 . . . . 3.5299999999999998 110.268 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -61.99 -40.94 97.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.373 -1.454 . . . . 3.5299999999999998 108.034 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . 87.7 mtp -103.65 -122.75 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.85 -1.068 . . . . 2.96 110.976 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.404 ' CD ' ' O ' ' A' ' 81' ' ' LEU . 28.6 mtpt 43.14 16.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.865 -0.522 . . . . 2.04 111.134 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.0 mt-10 -66.21 -35.61 80.89 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.566 -1.254 . . . . 2.6899999999999999 108.923 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 33.8 mttp 72.76 124.88 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.657 -2.349 . . . . 5.4100000000000001 104.657 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -61.1 -44.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.35 -1.34 . . . . 3.6699999999999999 111.669 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -130.46 136.64 49.21 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 121.316 1.871 . . . . 4.9500000000000002 108.658 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 94' ' ' PRO . 71.2 mt -120.82 128.03 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.082 -1.081 . . . . 5.9699999999999998 108.082 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.492 ' O ' ' SD ' ' A' ' 93' ' ' MET . 26.0 mmt85 -65.87 -40.64 91.82 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.4 -2.074 . . . . 7.2400000000000002 105.4 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.593 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 2.9 tpp 175.01 -43.83 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 CA-C-N 114.492 -1.231 . . . . 9.9399999999999995 108.133 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 93' ' ' MET . 18.7 Cg_exo -66.35 179.38 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 124.156 3.237 . . . . 8.0800000000000001 111.251 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.3 p -71.24 -10.94 60.59 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.221 -0.924 . . . . 7.7199999999999998 109.74 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 9.0600000000000005 109.175 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.998 0.427 . . . . 4.72 110.66 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 7' ' ' GLY . 10.8 m -72.43 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.081 -1.012 . . . . 2.38 108.972 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 79.91 37.72 21.63 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.722 -1.237 . . . . 1.47 111.187 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.76 HH21 HD11 ' A' ' 54' ' ' LEU . 29.1 ptt-85 -146.75 -177.93 5.91 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 120.92 -1.341 . . . . 3.56 108.789 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' CD ' ' A' ' 59' ' ' LYS . 61.4 mt -107.34 142.39 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.719 1.247 . . . . 1.43 112.213 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HB3' HD11 ' A' ' 24' ' ' ILE . 1.6 p -113.43 155.47 25.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.785 -1.552 . . . . 1.19 113.225 -175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.7 138.82 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 114.975 -1.011 . . . . 0.95 108.591 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 18' ' ' ALA . 63.1 tttm -86.16 126.93 34.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 118.682 -2.511 . . . . 3.12 110.826 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 55' ' ' GLU . 40.5 t -118.71 126.61 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.62 -1.232 . . . . 1.69 111.498 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 51.9 tttp -170.94 172.42 5.54 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 105.221 -2.141 . . . . 2.43 105.221 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -86.1 178.23 49.44 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.167 -1.973 . . . . 2.26 108.167 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 17' ' ' GLU . 40.9 ttm180 40.07 99.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.942 . . . . 4.93 111.291 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 33.3 109.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 113.441 0.904 . . . . 3.13 113.441 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -171.75 16.37 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.958 0 O-C-N 121.338 -0.851 . . . . 1.78 110.387 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.05 110.53 4.03 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 107.564 -2.214 . . . . 1.06 107.564 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -142.57 139.47 31.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.123 -1.436 . . . . 1.36 107.123 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HE3' ' H ' ' A' ' 86' ' ' LYS . 1.3 pttm -94.28 138.62 32.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.325 -1.484 . . . . 3.16 109.787 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.662 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 p -142.1 157.96 44.29 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.531 -0.868 . . . . 0.78 111.274 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 76' ' ' LEU . 37.5 t -104.06 134.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.113 -1.81 . . . . 0.43 106.113 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 10' ' ' CYS . 69.9 mt -96.89 133.71 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.032 -1.043 . . . . 0.51 110.371 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 17.1 m -151.94 69.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.457 -1.697 . . . . 1.3 113.594 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.6 t0 171.19 152.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.737 -1.227 . . . . 1.56 109.991 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.522 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.5 mt -117.66 127.57 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 103.038 -2.949 . . . . 1.8 103.038 171.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 29' ' ' ASP . 20.9 mm -99.75 -111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.017 -1.677 . . . . 0.77 111.853 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 91.6 m-20 -62.71 -41.36 99.1 Favored 'General case' 0 C--O 1.201 -1.452 0 O-C-N 121.695 -0.628 . . . . 2.4 110.157 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.582 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 89.9 m-20 164.34 -50.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 C-N-CA 124.833 1.253 . . . . 2.55 109.353 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -95.07 4.85 53.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 2.1 111.922 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.84 147.22 42.33 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.068 -1.02 . . . . 1.6 110.337 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.98 162.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.676 -0.49 . . . . 0.49 109.676 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 ' HE ' ' A' ' 46' ' ' ARG . 8.2 tt -97.4 132.48 43.07 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 119.361 -0.936 . . . . 0.93 108.643 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 47' ' ' ARG . 22.2 m -127.71 150.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.777 -0.769 . . . . 0.52 110.556 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.747 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -144.03 155.12 43.88 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.974 -0.69 . . . . 0.63 112.15 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA3' HG23 ' A' ' 44' ' ' VAL . . . -152.55 169.08 31.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.132 -1.987 . . . . 0.84 108.132 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 21' ' ' LYS . 36.9 Cg_endo -70.39 110.35 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 CA-C-N 118.938 1.369 . . . . 0.99 109.322 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -58.82 -39.5 81.36 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.057 -1.027 . . . . 3.44 111.202 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.26 -40.22 96.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.941 -1.099 . . . . 2.27 112.47 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.458 HD13 ' HD3' ' A' ' 86' ' ' LYS . 82.8 mt -96.87 -77.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.419 -0.801 . . . . 2.05 112.874 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.4 m -61.89 -35.06 77.24 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.729 -1.232 . . . . 1.1 109.492 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.54 -10.97 56.47 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.653 -0.654 . . . . 1.12 111.797 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -91.1 128.33 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 119.93 1.865 . . . . 1.06 108.15 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -95.33 -75.57 0.52 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.332 1.063 . . . . 3.49 110.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 1.06 ' HE ' HD11 ' A' ' 34' ' ' LEU . 65.2 ttt180 -148.7 125.44 11.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.301 -1.37 . . . . 2.78 107.301 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.712 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ptm180 -157.23 164.34 37.82 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 119.969 -1.707 . . . . 3.1 109.489 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -105.25 141.1 37.37 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.43 -0.793 . . . . 3.0 109.528 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -133.8 143.6 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 1.63 110.052 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 48.6 t-20 -80.87 154.24 27.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.669 0.747 . . . . 2.28 111.243 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 93.1 mt -58.36 -23.84 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.638 -0.664 . . . . 1.41 109.728 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.6 mt -53.26 -29.87 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 1.25 108.94 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -117.43 91.7 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.553 -1.647 . . . . 1.5 106.553 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.76 HD11 HH21 ' A' ' 8' ' ' ARG . 24.4 tp -113.82 130.38 56.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.684 -0.635 . . . . 1.56 110.548 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' CD ' HG21 ' A' ' 13' ' ' VAL . 14.7 tp10 -137.81 90.33 14.41 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 106.864 -1.532 . . . . 2.28 106.864 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 90.3 Cg_endo -90.26 148.13 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.629 1.553 . . . . 0.69 113.926 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 p -119.73 163.81 16.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.491 -0.929 . . . . 0.88 108.491 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.599 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 55.3 p30 -75.4 125.82 29.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.282 -1.747 . . . . 2.57 106.282 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.729 ' CD ' HD12 ' A' ' 9' ' ' ILE . 24.5 mttt -162.14 -173.03 3.46 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.083 1.42 . . . . 2.9 112.704 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' GLY . 25.3 tttt -81.48 150.88 28.08 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.722 -1.581 . . . . 5.03 111.231 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 61' ' ' ILE . 12.1 tt -120.6 120.16 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.503 0.668 . . . . 4.81 110.628 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -179.6 87.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 117.62 -1.181 . . . . 2.14 112.208 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 65' ' ' LYS . 15.6 mm -115.15 138.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 CA-C-N 123.543 2.883 . . . . 1.72 108.112 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.569 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.7 mt-30 -60.76 -41.28 95.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 115.166 -2.614 . . . . 2.59 106.282 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 59.3 tttt 114.11 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.139 -1.059 . . . . 3.48 108.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 119.849 -1.782 . . . . 0.64 111.539 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.76 144.8 17.23 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.201 -1.764 . . . . 0.62 112.225 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.8 p -69.89 167.02 18.26 Favored 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 108.152 -1.055 . . . . 0.73 108.152 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 93.0 m-20 -59.56 -47.35 85.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 119.585 -1.947 . . . . 2.02 112.088 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -41.1 98.3 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 117.003 -1.879 . . . . 2.3 108.022 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.8 -35.72 82.0 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.134 -1.061 . . . . 1.96 108.134 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 68' ' ' SER . 79.5 t -65.39 -42.82 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.59 110.094 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.68 -42.92 98.06 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.908 -1.117 . . . . 0.79 110.09 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -59.44 -38.19 80.08 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.182 -1.007 . . . . 2.33 109.072 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 11.8 mtpt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.882 -0.511 . . . . 2.62 110.169 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 36' ' ' THR . 88.4 mt -57.48 -37.68 73.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.662 -1.273 . . . . 1.3 108.641 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 97.1 mt-10 -58.65 -33.08 69.68 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 118.307 -1.357 . . . . 1.7 108.179 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.02 -35.68 75.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.145 -2.168 . . . . 2.29 105.145 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.701 ' OG ' HD11 ' A' ' 9' ' ' ILE . 31.1 m -70.01 -21.88 63.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.014 -0.539 . . . . 1.41 109.597 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 77' ' ' GLU . 74.4 m-20 66.83 46.7 1.62 Allowed 'General case' 0 N--CA 1.519 3.011 0 CA-C-O 122.229 1.014 . . . . 1.53 112.481 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.726 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.2 mp -65.52 -27.51 68.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.357 -0.838 . . . . 2.46 111.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.0 m -42.62 -33.59 0.74 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.965 -1.084 . . . . 2.54 111.29 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -157.66 -21.17 0.09 Allowed 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.009 -1.682 . . . . 3.53 110.952 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -60.59 -42.33 96.49 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 117.73 -1.588 . . . . 3.06 107.076 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' NZ ' ' A' ' 59' ' ' LYS . 62.3 mtt -94.82 -125.3 0.11 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.627 -1.624 . . . . 2.45 114.178 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.458 ' HD3' HD13 ' A' ' 41' ' ' ILE . 17.2 mttm 52.99 31.42 10.96 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.631 -1.248 . . . . 1.49 107.631 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 116.347 1.981 . . . . 2.69 116.347 -174.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 6' ' ' VAL . 95.9 mt-10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.063 -0.347 . . . . 4.72 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.642 ' O ' ' O ' ' A' ' 5' ' ' GLU . 7.2 m -43.19 -149.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.269 1.033 . . . . 2.38 112.585 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' HG23 ' A' ' 6' ' ' VAL . . . 79.35 21.81 66.4 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 106.721 -2.551 . . . . 1.47 106.721 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 57' ' ' THR . 71.1 mtp180 -128.74 170.43 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.431 -0.952 . . . . 3.56 108.431 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.703 ' O ' HG23 ' A' ' 57' ' ' THR . 82.8 mt -93.99 145.41 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.021 -1.05 . . . . 1.43 108.845 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.0 p -122.44 155.66 35.66 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.9 -1.045 . . . . 1.19 112.643 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 41.0 t -127.31 139.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 CA-C-N 115.625 -0.716 . . . . 0.95 110.158 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 18' ' ' ALA . 22.7 tptm -81.1 137.52 35.97 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 118.03 -2.919 . . . . 3.12 111.685 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.1 t -119.61 100.42 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 122.58 1.181 . . . . 1.69 109.476 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 31.6 mttm -157.02 169.08 25.63 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.153 -1.795 . . . . 2.43 106.153 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -82.84 178.83 53.15 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 117.353 -2.356 . . . . 2.26 107.305 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 15' ' ' GLY . 59.3 ttt85 49.35 106.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.172 -1.193 . . . . 4.93 111.01 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 48.33 53.55 11.73 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.996 0.903 . . . . 3.13 110.74 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 14' ' ' LYS . . . -67.88 -15.3 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.538 -1.351 . . . . 1.78 110.781 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.45 94.91 1.9 Allowed Glycine 0 C--N 1.285 -2.284 0 O-C-N 120.718 -1.239 . . . . 1.06 114.374 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -136.35 134.32 37.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.62 -1.992 . . . . 1.36 105.62 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.704 ' H ' HG21 ' A' ' 42' ' ' THR . 1.7 ptpt -100.53 136.84 39.78 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.622 -1.299 . . . . 3.16 111.455 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.2 p -137.5 159.57 41.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.772 0.796 . . . . 0.78 111.199 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 76' ' ' LEU . 41.1 t -111.12 136.27 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.056 -1.461 . . . . 0.43 107.056 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.657 HG12 HG12 ' A' ' 35' ' ' VAL . 62.7 mt -105.37 133.69 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.117 -0.989 . . . . 0.51 109.912 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.993 HG11 ' NZ ' ' A' ' 75' ' ' LYS . 1.1 m -149.18 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.884 -1.126 . . . . 1.3 111.668 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 6' ' ' VAL . 54.3 t0 172.14 137.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 1.56 109.183 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 5' ' ' GLU . 70.5 mt -118.78 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 104.177 -2.527 . . . . 1.8 104.177 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -97.05 -79.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.053 -1.03 . . . . 0.77 110.843 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 44.1 t0 -106.03 179.0 4.4 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.135 0.969 . . . . 2.4 108.871 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 91.8 m-20 -54.8 -38.51 67.39 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 118.969 -1.093 . . . . 2.55 108.81 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.54 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 33.6 p-10 -112.11 5.15 18.42 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 115.685 1.735 . . . . 2.1 115.685 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 89.3 m-85 -112.64 138.94 48.7 Favored 'General case' 0 N--CA 1.528 3.455 0 CA-C-N 121.696 2.044 . . . . 1.6 113.78 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 m -130.8 162.78 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 115.727 -0.67 . . . . 0.49 109.899 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.832 HD21 ' HE ' ' A' ' 46' ' ' ARG . 9.7 tt -100.28 135.61 41.44 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.272 -0.893 . . . . 0.93 108.829 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.3 m -126.75 150.5 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.613 -0.835 . . . . 0.52 110.541 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.57 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.9 t -146.89 153.09 39.72 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.648 -0.821 . . . . 0.63 112.015 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.7 29.82 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.571 -2.212 . . . . 0.84 107.571 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.88 108.06 0.86 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 CA-C-N 119.156 1.478 . . . . 0.99 110.594 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -58.6 -39.21 79.79 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.174 0.988 . . . . 3.44 109.592 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -38.99 93.25 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.43 -0.794 . . . . 2.27 112.251 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.691 HG21 ' HG2' ' A' ' 86' ' ' LYS . 26.8 mm -96.24 -78.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.028 . . . . 2.05 113.39 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.704 HG21 ' H ' ' A' ' 21' ' ' LYS . 26.2 m -63.0 -32.94 74.4 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.999 0.904 . . . . 1.1 108.605 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.12 56.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 111.438 -0.665 . . . . 1.12 111.438 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -68.37 148.94 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.8 1.8 . . . . 1.06 109.912 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -92.69 -131.18 0.13 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.524 -1.287 . . . . 3.49 107.524 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.832 ' HE ' HD21 ' A' ' 34' ' ' LEU . 73.9 ttt180 -139.86 122.32 16.15 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 103.982 -2.599 . . . . 2.78 103.982 173.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.744 ' O ' HG22 ' A' ' 35' ' ' VAL . 45.8 ptt85 -159.64 165.83 31.91 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 117.467 -1.693 . . . . 3.1 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -93.12 139.12 30.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.274 -0.891 . . . . 3.0 108.695 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.04 153.48 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.96 -1.087 . . . . 1.63 110.304 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' C ' HD22 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -86.3 167.7 14.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.955 0.883 . . . . 2.28 111.611 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.15 -24.84 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 115.999 -0.546 . . . . 1.41 110.234 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.512 HD12 ' OD1' ' A' ' 50' ' ' ASN . 63.7 mt -55.23 -30.87 60.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.207 -1.034 . . . . 1.25 108.207 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -116.04 88.53 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.508 -1.293 . . . . 1.5 107.508 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.6 tp -118.91 129.67 55.31 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.285 -0.635 . . . . 1.56 109.285 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -143.14 90.41 7.4 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 106.368 -1.715 . . . . 2.28 106.368 176.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -90.22 153.54 4.64 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 121.557 1.504 . . . . 0.69 114.322 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 9' ' ' ILE . 63.5 p -111.68 166.71 10.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.333 -1.728 . . . . 0.88 106.333 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 8' ' ' ARG . 88.4 m-20 -84.21 11.49 8.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.047 -1.033 . . . . 2.57 110.664 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 8' ' ' ARG 0.317 44.6 tttm -91.34 124.6 35.65 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.185 -0.947 . . . . 2.9 111.389 -177.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -133.57 119.04 18.97 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 118.596 -1.242 . . . . 5.03 111.382 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 78' ' ' GLU . 31.8 pt -128.5 157.12 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.872 -1.158 . . . . 4.81 107.872 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -86.13 128.37 34.87 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 122.891 1.329 . . . . 2.14 111.928 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.963 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.78 164.07 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 115.11 -0.95 . . . . 1.72 109.933 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -96.39 139.98 31.71 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.842 -1.17 . . . . 2.59 107.842 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -67.24 138.87 57.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 116.056 -0.52 . . . . 3.48 111.064 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.8 21.43 61.55 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.52 -1.324 . . . . 0.64 112.998 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.04 21.74 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 120.294 2.047 . . . . 0.62 111.389 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 51.7 p -71.2 166.27 21.87 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.696 -1.594 . . . . 0.73 106.696 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 53.0 p30 -60.65 -40.55 92.45 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 116.328 -2.149 . . . . 2.02 110.683 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 97.1 mt-10 -63.23 -39.31 94.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 119.517 -1.989 . . . . 2.3 107.731 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.73 -35.71 81.93 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.773 -1.171 . . . . 1.96 108.09 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 36' ' ' THR . 71.1 t -64.09 -43.52 97.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.436 -1.306 . . . . 0.59 107.881 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.74 -44.25 97.27 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.014 -1.074 . . . . 0.79 109.428 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.48 -42.32 96.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.371 -1.456 . . . . 2.33 108.315 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.993 ' NZ ' HG11 ' A' ' 25' ' ' VAL . 10.1 mtmp? -62.63 -34.93 78.04 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.507 -0.877 . . . . 2.62 109.588 176.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.622 ' O ' ' OG ' ' A' ' 79' ' ' SER . 38.1 tp -59.24 -40.5 86.11 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.735 -1.186 . . . . 1.3 108.392 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 80' ' ' ASN . 97.2 mt-10 -62.42 -34.38 76.64 Favored 'General case' 0 C--N 1.281 -2.373 0 O-C-N 120.175 -1.578 . . . . 1.7 108.135 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.482 ' HG2' HD12 ' A' ' 61' ' ' ILE . 48.8 tp10 -59.68 -36.97 77.52 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 105.589 -2.004 . . . . 2.29 105.589 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 95.8 p -71.11 -18.25 62.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.397 -1.705 . . . . 1.41 106.397 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 77' ' ' GLU . 72.0 m-20 61.6 35.02 17.45 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.123 -0.944 . . . . 1.53 111.065 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.58 HD13 ' OG ' ' A' ' 79' ' ' SER . 8.4 mp -74.55 -29.54 61.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.831 -0.543 . . . . 2.46 112.395 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 43.5 m -50.52 -33.09 20.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.122 -0.986 . . . . 2.54 110.856 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -147.42 -28.35 0.36 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 118.342 -1.343 . . . . 3.53 112.727 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -61.88 -48.57 79.89 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 114.94 -2.704 . . . . 3.06 105.606 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 62.2 mtt -88.09 -135.92 0.09 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.378 -1.737 . . . . 2.45 111.355 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.691 ' HG2' HG21 ' A' ' 41' ' ' ILE . 27.8 mtpt 62.81 29.67 16.67 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.521 -1.659 . . . . 1.49 106.521 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-N 116.103 -0.498 . . . . 2.69 112.112 -179.677 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.578 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 95.2 mt-10 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.281 -0.637 . . . . 4.72 109.281 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 61' ' ' ILE . 5.8 m -63.48 178.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.394 -1.335 . . . . 2.38 107.394 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 89.77 18.14 52.24 Favored Glycine 0 C--O 1.199 -2.042 0 C-N-CA 119.116 -1.516 . . . . 1.47 111.27 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 28.3 ptt-85 -137.53 176.02 9.08 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.147 -1.207 . . . . 3.56 108.275 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.779 HD12 ' NZ ' ' A' ' 59' ' ' LYS . 81.3 mt -104.81 146.98 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 123.171 1.462 . . . . 1.43 111.641 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -117.47 155.72 29.21 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 112.959 -1.928 . . . . 1.19 111.515 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 43.5 t -127.02 135.4 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 CA-C-N 115.437 -0.801 . . . . 0.95 111.144 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -87.96 139.05 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.296 -2.753 . . . . 3.12 110.189 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.32 120.12 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 118.834 -1.146 . . . . 1.69 110.659 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.537 ' NZ ' ' CE1' ' A' ' 53' ' ' HIS . 93.1 mttt -161.09 170.55 20.22 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.739 -1.578 . . . . 2.43 106.739 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.9 -178.63 51.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 106.142 -2.783 . . . . 2.26 106.142 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' O ' ' O ' ' A' ' 17' ' ' GLU . 84.7 mtt180 38.38 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 119.37 1.585 . . . . 4.93 111.332 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 35.27 110.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.905 0.86 . . . . 3.13 112.673 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.58 16.6 0.07 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.919 -1.113 . . . . 1.78 111.167 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.22 98.21 2.39 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.18 -1.968 . . . . 1.06 108.18 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -144.42 137.29 26.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.149 -1.207 . . . . 1.36 109.221 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.901 ' O ' HG21 ' A' ' 42' ' ' THR . 90.1 mttt -103.36 139.36 38.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 3.16 109.418 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.5 p -131.24 157.69 42.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.839 -1.144 . . . . 0.78 109.147 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 9' ' ' ILE . 42.9 t -105.17 135.18 44.33 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 N-CA-C 106.556 -1.646 . . . . 0.43 106.556 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 35' ' ' VAL . 68.8 mt -102.73 130.03 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.41 -0.916 . . . . 0.51 110.086 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -142.28 68.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.158 -1.417 . . . . 1.3 111.729 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 55.1 t0 164.97 148.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.116 -0.99 . . . . 1.56 108.542 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.1 tt -121.74 117.67 53.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.253 -2.499 . . . . 1.8 104.253 170.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.5 mt -97.64 -80.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.879 1.323 . . . . 0.77 109.653 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -106.18 161.26 14.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.105 -1.407 . . . . 2.4 107.845 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.14 -38.1 67.8 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 118.683 -1.207 . . . . 2.55 109.592 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.462 ' OD1' HD11 ' A' ' 51' ' ' ILE . 76.6 m-20 -96.25 0.3 50.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.357 . . . . 2.1 113.651 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -121.31 145.03 48.29 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.994 1.27 . . . . 1.6 113.091 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.91 161.98 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.926 -0.484 . . . . 0.49 110.064 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 35' ' ' VAL . 9.0 tt -101.36 133.9 45.25 Favored 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 108.122 -1.066 . . . . 0.93 108.122 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 24' ' ' ILE . 30.2 m -127.51 149.61 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.246 -0.909 . . . . 0.52 110.8 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -143.22 151.4 40.56 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.083 -1.047 . . . . 0.63 111.922 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.53 164.38 37.25 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.039 -2.025 . . . . 0.84 108.039 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -65.79 124.57 12.92 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-N 120.578 2.189 . . . . 0.99 109.56 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -60.37 -43.57 96.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.372 -1.455 . . . . 3.44 111.267 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.33 -37.43 87.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 2.27 113.729 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.594 HD13 ' HD3' ' A' ' 86' ' ' LYS . 85.2 mt -94.86 -71.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 114.751 1.389 . . . . 2.05 114.751 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.901 HG21 ' O ' ' A' ' 21' ' ' LYS . 28.5 m -70.17 -35.53 74.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.41 1.1 . . . . 1.1 109.635 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -18.17 47.03 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-N 115.136 -0.938 . . . . 1.12 112.316 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -92.26 124.04 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 CA-C-N 120.31 2.055 . . . . 1.06 107.582 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -88.98 -79.55 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.237 -1.764 . . . . 3.49 106.237 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.633 HH12 HG21 ' A' ' 72' ' ' VAL . 58.1 ttt85 -152.54 118.65 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.555 -1.276 . . . . 2.78 107.555 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' O ' HG22 ' A' ' 35' ' ' VAL . 10.6 ptm180 -156.13 163.17 39.96 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.353 -1.467 . . . . 3.1 109.838 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -95.39 138.21 33.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.147 -0.971 . . . . 3.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.64 150.62 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.6 -1.312 . . . . 1.63 110.908 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.531 HD22 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -86.07 172.72 10.39 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.731 0.777 . . . . 2.28 111.646 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.462 HD11 ' OD1' ' A' ' 31' ' ' ASN . 90.3 mt -57.04 -29.04 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.742 -0.599 . . . . 1.41 110.769 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB2' HD22 ' A' ' 50' ' ' ASN . 77.4 mt -53.71 -29.03 37.36 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.124 -0.985 . . . . 1.25 109.083 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.537 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 5.7 m-70 -115.96 88.61 2.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.257 -1.757 . . . . 1.5 106.257 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.8 tp -123.93 129.16 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 1.56 109.334 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 3.1 tp10 -152.37 94.89 3.18 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 107.584 -1.265 . . . . 2.28 107.584 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 72.6 Cg_endo -87.97 153.81 7.16 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 121.46 1.44 . . . . 0.69 112.541 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 9' ' ' ILE . 50.5 p -116.92 163.95 15.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.415 -0.958 . . . . 0.88 108.415 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 49.8 p30 -88.98 39.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.511 -0.743 . . . . 2.57 111.468 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.779 ' NZ ' HD12 ' A' ' 9' ' ' ILE . 15.2 mtpt -84.3 -166.65 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.007 -1.058 . . . . 2.9 111.805 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' ' O ' ' A' ' 7' ' ' GLY . 22.9 tttt -82.75 154.27 24.86 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.037 0.935 . . . . 5.03 108.988 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 6' ' ' VAL . 26.7 mm -116.42 117.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.987 -0.685 . . . . 4.81 109.77 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -173.39 85.94 0.05 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.983 -1.073 . . . . 2.14 113.464 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.979 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -131.59 159.32 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 120.23 -1.544 . . . . 1.72 109.153 176.005 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.1 mt-30 -63.41 -44.93 93.24 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 116.455 -2.098 . . . . 2.59 108.848 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 3.0 ttmp? 99.85 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 108.085 -1.08 . . . . 3.48 108.085 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 11.41 63.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.8 -1.72 . . . . 0.64 108.8 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . . . -56.98 149.44 18.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.662 -0.905 . . . . 0.62 112.36 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.4 p -65.23 164.4 13.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.661 -1.237 . . . . 0.73 107.661 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.58 -42.48 88.13 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.161 -1.587 . . . . 2.02 111.371 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.96 -39.56 95.03 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 117.269 -1.772 . . . . 2.3 108.747 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.9 -36.3 83.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.603 -0.839 . . . . 1.96 108.898 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.633 HG21 HH12 ' A' ' 46' ' ' ARG . 75.8 t -64.57 -42.81 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.59 109.844 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.16 -42.23 98.19 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.986 -1.086 . . . . 0.79 109.791 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.49 -43.39 97.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 2.33 110.176 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HZ1' ' HB3' ' A' ' 67' ' ' ALA . 37.5 mtmm -60.87 -31.67 71.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.763 -0.586 . . . . 2.62 110.637 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.64 ' O ' ' OG ' ' A' ' 79' ' ' SER . 36.4 tp -54.83 -37.48 66.21 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.51 -31.32 67.78 Favored 'General case' 0 C--N 1.277 -2.568 0 O-C-N 120.407 -1.433 . . . . 1.7 109.183 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.08 -35.64 69.63 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.305 -1.739 . . . . 2.29 106.305 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.64 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 57.6 p -66.57 -19.74 65.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.538 -1.282 . . . . 1.41 107.538 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 60.5 37.44 19.68 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 106.904 -1.517 . . . . 1.53 106.904 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.779 HD12 ' HB2' ' A' ' 85' ' ' MET . 13.9 tp -68.35 -30.42 69.37 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.454 -1.703 . . . . 2.46 111.413 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 38.9 m -43.28 -35.66 1.55 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.291 -0.881 . . . . 2.54 110.537 -175.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.79 -23.62 0.11 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.556 -1.658 . . . . 3.53 112.219 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -60.65 -48.01 83.67 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 116.404 -2.118 . . . . 3.06 107.417 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.779 ' HB2' HD12 ' A' ' 81' ' ' LEU . 84.7 mtp -84.25 -122.92 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 112.192 -2.276 . . . . 2.45 112.951 -174.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.672 ' HZ3' ' HG ' ' A' ' 81' ' ' LEU . 25.9 mttm 46.13 14.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.466 -0.939 . . . . 1.49 108.466 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.1 mt-10 . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 114.375 1.25 . . . . 2.69 114.375 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' OE1' ' CE ' ' A' ' 60' ' ' LYS . 95.4 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 122.024 0.916 . . . . 4.72 110.492 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -63.05 175.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.561 -0.904 . . . . 2.38 108.561 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 8' ' ' ARG . . . 75.55 -118.8 5.6 Favored Glycine 0 C--N 1.29 -2.023 0 C-N-CA 119.491 -1.338 . . . . 1.47 110.272 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 7' ' ' GLY . 39.5 mtp180 39.8 -171.43 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.894 0 O-C-N 121.507 -0.996 . . . . 3.56 109.933 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.72 HD13 ' SD ' ' A' ' 85' ' ' MET . 16.0 tt -118.09 147.95 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 106.277 -1.749 . . . . 1.43 106.277 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 4.7 p -128.01 159.8 33.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.058 0.932 . . . . 1.19 111.95 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.16 145.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.961 -1.126 . . . . 0.95 107.961 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -89.95 137.16 32.57 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 119.516 -1.99 . . . . 3.12 109.512 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.96 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.254 -1.378 . . . . 1.69 111.754 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -165.76 160.17 16.89 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.144 -2.169 . . . . 2.43 105.144 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.89 178.94 51.17 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 117.667 -2.206 . . . . 2.26 109.095 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' GLU . 95.0 mtt-85 45.13 94.63 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.618 -0.931 . . . . 4.93 110.097 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 41.59 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.719 0.771 . . . . 3.13 112.877 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 178.6 8.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.376 -0.827 . . . . 1.78 111.725 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.95 115.1 4.69 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 107.618 -2.193 . . . . 1.06 107.618 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -152.48 149.21 28.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.086 -1.243 . . . . 1.36 107.862 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 1.9 mptp? -94.93 141.77 28.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 3.16 110.516 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.0 p -139.57 158.8 43.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.78 110.313 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.01 135.68 52.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.476 -1.305 . . . . 0.43 107.476 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 35' ' ' VAL . 64.9 mt -94.49 133.78 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 C-N-CA 118.211 -1.395 . . . . 0.51 110.966 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -148.59 76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 118.442 -1.303 . . . . 1.3 111.422 176.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 47.1 t0 169.79 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.273 -1.517 . . . . 1.56 108.371 172.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 69.9 mt -119.44 121.88 67.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 103.411 -2.811 . . . . 1.8 103.411 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.9 mt -109.63 -38.82 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.941 -1.1 . . . . 0.77 109.927 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -164.69 173.93 11.32 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.962 -1.496 . . . . 2.4 106.962 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.93 -39.26 77.58 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.763 -1.175 . . . . 2.55 112.336 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -99.83 1.6 43.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.338 -1.476 . . . . 2.1 114.811 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -121.77 142.87 49.77 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.121 1.328 . . . . 1.6 111.814 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.7 162.42 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.44 -0.788 . . . . 0.49 109.411 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ASP . 13.3 tp -101.32 133.05 46.5 Favored 'General case' 0 N--CA 1.52 3.027 0 C-N-CA 118.894 -1.122 . . . . 0.93 109.163 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 24' ' ' ILE . 19.1 m -123.61 144.49 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.017 -1.073 . . . . 0.52 109.747 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.554 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.4 t -145.38 155.51 43.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.771 0.796 . . . . 0.63 112.293 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -155.34 164.51 32.01 Favored Glycine 0 N--CA 1.501 3.005 0 N-CA-C 107.168 -2.373 . . . . 0.84 107.168 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.71 115.6 3.02 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 119.145 1.472 . . . . 0.99 110.064 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.89 -34.9 72.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.76 0.79 . . . . 3.44 110.55 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.97 -40.96 99.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.635 -0.666 . . . . 2.27 112.683 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.659 HG21 ' HD3' ' A' ' 86' ' ' LYS . 81.6 mt -98.03 -78.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 2.05 112.767 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 m -61.34 -35.9 78.69 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.913 -1.117 . . . . 1.1 109.459 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.72 -3.82 57.64 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.658 -0.782 . . . . 1.12 112.112 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.5 m -90.73 131.68 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.497 -2.038 . . . . 1.06 105.497 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -94.15 -78.23 0.44 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.492 -1.283 . . . . 3.49 110.331 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -152.66 126.18 8.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.027 -1.842 . . . . 2.78 106.027 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -155.01 165.82 35.53 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.189 -1.569 . . . . 3.1 110.08 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -113.21 138.45 49.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.381 -0.824 . . . . 3.0 109.601 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 m -132.23 151.73 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 118.727 -1.189 . . . . 1.63 110.592 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.55 ' OD1' ' CE2' ' A' ' 32' ' ' PHE . 31.5 m-20 -87.3 163.25 16.94 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.268 -0.878 . . . . 2.28 108.717 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.3 mt -57.56 -24.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.02 -1.05 . . . . 1.41 111.062 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -55.2 -35.93 65.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.345 -1.472 . . . . 1.25 108.556 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -114.66 87.17 2.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.204 -1.036 . . . . 1.5 108.204 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.3 tp -128.5 127.85 43.23 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.655 -0.868 . . . . 1.56 108.655 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.34 87.09 39.19 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 107.314 -1.365 . . . . 2.28 107.314 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -92.17 147.95 3.04 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.107 1.872 . . . . 0.69 114.744 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 14.7 p -101.87 172.32 7.0 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.459 -1.312 . . . . 0.88 107.459 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 58' ' ' ASP . 50.3 p30 -83.1 16.37 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.088 0.947 . . . . 2.57 108.909 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HZ3' ' HB2' ' A' ' 79' ' ' SER 0.346 66.4 tttt -87.53 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.779 -0.823 . . . . 2.9 108.779 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' CE ' ' OE1' ' A' ' 5' ' ' GLU . 62.7 tttm -133.19 120.72 21.53 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.986 -1.086 . . . . 5.03 110.525 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -118.56 141.8 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.556 -1.646 . . . . 4.81 106.556 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.3 p30 -88.23 128.24 35.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.459 -1.4 . . . . 2.14 110.43 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.916 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -126.73 162.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.348 -0.845 . . . . 1.72 109.756 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -70.88 -107.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.092 -1.043 . . . . 2.59 108.308 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -177.35 119.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.802 -1.187 . . . . 3.48 109.663 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.88 20.61 70.23 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.227 -1.463 . . . . 0.64 110.855 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.56 147.19 6.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.981 -1.305 . . . . 0.62 111.316 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.82 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.0 p -66.64 163.37 19.06 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 107.737 -1.208 . . . . 0.73 107.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.9 -44.03 86.51 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 117.339 -1.744 . . . . 2.02 110.502 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.29 -39.58 94.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.092 -1.843 . . . . 2.3 109.404 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.87 -36.71 80.75 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.176 -1.01 . . . . 1.96 109.103 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 68' ' ' SER . 73.0 t -62.56 -41.63 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.591 -0.693 . . . . 0.59 110.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' HD13 ' A' ' 76' ' ' LEU . 97.2 mttt -58.65 -39.42 80.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.519 -0.872 . . . . 0.79 109.36 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.42 -40.79 87.86 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.221 -0.992 . . . . 2.33 111.217 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -60.51 -32.64 71.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.715 -1.241 . . . . 2.62 111.975 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' HA ' ' A' ' 73' ' ' LYS . 6.7 mp -58.62 -37.49 75.99 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 120.32 -1.488 . . . . 1.3 108.931 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -57.26 -32.67 66.83 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 116.957 -1.897 . . . . 1.7 107.353 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.98 -33.97 76.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.147 -1.797 . . . . 2.29 106.147 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 60.6 p -65.61 -26.92 68.05 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 105.74 -1.948 . . . . 1.41 105.74 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 61.66 38.59 15.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.472 -1.677 . . . . 1.53 106.472 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 9' ' ' ILE . 13.5 tp -69.16 -29.56 67.61 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.059 -1.428 . . . . 2.46 108.609 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 m -42.55 -34.46 0.86 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.133 -0.94 . . . . 2.54 111.365 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -156.35 -14.91 0.1 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 117.949 -1.501 . . . . 3.53 111.818 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -61.49 -41.96 98.07 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 116.41 -2.116 . . . . 3.06 105.967 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.72 ' SD ' HD13 ' A' ' 9' ' ' ILE . 75.3 mtp -109.39 -120.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.958 -1.019 . . . . 2.45 112.76 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.659 ' HD3' HG21 ' A' ' 41' ' ' ILE . 90.5 mttt 57.74 33.36 23.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.53 -0.545 . . . . 1.49 109.53 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.297 -1.682 0 C-N-CA 118.677 -1.209 . . . . 2.69 109.067 178.805 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.682 ' O ' HG23 ' A' ' 6' ' ' VAL . 97.0 mt-10 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.791 -0.818 . . . . 4.72 108.791 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 5' ' ' GLU . 57.4 t 111.12 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 106.782 -1.562 . . . . 2.38 106.782 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.914 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 89.42 9.33 67.06 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.366 -1.397 . . . . 1.47 110.398 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.599 HH21 ' N ' ' A' ' 5' ' ' GLU . 8.6 ptp180 -98.55 179.39 4.71 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.75 -1.441 . . . . 3.56 111.365 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 22' ' ' CYS . 70.0 mt -106.68 138.5 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.082 -2.192 . . . . 1.43 105.082 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 p -123.65 158.52 31.36 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.201 1.001 . . . . 1.19 113.128 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 21' ' ' LYS . 40.2 t -117.36 137.0 52.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.933 -1.506 . . . . 0.95 106.933 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 35' ' ' VAL . 16.7 mmtp -89.67 145.82 24.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 119.109 -2.245 . . . . 3.12 109.927 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.2 p -128.22 86.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 123.014 1.388 . . . . 1.69 112.664 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 tttt -139.06 144.14 38.66 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.615 -1.994 . . . . 2.43 105.615 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 179.65 53.06 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 117.795 -2.145 . . . . 2.26 109.373 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' GLU . 31.8 ttp180 53.2 91.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.799 -1.186 . . . . 4.93 107.799 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 84.3 tt0 45.1 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 120.99 0.424 . . . . 3.13 111.004 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.61 62.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 122.031 -0.418 . . . . 1.78 111.419 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.53 76.62 0.22 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 118.154 -1.974 . . . . 1.06 109.024 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.566 ' OG ' HG13 ' A' ' 44' ' ' VAL . 83.0 p -142.28 167.1 22.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.833 -0.804 . . . . 1.36 110.017 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 11' ' ' VAL . 66.3 mttm -86.9 152.56 22.34 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.806 1.289 . . . . 3.16 111.375 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 1.6 p -141.69 160.41 40.24 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.56 -1.2 . . . . 0.78 110.056 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.45 129.29 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 105.657 -1.979 . . . . 0.43 105.657 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 35' ' ' VAL . 69.2 mt -92.9 134.14 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.695 -1.253 . . . . 0.51 112.271 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG11 ' HZ2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -148.84 77.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.173 -1.411 . . . . 1.3 113.009 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 51.8 t0 169.08 148.75 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.361 -1.462 . . . . 1.56 110.051 172.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.545 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.9 tt -124.44 133.24 69.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 103.923 -2.621 . . . . 1.8 103.923 171.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.769 HG22 ' H ' ' A' ' 29' ' ' ASP . 21.5 mm -104.89 -122.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.271 -1.518 . . . . 0.77 110.423 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.769 ' H ' HG22 ' A' ' 28' ' ' ILE . 92.2 m-20 -61.69 -41.45 97.59 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 120.369 -0.532 . . . . 2.4 109.738 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 86.9 m-20 170.01 -58.47 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.559 1.143 . . . . 2.55 109.711 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -88.75 3.88 49.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.06 -1.025 . . . . 2.1 113.174 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' CD1' ' OD1' ' A' ' 50' ' ' ASN . 90.1 m-85 -110.94 144.29 40.25 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.094 -1.076 . . . . 1.6 108.094 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.06 161.11 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.235 -0.915 . . . . 0.49 108.883 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 35' ' ' VAL . 8.8 tt -106.82 131.96 53.32 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 118.698 -1.201 . . . . 0.93 108.974 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 12' ' ' LYS . 11.0 m -128.47 150.99 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 119.378 -0.929 . . . . 0.52 109.847 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -145.65 150.99 37.33 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.961 -1.096 . . . . 0.63 111.023 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -160.18 164.61 34.45 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.854 -2.099 . . . . 0.84 107.854 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' O ' ' OG1' ' A' ' 42' ' ' THR . 30.3 Cg_endo -69.11 101.46 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 CA-C-N 119.093 1.447 . . . . 0.99 109.874 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.32 -38.76 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 3.44 109.111 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.65 -36.55 67.18 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.681 -0.69 . . . . 2.27 110.755 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.734 HG21 ' HD3' ' A' ' 86' ' ' LYS . 22.9 mm -110.13 -40.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 119.065 -1.054 . . . . 2.05 111.1 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 38' ' ' PRO . 29.8 p -84.89 -31.29 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.225 -0.922 . . . . 1.1 112.292 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.98 -10.64 68.03 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.933 -1.267 . . . . 1.12 109.933 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 ' OG ' ' A' ' 20' ' ' SER . 9.8 m -103.0 128.46 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.913 -1.345 . . . . 1.06 107.972 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.72 ' H ' HH22 ' A' ' 47' ' ' ARG . 56.4 tttp -95.58 -81.59 0.4 Allowed 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.432 -1.307 . . . . 3.49 109.516 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 58.3 ttt85 -153.55 120.69 5.77 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.765 -1.198 . . . . 2.78 107.765 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.72 HH22 ' H ' ' A' ' 45' ' ' LYS . 9.4 ptp85 -156.86 168.45 27.41 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.709 -1.244 . . . . 3.1 109.999 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -110.76 140.42 45.18 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.429 -0.952 . . . . 3.0 108.429 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 53' ' ' HIS . 78.8 t -123.71 137.67 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 121.914 0.864 . . . . 1.63 112.069 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' OD1' ' CD1' ' A' ' 32' ' ' PHE . 36.3 m-20 -78.69 156.15 29.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.589 -1.263 . . . . 2.28 107.589 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.925 ' O ' HD23 ' A' ' 54' ' ' LEU . 28.5 mm -56.5 -27.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.495 -1.378 . . . . 1.41 109.301 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -54.23 -34.17 60.04 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 120.411 -1.431 . . . . 1.25 108.586 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.503 ' O ' HG11 ' A' ' 49' ' ' VAL . 77.9 m80 -115.72 93.29 4.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.198 -0.939 . . . . 1.5 108.958 176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.925 HD23 ' O ' ' A' ' 51' ' ' ILE . 1.7 pp -135.78 129.96 33.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.13 -1.606 . . . . 1.56 110.898 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -130.18 86.81 53.0 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 104.995 -2.224 . . . . 2.28 104.995 174.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' HD12 ' A' ' 54' ' ' LEU . 67.3 Cg_endo -91.52 157.41 3.61 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.283 2.655 . . . . 0.69 115.647 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.519 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 30.3 p -106.67 165.32 11.39 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.458 -0.942 . . . . 0.88 108.458 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -84.67 15.46 3.82 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.944 0.878 . . . . 2.57 108.849 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 45.8 mttp -88.53 141.91 28.14 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.19 -1.041 . . . . 2.9 108.19 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -135.69 129.21 32.35 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 5.03 110.545 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.914 HG22 ' O ' ' A' ' 7' ' ' GLY . 20.4 tt -125.18 148.03 29.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.925 -1.509 . . . . 4.81 106.925 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -84.86 119.95 25.91 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.472 -1.392 . . . . 2.14 108.281 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.523 HD13 ' HA2' ' A' ' 7' ' ' GLY . 30.6 pt -121.14 158.32 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.567 0.699 . . . . 1.72 111.848 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -86.76 0.35 54.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.732 . . . . 2.59 110.699 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 mttt 54.89 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.966 -1.084 . . . . 3.48 111.357 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.08 65.4 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.972 -1.109 . . . . 0.64 111.396 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.04 149.56 5.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.582 -1.54 . . . . 0.62 110.235 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.2 p -65.56 159.13 25.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.73 108.751 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.474 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 91.7 m-20 -57.12 -40.47 77.15 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.055 -1.028 . . . . 2.02 111.898 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.6 mp0 -63.03 -39.35 94.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 117.18 -1.808 . . . . 2.3 110.279 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.09 -38.15 82.02 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.685 -1.259 . . . . 1.96 109.357 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 68' ' ' SER . 69.0 t -64.24 -42.55 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.728 -0.608 . . . . 0.59 111.421 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -60.66 -42.27 96.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.009 -1.477 . . . . 0.79 109.763 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -60.98 -44.82 96.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 117.536 -1.665 . . . . 2.33 108.853 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HZ2' HG11 ' A' ' 25' ' ' VAL . 7.8 ttpm? -60.3 -36.26 77.47 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.514 -0.741 . . . . 2.62 111.347 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 81' ' ' LEU . 9.1 tt -53.83 -40.06 66.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.578 -0.849 . . . . 1.3 108.783 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.1 -33.68 67.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 117.843 -1.543 . . . . 1.7 107.732 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.67 ' OE1' HD11 ' A' ' 61' ' ' ILE . 84.5 tt0 -58.42 -34.08 70.39 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.042 -1.466 . . . . 2.29 107.042 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -61.56 -26.2 67.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.509 -1.663 . . . . 1.41 106.509 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 m120 71.63 43.85 0.55 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 122.684 1.231 . . . . 1.53 112.715 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -71.13 -22.37 62.08 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.277 -1.329 . . . . 2.46 109.517 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.6 ' CA ' ' HZ2' ' A' ' 86' ' ' LYS . 39.9 m -41.76 -37.8 1.31 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.785 -0.572 . . . . 2.54 109.774 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -168.82 -11.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.536 -1.353 . . . . 3.53 110.05 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -60.61 -44.05 96.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 123.559 1.647 . . . . 3.06 106.673 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.1 -127.09 0.16 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.836 -1.984 . . . . 2.45 111.548 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.734 ' HD3' HG21 ' A' ' 41' ' ' ILE . 23.5 mttt 52.72 21.76 2.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.74 -0.6 . . . . 1.49 112.155 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.489 1.514 0 C-N-CA 117.547 -1.661 . . . . 2.69 108.325 178.011 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 18.0 pt-20 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.256 -1.016 . . . . 4.72 108.256 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.412 HG21 ' HZ3' ' A' ' 65' ' ' LYS . 12.8 m -62.6 155.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.938 -1.134 . . . . 2.38 107.938 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 23.68 26.55 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.116 -1.516 . . . . 1.47 112.309 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.555 HH21 HD11 ' A' ' 54' ' ' LEU . 31.8 ptt-85 -123.62 170.59 10.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.173 -1.192 . . . . 3.56 110.842 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 57' ' ' THR . 13.9 mm -101.21 141.01 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.649 0.738 . . . . 1.43 109.713 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.595 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.56 156.02 28.8 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.817 1.294 . . . . 1.19 112.631 -176.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.446 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 42.0 t -120.65 138.32 51.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 106.536 -1.653 . . . . 0.95 106.536 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' ALA . 24.0 tttt -82.71 134.82 35.13 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 117.732 -3.105 . . . . 3.12 110.227 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.757 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.9 p -109.84 82.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.037 -1.065 . . . . 1.69 108.893 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 38.3 mtpt -155.66 164.84 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.498 -1.667 . . . . 2.43 106.498 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.5 165.82 43.0 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 116.908 -2.568 . . . . 2.26 107.045 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.587 ' O ' ' O ' ' A' ' 15' ' ' GLY . 93.1 mtt-85 55.73 134.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.087 -1.079 . . . . 4.93 108.087 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 48.75 20.4 0.33 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.615 -1.624 . . . . 3.13 106.615 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.513 ' N ' ' C ' ' A' ' 16' ' ' ARG . . . -56.97 -46.31 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.773 -1.103 . . . . 1.78 108.838 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.36 103.65 3.07 Favored Glycine 0 C--N 1.284 -2.307 0 N-CA-C 110.458 -1.057 . . . . 1.06 110.458 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 42' ' ' THR . 36.2 t -147.49 135.5 21.31 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.278 -1.379 . . . . 1.36 107.278 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.03 139.64 30.32 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.658 -1.217 . . . . 3.16 107.838 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -130.1 140.71 50.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.12 -0.632 . . . . 0.78 110.457 -177.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 9' ' ' ILE . 38.9 t -103.32 135.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.566 -2.383 . . . . 0.43 104.566 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.558 HG12 HG12 ' A' ' 35' ' ' VAL . 68.2 mt -103.14 132.29 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 119.246 -0.982 . . . . 0.51 110.826 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -151.43 72.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 118.409 -1.316 . . . . 1.3 111.693 175.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.8 t0 170.12 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.549 -1.345 . . . . 1.56 110.476 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.6 mt -120.51 127.74 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 104.345 -2.465 . . . . 1.8 104.345 171.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 17.8 mm -100.37 -104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 121.309 1.868 . . . . 0.77 110.988 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 56.1 t0 -64.19 -42.37 96.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.026 -1.046 . . . . 2.4 109.249 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.655 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 49.9 p30 164.0 -46.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.812 0.845 . . . . 2.55 109.291 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.655 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 79.7 m-20 -96.09 4.62 52.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.974 -1.079 . . . . 2.1 111.56 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 28' ' ' ILE . 96.7 m-85 -112.17 141.0 46.41 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.352 -0.842 . . . . 1.6 109.994 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.98 161.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.858 -0.526 . . . . 0.49 109.962 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.577 HD11 HH11 ' A' ' 46' ' ' ARG . 8.9 tt -100.9 132.45 46.29 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.69 -0.855 . . . . 0.93 108.69 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 24' ' ' ILE . 15.5 m -128.12 151.46 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 C-N-CA 119.234 -0.986 . . . . 0.52 110.564 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -146.01 152.59 39.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 0.63 111.104 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.0 154.38 25.14 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.692 -1.763 . . . . 0.84 108.692 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' O ' ' OG1' ' A' ' 42' ' ' THR . 6.2 Cg_exo -57.64 109.25 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 CA-C-N 119.978 1.889 . . . . 0.99 110.081 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.438 ' CE ' ' HZ1' ' A' ' 45' ' ' LYS . 34.9 tttp -56.64 -36.23 69.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.007 -1.058 . . . . 3.44 109.472 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.72 -38.58 69.94 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.192 -1.003 . . . . 2.27 109.626 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 86' ' ' LYS . 23.5 mm -114.32 -38.66 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.206 -0.998 . . . . 2.05 111.533 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' ' OG ' ' A' ' 20' ' ' SER . 80.6 p -81.19 -33.95 32.63 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.93 -1.106 . . . . 1.1 110.112 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.65 66.33 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.31 -0.716 . . . . 1.12 111.31 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 37' ' ' GLY . 15.2 m -103.38 133.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.48 -1.6 . . . . 1.06 109.832 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HZ1' ' CE ' ' A' ' 39' ' ' LYS . 63.5 mttp -86.11 -78.41 0.28 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.787 -1.821 . . . . 3.49 106.98 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.577 HH11 HD11 ' A' ' 34' ' ' LEU . 69.0 ttp85 -149.79 124.7 9.92 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.749 -2.315 . . . . 2.78 104.749 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 35' ' ' VAL . 46.8 ptt85 -155.55 166.38 33.71 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.827 -1.796 . . . . 3.1 109.912 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.441 HH12 HD12 ' A' ' 34' ' ' LEU . 77.3 mtt-85 -109.75 141.39 42.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.641 -0.824 . . . . 3.0 109.193 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.97 142.8 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 1.63 110.366 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -86.45 167.33 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.769 . . . . 2.28 110.982 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.39 -26.59 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.689 -0.632 . . . . 1.41 111.061 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.495 HD12 ' OD1' ' A' ' 50' ' ' ASN . 66.5 mt -55.06 -33.0 62.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.967 -1.083 . . . . 1.25 110.371 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -121.76 90.43 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.383 -1.34 . . . . 1.5 107.383 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.555 HD11 HH21 ' A' ' 8' ' ' ARG . 27.0 tp -118.68 131.89 56.16 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.825 -0.547 . . . . 1.56 110.332 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 2.6 tt0 -131.33 89.6 40.63 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 104.707 -2.331 . . . . 2.28 104.707 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.461 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 93.3 Cg_endo -87.88 149.93 7.15 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.495 1.463 . . . . 0.69 114.293 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 9' ' ' ILE . 39.8 p -110.38 165.82 11.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.718 -1.215 . . . . 0.88 107.718 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.15 14.33 3.52 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.351 -0.843 . . . . 2.57 110.124 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -91.65 125.55 36.42 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.49 -0.756 . . . . 2.9 109.743 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -134.88 122.31 21.81 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.444 -0.785 . . . . 5.03 110.465 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.71 152.96 37.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.97 -1.122 . . . . 4.81 107.97 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 52.6 p30 -83.71 133.09 34.82 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.856 1.313 . . . . 2.14 110.406 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 25' ' ' VAL . 28.7 pt -125.24 158.71 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 115.031 -0.986 . . . . 1.72 112.006 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 59.7 tp60 -64.38 -48.95 73.51 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.546 -1.662 . . . . 2.59 109.378 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 15.2 ttmm 100.66 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.323 0.965 . . . . 3.48 110.781 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.97 63.75 Favored Glycine 0 N--CA 1.506 3.334 0 O-C-N 120.556 -1.34 . . . . 0.64 111.784 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 71' ' ' GLU . . . -56.88 152.87 11.94 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.991 -1.299 . . . . 0.62 112.832 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 72' ' ' VAL . 55.7 p -63.14 167.59 4.89 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 108.284 -1.006 . . . . 0.73 108.284 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.61 -45.65 88.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.916 -1.74 . . . . 2.02 112.749 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.32 -40.11 92.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 116.6 -2.04 . . . . 2.3 107.844 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.526 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 97.2 mt-10 -64.8 -36.07 83.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.844 -1.169 . . . . 1.96 107.844 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 68' ' ' SER . 73.2 t -64.79 -42.99 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.579 -0.849 . . . . 0.59 109.499 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.88 -41.65 92.02 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.362 -1.335 . . . . 0.79 107.619 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.22 -43.34 92.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.844 -1.169 . . . . 2.33 107.844 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 67' ' ' ALA . 57.6 mtmt -62.07 -34.18 75.79 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.596 -0.69 . . . . 2.62 110.754 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 23' ' ' VAL . 49.4 tp -55.75 -41.19 73.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.475 -1.391 . . . . 1.3 108.473 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 80' ' ' ASN . 97.2 mt-10 -61.6 -33.94 74.78 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 119.297 -0.961 . . . . 1.7 109.063 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -38.48 81.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.212 -2.144 . . . . 2.29 105.212 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 81' ' ' LEU . 47.6 m -68.37 -29.4 68.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.338 -1.356 . . . . 1.41 107.338 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 77' ' ' GLU . 73.6 m-20 60.56 38.12 19.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.351 -2.092 . . . . 1.53 105.351 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 79' ' ' SER . 0.9 OUTLIER -96.95 -11.81 24.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.399 -0.819 . . . . 2.46 111.413 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 m -56.91 -39.72 74.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.306 -1.496 . . . . 2.54 110.098 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.582 ' HG3' ' HZ1' ' A' ' 86' ' ' LYS . 85.5 tt0 -156.09 -11.31 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.403 -1.319 . . . . 3.53 112.297 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 83' ' ' GLU . 70.7 t80 -58.7 -47.25 85.2 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 114.411 -2.915 . . . . 3.06 105.609 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.462 ' HG2' ' H ' ' A' ' 87' ' ' GLU . 48.7 ttm -90.73 -110.91 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.336 0.589 . . . . 2.45 112.034 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.663 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.4 mtmt 60.91 37.38 18.41 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.726 -1.213 . . . . 1.49 107.726 -175.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' A' ' 85' ' ' MET . 97.5 mt-10 . . . . . 0 N--CA 1.495 1.806 0 C-N-CA 119.83 -0.748 . . . . 2.69 111.286 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HE ' ' A' ' 8' ' ' ARG . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 107.679 -1.23 . . . . 4.72 107.679 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.56 154.85 35.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.383 -2.08 . . . . 2.38 105.383 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . 90.26 8.81 65.99 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.517 -2.233 . . . . 1.47 107.517 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HB2' HD12 ' A' ' 24' ' ' ILE . 79.7 mtt180 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.977 -0.612 . . . . 3.56 109.503 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 57' ' ' THR . 24.9 mm -108.03 135.31 47.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.311 -2.107 . . . . 1.43 105.311 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.647 ' HB3' HD11 ' A' ' 24' ' ' ILE . 3.8 p -127.92 155.89 43.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.07 -1.019 . . . . 1.19 113.107 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 20' ' ' SER . 43.1 t -126.56 138.02 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 115.701 -0.681 . . . . 0.95 109.827 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -85.71 130.81 34.46 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 118.74 -2.475 . . . . 3.12 109.817 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -121.19 123.03 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 117.992 -1.483 . . . . 1.69 112.622 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.862 ' HZ3' ' CE1' ' A' ' 53' ' ' HIS . 49.8 mttm -146.29 153.52 40.65 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.475 -1.306 . . . . 2.43 107.475 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 16' ' ' ARG . . . -86.75 102.84 2.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.226 -2.349 . . . . 2.26 107.226 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 38.5 ttm180 118.44 124.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.936 -1.505 . . . . 4.93 106.936 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 18' ' ' ALA . 77.6 mm-40 73.06 -86.26 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 107.528 -1.286 . . . . 3.13 107.528 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.586 ' CB ' ' H ' ' A' ' 14' ' ' LYS . . . 8.19 113.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.07 0.938 . . . . 1.78 111.962 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.85 80.21 0.05 OUTLIER Glycine 0 C--N 1.292 -1.914 0 N-CA-C 103.66 -3.776 . . . . 1.06 103.66 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 11' ' ' VAL . 75.0 p -162.67 150.55 13.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 117.849 -1.54 . . . . 1.36 110.839 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -114.59 147.84 38.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.362 -0.607 . . . . 3.16 109.362 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 3.8 p -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.551 -0.718 . . . . 0.78 110.387 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG21 HD12 ' A' ' 76' ' ' LEU . 44.7 t -103.93 136.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 105.874 -1.899 . . . . 0.43 105.874 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' HB2' ' A' ' 8' ' ' ARG . 70.6 mt -94.43 129.25 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 123.642 1.687 . . . . 0.51 111.847 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 26' ' ' ASP . 2.6 t -105.18 -151.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 112.61 -2.086 . . . . 1.3 109.332 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.84 ' H ' HG12 ' A' ' 25' ' ' VAL 0.272 36.3 t0 -67.4 163.49 20.72 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.733 -0.667 . . . . 1.56 110.625 -172.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 27' ' ' ILE . 16.3 tt -113.82 125.42 71.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 122.429 1.109 . . . . 1.8 110.103 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 48' ' ' ARG . 61.7 mt -74.26 -37.45 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.934 0.873 . . . . 0.77 110.671 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 47.4 t0 -159.62 167.78 27.64 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.637 -0.875 . . . . 2.4 108.637 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.0 m-20 -57.14 -37.99 72.86 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.013 -1.075 . . . . 2.55 108.615 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -80.45 -31.43 37.46 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.099 -1.0 . . . . 2.1 112.464 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -113.27 143.25 44.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.514 -0.741 . . . . 1.6 112.71 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.42 156.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.562 -0.532 . . . . 0.49 109.562 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CZ ' ' A' ' 46' ' ' ARG . 6.7 tt -100.04 125.54 46.12 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 105.743 -1.947 . . . . 0.93 105.743 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.27 155.47 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 120.812 -1.18 . . . . 0.52 110.965 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -142.47 155.09 45.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.261 -0.899 . . . . 0.63 110.966 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.89 163.7 29.43 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.013 -2.035 . . . . 0.84 108.013 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.13 111.5 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.532 1.666 . . . . 0.99 110.05 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -58.66 -39.35 80.37 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.252 -0.905 . . . . 3.44 110.843 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.36 -39.78 94.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.415 0.895 . . . . 2.27 113.415 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 86' ' ' LYS . 20.5 mm -96.22 -76.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.037 . . . . 2.05 112.309 -177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -62.4 -34.87 77.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.667 -0.645 . . . . 1.1 110.311 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.95 -4.41 57.53 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.874 -0.89 . . . . 1.12 110.874 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.2 m -89.07 126.51 42.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.187 -2.153 . . . . 1.06 105.187 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -94.04 -78.86 0.43 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.676 -1.265 . . . . 3.49 110.241 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 1.0 HH12 HG21 ' A' ' 72' ' ' VAL . 56.3 ttt85 -150.8 124.25 8.97 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.658 -1.979 . . . . 2.78 105.658 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.62 163.18 40.61 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 117.438 -1.705 . . . . 3.1 110.846 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HG3' HD12 ' A' ' 28' ' ' ILE . 30.1 ttm180 -98.29 138.97 34.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.223 -1.029 . . . . 3.0 108.223 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.92 140.14 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-N 119.915 1.234 . . . . 1.63 109.817 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.62 ' OD1' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.55 168.02 12.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.812 -0.555 . . . . 2.28 110.57 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.53 -27.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.246 -0.909 . . . . 1.41 110.549 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.62 HD12 ' OD1' ' A' ' 50' ' ' ASN . 73.0 mt -52.18 -33.2 39.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.25 109.666 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.862 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 91.4 m-70 -134.36 88.29 2.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.206 -1.405 . . . . 1.5 107.206 174.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.1 tp -124.49 132.24 53.48 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.648 -0.501 . . . . 1.56 109.648 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.49 89.0 32.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.481 -2.044 . . . . 2.28 105.481 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' HH11 ' A' ' 8' ' ' ARG . 74.0 Cg_endo -89.59 156.47 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.014 1.809 . . . . 0.69 112.701 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 9' ' ' ILE . 49.1 p -111.71 168.19 9.76 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.881 0.848 . . . . 0.88 108.748 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -81.95 18.44 1.32 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.794 0.807 . . . . 2.57 109.392 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 49.2 mttt -91.19 140.33 29.9 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 121.698 0.761 . . . . 2.9 112.386 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -136.87 122.62 19.9 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.942 -0.703 . . . . 5.03 109.472 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 71.7 mt -120.35 145.38 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.576 -0.898 . . . . 4.81 108.576 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -85.39 126.37 33.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.306 -1.497 . . . . 2.14 110.698 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -127.45 164.0 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 115.02 -0.991 . . . . 1.72 111.137 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 65' ' ' LYS . 95.6 mm-40 -84.27 1.49 44.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.763 -1.21 . . . . 2.59 109.679 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 64' ' ' GLN . 99.4 mttt 53.03 124.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.566 0.698 . . . . 3.48 112.07 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.04 70.63 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.574 -1.298 . . . . 0.64 110.183 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB1' ' CG ' ' A' ' 71' ' ' GLU . . . -54.08 146.64 14.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.015 -1.285 . . . . 0.62 111.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.0 p -67.16 164.4 18.16 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.878 -1.156 . . . . 0.73 107.878 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.28 -47.34 86.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.355 -1.465 . . . . 2.02 110.601 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -39.23 90.49 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.629 -1.628 . . . . 2.3 106.876 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' CG ' ' HB1' ' A' ' 67' ' ' ALA . 50.6 tp10 -64.72 -38.44 91.0 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.369 -0.832 . . . . 1.96 109.1 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.0 HG21 HH12 ' A' ' 46' ' ' ARG . 73.6 t -64.7 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.298 1.047 . . . . 0.59 109.697 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.8 -42.23 98.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.32 -1.352 . . . . 0.79 110.006 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -62.63 -42.89 99.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.998 -1.064 . . . . 2.33 112.821 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HZ3' HG13 ' A' ' 25' ' ' VAL . 18.1 ptmt -67.9 -27.53 66.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.902 -1.124 . . . . 2.62 109.593 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 53.9 tp -55.32 -39.33 69.83 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.326 -0.95 . . . . 1.3 108.75 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -29.37 66.83 Favored 'General case' 0 C--N 1.282 -2.328 0 O-C-N 121.043 -1.036 . . . . 1.7 109.349 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.51 -32.64 51.26 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.101 -0.999 . . . . 2.29 110.046 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.1 m -77.82 3.73 13.58 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 119.995 -1.691 . . . . 1.41 111.267 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 64.92 44.74 3.42 Favored 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 122.27 1.034 . . . . 1.53 112.485 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.714 HD22 ' H ' ' A' ' 81' ' ' LEU . 2.1 mm? -66.3 -24.95 66.63 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.484 -0.78 . . . . 2.46 110.398 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 m -42.51 -36.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.974 -1.079 . . . . 2.54 110.903 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -161.67 -18.83 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 119.574 -1.954 . . . . 3.53 111.029 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -60.49 -43.62 96.8 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 123.518 1.628 . . . . 3.06 108.049 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 81' ' ' LEU . 62.8 mtt -95.58 -123.95 0.11 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 112.91 -1.95 . . . . 2.45 111.972 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.642 ' HG2' HG21 ' A' ' 41' ' ' ILE . 14.8 mttm 56.45 29.53 15.46 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.867 0.691 . . . . 1.49 112.867 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 120.467 -1.396 . . . . 2.69 110.865 179.415 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 6' ' ' VAL . 95.3 mt-10 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 109.916 -0.401 . . . . 4.72 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG23 ' C ' ' A' ' 5' ' ' GLU . 3.1 t 94.95 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 CA-C-O 121.15 0.5 . . . . 2.38 111.162 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 83.26 27.83 38.76 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.172 -0.955 . . . . 1.47 110.991 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -149.01 -177.98 6.11 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.935 -1.333 . . . . 3.56 109.572 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.6 mt -99.78 140.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 124.031 1.872 . . . . 1.43 113.883 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.4 p -121.4 156.34 32.89 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.049 -2.341 . . . . 1.19 109.119 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.426 ' H ' ' HB3' ' A' ' 55' ' ' GLU . 42.5 t -124.77 136.29 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 108.668 -0.864 . . . . 0.95 108.668 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.585 ' CE ' HH21 ' A' ' 47' ' ' ARG . 36.2 mttp -91.17 125.49 35.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 118.987 -2.321 . . . . 3.12 110.851 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.2 124.29 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.635 -1.226 . . . . 1.69 109.583 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 24.0 mttm -146.66 156.14 42.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.532 -1.285 . . . . 2.43 107.532 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 16' ' ' ARG . . . -85.43 176.62 49.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 103.934 -3.666 . . . . 2.26 103.934 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 15' ' ' GLY . 37.0 mtm180 27.32 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.57 0 CA-C-N 120.049 1.924 . . . . 4.93 109.343 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 41.3 tp10 93.17 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 106.621 -1.622 . . . . 3.13 106.621 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 156.67 104.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.97 -0.456 . . . . 1.78 110.479 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.79 76.68 0.05 OUTLIER Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.634 -1.746 . . . . 1.06 110.645 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -155.64 135.8 13.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.394 -1.65 . . . . 1.36 109.928 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' O ' HG21 ' A' ' 42' ' ' THR . 67.8 mttm -98.35 145.83 26.3 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.409 -0.96 . . . . 3.16 108.409 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.1 p -134.61 162.58 31.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.346 0.593 . . . . 0.78 110.447 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.18 135.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.349 -2.093 . . . . 0.43 105.349 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.518 HG12 HG12 ' A' ' 35' ' ' VAL . 63.7 mt -97.31 132.17 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.694 -1.254 . . . . 0.51 110.37 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -143.78 70.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 C-N-CA 118.991 -1.084 . . . . 1.3 111.355 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 20.2 t70 165.83 148.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.505 -1.372 . . . . 1.56 109.582 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.98 115.45 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 103.815 -2.661 . . . . 1.8 103.815 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.3 mt -97.03 -81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.77 111.029 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -108.96 171.83 7.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.735 -1.12 . . . . 2.4 108.982 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -40.19 71.78 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 118.497 -1.281 . . . . 2.55 109.51 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -102.51 -0.96 31.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.635 -1.291 . . . . 2.1 113.82 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.04 141.14 48.99 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 120.935 1.698 . . . . 1.6 114.087 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.25 161.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.42 -0.955 . . . . 0.49 108.42 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.691 HD21 ' CG ' ' A' ' 46' ' ' ARG . 8.4 tt -99.46 136.04 39.98 Favored 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 108.215 -1.032 . . . . 0.93 108.215 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.7 m -128.09 150.43 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.258 -0.977 . . . . 0.52 111.944 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.662 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -143.07 155.05 44.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.472 0.654 . . . . 0.63 111.804 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -154.77 167.08 32.58 Favored Glycine 0 N--CA 1.506 3.361 0 N-CA-C 108.047 -2.021 . . . . 0.84 108.047 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.62 124.48 15.53 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 CA-C-N 119.037 1.418 . . . . 0.99 110.357 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' HZ3' ' HE2' ' A' ' 45' ' ' LYS . 23.5 mttt -60.51 -43.23 97.31 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.225 1.012 . . . . 3.44 110.869 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.87 -40.67 91.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.526 0.936 . . . . 2.27 113.526 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CD1' ' NZ ' ' A' ' 86' ' ' LYS . 81.6 mt -96.09 -76.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.325 -0.95 . . . . 2.05 113.145 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.62 HG21 ' O ' ' A' ' 21' ' ' LYS . 44.9 m -60.15 -36.6 77.89 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.354 -1.466 . . . . 1.1 109.035 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -6.65 63.46 Favored Glycine 0 C--N 1.293 -1.826 0 N-CA-C 110.249 -1.14 . . . . 1.12 110.249 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.5 m -91.64 131.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 119.267 1.533 . . . . 1.06 107.684 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HE2' ' HZ3' ' A' ' 39' ' ' LYS . 35.7 ttmt -89.16 -78.25 0.36 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.76 -1.176 . . . . 3.49 109.51 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.691 ' CG ' HD21 ' A' ' 34' ' ' LEU . 55.9 ttt180 -151.92 124.02 8.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 105.009 -2.219 . . . . 2.78 105.009 177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 38.1 ptt180 -158.8 166.96 30.7 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 119.385 -2.072 . . . . 3.1 110.191 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -96.23 143.38 27.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.112 -0.992 . . . . 3.0 111.435 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.93 143.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.595 -0.891 . . . . 1.63 108.595 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' OD1' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.85 164.14 13.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.145 -0.972 . . . . 2.28 111.768 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.38 -24.75 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 115.814 -0.63 . . . . 1.41 111.341 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.515 HD12 ' OD1' ' A' ' 50' ' ' ASN . 60.9 mt -54.79 -31.4 58.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.954 -1.091 . . . . 1.25 109.557 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -118.15 92.33 3.8 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.09 -1.819 . . . . 1.5 106.09 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.487 HD23 ' HD3' ' A' ' 56' ' ' PRO . 9.1 tt -113.93 129.53 56.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.138 0.494 . . . . 1.56 109.722 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -140.84 93.87 8.25 Favored Pre-proline 0 N--CA 1.502 2.162 0 N-CA-C 107.743 -1.206 . . . . 2.28 107.743 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' HD23 ' A' ' 54' ' ' LEU . 94.2 Cg_endo -93.23 147.46 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.692 1.595 . . . . 0.69 114.307 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 p -120.26 161.86 20.39 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.823 -1.177 . . . . 0.88 107.823 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 54.6 p30 -78.66 135.61 37.25 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.334 -1.728 . . . . 2.57 106.334 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' H ' ' A' ' 60' ' ' LYS . 40.3 tttm -171.61 -174.57 1.41 Allowed 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 117.298 -1.761 . . . . 2.9 109.504 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.751 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 15.7 tttp -82.78 153.1 25.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.767 -1.197 . . . . 5.03 107.767 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.4 pt -138.0 82.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 114.609 1.337 . . . . 4.81 114.609 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -146.77 91.75 2.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.96 -1.087 . . . . 2.14 112.13 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.889 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.65 162.64 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.728 0.775 . . . . 1.72 109.364 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -72.32 -121.02 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.26 -2.126 . . . . 2.59 105.26 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -173.78 131.45 0.43 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.84 -1.163 . . . . 3.48 108.834 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.52 17.8 70.12 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.555 -1.783 . . . . 0.64 110.178 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.16 144.94 22.54 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.685 -1.48 . . . . 0.62 111.715 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.875 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.5 p -68.45 169.22 11.2 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 107.175 -1.417 . . . . 0.73 107.175 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 91.6 m-20 -59.15 -47.69 84.37 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.181 -2.199 . . . . 2.02 111.18 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.45 -41.79 98.65 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 116.936 -1.906 . . . . 2.3 108.332 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.91 -35.93 82.75 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.266 -0.974 . . . . 1.96 108.403 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 68' ' ' SER . 78.4 t -62.17 -40.12 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.73 0.776 . . . . 0.59 109.041 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 99.4 mttt -59.53 -40.66 87.93 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.701 -1.2 . . . . 0.79 108.775 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -60.31 -43.13 96.64 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 117.491 -1.684 . . . . 2.33 109.222 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.52 78.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.082 -1.011 . . . . 2.62 109.956 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.778 ' O ' HD11 ' A' ' 81' ' ' LEU . 9.4 tt -58.18 -42.98 87.23 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.956 . . . . 1.3 110.245 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.642 ' HA ' HD21 ' A' ' 81' ' ' LEU . 96.6 mt-10 -59.19 -31.15 68.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.183 -0.948 . . . . 1.7 108.715 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -52.57 -32.37 40.75 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.281 -1.748 . . . . 2.29 106.281 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.3 m -62.9 -18.41 62.98 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.783 -0.573 . . . . 1.41 111.668 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 70.4 50.35 0.4 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-O 123.257 1.503 . . . . 1.53 110.505 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.845 ' N ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.4 -28.22 69.1 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.544 -1.662 . . . . 2.46 112.362 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.354 -1.466 . . . . 2.54 112.988 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.39 -18.2 0.11 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 119.411 -2.055 . . . . 3.53 110.343 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.99 -38.58 86.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.699 1.238 . . . . 3.06 107.837 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.06 -125.95 0.22 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.477 -1.238 . . . . 2.45 111.004 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' NZ ' ' CD1' ' A' ' 41' ' ' ILE . 33.1 mttm 54.27 26.42 6.8 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.12 1.368 . . . . 1.49 114.369 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 . . . . . 0 N--CA 1.512 2.634 0 O-C-N 119.394 -2.066 . . . . 2.69 110.502 179.755 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 8' ' ' ARG . 94.6 mt-10 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 4.72 108.565 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 27' ' ' ILE . 23.7 t -100.39 142.69 15.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.549 -1.278 . . . . 2.38 107.549 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.475 ' HA3' ' H ' ' A' ' 62' ' ' ASP . . . 96.83 -3.4 62.64 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.492 -1.38 . . . . 1.47 110.329 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 5' ' ' GLU . 95.1 mtt180 -89.92 177.2 6.54 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.33 -1.1 . . . . 3.56 110.786 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.439 HD12 ' HD3' ' A' ' 59' ' ' LYS . 73.9 mt -95.9 137.34 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 106.569 -1.641 . . . . 1.43 106.569 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.8 p -127.79 158.62 37.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.515 -0.741 . . . . 1.19 110.441 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.08 132.22 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.467 -1.679 . . . . 0.95 106.467 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' NZ ' HG23 ' A' ' 49' ' ' VAL . 10.6 tptm -93.4 119.59 32.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.861 -1.774 . . . . 3.12 112.84 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.08 128.99 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.493 -1.299 . . . . 1.69 107.493 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -143.85 175.82 9.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.833 -0.803 . . . . 2.43 108.833 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -81.14 143.19 23.79 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.383 -1.865 . . . . 2.26 108.77 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 33.6 ttm180 49.6 87.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.19 -1.411 . . . . 4.93 107.19 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 48.9 tp10 112.62 152.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 105.92 -1.882 . . . . 3.13 105.92 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.95 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 112.662 0.616 . . . . 1.78 112.662 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.83 84.21 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.81 -1.662 . . . . 1.06 110.591 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -161.42 147.62 14.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.276 . . . . 1.36 108.798 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.826 ' O ' HG21 ' A' ' 42' ' ' THR . 97.1 mttt -96.63 147.77 23.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.161 -0.962 . . . . 3.16 108.707 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 4.9 p -143.93 162.81 35.18 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.228 -0.92 . . . . 0.78 110.396 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 76' ' ' LEU . 26.5 t -114.7 135.03 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 105.911 -1.885 . . . . 0.43 105.911 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 6' ' ' VAL . 66.5 mt -91.29 134.83 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.693 -1.203 . . . . 0.51 110.066 -175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 72' ' ' VAL . 13.1 m -156.78 76.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.464 1.653 . . . . 1.3 115.464 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 54.2 t0 171.63 150.89 0.05 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.094 -1.004 . . . . 1.56 109.249 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.793 HD11 HG21 ' A' ' 6' ' ' VAL . 26.4 mm -119.22 129.67 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.494 -2.039 . . . . 1.8 105.494 171.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.82 HG22 ' H ' ' A' ' 29' ' ' ASP . 88.6 mt -121.55 -117.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.816 -1.178 . . . . 0.77 109.552 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.82 ' H ' HG22 ' A' ' 28' ' ' ILE . 52.4 t0 -58.22 -35.23 71.37 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.082 -1.451 . . . . 2.4 107.082 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 91.9 m-20 121.98 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.119 -1.808 . . . . 2.55 106.119 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.59 4.7 53.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.437 -1.32 . . . . 2.1 107.437 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.69 148.48 52.48 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.541 -0.754 . . . . 1.6 109.736 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.29 161.11 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 108.12 -1.067 . . . . 0.49 108.12 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.654 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.3 tt -104.66 129.71 52.78 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 117.844 -1.542 . . . . 0.93 107.807 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 34' ' ' LEU . 7.4 m -125.7 154.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 118.815 -1.154 . . . . 0.52 110.708 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.732 HG21 ' CG1' ' A' ' 72' ' ' VAL . 10.5 t -140.61 156.88 46.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.63 112.109 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.47 163.54 31.65 Favored Glycine 0 N--CA 1.507 3.371 0 N-CA-C 107.523 -2.231 . . . . 0.84 107.523 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.24 122.82 12.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 CA-C-N 119.506 1.653 . . . . 0.99 110.78 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.6 -40.43 87.46 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.817 -0.552 . . . . 3.44 111.715 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.28 -43.11 95.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.15 1.167 . . . . 2.27 114.15 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.673 HG21 ' O ' ' A' ' 86' ' ' LYS . 15.8 mm -96.5 -71.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.32 -1.487 . . . . 2.05 114.016 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 21' ' ' LYS . 31.5 m -56.34 -37.06 69.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.723 -0.671 . . . . 1.1 111.002 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.83 7.52 47.45 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.31 -1.424 . . . . 1.12 110.03 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' HH21 ' A' ' 47' ' ' ARG . 18.2 m -122.08 162.62 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 105.527 -2.027 . . . . 1.06 105.527 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -139.16 -69.92 0.42 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.989 -1.115 . . . . 3.49 107.989 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.654 ' HG3' HD21 ' A' ' 34' ' ' LEU . 34.7 ttp180 -146.16 124.63 12.39 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 44' ' ' VAL . 18.9 ptp180 -155.17 168.06 28.29 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.876 -1.14 . . . . 3.1 109.543 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -116.62 143.6 45.42 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.662 -1.236 . . . . 3.0 107.662 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.453 HG23 ' NZ ' ' A' ' 12' ' ' LYS . 14.8 p -132.48 140.12 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.379 1.085 . . . . 1.63 111.365 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 44.6 t-20 -80.79 163.36 23.53 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.967 -1.015 . . . . 2.28 110.321 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 24.1 mm -59.2 -27.33 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 115.917 -0.583 . . . . 1.41 110.696 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.0 mt -54.55 -37.9 65.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.934 -1.104 . . . . 1.25 111.369 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.99 89.32 3.0 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.35 -1.34 . . . . 1.5 109.953 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.2 tp -118.83 128.82 54.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.928 -0.768 . . . . 1.56 108.928 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -135.26 85.88 31.99 Favored Pre-proline 0 N--CA 1.508 2.443 0 O-C-N 120.542 -1.348 . . . . 2.28 108.668 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -96.13 151.69 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.89 2.393 . . . . 0.69 115.512 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.461 ' OG1' ' NZ ' ' A' ' 59' ' ' LYS . 19.4 p -112.19 162.0 15.94 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 106.297 -1.742 . . . . 0.88 106.297 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.19 98.47 5.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.515 -1.99 . . . . 2.57 110.657 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' NZ ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -114.06 -164.63 0.94 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.416 1.103 . . . . 2.9 111.137 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -84.58 163.36 19.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.212 -1.774 . . . . 5.03 106.212 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 61' ' ' ILE . 13.7 tt -121.19 123.47 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.688 -1.258 . . . . 4.81 109.61 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 60.7 t0 -161.63 107.09 1.31 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.73 -0.606 . . . . 2.14 110.267 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -129.54 135.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.333 -1.728 . . . . 1.72 106.333 176.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.689 ' H ' ' HZ3' ' A' ' 75' ' ' LYS . 60.3 tp60 -64.78 -50.61 66.11 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 115.128 -2.629 . . . . 2.59 108.657 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 50.3 tttt 131.2 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 107.268 -1.382 . . . . 3.48 107.268 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.18 22.3 59.3 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.712 -1.355 . . . . 0.64 109.712 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -54.66 143.64 24.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.236 . . . . 0.62 112.436 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.6 p -71.08 163.91 26.65 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 109.059 -0.719 . . . . 0.73 109.059 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -54.97 -43.14 73.21 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.304 -1.498 . . . . 2.02 109.908 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -38.47 87.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 117.401 -1.72 . . . . 2.3 108.971 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 97.1 mt-10 -67.24 -37.38 83.43 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.557 -1.257 . . . . 1.96 108.581 177.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 36' ' ' THR . 67.2 t -63.7 -43.73 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 120.121 -0.632 . . . . 0.59 111.371 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.51 -42.05 91.33 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.103 -1.439 . . . . 0.79 108.322 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.99 -43.4 91.47 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 117.6 -1.64 . . . . 2.33 107.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.689 ' HZ3' ' H ' ' A' ' 64' ' ' GLN . 56.5 mtmt -60.26 -32.02 70.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 2.62 112.12 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.646 ' O ' ' OG ' ' A' ' 79' ' ' SER . 32.0 tp -52.8 -40.91 63.67 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.043 -1.661 . . . . 1.3 107.441 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 80' ' ' ASN . 97.2 mt-10 -58.57 -34.46 71.08 Favored 'General case' 0 C--N 1.272 -2.776 0 C-N-CA 116.888 -1.925 . . . . 1.7 108.381 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.464 ' OE1' ' OD2' ' A' ' 62' ' ' ASP . 97.6 mt-10 -62.33 -33.47 74.76 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.888 -1.523 . . . . 2.29 106.888 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.646 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 83.7 p -65.34 -26.07 67.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.859 -2.274 . . . . 1.41 104.859 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 77' ' ' GLU . 69.0 m-20 63.12 42.15 7.47 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.743 0.783 . . . . 1.53 109.946 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 34.2 mt -92.11 3.73 54.67 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.685 -0.806 . . . . 2.46 111.35 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 m -46.61 -33.74 4.43 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.912 -1.118 . . . . 2.54 110.052 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -164.84 0.26 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.051 -1.031 . . . . 3.53 108.648 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -61.42 -43.86 98.14 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 103.176 -2.898 . . . . 3.06 103.176 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.592 ' CE ' ' HZ3' ' A' ' 21' ' ' LYS . 85.3 mmm -121.3 -120.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.281 -1.327 . . . . 2.45 110.388 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 41' ' ' ILE . 36.4 mtpt 64.97 39.45 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.152 -1.385 . . . . 1.49 109.878 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.471 0.653 . . . . 2.69 109.687 179.0 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.591 ' C ' HG12 ' A' ' 6' ' ' VAL . 58.3 mp0 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.931 -0.766 . . . . 4.72 108.931 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.591 HG12 ' C ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER 169.46 123.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.4 -0.963 . . . . 2.38 108.4 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 71.28 24.53 76.86 Favored Glycine 0 N--CA 1.502 3.1 0 C-N-CA 119.499 -1.334 . . . . 1.47 110.016 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 57' ' ' THR . 80.9 mtp180 -117.97 164.61 14.82 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.83 -0.806 . . . . 3.56 110.294 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.63 137.94 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 122.358 1.075 . . . . 1.43 109.448 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.85 156.69 27.96 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.994 -1.003 . . . . 1.19 111.554 -175.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 t -122.09 134.99 63.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 N-CA-C 105.979 -1.86 . . . . 0.95 105.979 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.43 130.05 38.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 119.202 -2.186 . . . . 3.12 111.443 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.89 120.46 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 118.197 -1.401 . . . . 1.69 110.409 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 91.1 mttt -146.59 152.71 39.36 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.664 -1.606 . . . . 2.43 106.664 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -85.29 174.1 48.73 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 105.333 -3.107 . . . . 2.26 105.333 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 15' ' ' GLY . 73.0 mtm180 34.68 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 CA-C-N 118.643 1.221 . . . . 4.93 107.756 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.699 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 82.6 tt0 89.71 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.364 -1.347 . . . . 3.13 107.364 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 153.59 106.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.78 0.324 . . . . 1.78 110.798 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.89 80.88 0.05 OUTLIER Glycine 0 C--N 1.297 -1.62 0 C-N-CA 118.906 -1.616 . . . . 1.06 109.835 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -156.71 141.76 17.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.399 -1.648 . . . . 1.36 110.346 176.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 42' ' ' THR . 68.5 mttm -93.62 148.38 22.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.383 -1.448 . . . . 3.16 107.725 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -137.02 142.95 42.5 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.249 -0.907 . . . . 0.78 112.634 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.82 137.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.228 -1.767 . . . . 0.43 106.228 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 35' ' ' VAL . 69.7 mt -100.43 131.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.465 -0.894 . . . . 0.51 111.706 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -143.84 72.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.145 -1.022 . . . . 1.3 109.966 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 56.9 t0 168.12 144.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.788 -1.195 . . . . 1.56 109.716 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.2 tt -124.0 124.42 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.331 -2.47 . . . . 1.8 104.331 170.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -99.56 -84.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.878 -1.139 . . . . 0.77 112.059 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 59.5 t0 -104.47 8.14 35.55 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.188 -0.671 . . . . 2.4 109.188 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 81.4 m-20 90.08 -26.86 0.05 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 124.043 0.937 . . . . 2.55 109.759 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 39.3 p-10 -103.09 -3.45 25.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 2.1 109.78 177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 95.9 m-85 -119.1 140.39 50.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.958 -1.127 . . . . 1.6 107.958 175.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.45 158.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.49 109.177 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.677 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.5 tt -103.53 135.88 44.29 Favored 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.026 -1.07 . . . . 0.93 108.333 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 24' ' ' ILE . 17.6 m -126.39 149.09 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.034 -1.066 . . . . 0.52 109.949 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.439 HG23 HD13 ' A' ' 76' ' ' LEU . 6.3 t -142.84 154.04 43.77 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.642 0.735 . . . . 0.63 111.236 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -156.54 160.14 30.01 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.698 -2.561 . . . . 0.84 106.698 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' HD21 ' A' ' 76' ' ' LEU . 17.2 Cg_exo -60.86 121.81 10.26 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 CA-C-N 120.629 2.215 . . . . 0.99 110.017 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -58.88 -36.57 74.86 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.522 1.153 . . . . 3.44 108.63 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.51 -38.86 91.58 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.511 -0.768 . . . . 2.27 112.373 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 86' ' ' LYS . 76.1 mt -96.5 -81.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.915 -1.116 . . . . 2.05 111.369 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 21' ' ' LYS . 53.5 m -63.03 -36.79 84.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.927 . . . . 1.1 111.067 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.73 -7.45 57.62 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 120.509 -0.853 . . . . 1.12 111.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.3 m -91.55 130.72 40.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 120.554 2.177 . . . . 1.06 105.929 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -92.38 -75.64 0.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.516 -1.273 . . . . 3.49 109.551 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.827 HH12 HG21 ' A' ' 72' ' ' VAL . 55.6 ttt85 -149.78 125.84 10.62 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.897 -1.89 . . . . 2.78 105.897 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -156.58 165.51 36.08 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 119.714 -1.866 . . . . 3.1 110.909 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -106.9 136.04 47.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.289 -0.882 . . . . 3.0 111.155 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 53' ' ' HIS . 62.7 t -124.88 136.74 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.033 -1.042 . . . . 1.63 110.674 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.24 167.62 16.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.331 -0.856 . . . . 2.28 109.474 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.5 mt -56.86 -26.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.231 -0.918 . . . . 1.41 111.375 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.88 -34.88 68.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.426 -1.421 . . . . 1.25 110.253 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.501 ' O ' HG11 ' A' ' 49' ' ' VAL . 98.6 m-70 -116.44 87.07 2.61 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.296 -0.962 . . . . 1.5 108.625 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 5' ' ' GLU . 30.7 tp -125.35 127.59 46.86 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.314 -0.866 . . . . 1.56 109.079 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -134.45 88.9 28.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.45 -1.315 . . . . 2.28 107.45 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -90.5 148.05 4.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.85 1.7 . . . . 0.69 114.866 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 30.4 p -117.1 165.46 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.99 -1.115 . . . . 0.88 107.99 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.85 137.0 53.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.264 -1.754 . . . . 2.57 106.264 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.32 -175.78 1.47 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.024 0.916 . . . . 2.9 110.127 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 7' ' ' GLY . 48.7 mmtm -86.61 163.15 17.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.781 -1.192 . . . . 5.03 107.781 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 61' ' ' ILE . 31.4 pt -130.89 87.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 123.595 1.664 . . . . 4.81 111.823 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.1 p30 -150.68 93.05 1.91 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 113.735 1.013 . . . . 2.14 113.735 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.1 pt -121.95 153.41 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.728 -1.233 . . . . 1.72 110.432 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 83.4 mt-30 -63.05 -42.34 99.69 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.477 -1.689 . . . . 2.59 109.216 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 34.4 mtmt 98.21 90.17 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.448 0.567 . . . . 3.48 110.037 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.11 8.47 60.21 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.893 -1.129 . . . . 0.64 111.66 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.81 148.47 10.12 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.822 -1.399 . . . . 0.62 112.158 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.815 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 p -65.49 165.71 11.65 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.616 -1.253 . . . . 0.73 107.616 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -59.33 -45.1 92.3 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 119.798 -1.814 . . . . 2.02 111.484 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.43 -39.72 95.25 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.089 -1.844 . . . . 2.3 108.777 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.99 -36.39 83.18 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.903 -1.119 . . . . 1.96 108.353 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.827 HG21 HH12 ' A' ' 46' ' ' ARG . 74.6 t -65.3 -42.59 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.768 . . . . 0.59 110.654 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.07 -41.95 93.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 118.716 -1.194 . . . . 0.79 109.666 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -59.23 -41.79 89.5 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 117.484 -1.686 . . . . 2.33 107.244 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -62.69 -34.92 78.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.63 -0.669 . . . . 2.62 110.704 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.56 HD21 ' HD3' ' A' ' 38' ' ' PRO . 50.3 tp -56.55 -41.38 76.75 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.812 -1.18 . . . . 1.3 108.983 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.27 -30.75 66.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.891 -0.781 . . . . 1.7 108.891 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' OD2' ' A' ' 62' ' ' ASP . 84.5 tt0 -53.62 -34.91 60.13 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.66 -1.237 . . . . 2.29 107.66 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.1 m -65.74 -18.31 65.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 1.41 109.907 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 71.16 51.13 0.28 Allowed 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.932 1.349 . . . . 1.53 111.551 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.5 mp -63.51 -28.59 70.06 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.265 -1.334 . . . . 2.46 112.153 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 39.8 m -44.88 -35.63 2.9 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.577 -1.327 . . . . 2.54 110.945 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -153.92 -19.06 0.14 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.046 -1.659 . . . . 3.53 110.268 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -61.99 -40.94 97.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.373 -1.454 . . . . 3.06 108.034 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . 87.7 mtp -103.65 -122.75 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.85 -1.068 . . . . 2.45 110.976 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 41' ' ' ILE . 28.6 mtpt 43.14 16.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.865 -0.522 . . . . 1.49 111.134 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.0 mt-10 . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 118.566 -1.254 . . . . 2.69 108.923 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 5' ' ' GLU . 18.7 Cg_endo . . . . . 0 N--CA 1.496 1.629 0 CA-C-O 121.773 0.655 . . . . 3.54 111.335 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.55 12.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.873 -0.517 . . . . 3.57 111.03 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.75 -39.55 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.065 -1.454 . . . . 5.43 107.728 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' PRO . 95.5 mt-10 -127.17 151.3 48.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 115.756 -0.656 . . . . 4.72 110.66 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 7' ' ' GLY . 10.8 m -72.43 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.081 -1.012 . . . . 2.38 108.972 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 79.91 37.72 21.63 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.722 -1.237 . . . . 1.47 111.187 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.76 HH21 HD11 ' A' ' 54' ' ' LEU . 29.1 ptt-85 -146.75 -177.93 5.91 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 120.92 -1.341 . . . . 3.56 108.789 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' CD ' ' A' ' 59' ' ' LYS . 61.4 mt -107.34 142.39 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.719 1.247 . . . . 1.43 112.213 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HB3' HD11 ' A' ' 24' ' ' ILE . 1.6 p -113.43 155.47 25.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.785 -1.552 . . . . 1.19 113.225 -175.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.7 138.82 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 114.975 -1.011 . . . . 0.95 108.591 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 18' ' ' ALA . 63.1 tttm -86.16 126.93 34.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 118.682 -2.511 . . . . 3.12 110.826 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 55' ' ' GLU . 40.5 t -118.71 126.61 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.62 -1.232 . . . . 1.69 111.498 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 51.9 tttp -170.94 172.42 5.54 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 105.221 -2.141 . . . . 2.43 105.221 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -86.1 178.23 49.44 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.167 -1.973 . . . . 2.26 108.167 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 17' ' ' GLU . 40.9 ttm180 40.07 99.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.942 . . . . 4.93 111.291 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 33.3 109.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 113.441 0.904 . . . . 3.13 113.441 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -171.75 16.37 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.958 0 O-C-N 121.338 -0.851 . . . . 1.78 110.387 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.573 ' C ' HD12 ' A' ' 89' ' ' ILE . . . -95.05 110.53 4.03 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 107.564 -2.214 . . . . 1.06 107.564 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 89' ' ' ILE . 73.1 m -142.57 139.47 31.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.123 -1.436 . . . . 1.36 107.123 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HE3' ' H ' ' A' ' 86' ' ' LYS . 1.3 pttm -94.28 138.62 32.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.325 -1.484 . . . . 3.16 109.787 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.662 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 p -142.1 157.96 44.29 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.531 -0.868 . . . . 0.78 111.274 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 76' ' ' LEU . 37.5 t -104.06 134.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.113 -1.81 . . . . 0.43 106.113 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 10' ' ' CYS . 69.9 mt -96.89 133.71 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.032 -1.043 . . . . 0.51 110.371 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 17.1 m -151.94 69.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.457 -1.697 . . . . 1.3 113.594 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.6 t0 171.19 152.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.737 -1.227 . . . . 1.56 109.991 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.522 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.5 mt -117.66 127.57 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 103.038 -2.949 . . . . 1.8 103.038 171.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 29' ' ' ASP . 20.9 mm -99.75 -111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.017 -1.677 . . . . 0.77 111.853 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 91.6 m-20 -62.71 -41.36 99.1 Favored 'General case' 0 C--O 1.201 -1.452 0 O-C-N 121.695 -0.628 . . . . 2.4 110.157 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.582 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 89.9 m-20 164.34 -50.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 C-N-CA 124.833 1.253 . . . . 2.55 109.353 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -95.07 4.85 53.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 2.1 111.922 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.84 147.22 42.33 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.068 -1.02 . . . . 1.6 110.337 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.98 162.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.676 -0.49 . . . . 0.49 109.676 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 ' HE ' ' A' ' 46' ' ' ARG . 8.2 tt -97.4 132.48 43.07 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 119.361 -0.936 . . . . 0.93 108.643 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 47' ' ' ARG . 22.2 m -127.71 150.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.777 -0.769 . . . . 0.52 110.556 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.747 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -144.03 155.12 43.88 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.974 -0.69 . . . . 0.63 112.15 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA3' HG23 ' A' ' 44' ' ' VAL . . . -152.55 169.08 31.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.132 -1.987 . . . . 0.84 108.132 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 21' ' ' LYS . 36.9 Cg_endo -70.39 110.35 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 CA-C-N 118.938 1.369 . . . . 0.99 109.322 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -58.82 -39.5 81.36 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.057 -1.027 . . . . 3.44 111.202 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.26 -40.22 96.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.941 -1.099 . . . . 2.27 112.47 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.458 HD13 ' HD3' ' A' ' 86' ' ' LYS . 82.8 mt -96.87 -77.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.419 -0.801 . . . . 2.05 112.874 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.4 m -61.89 -35.06 77.24 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.729 -1.232 . . . . 1.1 109.492 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.54 -10.97 56.47 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.653 -0.654 . . . . 1.12 111.797 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -91.1 128.33 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 119.93 1.865 . . . . 1.06 108.15 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -95.33 -75.57 0.52 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.332 1.063 . . . . 3.49 110.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 1.06 ' HE ' HD11 ' A' ' 34' ' ' LEU . 65.2 ttt180 -148.7 125.44 11.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.301 -1.37 . . . . 2.78 107.301 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.712 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ptm180 -157.23 164.34 37.82 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 119.969 -1.707 . . . . 3.1 109.489 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -105.25 141.1 37.37 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.43 -0.793 . . . . 3.0 109.528 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -133.8 143.6 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 1.63 110.052 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 48.6 t-20 -80.87 154.24 27.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.669 0.747 . . . . 2.28 111.243 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 93.1 mt -58.36 -23.84 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.638 -0.664 . . . . 1.41 109.728 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.6 mt -53.26 -29.87 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 1.25 108.94 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -117.43 91.7 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.553 -1.647 . . . . 1.5 106.553 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.76 HD11 HH21 ' A' ' 8' ' ' ARG . 24.4 tp -113.82 130.38 56.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.684 -0.635 . . . . 1.56 110.548 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' CD ' HG21 ' A' ' 13' ' ' VAL . 14.7 tp10 -137.81 90.33 14.41 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 106.864 -1.532 . . . . 2.28 106.864 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 90.3 Cg_endo -90.26 148.13 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.629 1.553 . . . . 0.69 113.926 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 p -119.73 163.81 16.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.491 -0.929 . . . . 0.88 108.491 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.599 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 55.3 p30 -75.4 125.82 29.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.282 -1.747 . . . . 2.57 106.282 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.729 ' CD ' HD12 ' A' ' 9' ' ' ILE . 24.5 mttt -162.14 -173.03 3.46 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.083 1.42 . . . . 2.9 112.704 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' GLY . 25.3 tttt -81.48 150.88 28.08 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.722 -1.581 . . . . 5.03 111.231 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 61' ' ' ILE . 12.1 tt -120.6 120.16 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.503 0.668 . . . . 4.81 110.628 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -179.6 87.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 117.62 -1.181 . . . . 2.14 112.208 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 65' ' ' LYS . 15.6 mm -115.15 138.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 CA-C-N 123.543 2.883 . . . . 1.72 108.112 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.569 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.7 mt-30 -60.76 -41.28 95.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 115.166 -2.614 . . . . 2.59 106.282 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 59.3 tttt 114.11 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.139 -1.059 . . . . 3.48 108.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 119.849 -1.782 . . . . 0.64 111.539 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.76 144.8 17.23 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.201 -1.764 . . . . 0.62 112.225 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.8 p -69.89 167.02 18.26 Favored 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 108.152 -1.055 . . . . 0.73 108.152 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 93.0 m-20 -59.56 -47.35 85.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 119.585 -1.947 . . . . 2.02 112.088 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -41.1 98.3 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 117.003 -1.879 . . . . 2.3 108.022 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.8 -35.72 82.0 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.134 -1.061 . . . . 1.96 108.134 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 68' ' ' SER . 79.5 t -65.39 -42.82 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.59 110.094 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.68 -42.92 98.06 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.908 -1.117 . . . . 0.79 110.09 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -59.44 -38.19 80.08 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.182 -1.007 . . . . 2.33 109.072 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 11.8 mtpt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.882 -0.511 . . . . 2.62 110.169 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 36' ' ' THR . 88.4 mt -57.48 -37.68 73.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.662 -1.273 . . . . 1.3 108.641 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 97.1 mt-10 -58.65 -33.08 69.68 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 118.307 -1.357 . . . . 1.7 108.179 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.02 -35.68 75.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.145 -2.168 . . . . 2.29 105.145 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.701 ' OG ' HD11 ' A' ' 9' ' ' ILE . 31.1 m -70.01 -21.88 63.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.014 -0.539 . . . . 1.41 109.597 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 77' ' ' GLU . 74.4 m-20 66.83 46.7 1.62 Allowed 'General case' 0 N--CA 1.519 3.011 0 CA-C-O 122.229 1.014 . . . . 1.53 112.481 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.726 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.2 mp -65.52 -27.51 68.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.357 -0.838 . . . . 2.46 111.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.0 m -42.62 -33.59 0.74 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.965 -1.084 . . . . 2.54 111.29 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -157.66 -21.17 0.09 Allowed 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.009 -1.682 . . . . 3.53 110.952 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -60.59 -42.33 96.49 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 117.73 -1.588 . . . . 3.06 107.076 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' NZ ' ' A' ' 59' ' ' LYS . 62.3 mtt -94.82 -125.3 0.11 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.627 -1.624 . . . . 2.45 114.178 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' HD3' HD13 ' A' ' 41' ' ' ILE . 17.2 mttm 52.99 31.42 10.96 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.631 -1.248 . . . . 1.49 107.631 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.2 mt-10 -62.71 -28.4 69.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 116.347 1.981 . . . . 2.69 116.347 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 28.8 mtpt 61.03 75.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 102.894 -3.002 . . . . 5.0 102.894 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.573 HD12 ' C ' ' A' ' 19' ' ' GLY . 86.7 mt -58.39 -38.52 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 120.045 -0.662 . . . . 3.26 110.702 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -115.99 140.0 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.546 -1.346 . . . . 4.47 107.994 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.08 -33.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.64 -1.245 . . . . 5.67 107.64 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -83.14 130.68 35.13 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.017 -1.105 . . . . 6.75 108.017 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.4 mmm -172.04 -58.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.657 -1.277 . . . . 9.5 112.018 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.27 -67.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.725 1.617 . . . . 7.68 115.846 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.3 p -93.38 -5.6 49.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.14 -0.975 . . . . 7.69 110.536 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.018 -0.991 . . . . 8.53 109.456 -179.015 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.492 1.383 0 CA-C-O 121.576 0.573 . . . . 3.54 113.095 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.66 70.12 1.0 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.393 1.092 . . . . 3.57 108.646 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.578 HG21 ' HD2' ' A' ' 60' ' ' LYS . 73.3 mt -113.61 146.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.007 -0.997 . . . . 5.43 109.544 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 6' ' ' VAL . 95.9 mt-10 -63.17 155.45 28.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.004 -1.06 . . . . 4.72 110.063 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.642 ' O ' ' O ' ' A' ' 5' ' ' GLU . 7.2 m -43.19 -149.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.269 1.033 . . . . 2.38 112.585 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' HG23 ' A' ' 6' ' ' VAL . . . 79.35 21.81 66.4 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 106.721 -2.551 . . . . 1.47 106.721 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 57' ' ' THR . 71.1 mtp180 -128.74 170.43 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.431 -0.952 . . . . 3.56 108.431 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.703 ' O ' HG23 ' A' ' 57' ' ' THR . 82.8 mt -93.99 145.41 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.021 -1.05 . . . . 1.43 108.845 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.0 p -122.44 155.66 35.66 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.9 -1.045 . . . . 1.19 112.643 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 41.0 t -127.31 139.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 CA-C-N 115.625 -0.716 . . . . 0.95 110.158 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 18' ' ' ALA . 22.7 tptm -81.1 137.52 35.97 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 118.03 -2.919 . . . . 3.12 111.685 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.1 t -119.61 100.42 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 122.58 1.181 . . . . 1.69 109.476 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 31.6 mttm -157.02 169.08 25.63 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.153 -1.795 . . . . 2.43 106.153 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -82.84 178.83 53.15 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 117.353 -2.356 . . . . 2.26 107.305 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 15' ' ' GLY . 59.3 ttt85 49.35 106.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.172 -1.193 . . . . 4.93 111.01 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 48.33 53.55 11.73 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.996 0.903 . . . . 3.13 110.74 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 14' ' ' LYS . . . -67.88 -15.3 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.538 -1.351 . . . . 1.78 110.781 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.45 94.91 1.9 Allowed Glycine 0 C--N 1.285 -2.284 0 O-C-N 120.718 -1.239 . . . . 1.06 114.374 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -136.35 134.32 37.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.62 -1.992 . . . . 1.36 105.62 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.704 ' H ' HG21 ' A' ' 42' ' ' THR . 1.7 ptpt -100.53 136.84 39.78 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.622 -1.299 . . . . 3.16 111.455 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.2 p -137.5 159.57 41.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.772 0.796 . . . . 0.78 111.199 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 76' ' ' LEU . 41.1 t -111.12 136.27 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.056 -1.461 . . . . 0.43 107.056 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.657 HG12 HG12 ' A' ' 35' ' ' VAL . 62.7 mt -105.37 133.69 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.117 -0.989 . . . . 0.51 109.912 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.993 HG11 ' NZ ' ' A' ' 75' ' ' LYS . 1.1 m -149.18 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.884 -1.126 . . . . 1.3 111.668 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 6' ' ' VAL . 54.3 t0 172.14 137.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 1.56 109.183 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 5' ' ' GLU . 70.5 mt -118.78 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 104.177 -2.527 . . . . 1.8 104.177 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -97.05 -79.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.053 -1.03 . . . . 0.77 110.843 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 44.1 t0 -106.03 179.0 4.4 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.135 0.969 . . . . 2.4 108.871 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 91.8 m-20 -54.8 -38.51 67.39 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 118.969 -1.093 . . . . 2.55 108.81 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.54 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 33.6 p-10 -112.11 5.15 18.42 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 115.685 1.735 . . . . 2.1 115.685 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 89.3 m-85 -112.64 138.94 48.7 Favored 'General case' 0 N--CA 1.528 3.455 0 CA-C-N 121.696 2.044 . . . . 1.6 113.78 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 m -130.8 162.78 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 115.727 -0.67 . . . . 0.49 109.899 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.832 HD21 ' HE ' ' A' ' 46' ' ' ARG . 9.7 tt -100.28 135.61 41.44 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.272 -0.893 . . . . 0.93 108.829 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.3 m -126.75 150.5 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.613 -0.835 . . . . 0.52 110.541 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.57 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.9 t -146.89 153.09 39.72 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.648 -0.821 . . . . 0.63 112.015 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.7 29.82 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.571 -2.212 . . . . 0.84 107.571 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.88 108.06 0.86 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 CA-C-N 119.156 1.478 . . . . 0.99 110.594 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -58.6 -39.21 79.79 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.174 0.988 . . . . 3.44 109.592 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -38.99 93.25 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.43 -0.794 . . . . 2.27 112.251 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.691 HG21 ' HG2' ' A' ' 86' ' ' LYS . 26.8 mm -96.24 -78.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.028 . . . . 2.05 113.39 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.704 HG21 ' H ' ' A' ' 21' ' ' LYS . 26.2 m -63.0 -32.94 74.4 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.999 0.904 . . . . 1.1 108.605 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.12 56.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 111.438 -0.665 . . . . 1.12 111.438 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -68.37 148.94 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.8 1.8 . . . . 1.06 109.912 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -92.69 -131.18 0.13 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.524 -1.287 . . . . 3.49 107.524 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.832 ' HE ' HD21 ' A' ' 34' ' ' LEU . 73.9 ttt180 -139.86 122.32 16.15 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 103.982 -2.599 . . . . 2.78 103.982 173.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.744 ' O ' HG22 ' A' ' 35' ' ' VAL . 45.8 ptt85 -159.64 165.83 31.91 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 117.467 -1.693 . . . . 3.1 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -93.12 139.12 30.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.274 -0.891 . . . . 3.0 108.695 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.04 153.48 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.96 -1.087 . . . . 1.63 110.304 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' C ' HD22 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -86.3 167.7 14.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.955 0.883 . . . . 2.28 111.611 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.15 -24.84 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 115.999 -0.546 . . . . 1.41 110.234 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.512 HD12 ' OD1' ' A' ' 50' ' ' ASN . 63.7 mt -55.23 -30.87 60.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.207 -1.034 . . . . 1.25 108.207 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -116.04 88.53 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.508 -1.293 . . . . 1.5 107.508 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.6 tp -118.91 129.67 55.31 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.285 -0.635 . . . . 1.56 109.285 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -143.14 90.41 7.4 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 106.368 -1.715 . . . . 2.28 106.368 176.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -90.22 153.54 4.64 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 121.557 1.504 . . . . 0.69 114.322 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 9' ' ' ILE . 63.5 p -111.68 166.71 10.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.333 -1.728 . . . . 0.88 106.333 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 8' ' ' ARG . 88.4 m-20 -84.21 11.49 8.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.047 -1.033 . . . . 2.57 110.664 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 8' ' ' ARG 0.317 44.6 tttm -91.34 124.6 35.65 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.185 -0.947 . . . . 2.9 111.389 -177.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD2' HG21 ' A' ' 4' ' ' ILE . 65.0 tttm -133.57 119.04 18.97 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 118.596 -1.242 . . . . 5.03 111.382 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 78' ' ' GLU . 31.8 pt -128.5 157.12 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.872 -1.158 . . . . 4.81 107.872 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -86.13 128.37 34.87 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 122.891 1.329 . . . . 2.14 111.928 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.963 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.78 164.07 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 115.11 -0.95 . . . . 1.72 109.933 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -96.39 139.98 31.71 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.842 -1.17 . . . . 2.59 107.842 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -67.24 138.87 57.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 116.056 -0.52 . . . . 3.48 111.064 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.8 21.43 61.55 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.52 -1.324 . . . . 0.64 112.998 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.04 21.74 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 120.294 2.047 . . . . 0.62 111.389 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 51.7 p -71.2 166.27 21.87 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.696 -1.594 . . . . 0.73 106.696 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 53.0 p30 -60.65 -40.55 92.45 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 116.328 -2.149 . . . . 2.02 110.683 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 97.1 mt-10 -63.23 -39.31 94.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 119.517 -1.989 . . . . 2.3 107.731 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.73 -35.71 81.93 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.773 -1.171 . . . . 1.96 108.09 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 36' ' ' THR . 71.1 t -64.09 -43.52 97.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.436 -1.306 . . . . 0.59 107.881 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.74 -44.25 97.27 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.014 -1.074 . . . . 0.79 109.428 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.48 -42.32 96.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.371 -1.456 . . . . 2.33 108.315 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.993 ' NZ ' HG11 ' A' ' 25' ' ' VAL . 10.1 mtmp? -62.63 -34.93 78.04 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.507 -0.877 . . . . 2.62 109.588 176.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.622 ' O ' ' OG ' ' A' ' 79' ' ' SER . 38.1 tp -59.24 -40.5 86.11 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.735 -1.186 . . . . 1.3 108.392 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 80' ' ' ASN . 97.2 mt-10 -62.42 -34.38 76.64 Favored 'General case' 0 C--N 1.281 -2.373 0 O-C-N 120.175 -1.578 . . . . 1.7 108.135 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.482 ' HG2' HD12 ' A' ' 61' ' ' ILE . 48.8 tp10 -59.68 -36.97 77.52 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 105.589 -2.004 . . . . 2.29 105.589 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 95.8 p -71.11 -18.25 62.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.397 -1.705 . . . . 1.41 106.397 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 77' ' ' GLU . 72.0 m-20 61.6 35.02 17.45 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.123 -0.944 . . . . 1.53 111.065 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.58 HD13 ' OG ' ' A' ' 79' ' ' SER . 8.4 mp -74.55 -29.54 61.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.831 -0.543 . . . . 2.46 112.395 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 43.5 m -50.52 -33.09 20.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.122 -0.986 . . . . 2.54 110.856 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -147.42 -28.35 0.36 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 118.342 -1.343 . . . . 3.53 112.727 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -61.88 -48.57 79.89 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 114.94 -2.704 . . . . 3.06 105.606 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 62.2 mtt -88.09 -135.92 0.09 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.378 -1.737 . . . . 2.45 111.355 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.691 ' HG2' HG21 ' A' ' 41' ' ' ILE . 27.8 mtpt 62.81 29.67 16.67 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.521 -1.659 . . . . 1.49 106.521 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' O ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt-10 -86.78 2.08 50.06 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.103 -0.498 . . . . 2.69 112.112 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 87' ' ' GLU . 27.6 mttt 56.86 117.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.562 1.073 . . . . 5.0 108.73 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.47 -39.36 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 119.94 -1.725 . . . . 3.26 108.708 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -95.45 132.92 40.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.722 -1.214 . . . . 4.47 107.722 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.68 128.8 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 5.67 110.383 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -129.44 143.32 50.79 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.085 0.945 . . . . 6.75 110.714 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.754 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -146.81 -45.58 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.576 -1.268 . . . . 9.5 107.576 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 93' ' ' MET . 25.5 Cg_exo -63.76 -171.96 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 122.514 2.142 . . . . 7.68 110.354 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -59.75 -36.44 76.64 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.0 -1.063 . . . . 7.69 109.633 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.003 -1.061 . . . . 8.53 109.255 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 14.9 Cg_endo . . . . . 0 N--CA 1.49 1.27 0 N-CA-C 112.937 0.322 . . . . 3.54 112.937 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 2' ' ' PRO . . . 62.08 175.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.269 -1.752 . . . . 3.57 106.269 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.402 ' CG2' ' NH2' ' A' ' 8' ' ' ARG . 71.4 mt -118.33 125.72 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.77 1.168 . . . . 5.43 109.349 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.578 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 95.2 mt-10 -126.93 149.02 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.281 -0.637 . . . . 4.72 109.281 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 61' ' ' ILE . 5.8 m -63.48 178.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.394 -1.335 . . . . 2.38 107.394 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 89.77 18.14 52.24 Favored Glycine 0 C--O 1.199 -2.042 0 C-N-CA 119.116 -1.516 . . . . 1.47 111.27 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 28.3 ptt-85 -137.53 176.02 9.08 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.147 -1.207 . . . . 3.56 108.275 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.779 HD12 ' NZ ' ' A' ' 59' ' ' LYS . 81.3 mt -104.81 146.98 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 123.171 1.462 . . . . 1.43 111.641 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -117.47 155.72 29.21 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 112.959 -1.928 . . . . 1.19 111.515 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 43.5 t -127.02 135.4 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 CA-C-N 115.437 -0.801 . . . . 0.95 111.144 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -87.96 139.05 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.296 -2.753 . . . . 3.12 110.189 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.32 120.12 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 118.834 -1.146 . . . . 1.69 110.659 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' NZ ' ' CE1' ' A' ' 53' ' ' HIS . 93.1 mttt -161.09 170.55 20.22 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.739 -1.578 . . . . 2.43 106.739 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.9 -178.63 51.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 106.142 -2.783 . . . . 2.26 106.142 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' O ' ' O ' ' A' ' 17' ' ' GLU . 84.7 mtt180 38.38 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 119.37 1.585 . . . . 4.93 111.332 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 35.27 110.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.905 0.86 . . . . 3.13 112.673 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.58 16.6 0.07 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.919 -1.113 . . . . 1.78 111.167 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.22 98.21 2.39 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.18 -1.968 . . . . 1.06 108.18 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -144.42 137.29 26.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.149 -1.207 . . . . 1.36 109.221 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.901 ' O ' HG21 ' A' ' 42' ' ' THR . 90.1 mttt -103.36 139.36 38.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 3.16 109.418 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.5 p -131.24 157.69 42.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.839 -1.144 . . . . 0.78 109.147 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 9' ' ' ILE . 42.9 t -105.17 135.18 44.33 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 N-CA-C 106.556 -1.646 . . . . 0.43 106.556 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 35' ' ' VAL . 68.8 mt -102.73 130.03 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.41 -0.916 . . . . 0.51 110.086 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -142.28 68.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.158 -1.417 . . . . 1.3 111.729 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 55.1 t0 164.97 148.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.116 -0.99 . . . . 1.56 108.542 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.1 tt -121.74 117.67 53.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.253 -2.499 . . . . 1.8 104.253 170.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.5 mt -97.64 -80.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.879 1.323 . . . . 0.77 109.653 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -106.18 161.26 14.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.105 -1.407 . . . . 2.4 107.845 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.14 -38.1 67.8 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 118.683 -1.207 . . . . 2.55 109.592 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.462 ' OD1' HD11 ' A' ' 51' ' ' ILE . 76.6 m-20 -96.25 0.3 50.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.357 . . . . 2.1 113.651 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -121.31 145.03 48.29 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.994 1.27 . . . . 1.6 113.091 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.91 161.98 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.926 -0.484 . . . . 0.49 110.064 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 35' ' ' VAL . 9.0 tt -101.36 133.9 45.25 Favored 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 108.122 -1.066 . . . . 0.93 108.122 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 24' ' ' ILE . 30.2 m -127.51 149.61 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.246 -0.909 . . . . 0.52 110.8 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -143.22 151.4 40.56 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.083 -1.047 . . . . 0.63 111.922 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.53 164.38 37.25 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.039 -2.025 . . . . 0.84 108.039 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -65.79 124.57 12.92 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-N 120.578 2.189 . . . . 0.99 109.56 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -60.37 -43.57 96.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.372 -1.455 . . . . 3.44 111.267 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.33 -37.43 87.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 2.27 113.729 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.594 HD13 ' HD3' ' A' ' 86' ' ' LYS . 85.2 mt -94.86 -71.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 114.751 1.389 . . . . 2.05 114.751 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.901 HG21 ' O ' ' A' ' 21' ' ' LYS . 28.5 m -70.17 -35.53 74.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.41 1.1 . . . . 1.1 109.635 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -18.17 47.03 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-N 115.136 -0.938 . . . . 1.12 112.316 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -92.26 124.04 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 CA-C-N 120.31 2.055 . . . . 1.06 107.582 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -88.98 -79.55 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.237 -1.764 . . . . 3.49 106.237 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.633 HH12 HG21 ' A' ' 72' ' ' VAL . 58.1 ttt85 -152.54 118.65 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.555 -1.276 . . . . 2.78 107.555 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' O ' HG22 ' A' ' 35' ' ' VAL . 10.6 ptm180 -156.13 163.17 39.96 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.353 -1.467 . . . . 3.1 109.838 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -95.39 138.21 33.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.147 -0.971 . . . . 3.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.64 150.62 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.6 -1.312 . . . . 1.63 110.908 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.531 HD22 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -86.07 172.72 10.39 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.731 0.777 . . . . 2.28 111.646 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.462 HD11 ' OD1' ' A' ' 31' ' ' ASN . 90.3 mt -57.04 -29.04 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.742 -0.599 . . . . 1.41 110.769 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB2' HD22 ' A' ' 50' ' ' ASN . 77.4 mt -53.71 -29.03 37.36 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.124 -0.985 . . . . 1.25 109.083 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.537 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 5.7 m-70 -115.96 88.61 2.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.257 -1.757 . . . . 1.5 106.257 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.8 tp -123.93 129.16 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 1.56 109.334 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 3.1 tp10 -152.37 94.89 3.18 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 107.584 -1.265 . . . . 2.28 107.584 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 72.6 Cg_endo -87.97 153.81 7.16 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 121.46 1.44 . . . . 0.69 112.541 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 9' ' ' ILE . 50.5 p -116.92 163.95 15.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.415 -0.958 . . . . 0.88 108.415 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 49.8 p30 -88.98 39.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.511 -0.743 . . . . 2.57 111.468 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.779 ' NZ ' HD12 ' A' ' 9' ' ' ILE . 15.2 mtpt -84.3 -166.65 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.007 -1.058 . . . . 2.9 111.805 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' ' O ' ' A' ' 7' ' ' GLY . 22.9 tttt -82.75 154.27 24.86 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.037 0.935 . . . . 5.03 108.988 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 6' ' ' VAL . 26.7 mm -116.42 117.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.987 -0.685 . . . . 4.81 109.77 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -173.39 85.94 0.05 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.983 -1.073 . . . . 2.14 113.464 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.979 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -131.59 159.32 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 120.23 -1.544 . . . . 1.72 109.153 176.005 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.1 mt-30 -63.41 -44.93 93.24 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 116.455 -2.098 . . . . 2.59 108.848 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 3.0 ttmp? 99.85 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 108.085 -1.08 . . . . 3.48 108.085 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 11.41 63.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.8 -1.72 . . . . 0.64 108.8 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . . . -56.98 149.44 18.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.662 -0.905 . . . . 0.62 112.36 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.4 p -65.23 164.4 13.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.661 -1.237 . . . . 0.73 107.661 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.58 -42.48 88.13 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.161 -1.587 . . . . 2.02 111.371 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.96 -39.56 95.03 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 117.269 -1.772 . . . . 2.3 108.747 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.9 -36.3 83.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.603 -0.839 . . . . 1.96 108.898 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.633 HG21 HH12 ' A' ' 46' ' ' ARG . 75.8 t -64.57 -42.81 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.59 109.844 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.16 -42.23 98.19 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.986 -1.086 . . . . 0.79 109.791 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.49 -43.39 97.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 2.33 110.176 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HZ1' ' HB3' ' A' ' 67' ' ' ALA . 37.5 mtmm -60.87 -31.67 71.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.763 -0.586 . . . . 2.62 110.637 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.64 ' O ' ' OG ' ' A' ' 79' ' ' SER . 36.4 tp -54.83 -37.48 66.21 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.51 -31.32 67.78 Favored 'General case' 0 C--N 1.277 -2.568 0 O-C-N 120.407 -1.433 . . . . 1.7 109.183 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.08 -35.64 69.63 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.305 -1.739 . . . . 2.29 106.305 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.64 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 57.6 p -66.57 -19.74 65.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.538 -1.282 . . . . 1.41 107.538 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 60.5 37.44 19.68 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 106.904 -1.517 . . . . 1.53 106.904 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.779 HD12 ' HB2' ' A' ' 85' ' ' MET . 13.9 tp -68.35 -30.42 69.37 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.454 -1.703 . . . . 2.46 111.413 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 38.9 m -43.28 -35.66 1.55 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.291 -0.881 . . . . 2.54 110.537 -175.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.79 -23.62 0.11 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.556 -1.658 . . . . 3.53 112.219 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -60.65 -48.01 83.67 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 116.404 -2.118 . . . . 3.06 107.417 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.779 ' HB2' HD12 ' A' ' 81' ' ' LEU . 84.7 mtp -84.25 -122.92 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 112.192 -2.276 . . . . 2.45 112.951 -174.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.672 ' HZ3' ' HG ' ' A' ' 81' ' ' LEU . 25.9 mttm 46.13 14.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.466 -0.939 . . . . 1.49 108.466 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' O ' ' O ' ' A' ' 88' ' ' LYS . 97.1 mt-10 -68.31 -24.69 64.87 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.375 1.25 . . . . 2.69 114.375 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' O ' ' O ' ' A' ' 87' ' ' GLU . 91.5 mttt 57.08 143.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.139 1.336 . . . . 5.0 108.766 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' O ' HD12 ' A' ' 89' ' ' ILE . 1.3 pp -73.03 -8.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.052 -1.655 . . . . 3.26 108.402 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.52 -157.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 4.47 109.998 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.01 127.93 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.205 -1.035 . . . . 5.67 108.205 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' ' SD ' ' A' ' 93' ' ' MET . 81.9 mtp180 -133.34 134.76 44.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.799 -1.188 . . . . 6.75 113.358 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.564 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -155.83 -51.11 0.01 OUTLIER Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.156 -1.424 . . . . 9.5 107.156 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.564 ' CD ' ' H ' ' A' ' 93' ' ' MET . 17.9 Cg_exo -63.89 -22.87 68.68 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.914 1.743 . . . . 7.68 111.051 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.3 p -75.05 -24.53 58.26 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.298 0.57 . . . . 7.69 109.548 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.961 -1.018 . . . . 8.53 109.088 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ALA . 12.4 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 N-CA-C 112.938 0.322 . . . . 3.54 112.938 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . 48.38 -171.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.591 -1.263 . . . . 3.57 107.591 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.476 HG21 HD21 ' A' ' 54' ' ' LEU . 69.6 mt -115.9 126.02 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.869 -1.144 . . . . 5.43 110.442 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.759 ' H ' HH11 ' A' ' 8' ' ' ARG . 95.4 mt-10 -108.8 154.98 21.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.024 0.916 . . . . 4.72 110.492 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -63.05 175.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.561 -0.904 . . . . 2.38 108.561 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 8' ' ' ARG . . . 75.55 -118.8 5.6 Favored Glycine 0 C--N 1.29 -2.023 0 C-N-CA 119.491 -1.338 . . . . 1.47 110.272 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.759 HH11 ' H ' ' A' ' 5' ' ' GLU . 39.5 mtp180 39.8 -171.43 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.894 0 O-C-N 121.507 -0.996 . . . . 3.56 109.933 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.72 HD13 ' SD ' ' A' ' 85' ' ' MET . 16.0 tt -118.09 147.95 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 106.277 -1.749 . . . . 1.43 106.277 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 4.7 p -128.01 159.8 33.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.058 0.932 . . . . 1.19 111.95 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.16 145.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.961 -1.126 . . . . 0.95 107.961 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -89.95 137.16 32.57 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 119.516 -1.99 . . . . 3.12 109.512 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.96 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.254 -1.378 . . . . 1.69 111.754 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -165.76 160.17 16.89 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.144 -2.169 . . . . 2.43 105.144 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.89 178.94 51.17 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 117.667 -2.206 . . . . 2.26 109.095 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' GLU . 95.0 mtt-85 45.13 94.63 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.618 -0.931 . . . . 4.93 110.097 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 41.59 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.719 0.771 . . . . 3.13 112.877 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 178.6 8.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.376 -0.827 . . . . 1.78 111.725 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 1.006 ' H ' HD12 ' A' ' 89' ' ' ILE . . . -91.95 115.1 4.69 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 107.618 -2.193 . . . . 1.06 107.618 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -152.48 149.21 28.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.086 -1.243 . . . . 1.36 107.862 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 1.9 mptp? -94.93 141.77 28.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 3.16 110.516 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.0 p -139.57 158.8 43.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.78 110.313 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.01 135.68 52.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.476 -1.305 . . . . 0.43 107.476 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 35' ' ' VAL . 64.9 mt -94.49 133.78 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 C-N-CA 118.211 -1.395 . . . . 0.51 110.966 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -148.59 76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 118.442 -1.303 . . . . 1.3 111.422 176.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 47.1 t0 169.79 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.273 -1.517 . . . . 1.56 108.371 172.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 69.9 mt -119.44 121.88 67.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 103.411 -2.811 . . . . 1.8 103.411 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.9 mt -109.63 -38.82 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.941 -1.1 . . . . 0.77 109.927 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -164.69 173.93 11.32 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.962 -1.496 . . . . 2.4 106.962 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.93 -39.26 77.58 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.763 -1.175 . . . . 2.55 112.336 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -99.83 1.6 43.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.338 -1.476 . . . . 2.1 114.811 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -121.77 142.87 49.77 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.121 1.328 . . . . 1.6 111.814 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.7 162.42 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.44 -0.788 . . . . 0.49 109.411 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ASP . 13.3 tp -101.32 133.05 46.5 Favored 'General case' 0 N--CA 1.52 3.027 0 C-N-CA 118.894 -1.122 . . . . 0.93 109.163 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 24' ' ' ILE . 19.1 m -123.61 144.49 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.017 -1.073 . . . . 0.52 109.747 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.554 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.4 t -145.38 155.51 43.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.771 0.796 . . . . 0.63 112.293 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -155.34 164.51 32.01 Favored Glycine 0 N--CA 1.501 3.005 0 N-CA-C 107.168 -2.373 . . . . 0.84 107.168 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.71 115.6 3.02 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 119.145 1.472 . . . . 0.99 110.064 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.89 -34.9 72.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.76 0.79 . . . . 3.44 110.55 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.97 -40.96 99.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.635 -0.666 . . . . 2.27 112.683 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.659 HG21 ' HD3' ' A' ' 86' ' ' LYS . 81.6 mt -98.03 -78.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 2.05 112.767 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 m -61.34 -35.9 78.69 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.913 -1.117 . . . . 1.1 109.459 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.72 -3.82 57.64 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.658 -0.782 . . . . 1.12 112.112 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.5 m -90.73 131.68 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.497 -2.038 . . . . 1.06 105.497 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -94.15 -78.23 0.44 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.492 -1.283 . . . . 3.49 110.331 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -152.66 126.18 8.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.027 -1.842 . . . . 2.78 106.027 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -155.01 165.82 35.53 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.189 -1.569 . . . . 3.1 110.08 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -113.21 138.45 49.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.381 -0.824 . . . . 3.0 109.601 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 m -132.23 151.73 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 118.727 -1.189 . . . . 1.63 110.592 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.55 ' OD1' ' CE2' ' A' ' 32' ' ' PHE . 31.5 m-20 -87.3 163.25 16.94 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.268 -0.878 . . . . 2.28 108.717 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.3 mt -57.56 -24.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.02 -1.05 . . . . 1.41 111.062 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -55.2 -35.93 65.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.345 -1.472 . . . . 1.25 108.556 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -114.66 87.17 2.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.204 -1.036 . . . . 1.5 108.204 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.476 HD21 HG21 ' A' ' 4' ' ' ILE . 25.3 tp -128.5 127.85 43.23 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.655 -0.868 . . . . 1.56 108.655 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.34 87.09 39.19 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 107.314 -1.365 . . . . 2.28 107.314 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -92.17 147.95 3.04 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.107 1.872 . . . . 0.69 114.744 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 14.7 p -101.87 172.32 7.0 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.459 -1.312 . . . . 0.88 107.459 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 58' ' ' ASP . 50.3 p30 -83.1 16.37 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.088 0.947 . . . . 2.57 108.909 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HZ3' ' HB2' ' A' ' 79' ' ' SER 0.346 66.4 tttt -87.53 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.779 -0.823 . . . . 2.9 108.779 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' CE ' ' OE1' ' A' ' 5' ' ' GLU . 62.7 tttm -133.19 120.72 21.53 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.986 -1.086 . . . . 5.03 110.525 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -118.56 141.8 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.556 -1.646 . . . . 4.81 106.556 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.3 p30 -88.23 128.24 35.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.459 -1.4 . . . . 2.14 110.43 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.916 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -126.73 162.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.348 -0.845 . . . . 1.72 109.756 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -70.88 -107.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.092 -1.043 . . . . 2.59 108.308 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -177.35 119.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.802 -1.187 . . . . 3.48 109.663 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.88 20.61 70.23 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.227 -1.463 . . . . 0.64 110.855 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.56 147.19 6.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.981 -1.305 . . . . 0.62 111.316 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.82 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.0 p -66.64 163.37 19.06 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 107.737 -1.208 . . . . 0.73 107.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.9 -44.03 86.51 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 117.339 -1.744 . . . . 2.02 110.502 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.29 -39.58 94.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.092 -1.843 . . . . 2.3 109.404 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.87 -36.71 80.75 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.176 -1.01 . . . . 1.96 109.103 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 68' ' ' SER . 73.0 t -62.56 -41.63 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.591 -0.693 . . . . 0.59 110.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' HD13 ' A' ' 76' ' ' LEU . 97.2 mttt -58.65 -39.42 80.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.519 -0.872 . . . . 0.79 109.36 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.42 -40.79 87.86 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.221 -0.992 . . . . 2.33 111.217 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -60.51 -32.64 71.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.715 -1.241 . . . . 2.62 111.975 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' HA ' ' A' ' 73' ' ' LYS . 6.7 mp -58.62 -37.49 75.99 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 120.32 -1.488 . . . . 1.3 108.931 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -57.26 -32.67 66.83 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 116.957 -1.897 . . . . 1.7 107.353 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.98 -33.97 76.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.147 -1.797 . . . . 2.29 106.147 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 60.6 p -65.61 -26.92 68.05 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 105.74 -1.948 . . . . 1.41 105.74 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 61.66 38.59 15.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.472 -1.677 . . . . 1.53 106.472 -176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 9' ' ' ILE . 13.5 tp -69.16 -29.56 67.61 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.059 -1.428 . . . . 2.46 108.609 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 m -42.55 -34.46 0.86 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.133 -0.94 . . . . 2.54 111.365 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -156.35 -14.91 0.1 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 117.949 -1.501 . . . . 3.53 111.818 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -61.49 -41.96 98.07 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 116.41 -2.116 . . . . 3.06 105.967 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.72 ' SD ' HD13 ' A' ' 9' ' ' ILE . 75.3 mtp -109.39 -120.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.958 -1.019 . . . . 2.45 112.76 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.659 ' HD3' HG21 ' A' ' 41' ' ' ILE . 90.5 mttt 57.74 33.36 23.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.53 -0.545 . . . . 1.49 109.53 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.1 mt-10 -67.18 -37.65 84.07 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.677 -1.209 . . . . 2.69 109.067 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 43.5 mtpt 100.43 -137.68 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 106.811 -1.551 . . . . 5.0 106.811 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 1.006 HD12 ' H ' ' A' ' 19' ' ' GLY . 13.0 tt -110.39 -108.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.09 -1.448 . . . . 3.26 107.09 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.923 ' H ' HG23 ' A' ' 89' ' ' ILE . 18.2 mttp -138.3 130.7 28.98 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.366 -0.833 . . . . 4.47 110.273 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 91' ' ' ILE . 14.7 tt -129.85 129.82 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.866 -1.161 . . . . 5.67 107.866 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -136.41 133.67 36.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.004 1.275 . . . . 6.75 113.362 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.521 ' H ' ' HD2' ' A' ' 94' ' ' PRO . 2.8 mtm -157.96 -53.06 0.01 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 106.977 -1.49 . . . . 9.5 106.977 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 93' ' ' MET . 23.0 Cg_exo -61.12 -22.14 73.76 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.447 1.431 . . . . 7.68 110.255 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.9 p -74.58 -24.52 58.91 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.768 -0.827 . . . . 7.69 108.768 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.946 -1.026 . . . . 8.53 109.274 179.909 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.494 ' O ' ' C ' ' A' ' 3' ' ' ALA . 10.8 Cg_endo . . . . . 0 N--CA 1.491 1.373 0 CA-C-O 120.548 0.145 . . . . 3.54 112.398 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 2' ' ' PRO . . . 37.2 -124.68 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.726 -1.213 . . . . 3.57 107.726 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -116.8 115.69 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.724 -1.19 . . . . 5.43 108.722 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.869 ' H ' HH21 ' A' ' 8' ' ' ARG . 97.0 mt-10 -73.44 -36.37 65.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 4.72 108.791 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 5' ' ' GLU . 57.4 t 111.12 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 106.782 -1.562 . . . . 2.38 106.782 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.914 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 89.42 9.33 67.06 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.366 -1.397 . . . . 1.47 110.398 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.869 HH21 ' H ' ' A' ' 5' ' ' GLU . 8.6 ptp180 -98.55 179.39 4.71 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.75 -1.441 . . . . 3.56 111.365 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 22' ' ' CYS . 70.0 mt -106.68 138.5 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.082 -2.192 . . . . 1.43 105.082 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 p -123.65 158.52 31.36 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.201 1.001 . . . . 1.19 113.128 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 21' ' ' LYS . 40.2 t -117.36 137.0 52.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.933 -1.506 . . . . 0.95 106.933 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 35' ' ' VAL . 16.7 mmtp -89.67 145.82 24.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 119.109 -2.245 . . . . 3.12 109.927 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.2 p -128.22 86.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 123.014 1.388 . . . . 1.69 112.664 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 tttt -139.06 144.14 38.66 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.615 -1.994 . . . . 2.43 105.615 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 179.65 53.06 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 117.795 -2.145 . . . . 2.26 109.373 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' GLU . 31.8 ttp180 53.2 91.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.799 -1.186 . . . . 4.93 107.799 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 84.3 tt0 45.1 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 120.99 0.424 . . . . 3.13 111.004 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.61 62.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 122.031 -0.418 . . . . 1.78 111.419 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.53 76.62 0.22 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 118.154 -1.974 . . . . 1.06 109.024 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.566 ' OG ' HG13 ' A' ' 44' ' ' VAL . 83.0 p -142.28 167.1 22.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.833 -0.804 . . . . 1.36 110.017 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 11' ' ' VAL . 66.3 mttm -86.9 152.56 22.34 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.806 1.289 . . . . 3.16 111.375 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 1.6 p -141.69 160.41 40.24 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.56 -1.2 . . . . 0.78 110.056 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.45 129.29 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 105.657 -1.979 . . . . 0.43 105.657 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 35' ' ' VAL . 69.2 mt -92.9 134.14 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.695 -1.253 . . . . 0.51 112.271 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG11 ' HZ2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -148.84 77.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.173 -1.411 . . . . 1.3 113.009 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 51.8 t0 169.08 148.75 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.361 -1.462 . . . . 1.56 110.051 172.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.545 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.9 tt -124.44 133.24 69.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 103.923 -2.621 . . . . 1.8 103.923 171.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.769 HG22 ' H ' ' A' ' 29' ' ' ASP . 21.5 mm -104.89 -122.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.271 -1.518 . . . . 0.77 110.423 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.769 ' H ' HG22 ' A' ' 28' ' ' ILE . 92.2 m-20 -61.69 -41.45 97.59 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 120.369 -0.532 . . . . 2.4 109.738 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 86.9 m-20 170.01 -58.47 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.559 1.143 . . . . 2.55 109.711 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -88.75 3.88 49.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.06 -1.025 . . . . 2.1 113.174 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' CD1' ' OD1' ' A' ' 50' ' ' ASN . 90.1 m-85 -110.94 144.29 40.25 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.094 -1.076 . . . . 1.6 108.094 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.06 161.11 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.235 -0.915 . . . . 0.49 108.883 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 35' ' ' VAL . 8.8 tt -106.82 131.96 53.32 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 118.698 -1.201 . . . . 0.93 108.974 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 12' ' ' LYS . 11.0 m -128.47 150.99 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 119.378 -0.929 . . . . 0.52 109.847 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -145.65 150.99 37.33 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.961 -1.096 . . . . 0.63 111.023 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -160.18 164.61 34.45 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.854 -2.099 . . . . 0.84 107.854 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' O ' ' OG1' ' A' ' 42' ' ' THR . 30.3 Cg_endo -69.11 101.46 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 CA-C-N 119.093 1.447 . . . . 0.99 109.874 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.32 -38.76 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 3.44 109.111 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.65 -36.55 67.18 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.681 -0.69 . . . . 2.27 110.755 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.734 HG21 ' HD3' ' A' ' 86' ' ' LYS . 22.9 mm -110.13 -40.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 119.065 -1.054 . . . . 2.05 111.1 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 38' ' ' PRO . 29.8 p -84.89 -31.29 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.225 -0.922 . . . . 1.1 112.292 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.98 -10.64 68.03 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.933 -1.267 . . . . 1.12 109.933 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 ' OG ' ' A' ' 20' ' ' SER . 9.8 m -103.0 128.46 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.913 -1.345 . . . . 1.06 107.972 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.72 ' H ' HH22 ' A' ' 47' ' ' ARG . 56.4 tttp -95.58 -81.59 0.4 Allowed 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.432 -1.307 . . . . 3.49 109.516 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 58.3 ttt85 -153.55 120.69 5.77 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.765 -1.198 . . . . 2.78 107.765 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.72 HH22 ' H ' ' A' ' 45' ' ' LYS . 9.4 ptp85 -156.86 168.45 27.41 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.709 -1.244 . . . . 3.1 109.999 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -110.76 140.42 45.18 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.429 -0.952 . . . . 3.0 108.429 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 53' ' ' HIS . 78.8 t -123.71 137.67 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 121.914 0.864 . . . . 1.63 112.069 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' OD1' ' CD1' ' A' ' 32' ' ' PHE . 36.3 m-20 -78.69 156.15 29.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.589 -1.263 . . . . 2.28 107.589 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.925 ' O ' HD23 ' A' ' 54' ' ' LEU . 28.5 mm -56.5 -27.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.495 -1.378 . . . . 1.41 109.301 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -54.23 -34.17 60.04 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 120.411 -1.431 . . . . 1.25 108.586 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.503 ' O ' HG11 ' A' ' 49' ' ' VAL . 77.9 m80 -115.72 93.29 4.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.198 -0.939 . . . . 1.5 108.958 176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.925 HD23 ' O ' ' A' ' 51' ' ' ILE . 1.7 pp -135.78 129.96 33.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.13 -1.606 . . . . 1.56 110.898 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -130.18 86.81 53.0 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 104.995 -2.224 . . . . 2.28 104.995 174.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' HD12 ' A' ' 54' ' ' LEU . 67.3 Cg_endo -91.52 157.41 3.61 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.283 2.655 . . . . 0.69 115.647 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.519 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 30.3 p -106.67 165.32 11.39 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.458 -0.942 . . . . 0.88 108.458 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -84.67 15.46 3.82 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.944 0.878 . . . . 2.57 108.849 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 45.8 mttp -88.53 141.91 28.14 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.19 -1.041 . . . . 2.9 108.19 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -135.69 129.21 32.35 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 5.03 110.545 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.914 HG22 ' O ' ' A' ' 7' ' ' GLY . 20.4 tt -125.18 148.03 29.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.925 -1.509 . . . . 4.81 106.925 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -84.86 119.95 25.91 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.472 -1.392 . . . . 2.14 108.281 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.523 HD13 ' HA2' ' A' ' 7' ' ' GLY . 30.6 pt -121.14 158.32 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.567 0.699 . . . . 1.72 111.848 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -86.76 0.35 54.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.732 . . . . 2.59 110.699 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 mttt 54.89 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.966 -1.084 . . . . 3.48 111.357 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.08 65.4 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.972 -1.109 . . . . 0.64 111.396 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.04 149.56 5.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.582 -1.54 . . . . 0.62 110.235 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.2 p -65.56 159.13 25.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.73 108.751 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.474 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 91.7 m-20 -57.12 -40.47 77.15 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.055 -1.028 . . . . 2.02 111.898 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.6 mp0 -63.03 -39.35 94.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 117.18 -1.808 . . . . 2.3 110.279 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.09 -38.15 82.02 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.685 -1.259 . . . . 1.96 109.357 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 68' ' ' SER . 69.0 t -64.24 -42.55 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.728 -0.608 . . . . 0.59 111.421 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -60.66 -42.27 96.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.009 -1.477 . . . . 0.79 109.763 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -60.98 -44.82 96.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 117.536 -1.665 . . . . 2.33 108.853 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HZ2' HG11 ' A' ' 25' ' ' VAL . 7.8 ttpm? -60.3 -36.26 77.47 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.514 -0.741 . . . . 2.62 111.347 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 81' ' ' LEU . 9.1 tt -53.83 -40.06 66.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.578 -0.849 . . . . 1.3 108.783 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.1 -33.68 67.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 117.843 -1.543 . . . . 1.7 107.732 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.67 ' OE1' HD11 ' A' ' 61' ' ' ILE . 84.5 tt0 -58.42 -34.08 70.39 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.042 -1.466 . . . . 2.29 107.042 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -61.56 -26.2 67.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.509 -1.663 . . . . 1.41 106.509 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 m120 71.63 43.85 0.55 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 122.684 1.231 . . . . 1.53 112.715 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -71.13 -22.37 62.08 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.277 -1.329 . . . . 2.46 109.517 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.6 ' CA ' ' HZ2' ' A' ' 86' ' ' LYS . 39.9 m -41.76 -37.8 1.31 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.785 -0.572 . . . . 2.54 109.774 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -168.82 -11.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.536 -1.353 . . . . 3.53 110.05 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -60.61 -44.05 96.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 123.559 1.647 . . . . 3.06 106.673 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.1 -127.09 0.16 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.836 -1.984 . . . . 2.45 111.548 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.734 ' HD3' HG21 ' A' ' 41' ' ' ILE . 23.5 mttt 52.72 21.76 2.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.74 -0.6 . . . . 1.49 112.155 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.1 mt-10 -68.17 -38.81 82.46 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 117.547 -1.661 . . . . 2.69 108.325 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 41' ' ' ILE . 25.7 mttm 88.74 123.06 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 105.368 -2.086 . . . . 5.0 105.368 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 mm -59.02 -42.09 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.495 -1.378 . . . . 3.26 112.496 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -123.27 136.07 54.53 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 121.521 1.964 . . . . 4.47 109.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 91' ' ' ILE . 42.2 pt -148.43 76.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.312 1.053 . . . . 5.67 110.956 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 93' ' ' MET . 30.1 ptt180 -64.12 -39.57 94.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.139 -1.601 . . . . 6.75 109.484 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.43 ' N ' ' CG ' ' A' ' 92' ' ' ARG . 39.8 mtt -146.85 88.48 5.95 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.422 -0.799 . . . . 9.5 109.452 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.25 -26.71 44.14 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.957 1.104 . . . . 7.68 110.235 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -62.36 -37.5 85.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.745 -0.835 . . . . 7.69 108.745 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.099 -0.953 . . . . 8.53 109.227 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.491 1.327 0 CA-C-O 121.387 0.494 . . . . 3.54 112.3 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.79 146.17 42.68 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.881 0.848 . . . . 3.57 110.765 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.86 137.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.288 -1.005 . . . . 5.43 108.288 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 18.0 pt-20 -166.77 -177.08 3.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.648 -1.282 . . . . 4.72 108.256 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG21 ' HZ3' ' A' ' 65' ' ' LYS . 12.8 m -62.6 155.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.938 -1.134 . . . . 2.38 107.938 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 23.68 26.55 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.116 -1.516 . . . . 1.47 112.309 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.555 HH21 HD11 ' A' ' 54' ' ' LEU . 31.8 ptt-85 -123.62 170.59 10.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.173 -1.192 . . . . 3.56 110.842 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 57' ' ' THR . 13.9 mm -101.21 141.01 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.649 0.738 . . . . 1.43 109.713 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.595 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.56 156.02 28.8 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.817 1.294 . . . . 1.19 112.631 -176.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.446 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 42.0 t -120.65 138.32 51.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 106.536 -1.653 . . . . 0.95 106.536 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' ALA . 24.0 tttt -82.71 134.82 35.13 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 117.732 -3.105 . . . . 3.12 110.227 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.757 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.9 p -109.84 82.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.037 -1.065 . . . . 1.69 108.893 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 38.3 mtpt -155.66 164.84 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.498 -1.667 . . . . 2.43 106.498 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.5 165.82 43.0 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 116.908 -2.568 . . . . 2.26 107.045 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.587 ' O ' ' O ' ' A' ' 15' ' ' GLY . 93.1 mtt-85 55.73 134.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.087 -1.079 . . . . 4.93 108.087 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 48.75 20.4 0.33 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.615 -1.624 . . . . 3.13 106.615 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.513 ' N ' ' C ' ' A' ' 16' ' ' ARG . . . -56.97 -46.31 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.773 -1.103 . . . . 1.78 108.838 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.36 103.65 3.07 Favored Glycine 0 C--N 1.284 -2.307 0 N-CA-C 110.458 -1.057 . . . . 1.06 110.458 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 42' ' ' THR . 36.2 t -147.49 135.5 21.31 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.278 -1.379 . . . . 1.36 107.278 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.03 139.64 30.32 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.658 -1.217 . . . . 3.16 107.838 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -130.1 140.71 50.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.12 -0.632 . . . . 0.78 110.457 -177.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 9' ' ' ILE . 38.9 t -103.32 135.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.566 -2.383 . . . . 0.43 104.566 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.558 HG12 HG12 ' A' ' 35' ' ' VAL . 68.2 mt -103.14 132.29 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 119.246 -0.982 . . . . 0.51 110.826 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -151.43 72.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 118.409 -1.316 . . . . 1.3 111.693 175.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.8 t0 170.12 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.549 -1.345 . . . . 1.56 110.476 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.6 mt -120.51 127.74 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 104.345 -2.465 . . . . 1.8 104.345 171.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 17.8 mm -100.37 -104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 121.309 1.868 . . . . 0.77 110.988 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 56.1 t0 -64.19 -42.37 96.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.026 -1.046 . . . . 2.4 109.249 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.655 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 49.9 p30 164.0 -46.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.812 0.845 . . . . 2.55 109.291 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.655 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 79.7 m-20 -96.09 4.62 52.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.974 -1.079 . . . . 2.1 111.56 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 28' ' ' ILE . 96.7 m-85 -112.17 141.0 46.41 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.352 -0.842 . . . . 1.6 109.994 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.98 161.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.858 -0.526 . . . . 0.49 109.962 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.577 HD11 HH11 ' A' ' 46' ' ' ARG . 8.9 tt -100.9 132.45 46.29 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.69 -0.855 . . . . 0.93 108.69 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 24' ' ' ILE . 15.5 m -128.12 151.46 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 C-N-CA 119.234 -0.986 . . . . 0.52 110.564 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -146.01 152.59 39.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 0.63 111.104 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.0 154.38 25.14 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.692 -1.763 . . . . 0.84 108.692 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' O ' ' OG1' ' A' ' 42' ' ' THR . 6.2 Cg_exo -57.64 109.25 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 CA-C-N 119.978 1.889 . . . . 0.99 110.081 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' CE ' ' HZ1' ' A' ' 45' ' ' LYS . 34.9 tttp -56.64 -36.23 69.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.007 -1.058 . . . . 3.44 109.472 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.72 -38.58 69.94 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.192 -1.003 . . . . 2.27 109.626 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 86' ' ' LYS . 23.5 mm -114.32 -38.66 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.206 -0.998 . . . . 2.05 111.533 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' ' OG ' ' A' ' 20' ' ' SER . 80.6 p -81.19 -33.95 32.63 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.93 -1.106 . . . . 1.1 110.112 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.65 66.33 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.31 -0.716 . . . . 1.12 111.31 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 37' ' ' GLY . 15.2 m -103.38 133.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.48 -1.6 . . . . 1.06 109.832 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HZ1' ' CE ' ' A' ' 39' ' ' LYS . 63.5 mttp -86.11 -78.41 0.28 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.787 -1.821 . . . . 3.49 106.98 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.577 HH11 HD11 ' A' ' 34' ' ' LEU . 69.0 ttp85 -149.79 124.7 9.92 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.749 -2.315 . . . . 2.78 104.749 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 35' ' ' VAL . 46.8 ptt85 -155.55 166.38 33.71 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.827 -1.796 . . . . 3.1 109.912 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.441 HH12 HD12 ' A' ' 34' ' ' LEU . 77.3 mtt-85 -109.75 141.39 42.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.641 -0.824 . . . . 3.0 109.193 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.97 142.8 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 1.63 110.366 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -86.45 167.33 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.769 . . . . 2.28 110.982 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.39 -26.59 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.689 -0.632 . . . . 1.41 111.061 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.495 HD12 ' OD1' ' A' ' 50' ' ' ASN . 66.5 mt -55.06 -33.0 62.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.967 -1.083 . . . . 1.25 110.371 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -121.76 90.43 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.383 -1.34 . . . . 1.5 107.383 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.555 HD11 HH21 ' A' ' 8' ' ' ARG . 27.0 tp -118.68 131.89 56.16 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.825 -0.547 . . . . 1.56 110.332 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 2.6 tt0 -131.33 89.6 40.63 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 104.707 -2.331 . . . . 2.28 104.707 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.461 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 93.3 Cg_endo -87.88 149.93 7.15 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.495 1.463 . . . . 0.69 114.293 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 9' ' ' ILE . 39.8 p -110.38 165.82 11.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.718 -1.215 . . . . 0.88 107.718 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.15 14.33 3.52 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.351 -0.843 . . . . 2.57 110.124 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -91.65 125.55 36.42 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.49 -0.756 . . . . 2.9 109.743 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -134.88 122.31 21.81 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.444 -0.785 . . . . 5.03 110.465 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.71 152.96 37.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.97 -1.122 . . . . 4.81 107.97 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 52.6 p30 -83.71 133.09 34.82 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.856 1.313 . . . . 2.14 110.406 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 25' ' ' VAL . 28.7 pt -125.24 158.71 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 115.031 -0.986 . . . . 1.72 112.006 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 59.7 tp60 -64.38 -48.95 73.51 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.546 -1.662 . . . . 2.59 109.378 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 15.2 ttmm 100.66 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.323 0.965 . . . . 3.48 110.781 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.97 63.75 Favored Glycine 0 N--CA 1.506 3.334 0 O-C-N 120.556 -1.34 . . . . 0.64 111.784 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 71' ' ' GLU . . . -56.88 152.87 11.94 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.991 -1.299 . . . . 0.62 112.832 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 72' ' ' VAL . 55.7 p -63.14 167.59 4.89 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 108.284 -1.006 . . . . 0.73 108.284 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.61 -45.65 88.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.916 -1.74 . . . . 2.02 112.749 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.32 -40.11 92.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 116.6 -2.04 . . . . 2.3 107.844 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.526 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 97.2 mt-10 -64.8 -36.07 83.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.844 -1.169 . . . . 1.96 107.844 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 68' ' ' SER . 73.2 t -64.79 -42.99 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.579 -0.849 . . . . 0.59 109.499 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.88 -41.65 92.02 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.362 -1.335 . . . . 0.79 107.619 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.22 -43.34 92.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.844 -1.169 . . . . 2.33 107.844 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 67' ' ' ALA . 57.6 mtmt -62.07 -34.18 75.79 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.596 -0.69 . . . . 2.62 110.754 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 23' ' ' VAL . 49.4 tp -55.75 -41.19 73.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.475 -1.391 . . . . 1.3 108.473 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 80' ' ' ASN . 97.2 mt-10 -61.6 -33.94 74.78 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 119.297 -0.961 . . . . 1.7 109.063 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -38.48 81.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.212 -2.144 . . . . 2.29 105.212 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 81' ' ' LEU . 47.6 m -68.37 -29.4 68.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.338 -1.356 . . . . 1.41 107.338 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 77' ' ' GLU . 73.6 m-20 60.56 38.12 19.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.351 -2.092 . . . . 1.53 105.351 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 79' ' ' SER . 0.9 OUTLIER -96.95 -11.81 24.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.399 -0.819 . . . . 2.46 111.413 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 m -56.91 -39.72 74.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.306 -1.496 . . . . 2.54 110.098 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.582 ' HG3' ' HZ1' ' A' ' 86' ' ' LYS . 85.5 tt0 -156.09 -11.31 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.403 -1.319 . . . . 3.53 112.297 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 83' ' ' GLU . 70.7 t80 -58.7 -47.25 85.2 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 114.411 -2.915 . . . . 3.06 105.609 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.462 ' HG2' ' H ' ' A' ' 87' ' ' GLU . 48.7 ttm -90.73 -110.91 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.336 0.589 . . . . 2.45 112.034 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.663 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.4 mtmt 60.91 37.38 18.41 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.726 -1.213 . . . . 1.49 107.726 -175.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.5 mt-10 -67.57 -37.65 82.95 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.83 -0.748 . . . . 2.69 111.286 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 62.0 mttp 85.16 126.46 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 105.768 -1.938 . . . . 5.0 105.768 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.8 tt -61.3 -28.91 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.842 -1.543 . . . . 3.26 108.797 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -101.38 125.56 48.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.821 -1.548 . . . . 4.47 106.821 176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.839 HG23 HD21 ' A' ' 96' ' ' LEU . 70.1 mt -117.64 131.73 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.942 -1.099 . . . . 5.67 111.055 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.7 mmt-85 -60.16 152.26 24.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 6.75 108.792 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.482 ' SD ' ' C ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -57.04 -48.66 97.06 Favored Pre-proline 0 N--CA 1.489 1.51 0 CA-C-N 116.046 -0.525 . . . . 9.5 112.278 -177.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.39 -73.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 CA-C-N 120.457 1.199 . . . . 7.68 113.89 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.8 t -142.45 162.08 36.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.098 -1.001 . . . . 7.69 109.891 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.839 HD21 HG23 ' A' ' 91' ' ' ILE . 67.2 mt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.048 -0.977 . . . . 8.53 108.962 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.494 1.554 0 CA-C-O 121.545 0.56 . . . . 3.54 111.674 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.28 -101.88 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.099 -0.704 . . . . 3.57 109.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.52 136.43 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 5.43 108.692 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HE ' ' A' ' 8' ' ' ARG . 95.5 mt-10 -131.69 148.15 52.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.679 -1.23 . . . . 4.72 107.679 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.56 154.85 35.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.383 -2.08 . . . . 2.38 105.383 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . 90.26 8.81 65.99 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.517 -2.233 . . . . 1.47 107.517 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HB2' HD12 ' A' ' 24' ' ' ILE . 79.7 mtt180 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.977 -0.612 . . . . 3.56 109.503 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 57' ' ' THR . 24.9 mm -108.03 135.31 47.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.311 -2.107 . . . . 1.43 105.311 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.647 ' HB3' HD11 ' A' ' 24' ' ' ILE . 3.8 p -127.92 155.89 43.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.07 -1.019 . . . . 1.19 113.107 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 20' ' ' SER . 43.1 t -126.56 138.02 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 115.701 -0.681 . . . . 0.95 109.827 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -85.71 130.81 34.46 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 118.74 -2.475 . . . . 3.12 109.817 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -121.19 123.03 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 117.992 -1.483 . . . . 1.69 112.622 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.862 ' HZ3' ' CE1' ' A' ' 53' ' ' HIS . 49.8 mttm -146.29 153.52 40.65 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.475 -1.306 . . . . 2.43 107.475 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 16' ' ' ARG . . . -86.75 102.84 2.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.226 -2.349 . . . . 2.26 107.226 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 38.5 ttm180 118.44 124.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.936 -1.505 . . . . 4.93 106.936 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 18' ' ' ALA . 77.6 mm-40 73.06 -86.26 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 107.528 -1.286 . . . . 3.13 107.528 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.586 ' CB ' ' H ' ' A' ' 14' ' ' LYS . . . 8.19 113.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.07 0.938 . . . . 1.78 111.962 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.85 80.21 0.05 OUTLIER Glycine 0 C--N 1.292 -1.914 0 N-CA-C 103.66 -3.776 . . . . 1.06 103.66 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 11' ' ' VAL . 75.0 p -162.67 150.55 13.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 117.849 -1.54 . . . . 1.36 110.839 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 1.2 ptpp? -114.59 147.84 38.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.362 -0.607 . . . . 3.16 109.362 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 3.8 p -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.551 -0.718 . . . . 0.78 110.387 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG21 HD12 ' A' ' 76' ' ' LEU . 44.7 t -103.93 136.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 105.874 -1.899 . . . . 0.43 105.874 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' HB2' ' A' ' 8' ' ' ARG . 70.6 mt -94.43 129.25 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 123.642 1.687 . . . . 0.51 111.847 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 26' ' ' ASP . 2.6 t -105.18 -151.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 112.61 -2.086 . . . . 1.3 109.332 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.84 ' H ' HG12 ' A' ' 25' ' ' VAL 0.272 36.3 t0 -67.4 163.49 20.72 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.733 -0.667 . . . . 1.56 110.625 -172.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 27' ' ' ILE . 16.3 tt -113.82 125.42 71.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 122.429 1.109 . . . . 1.8 110.103 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 48' ' ' ARG . 61.7 mt -74.26 -37.45 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.934 0.873 . . . . 0.77 110.671 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 47.4 t0 -159.62 167.78 27.64 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.637 -0.875 . . . . 2.4 108.637 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.0 m-20 -57.14 -37.99 72.86 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.013 -1.075 . . . . 2.55 108.615 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -80.45 -31.43 37.46 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.099 -1.0 . . . . 2.1 112.464 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -113.27 143.25 44.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.514 -0.741 . . . . 1.6 112.71 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.42 156.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.562 -0.532 . . . . 0.49 109.562 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CZ ' ' A' ' 46' ' ' ARG . 6.7 tt -100.04 125.54 46.12 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 105.743 -1.947 . . . . 0.93 105.743 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.27 155.47 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 120.812 -1.18 . . . . 0.52 110.965 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -142.47 155.09 45.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.261 -0.899 . . . . 0.63 110.966 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.89 163.7 29.43 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.013 -2.035 . . . . 0.84 108.013 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.13 111.5 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.532 1.666 . . . . 0.99 110.05 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -58.66 -39.35 80.37 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.252 -0.905 . . . . 3.44 110.843 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.36 -39.78 94.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.415 0.895 . . . . 2.27 113.415 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 86' ' ' LYS . 20.5 mm -96.22 -76.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.037 . . . . 2.05 112.309 -177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -62.4 -34.87 77.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.667 -0.645 . . . . 1.1 110.311 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.95 -4.41 57.53 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.874 -0.89 . . . . 1.12 110.874 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.2 m -89.07 126.51 42.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.187 -2.153 . . . . 1.06 105.187 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -94.04 -78.86 0.43 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.676 -1.265 . . . . 3.49 110.241 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 1.0 HH12 HG21 ' A' ' 72' ' ' VAL . 56.3 ttt85 -150.8 124.25 8.97 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.658 -1.979 . . . . 2.78 105.658 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.62 163.18 40.61 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 117.438 -1.705 . . . . 3.1 110.846 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HG3' HD12 ' A' ' 28' ' ' ILE . 30.1 ttm180 -98.29 138.97 34.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.223 -1.029 . . . . 3.0 108.223 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.92 140.14 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-N 119.915 1.234 . . . . 1.63 109.817 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.62 ' OD1' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -90.55 168.02 12.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.812 -0.555 . . . . 2.28 110.57 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.53 -27.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.246 -0.909 . . . . 1.41 110.549 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.62 HD12 ' OD1' ' A' ' 50' ' ' ASN . 73.0 mt -52.18 -33.2 39.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.25 109.666 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.862 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 91.4 m-70 -134.36 88.29 2.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.206 -1.405 . . . . 1.5 107.206 174.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.1 tp -124.49 132.24 53.48 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.648 -0.501 . . . . 1.56 109.648 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.49 89.0 32.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.481 -2.044 . . . . 2.28 105.481 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' HH11 ' A' ' 8' ' ' ARG . 74.0 Cg_endo -89.59 156.47 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.014 1.809 . . . . 0.69 112.701 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 9' ' ' ILE . 49.1 p -111.71 168.19 9.76 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.881 0.848 . . . . 0.88 108.748 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -81.95 18.44 1.32 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.794 0.807 . . . . 2.57 109.392 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 49.2 mttt -91.19 140.33 29.9 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 121.698 0.761 . . . . 2.9 112.386 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -136.87 122.62 19.9 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.942 -0.703 . . . . 5.03 109.472 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 71.7 mt -120.35 145.38 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.576 -0.898 . . . . 4.81 108.576 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -85.39 126.37 33.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.306 -1.497 . . . . 2.14 110.698 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -127.45 164.0 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 115.02 -0.991 . . . . 1.72 111.137 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 65' ' ' LYS . 95.6 mm-40 -84.27 1.49 44.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.763 -1.21 . . . . 2.59 109.679 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 64' ' ' GLN . 99.4 mttt 53.03 124.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.566 0.698 . . . . 3.48 112.07 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.04 70.63 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.574 -1.298 . . . . 0.64 110.183 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB1' ' CG ' ' A' ' 71' ' ' GLU . . . -54.08 146.64 14.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.015 -1.285 . . . . 0.62 111.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.0 p -67.16 164.4 18.16 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.878 -1.156 . . . . 0.73 107.878 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.28 -47.34 86.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.355 -1.465 . . . . 2.02 110.601 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -39.23 90.49 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.629 -1.628 . . . . 2.3 106.876 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' CG ' ' HB1' ' A' ' 67' ' ' ALA . 50.6 tp10 -64.72 -38.44 91.0 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.369 -0.832 . . . . 1.96 109.1 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.0 HG21 HH12 ' A' ' 46' ' ' ARG . 73.6 t -64.7 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.298 1.047 . . . . 0.59 109.697 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.8 -42.23 98.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.32 -1.352 . . . . 0.79 110.006 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -62.63 -42.89 99.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.998 -1.064 . . . . 2.33 112.821 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HZ3' HG13 ' A' ' 25' ' ' VAL . 18.1 ptmt -67.9 -27.53 66.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.902 -1.124 . . . . 2.62 109.593 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 53.9 tp -55.32 -39.33 69.83 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.326 -0.95 . . . . 1.3 108.75 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -29.37 66.83 Favored 'General case' 0 C--N 1.282 -2.328 0 O-C-N 121.043 -1.036 . . . . 1.7 109.349 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.51 -32.64 51.26 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.101 -0.999 . . . . 2.29 110.046 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.1 m -77.82 3.73 13.58 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 119.995 -1.691 . . . . 1.41 111.267 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 64.92 44.74 3.42 Favored 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 122.27 1.034 . . . . 1.53 112.485 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.714 HD22 ' H ' ' A' ' 81' ' ' LEU . 2.1 mm? -66.3 -24.95 66.63 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.484 -0.78 . . . . 2.46 110.398 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 m -42.51 -36.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.974 -1.079 . . . . 2.54 110.903 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -161.67 -18.83 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 119.574 -1.954 . . . . 3.53 111.029 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -60.49 -43.62 96.8 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 123.518 1.628 . . . . 3.06 108.049 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 81' ' ' LEU . 62.8 mtt -95.58 -123.95 0.11 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 112.91 -1.95 . . . . 2.45 111.972 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.642 ' HG2' HG21 ' A' ' 41' ' ' ILE . 14.8 mttm 56.45 29.53 15.46 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.867 0.691 . . . . 1.49 112.867 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' CG ' ' N ' ' A' ' 88' ' ' LYS . 17.6 pt-20 -150.17 -60.5 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.467 -1.396 . . . . 2.69 110.865 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' NZ ' HG21 ' A' ' 11' ' ' VAL . 44.4 tptt 45.69 -124.43 1.21 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.243 -1.536 . . . . 5.0 111.289 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.52 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 83.7 mt -119.92 131.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.947 0.879 . . . . 3.26 110.306 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -130.92 149.14 52.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.343 1.068 . . . . 4.47 111.806 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.31 142.21 21.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.825 -1.176 . . . . 5.67 107.825 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -127.18 138.81 53.21 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.121 0.962 . . . . 6.75 110.567 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.544 ' H ' ' HD2' ' A' ' 94' ' ' PRO . 2.2 ttt -166.32 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 106.98 -1.489 . . . . 9.5 106.98 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' A' ' 93' ' ' MET . 23.8 Cg_exo -60.09 -28.0 86.07 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.612 1.541 . . . . 7.68 111.916 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.4 m -66.88 -38.71 86.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.924 -1.11 . . . . 7.69 108.331 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.098 -0.953 . . . . 8.53 109.334 -179.607 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 121.537 0.557 . . . . 3.54 112.067 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.65 69.88 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.587 -0.695 . . . . 3.57 109.633 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.45 HG21 HD12 ' A' ' 61' ' ' ILE . 72.0 mt -110.71 137.2 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.957 1.36 . . . . 5.43 112.147 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 6' ' ' VAL . 95.3 mt-10 -112.76 152.44 29.11 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.161 -1.381 . . . . 4.72 109.916 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG23 ' C ' ' A' ' 5' ' ' GLU . 3.1 t 94.95 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 CA-C-O 121.15 0.5 . . . . 2.38 111.162 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 83.26 27.83 38.76 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.172 -0.955 . . . . 1.47 110.991 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 4' ' ' ILE . 12.7 ptm180 -149.01 -177.98 6.11 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.935 -1.333 . . . . 3.56 109.572 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.6 mt -99.78 140.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 124.031 1.872 . . . . 1.43 113.883 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.4 p -121.4 156.34 32.89 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.049 -2.341 . . . . 1.19 109.119 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.426 ' H ' ' HB3' ' A' ' 55' ' ' GLU . 42.5 t -124.77 136.29 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 108.668 -0.864 . . . . 0.95 108.668 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.585 ' CE ' HH21 ' A' ' 47' ' ' ARG . 36.2 mttp -91.17 125.49 35.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 118.987 -2.321 . . . . 3.12 110.851 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.2 124.29 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.635 -1.226 . . . . 1.69 109.583 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 24.0 mttm -146.66 156.14 42.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.532 -1.285 . . . . 2.43 107.532 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 16' ' ' ARG . . . -85.43 176.62 49.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 103.934 -3.666 . . . . 2.26 103.934 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 15' ' ' GLY . 37.0 mtm180 27.32 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.57 0 CA-C-N 120.049 1.924 . . . . 4.93 109.343 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 41.3 tp10 93.17 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 106.621 -1.622 . . . . 3.13 106.621 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 156.67 104.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.97 -0.456 . . . . 1.78 110.479 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.79 76.68 0.05 OUTLIER Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.634 -1.746 . . . . 1.06 110.645 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.422 ' OG ' ' CE ' ' A' ' 90' ' ' LYS . 3.2 m -155.64 135.8 13.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.394 -1.65 . . . . 1.36 109.928 175.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' O ' HG21 ' A' ' 42' ' ' THR . 67.8 mttm -98.35 145.83 26.3 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.409 -0.96 . . . . 3.16 108.409 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.1 p -134.61 162.58 31.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.346 0.593 . . . . 0.78 110.447 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.18 135.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.349 -2.093 . . . . 0.43 105.349 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG12 HG12 ' A' ' 35' ' ' VAL . 63.7 mt -97.31 132.17 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.694 -1.254 . . . . 0.51 110.37 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -143.78 70.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 C-N-CA 118.991 -1.084 . . . . 1.3 111.355 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 20.2 t70 165.83 148.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.505 -1.372 . . . . 1.56 109.582 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.98 115.45 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 103.815 -2.661 . . . . 1.8 103.815 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.3 mt -97.03 -81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.77 111.029 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -108.96 171.83 7.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.735 -1.12 . . . . 2.4 108.982 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -40.19 71.78 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 118.497 -1.281 . . . . 2.55 109.51 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -102.51 -0.96 31.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.635 -1.291 . . . . 2.1 113.82 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.04 141.14 48.99 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 120.935 1.698 . . . . 1.6 114.087 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.25 161.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.42 -0.955 . . . . 0.49 108.42 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD21 ' CG ' ' A' ' 46' ' ' ARG . 8.4 tt -99.46 136.04 39.98 Favored 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 108.215 -1.032 . . . . 0.93 108.215 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.7 m -128.09 150.43 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.258 -0.977 . . . . 0.52 111.944 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.662 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -143.07 155.05 44.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.472 0.654 . . . . 0.63 111.804 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -154.77 167.08 32.58 Favored Glycine 0 N--CA 1.506 3.361 0 N-CA-C 108.047 -2.021 . . . . 0.84 108.047 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.62 124.48 15.53 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 CA-C-N 119.037 1.418 . . . . 0.99 110.357 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' HZ3' ' HE2' ' A' ' 45' ' ' LYS . 23.5 mttt -60.51 -43.23 97.31 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.225 1.012 . . . . 3.44 110.869 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.87 -40.67 91.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.526 0.936 . . . . 2.27 113.526 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CD1' ' NZ ' ' A' ' 86' ' ' LYS . 81.6 mt -96.09 -76.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.325 -0.95 . . . . 2.05 113.145 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.62 HG21 ' O ' ' A' ' 21' ' ' LYS . 44.9 m -60.15 -36.6 77.89 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.354 -1.466 . . . . 1.1 109.035 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -6.65 63.46 Favored Glycine 0 C--N 1.293 -1.826 0 N-CA-C 110.249 -1.14 . . . . 1.12 110.249 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.5 m -91.64 131.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 119.267 1.533 . . . . 1.06 107.684 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HE2' ' HZ3' ' A' ' 39' ' ' LYS . 35.7 ttmt -89.16 -78.25 0.36 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.76 -1.176 . . . . 3.49 109.51 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.691 ' CG ' HD21 ' A' ' 34' ' ' LEU . 55.9 ttt180 -151.92 124.02 8.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 105.009 -2.219 . . . . 2.78 105.009 177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 38.1 ptt180 -158.8 166.96 30.7 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 119.385 -2.072 . . . . 3.1 110.191 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -96.23 143.38 27.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.112 -0.992 . . . . 3.0 111.435 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.93 143.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.595 -0.891 . . . . 1.63 108.595 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' OD1' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -91.85 164.14 13.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.145 -0.972 . . . . 2.28 111.768 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.38 -24.75 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 115.814 -0.63 . . . . 1.41 111.341 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.515 HD12 ' OD1' ' A' ' 50' ' ' ASN . 60.9 mt -54.79 -31.4 58.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.954 -1.091 . . . . 1.25 109.557 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -118.15 92.33 3.8 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.09 -1.819 . . . . 1.5 106.09 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.487 HD23 ' HD3' ' A' ' 56' ' ' PRO . 9.1 tt -113.93 129.53 56.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.138 0.494 . . . . 1.56 109.722 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -140.84 93.87 8.25 Favored Pre-proline 0 N--CA 1.502 2.162 0 N-CA-C 107.743 -1.206 . . . . 2.28 107.743 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' HD23 ' A' ' 54' ' ' LEU . 94.2 Cg_endo -93.23 147.46 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.692 1.595 . . . . 0.69 114.307 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 p -120.26 161.86 20.39 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.823 -1.177 . . . . 0.88 107.823 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 54.6 p30 -78.66 135.61 37.25 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.334 -1.728 . . . . 2.57 106.334 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' H ' ' A' ' 60' ' ' LYS . 40.3 tttm -171.61 -174.57 1.41 Allowed 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 117.298 -1.761 . . . . 2.9 109.504 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.751 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 15.7 tttp -82.78 153.1 25.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.767 -1.197 . . . . 5.03 107.767 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 HG21 ' A' ' 4' ' ' ILE . 12.4 pt -138.0 82.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 114.609 1.337 . . . . 4.81 114.609 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -146.77 91.75 2.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.96 -1.087 . . . . 2.14 112.13 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.889 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.65 162.64 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.728 0.775 . . . . 1.72 109.364 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -72.32 -121.02 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.26 -2.126 . . . . 2.59 105.26 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -173.78 131.45 0.43 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.84 -1.163 . . . . 3.48 108.834 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.52 17.8 70.12 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.555 -1.783 . . . . 0.64 110.178 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.16 144.94 22.54 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.685 -1.48 . . . . 0.62 111.715 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.875 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.5 p -68.45 169.22 11.2 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 107.175 -1.417 . . . . 0.73 107.175 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 91.6 m-20 -59.15 -47.69 84.37 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.181 -2.199 . . . . 2.02 111.18 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.45 -41.79 98.65 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 116.936 -1.906 . . . . 2.3 108.332 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.91 -35.93 82.75 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.266 -0.974 . . . . 1.96 108.403 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 68' ' ' SER . 78.4 t -62.17 -40.12 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.73 0.776 . . . . 0.59 109.041 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 99.4 mttt -59.53 -40.66 87.93 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.701 -1.2 . . . . 0.79 108.775 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -60.31 -43.13 96.64 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 117.491 -1.684 . . . . 2.33 109.222 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.52 78.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.082 -1.011 . . . . 2.62 109.956 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.778 ' O ' HD11 ' A' ' 81' ' ' LEU . 9.4 tt -58.18 -42.98 87.23 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.956 . . . . 1.3 110.245 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.642 ' HA ' HD21 ' A' ' 81' ' ' LEU . 96.6 mt-10 -59.19 -31.15 68.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.183 -0.948 . . . . 1.7 108.715 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -52.57 -32.37 40.75 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.281 -1.748 . . . . 2.29 106.281 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.3 m -62.9 -18.41 62.98 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.783 -0.573 . . . . 1.41 111.668 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 70.4 50.35 0.4 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-O 123.257 1.503 . . . . 1.53 110.505 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.845 ' N ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.4 -28.22 69.1 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.544 -1.662 . . . . 2.46 112.362 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.354 -1.466 . . . . 2.54 112.988 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.39 -18.2 0.11 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 119.411 -2.055 . . . . 3.53 110.343 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.99 -38.58 86.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.699 1.238 . . . . 3.06 107.837 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.06 -125.95 0.22 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.477 -1.238 . . . . 2.45 111.004 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' NZ ' ' CD1' ' A' ' 41' ' ' ILE . 33.1 mttm 54.27 26.42 6.8 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.12 1.368 . . . . 1.49 114.369 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -66.0 -38.7 89.14 Favored 'General case' 0 N--CA 1.512 2.634 0 O-C-N 119.394 -2.066 . . . . 2.69 110.502 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.974 ' NZ ' HD12 ' A' ' 91' ' ' ILE . 23.0 tttt 37.07 60.34 1.01 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.779 0.659 . . . . 5.0 112.779 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.811 HG23 HD12 ' A' ' 96' ' ' LEU . 86.4 mt -64.64 -34.09 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 119.456 -2.028 . . . . 3.26 107.846 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' CE ' ' OG ' ' A' ' 20' ' ' SER . 63.0 mttm -52.47 -29.78 26.52 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.927 -1.488 . . . . 4.47 109.773 -173.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.974 HD12 ' NZ ' ' A' ' 88' ' ' LYS . 19.7 tt -64.89 -23.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.302 -1.499 . . . . 5.67 109.652 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.711 ' HG3' HG23 ' A' ' 91' ' ' ILE . 98.0 mtt180 -125.92 147.07 49.59 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.37 1.081 . . . . 6.75 112.004 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.552 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 1.7 ttm -131.25 -50.64 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.287 -0.87 . . . . 9.5 109.242 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 93' ' ' MET . 21.8 Cg_exo -61.37 -33.12 89.51 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.998 1.035 . . . . 7.68 111.257 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.2 m -64.12 -39.37 93.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.726 -0.608 . . . . 7.69 109.385 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.811 HD12 HG23 ' A' ' 89' ' ' ILE . 62.1 mt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.989 -1.005 . . . . 8.53 109.172 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo . . . . . 0 N--CA 1.488 1.189 0 CA-C-O 121.809 0.671 . . . . 3.54 112.058 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.52 158.33 31.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.045 -1.465 . . . . 3.57 107.045 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.638 HG23 HD21 ' A' ' 54' ' ' LEU . 70.8 mt -110.04 132.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.705 -1.247 . . . . 5.43 108.681 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 8' ' ' ARG . 94.6 mt-10 -149.08 160.51 43.27 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.565 -0.902 . . . . 4.72 108.565 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 27' ' ' ILE . 23.7 t -100.39 142.69 15.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.549 -1.278 . . . . 2.38 107.549 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' HA3' ' H ' ' A' ' 62' ' ' ASP . . . 96.83 -3.4 62.64 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.492 -1.38 . . . . 1.47 110.329 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 5' ' ' GLU . 95.1 mtt180 -89.92 177.2 6.54 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.33 -1.1 . . . . 3.56 110.786 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.439 HD12 ' HD3' ' A' ' 59' ' ' LYS . 73.9 mt -95.9 137.34 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 106.569 -1.641 . . . . 1.43 106.569 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.8 p -127.79 158.62 37.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.515 -0.741 . . . . 1.19 110.441 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.08 132.22 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.467 -1.679 . . . . 0.95 106.467 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' NZ ' HG23 ' A' ' 49' ' ' VAL . 10.6 tptm -93.4 119.59 32.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.861 -1.774 . . . . 3.12 112.84 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.08 128.99 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.493 -1.299 . . . . 1.69 107.493 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -143.85 175.82 9.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.833 -0.803 . . . . 2.43 108.833 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -81.14 143.19 23.79 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.383 -1.865 . . . . 2.26 108.77 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 33.6 ttm180 49.6 87.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.19 -1.411 . . . . 4.93 107.19 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 48.9 tp10 112.62 152.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 105.92 -1.882 . . . . 3.13 105.92 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.95 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 112.662 0.616 . . . . 1.78 112.662 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.83 84.21 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.81 -1.662 . . . . 1.06 110.591 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.515 ' N ' HD12 ' A' ' 89' ' ' ILE . 79.8 p -161.42 147.62 14.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.276 . . . . 1.36 108.798 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.826 ' O ' HG21 ' A' ' 42' ' ' THR . 97.1 mttt -96.63 147.77 23.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.161 -0.962 . . . . 3.16 108.707 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 4.9 p -143.93 162.81 35.18 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.228 -0.92 . . . . 0.78 110.396 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 76' ' ' LEU . 26.5 t -114.7 135.03 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 105.911 -1.885 . . . . 0.43 105.911 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 6' ' ' VAL . 66.5 mt -91.29 134.83 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.693 -1.203 . . . . 0.51 110.066 -175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 72' ' ' VAL . 13.1 m -156.78 76.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.464 1.653 . . . . 1.3 115.464 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 54.2 t0 171.63 150.89 0.05 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.094 -1.004 . . . . 1.56 109.249 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.793 HD11 HG21 ' A' ' 6' ' ' VAL . 26.4 mm -119.22 129.67 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.494 -2.039 . . . . 1.8 105.494 171.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.82 HG22 ' H ' ' A' ' 29' ' ' ASP . 88.6 mt -121.55 -117.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.816 -1.178 . . . . 0.77 109.552 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.82 ' H ' HG22 ' A' ' 28' ' ' ILE . 52.4 t0 -58.22 -35.23 71.37 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.082 -1.451 . . . . 2.4 107.082 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 91.9 m-20 121.98 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.119 -1.808 . . . . 2.55 106.119 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.59 4.7 53.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.437 -1.32 . . . . 2.1 107.437 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.69 148.48 52.48 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.541 -0.754 . . . . 1.6 109.736 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.29 161.11 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 108.12 -1.067 . . . . 0.49 108.12 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.654 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.3 tt -104.66 129.71 52.78 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 117.844 -1.542 . . . . 0.93 107.807 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 34' ' ' LEU . 7.4 m -125.7 154.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 118.815 -1.154 . . . . 0.52 110.708 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.732 HG21 ' CG1' ' A' ' 72' ' ' VAL . 10.5 t -140.61 156.88 46.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.63 112.109 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.47 163.54 31.65 Favored Glycine 0 N--CA 1.507 3.371 0 N-CA-C 107.523 -2.231 . . . . 0.84 107.523 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.24 122.82 12.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 CA-C-N 119.506 1.653 . . . . 0.99 110.78 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.6 -40.43 87.46 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.817 -0.552 . . . . 3.44 111.715 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.28 -43.11 95.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.15 1.167 . . . . 2.27 114.15 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.673 HG21 ' O ' ' A' ' 86' ' ' LYS . 15.8 mm -96.5 -71.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.32 -1.487 . . . . 2.05 114.016 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 21' ' ' LYS . 31.5 m -56.34 -37.06 69.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.723 -0.671 . . . . 1.1 111.002 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.83 7.52 47.45 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.31 -1.424 . . . . 1.12 110.03 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' HH21 ' A' ' 47' ' ' ARG . 18.2 m -122.08 162.62 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 105.527 -2.027 . . . . 1.06 105.527 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -139.16 -69.92 0.42 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.989 -1.115 . . . . 3.49 107.989 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' HG3' HD21 ' A' ' 34' ' ' LEU . 34.7 ttp180 -146.16 124.63 12.39 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 44' ' ' VAL . 18.9 ptp180 -155.17 168.06 28.29 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.876 -1.14 . . . . 3.1 109.543 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -116.62 143.6 45.42 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.662 -1.236 . . . . 3.0 107.662 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.453 HG23 ' NZ ' ' A' ' 12' ' ' LYS . 14.8 p -132.48 140.12 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.379 1.085 . . . . 1.63 111.365 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 44.6 t-20 -80.79 163.36 23.53 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.967 -1.015 . . . . 2.28 110.321 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 24.1 mm -59.2 -27.33 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 115.917 -0.583 . . . . 1.41 110.696 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.0 mt -54.55 -37.9 65.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.934 -1.104 . . . . 1.25 111.369 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.99 89.32 3.0 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.35 -1.34 . . . . 1.5 109.953 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.638 HD21 HG23 ' A' ' 4' ' ' ILE . 28.2 tp -118.83 128.82 54.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.928 -0.768 . . . . 1.56 108.928 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -135.26 85.88 31.99 Favored Pre-proline 0 N--CA 1.508 2.443 0 O-C-N 120.542 -1.348 . . . . 2.28 108.668 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -96.13 151.69 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.89 2.393 . . . . 0.69 115.512 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.461 ' OG1' ' NZ ' ' A' ' 59' ' ' LYS . 19.4 p -112.19 162.0 15.94 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 106.297 -1.742 . . . . 0.88 106.297 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.19 98.47 5.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.515 -1.99 . . . . 2.57 110.657 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' NZ ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -114.06 -164.63 0.94 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.416 1.103 . . . . 2.9 111.137 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -84.58 163.36 19.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.212 -1.774 . . . . 5.03 106.212 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 61' ' ' ILE . 13.7 tt -121.19 123.47 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.688 -1.258 . . . . 4.81 109.61 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 60.7 t0 -161.63 107.09 1.31 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.73 -0.606 . . . . 2.14 110.267 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -129.54 135.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.333 -1.728 . . . . 1.72 106.333 176.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.689 ' H ' ' HZ3' ' A' ' 75' ' ' LYS . 60.3 tp60 -64.78 -50.61 66.11 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 115.128 -2.629 . . . . 2.59 108.657 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 50.3 tttt 131.2 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 107.268 -1.382 . . . . 3.48 107.268 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.18 22.3 59.3 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.712 -1.355 . . . . 0.64 109.712 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -54.66 143.64 24.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.236 . . . . 0.62 112.436 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.6 p -71.08 163.91 26.65 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 109.059 -0.719 . . . . 0.73 109.059 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -54.97 -43.14 73.21 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.304 -1.498 . . . . 2.02 109.908 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -38.47 87.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 117.401 -1.72 . . . . 2.3 108.971 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 97.1 mt-10 -67.24 -37.38 83.43 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.557 -1.257 . . . . 1.96 108.581 177.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 36' ' ' THR . 67.2 t -63.7 -43.73 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 120.121 -0.632 . . . . 0.59 111.371 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.51 -42.05 91.33 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.103 -1.439 . . . . 0.79 108.322 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.99 -43.4 91.47 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 117.6 -1.64 . . . . 2.33 107.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.689 ' HZ3' ' H ' ' A' ' 64' ' ' GLN . 56.5 mtmt -60.26 -32.02 70.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 2.62 112.12 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.646 ' O ' ' OG ' ' A' ' 79' ' ' SER . 32.0 tp -52.8 -40.91 63.67 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.043 -1.661 . . . . 1.3 107.441 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 80' ' ' ASN . 97.2 mt-10 -58.57 -34.46 71.08 Favored 'General case' 0 C--N 1.272 -2.776 0 C-N-CA 116.888 -1.925 . . . . 1.7 108.381 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.464 ' OE1' ' OD2' ' A' ' 62' ' ' ASP . 97.6 mt-10 -62.33 -33.47 74.76 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.888 -1.523 . . . . 2.29 106.888 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.646 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 83.7 p -65.34 -26.07 67.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.859 -2.274 . . . . 1.41 104.859 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 77' ' ' GLU . 69.0 m-20 63.12 42.15 7.47 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.743 0.783 . . . . 1.53 109.946 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 34.2 mt -92.11 3.73 54.67 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.685 -0.806 . . . . 2.46 111.35 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 m -46.61 -33.74 4.43 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.912 -1.118 . . . . 2.54 110.052 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -164.84 0.26 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.051 -1.031 . . . . 3.53 108.648 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -61.42 -43.86 98.14 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 103.176 -2.898 . . . . 3.06 103.176 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.592 ' CE ' ' HZ3' ' A' ' 21' ' ' LYS . 85.3 mmm -121.3 -120.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.281 -1.327 . . . . 2.45 110.388 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 41' ' ' ILE . 36.4 mtpt 64.97 39.45 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.152 -1.385 . . . . 1.49 109.878 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -98.28 172.28 7.67 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.471 0.653 . . . . 2.69 109.687 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -95.04 128.53 41.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.737 -1.209 . . . . 5.0 107.737 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 20' ' ' SER . 80.1 mt -68.36 -39.72 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.358 -1.464 . . . . 3.26 113.705 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 18' ' ' ALA . 22.8 mttt -128.71 139.21 52.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.357 1.89 . . . . 4.47 109.286 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.529 HD11 HD23 ' A' ' 96' ' ' LEU . 15.8 tt -125.66 134.15 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.572 -0.899 . . . . 5.67 108.572 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -126.38 147.22 49.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.87 -1.144 . . . . 6.75 109.274 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 93' ' ' MET . 2.3 tpt -54.65 -56.15 30.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 C-N-CA 118.96 -1.096 . . . . 9.5 110.065 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -60.1 -40.14 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.488 1.21 . . . . 7.68 112.119 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -65.72 -39.12 90.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 7.69 108.192 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD23 HD11 ' A' ' 91' ' ' ILE . 29.3 tp . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.983 -1.008 . . . . 8.53 109.181 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 121.307 0.461 . . . . 3.54 112.513 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.66 -40.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.849 . . . . 3.57 109.511 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.66 140.18 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 105.963 -1.866 . . . . 5.43 105.963 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.591 ' C ' HG12 ' A' ' 6' ' ' VAL . 58.3 mp0 -104.18 147.11 27.83 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 120.614 1.552 . . . . 4.72 108.931 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG12 ' C ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER 169.46 123.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.4 -0.963 . . . . 2.38 108.4 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 71.28 24.53 76.86 Favored Glycine 0 N--CA 1.502 3.1 0 C-N-CA 119.499 -1.334 . . . . 1.47 110.016 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 57' ' ' THR . 80.9 mtp180 -117.97 164.61 14.82 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.83 -0.806 . . . . 3.56 110.294 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.63 137.94 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 122.358 1.075 . . . . 1.43 109.448 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.85 156.69 27.96 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.994 -1.003 . . . . 1.19 111.554 -175.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 t -122.09 134.99 63.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 N-CA-C 105.979 -1.86 . . . . 0.95 105.979 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.43 130.05 38.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 119.202 -2.186 . . . . 3.12 111.443 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.89 120.46 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 118.197 -1.401 . . . . 1.69 110.409 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 91.1 mttt -146.59 152.71 39.36 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.664 -1.606 . . . . 2.43 106.664 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -85.29 174.1 48.73 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 105.333 -3.107 . . . . 2.26 105.333 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 15' ' ' GLY . 73.0 mtm180 34.68 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 CA-C-N 118.643 1.221 . . . . 4.93 107.756 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.699 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 82.6 tt0 89.71 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.364 -1.347 . . . . 3.13 107.364 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 153.59 106.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.78 0.324 . . . . 1.78 110.798 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.89 80.88 0.05 OUTLIER Glycine 0 C--N 1.297 -1.62 0 C-N-CA 118.906 -1.616 . . . . 1.06 109.835 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -156.71 141.76 17.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.399 -1.648 . . . . 1.36 110.346 176.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 42' ' ' THR . 68.5 mttm -93.62 148.38 22.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.383 -1.448 . . . . 3.16 107.725 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -137.02 142.95 42.5 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.249 -0.907 . . . . 0.78 112.634 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.82 137.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.228 -1.767 . . . . 0.43 106.228 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 35' ' ' VAL . 69.7 mt -100.43 131.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.465 -0.894 . . . . 0.51 111.706 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -143.84 72.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.145 -1.022 . . . . 1.3 109.966 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 56.9 t0 168.12 144.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.788 -1.195 . . . . 1.56 109.716 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.2 tt -124.0 124.42 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.331 -2.47 . . . . 1.8 104.331 170.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -99.56 -84.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.878 -1.139 . . . . 0.77 112.059 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 59.5 t0 -104.47 8.14 35.55 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.188 -0.671 . . . . 2.4 109.188 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 81.4 m-20 90.08 -26.86 0.05 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 124.043 0.937 . . . . 2.55 109.759 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 39.3 p-10 -103.09 -3.45 25.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 2.1 109.78 177.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 95.9 m-85 -119.1 140.39 50.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.958 -1.127 . . . . 1.6 107.958 175.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.45 158.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.49 109.177 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.677 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.5 tt -103.53 135.88 44.29 Favored 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.026 -1.07 . . . . 0.93 108.333 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 24' ' ' ILE . 17.6 m -126.39 149.09 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.034 -1.066 . . . . 0.52 109.949 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.439 HG23 HD13 ' A' ' 76' ' ' LEU . 6.3 t -142.84 154.04 43.77 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.642 0.735 . . . . 0.63 111.236 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -156.54 160.14 30.01 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.698 -2.561 . . . . 0.84 106.698 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' HD21 ' A' ' 76' ' ' LEU . 17.2 Cg_exo -60.86 121.81 10.26 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 CA-C-N 120.629 2.215 . . . . 0.99 110.017 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -58.88 -36.57 74.86 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.522 1.153 . . . . 3.44 108.63 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.51 -38.86 91.58 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.511 -0.768 . . . . 2.27 112.373 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 86' ' ' LYS . 76.1 mt -96.5 -81.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.915 -1.116 . . . . 2.05 111.369 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 21' ' ' LYS . 53.5 m -63.03 -36.79 84.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.927 . . . . 1.1 111.067 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.73 -7.45 57.62 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 120.509 -0.853 . . . . 1.12 111.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.3 m -91.55 130.72 40.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 120.554 2.177 . . . . 1.06 105.929 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -92.38 -75.64 0.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.516 -1.273 . . . . 3.49 109.551 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.827 HH12 HG21 ' A' ' 72' ' ' VAL . 55.6 ttt85 -149.78 125.84 10.62 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.897 -1.89 . . . . 2.78 105.897 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -156.58 165.51 36.08 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 119.714 -1.866 . . . . 3.1 110.909 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -106.9 136.04 47.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.289 -0.882 . . . . 3.0 111.155 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 53' ' ' HIS . 62.7 t -124.88 136.74 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.033 -1.042 . . . . 1.63 110.674 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.24 167.62 16.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.331 -0.856 . . . . 2.28 109.474 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.5 mt -56.86 -26.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.231 -0.918 . . . . 1.41 111.375 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.88 -34.88 68.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.426 -1.421 . . . . 1.25 110.253 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' O ' HG11 ' A' ' 49' ' ' VAL . 98.6 m-70 -116.44 87.07 2.61 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.296 -0.962 . . . . 1.5 108.625 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 5' ' ' GLU . 30.7 tp -125.35 127.59 46.86 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.314 -0.866 . . . . 1.56 109.079 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -134.45 88.9 28.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.45 -1.315 . . . . 2.28 107.45 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -90.5 148.05 4.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.85 1.7 . . . . 0.69 114.866 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 30.4 p -117.1 165.46 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.99 -1.115 . . . . 0.88 107.99 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.85 137.0 53.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.264 -1.754 . . . . 2.57 106.264 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.32 -175.78 1.47 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.024 0.916 . . . . 2.9 110.127 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 7' ' ' GLY . 48.7 mmtm -86.61 163.15 17.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.781 -1.192 . . . . 5.03 107.781 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 61' ' ' ILE . 31.4 pt -130.89 87.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 123.595 1.664 . . . . 4.81 111.823 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.1 p30 -150.68 93.05 1.91 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 113.735 1.013 . . . . 2.14 113.735 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.1 pt -121.95 153.41 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.728 -1.233 . . . . 1.72 110.432 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 83.4 mt-30 -63.05 -42.34 99.69 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.477 -1.689 . . . . 2.59 109.216 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 34.4 mtmt 98.21 90.17 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.448 0.567 . . . . 3.48 110.037 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.11 8.47 60.21 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.893 -1.129 . . . . 0.64 111.66 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.81 148.47 10.12 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.822 -1.399 . . . . 0.62 112.158 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.815 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 p -65.49 165.71 11.65 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.616 -1.253 . . . . 0.73 107.616 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -59.33 -45.1 92.3 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 119.798 -1.814 . . . . 2.02 111.484 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.43 -39.72 95.25 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.089 -1.844 . . . . 2.3 108.777 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.99 -36.39 83.18 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.903 -1.119 . . . . 1.96 108.353 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.827 HG21 HH12 ' A' ' 46' ' ' ARG . 74.6 t -65.3 -42.59 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.768 . . . . 0.59 110.654 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.07 -41.95 93.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 118.716 -1.194 . . . . 0.79 109.666 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -59.23 -41.79 89.5 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 117.484 -1.686 . . . . 2.33 107.244 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -62.69 -34.92 78.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.63 -0.669 . . . . 2.62 110.704 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.56 HD21 ' HD3' ' A' ' 38' ' ' PRO . 50.3 tp -56.55 -41.38 76.75 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.812 -1.18 . . . . 1.3 108.983 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.27 -30.75 66.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.891 -0.781 . . . . 1.7 108.891 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' OD2' ' A' ' 62' ' ' ASP . 84.5 tt0 -53.62 -34.91 60.13 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.66 -1.237 . . . . 2.29 107.66 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.1 m -65.74 -18.31 65.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 1.41 109.907 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 71.16 51.13 0.28 Allowed 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.932 1.349 . . . . 1.53 111.551 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.5 mp -63.51 -28.59 70.06 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.265 -1.334 . . . . 2.46 112.153 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 39.8 m -44.88 -35.63 2.9 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.577 -1.327 . . . . 2.54 110.945 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -153.92 -19.06 0.14 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.046 -1.659 . . . . 3.53 110.268 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -61.99 -40.94 97.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.373 -1.454 . . . . 3.06 108.034 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . 87.7 mtp -103.65 -122.75 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.85 -1.068 . . . . 2.45 110.976 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 41' ' ' ILE . 28.6 mtpt 43.14 16.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.865 -0.522 . . . . 1.49 111.134 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.0 mt-10 -66.21 -35.61 80.89 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.566 -1.254 . . . . 2.69 108.923 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 33.8 mttp 72.76 124.88 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.657 -2.349 . . . . 5.0 104.657 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -61.1 -44.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.35 -1.34 . . . . 3.26 111.669 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -130.46 136.64 49.21 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 121.316 1.871 . . . . 4.47 108.658 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 94' ' ' PRO . 71.2 mt -120.82 128.03 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.082 -1.081 . . . . 5.67 108.082 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.492 ' O ' ' SD ' ' A' ' 93' ' ' MET . 26.0 mmt85 -65.87 -40.64 91.82 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.4 -2.074 . . . . 6.75 105.4 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.593 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 2.9 tpp 175.01 -43.83 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 CA-C-N 114.492 -1.231 . . . . 9.5 108.133 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 93' ' ' MET . 18.7 Cg_exo -66.35 179.38 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 124.156 3.237 . . . . 7.68 111.251 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.3 p -71.24 -10.94 60.59 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.221 -0.924 . . . . 7.69 109.74 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 8.53 109.175 -179.735 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.5 2.036 0 CA-C-O 120.998 0.427 . . . . 4.72 110.66 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 7' ' ' GLY . 10.8 m -72.43 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.081 -1.012 . . . . 2.38 108.972 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 79.91 37.72 21.63 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.722 -1.237 . . . . 1.47 111.187 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.76 HH21 HD11 ' A' ' 54' ' ' LEU . 29.1 ptt-85 -146.75 -177.93 5.91 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 120.92 -1.341 . . . . 3.56 108.789 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' CD ' ' A' ' 59' ' ' LYS . 61.4 mt -107.34 142.39 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.719 1.247 . . . . 1.43 112.213 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HB3' HD11 ' A' ' 24' ' ' ILE . 1.6 p -113.43 155.47 25.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.785 -1.552 . . . . 1.19 113.225 -175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.7 138.82 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 114.975 -1.011 . . . . 0.95 108.591 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 18' ' ' ALA . 63.1 tttm -86.16 126.93 34.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 118.682 -2.511 . . . . 3.12 110.826 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 55' ' ' GLU . 40.5 t -118.71 126.61 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.62 -1.232 . . . . 1.69 111.498 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 51.9 tttp -170.94 172.42 5.54 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 105.221 -2.141 . . . . 2.43 105.221 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -86.1 178.23 49.44 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.167 -1.973 . . . . 2.26 108.167 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 17' ' ' GLU . 40.9 ttm180 40.07 99.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.942 . . . . 4.93 111.291 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 33.3 109.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 113.441 0.904 . . . . 3.13 113.441 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -171.75 16.37 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.958 0 O-C-N 121.338 -0.851 . . . . 1.78 110.387 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.05 110.53 4.03 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 107.564 -2.214 . . . . 1.06 107.564 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.1 m -142.57 139.47 31.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.123 -1.436 . . . . 1.36 107.123 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HE3' ' H ' ' A' ' 86' ' ' LYS . 1.3 pttm -94.28 138.62 32.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.325 -1.484 . . . . 3.16 109.787 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.662 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 p -142.1 157.96 44.29 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.531 -0.868 . . . . 0.78 111.274 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 76' ' ' LEU . 37.5 t -104.06 134.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.113 -1.81 . . . . 0.43 106.113 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 10' ' ' CYS . 69.9 mt -96.89 133.71 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.032 -1.043 . . . . 0.51 110.371 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 17.1 m -151.94 69.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.457 -1.697 . . . . 1.3 113.594 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.6 t0 171.19 152.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.737 -1.227 . . . . 1.56 109.991 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.522 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.5 mt -117.66 127.57 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 103.038 -2.949 . . . . 1.8 103.038 171.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 29' ' ' ASP . 20.9 mm -99.75 -111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.017 -1.677 . . . . 0.77 111.853 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 91.6 m-20 -62.71 -41.36 99.1 Favored 'General case' 0 C--O 1.201 -1.452 0 O-C-N 121.695 -0.628 . . . . 2.4 110.157 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.582 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 89.9 m-20 164.34 -50.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 C-N-CA 124.833 1.253 . . . . 2.55 109.353 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -95.07 4.85 53.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 2.1 111.922 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.84 147.22 42.33 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.068 -1.02 . . . . 1.6 110.337 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.98 162.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.676 -0.49 . . . . 0.49 109.676 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 ' HE ' ' A' ' 46' ' ' ARG . 8.2 tt -97.4 132.48 43.07 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 119.361 -0.936 . . . . 0.93 108.643 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 47' ' ' ARG . 22.2 m -127.71 150.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.777 -0.769 . . . . 0.52 110.556 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.747 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -144.03 155.12 43.88 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.974 -0.69 . . . . 0.63 112.15 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA3' HG23 ' A' ' 44' ' ' VAL . . . -152.55 169.08 31.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.132 -1.987 . . . . 0.84 108.132 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 21' ' ' LYS . 36.9 Cg_endo -70.39 110.35 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 CA-C-N 118.938 1.369 . . . . 0.99 109.322 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -58.82 -39.5 81.36 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.057 -1.027 . . . . 3.44 111.202 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.26 -40.22 96.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.941 -1.099 . . . . 2.27 112.47 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.458 HD13 ' HD3' ' A' ' 86' ' ' LYS . 82.8 mt -96.87 -77.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.419 -0.801 . . . . 2.05 112.874 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.4 m -61.89 -35.06 77.24 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.729 -1.232 . . . . 1.1 109.492 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.54 -10.97 56.47 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.653 -0.654 . . . . 1.12 111.797 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -91.1 128.33 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 119.93 1.865 . . . . 1.06 108.15 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -95.33 -75.57 0.52 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.332 1.063 . . . . 3.49 110.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 1.06 ' HE ' HD11 ' A' ' 34' ' ' LEU . 65.2 ttt180 -148.7 125.44 11.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.301 -1.37 . . . . 2.78 107.301 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.712 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ptm180 -157.23 164.34 37.82 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 119.969 -1.707 . . . . 3.1 109.489 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -105.25 141.1 37.37 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.43 -0.793 . . . . 3.0 109.528 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -133.8 143.6 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 1.63 110.052 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 48.6 t-20 -80.87 154.24 27.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.669 0.747 . . . . 2.28 111.243 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 93.1 mt -58.36 -23.84 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.638 -0.664 . . . . 1.41 109.728 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.6 mt -53.26 -29.87 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 1.25 108.94 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -117.43 91.7 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.553 -1.647 . . . . 1.5 106.553 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.76 HD11 HH21 ' A' ' 8' ' ' ARG . 24.4 tp -113.82 130.38 56.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.684 -0.635 . . . . 1.56 110.548 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' CD ' HG21 ' A' ' 13' ' ' VAL . 14.7 tp10 -137.81 90.33 14.41 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 106.864 -1.532 . . . . 2.28 106.864 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 90.3 Cg_endo -90.26 148.13 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.629 1.553 . . . . 0.69 113.926 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 p -119.73 163.81 16.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.491 -0.929 . . . . 0.88 108.491 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.599 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 55.3 p30 -75.4 125.82 29.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.282 -1.747 . . . . 2.57 106.282 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.729 ' CD ' HD12 ' A' ' 9' ' ' ILE . 24.5 mttt -162.14 -173.03 3.46 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.083 1.42 . . . . 2.9 112.704 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' GLY . 25.3 tttt -81.48 150.88 28.08 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.722 -1.581 . . . . 5.03 111.231 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 61' ' ' ILE . 12.1 tt -120.6 120.16 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.503 0.668 . . . . 4.81 110.628 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -179.6 87.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 117.62 -1.181 . . . . 2.14 112.208 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 65' ' ' LYS . 15.6 mm -115.15 138.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 CA-C-N 123.543 2.883 . . . . 1.72 108.112 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.569 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.7 mt-30 -60.76 -41.28 95.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 115.166 -2.614 . . . . 2.59 106.282 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 59.3 tttt 114.11 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.139 -1.059 . . . . 3.48 108.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 119.849 -1.782 . . . . 0.64 111.539 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.76 144.8 17.23 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.201 -1.764 . . . . 0.62 112.225 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.8 p -69.89 167.02 18.26 Favored 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 108.152 -1.055 . . . . 0.73 108.152 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 93.0 m-20 -59.56 -47.35 85.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 119.585 -1.947 . . . . 2.02 112.088 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -41.1 98.3 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 117.003 -1.879 . . . . 2.3 108.022 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.8 -35.72 82.0 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.134 -1.061 . . . . 1.96 108.134 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 68' ' ' SER . 79.5 t -65.39 -42.82 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.59 110.094 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.68 -42.92 98.06 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.908 -1.117 . . . . 0.79 110.09 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -59.44 -38.19 80.08 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.182 -1.007 . . . . 2.33 109.072 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 11.8 mtpt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.882 -0.511 . . . . 2.62 110.169 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 36' ' ' THR . 88.4 mt -57.48 -37.68 73.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.662 -1.273 . . . . 1.3 108.641 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 97.1 mt-10 -58.65 -33.08 69.68 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 118.307 -1.357 . . . . 1.7 108.179 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.02 -35.68 75.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.145 -2.168 . . . . 2.29 105.145 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.701 ' OG ' HD11 ' A' ' 9' ' ' ILE . 31.1 m -70.01 -21.88 63.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.014 -0.539 . . . . 1.41 109.597 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 77' ' ' GLU . 74.4 m-20 66.83 46.7 1.62 Allowed 'General case' 0 N--CA 1.519 3.011 0 CA-C-O 122.229 1.014 . . . . 1.53 112.481 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.726 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.2 mp -65.52 -27.51 68.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.357 -0.838 . . . . 2.46 111.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.0 m -42.62 -33.59 0.74 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.965 -1.084 . . . . 2.54 111.29 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -157.66 -21.17 0.09 Allowed 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.009 -1.682 . . . . 3.53 110.952 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -60.59 -42.33 96.49 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 117.73 -1.588 . . . . 3.06 107.076 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' NZ ' ' A' ' 59' ' ' LYS . 62.3 mtt -94.82 -125.3 0.11 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.627 -1.624 . . . . 2.45 114.178 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.458 ' HD3' HD13 ' A' ' 41' ' ' ILE . 17.2 mttm 52.99 31.42 10.96 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.631 -1.248 . . . . 1.49 107.631 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 C--N 1.302 -1.465 0 N-CA-C 116.347 1.981 . . . . 2.69 116.347 -174.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 6' ' ' VAL . 95.9 mt-10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.063 -0.347 . . . . 4.72 110.063 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.642 ' O ' ' O ' ' A' ' 5' ' ' GLU . 7.2 m -43.19 -149.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.269 1.033 . . . . 2.38 112.585 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' HG23 ' A' ' 6' ' ' VAL . . . 79.35 21.81 66.4 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 106.721 -2.551 . . . . 1.47 106.721 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 57' ' ' THR . 71.1 mtp180 -128.74 170.43 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.431 -0.952 . . . . 3.56 108.431 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.703 ' O ' HG23 ' A' ' 57' ' ' THR . 82.8 mt -93.99 145.41 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.021 -1.05 . . . . 1.43 108.845 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.0 p -122.44 155.66 35.66 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.9 -1.045 . . . . 1.19 112.643 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 41.0 t -127.31 139.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 CA-C-N 115.625 -0.716 . . . . 0.95 110.158 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 18' ' ' ALA . 22.7 tptm -81.1 137.52 35.97 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 118.03 -2.919 . . . . 3.12 111.685 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.1 t -119.61 100.42 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 122.58 1.181 . . . . 1.69 109.476 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 31.6 mttm -157.02 169.08 25.63 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.153 -1.795 . . . . 2.43 106.153 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -82.84 178.83 53.15 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 117.353 -2.356 . . . . 2.26 107.305 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 15' ' ' GLY . 59.3 ttt85 49.35 106.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.172 -1.193 . . . . 4.93 111.01 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 48.33 53.55 11.73 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.996 0.903 . . . . 3.13 110.74 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 14' ' ' LYS . . . -67.88 -15.3 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.538 -1.351 . . . . 1.78 110.781 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.45 94.91 1.9 Allowed Glycine 0 C--N 1.285 -2.284 0 O-C-N 120.718 -1.239 . . . . 1.06 114.374 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -136.35 134.32 37.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.62 -1.992 . . . . 1.36 105.62 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.704 ' H ' HG21 ' A' ' 42' ' ' THR . 1.7 ptpt -100.53 136.84 39.78 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.622 -1.299 . . . . 3.16 111.455 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.2 p -137.5 159.57 41.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.772 0.796 . . . . 0.78 111.199 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 76' ' ' LEU . 41.1 t -111.12 136.27 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.056 -1.461 . . . . 0.43 107.056 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.657 HG12 HG12 ' A' ' 35' ' ' VAL . 62.7 mt -105.37 133.69 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.117 -0.989 . . . . 0.51 109.912 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.993 HG11 ' NZ ' ' A' ' 75' ' ' LYS . 1.1 m -149.18 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.884 -1.126 . . . . 1.3 111.668 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 6' ' ' VAL . 54.3 t0 172.14 137.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 1.56 109.183 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 5' ' ' GLU . 70.5 mt -118.78 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 104.177 -2.527 . . . . 1.8 104.177 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -97.05 -79.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.053 -1.03 . . . . 0.77 110.843 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 44.1 t0 -106.03 179.0 4.4 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.135 0.969 . . . . 2.4 108.871 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 91.8 m-20 -54.8 -38.51 67.39 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 118.969 -1.093 . . . . 2.55 108.81 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.54 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 33.6 p-10 -112.11 5.15 18.42 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 115.685 1.735 . . . . 2.1 115.685 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 89.3 m-85 -112.64 138.94 48.7 Favored 'General case' 0 N--CA 1.528 3.455 0 CA-C-N 121.696 2.044 . . . . 1.6 113.78 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 m -130.8 162.78 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 115.727 -0.67 . . . . 0.49 109.899 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.832 HD21 ' HE ' ' A' ' 46' ' ' ARG . 9.7 tt -100.28 135.61 41.44 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.272 -0.893 . . . . 0.93 108.829 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.3 m -126.75 150.5 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.613 -0.835 . . . . 0.52 110.541 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.57 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.9 t -146.89 153.09 39.72 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.648 -0.821 . . . . 0.63 112.015 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.7 29.82 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.571 -2.212 . . . . 0.84 107.571 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.88 108.06 0.86 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 CA-C-N 119.156 1.478 . . . . 0.99 110.594 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -58.6 -39.21 79.79 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.174 0.988 . . . . 3.44 109.592 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -38.99 93.25 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.43 -0.794 . . . . 2.27 112.251 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.691 HG21 ' HG2' ' A' ' 86' ' ' LYS . 26.8 mm -96.24 -78.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.028 . . . . 2.05 113.39 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.704 HG21 ' H ' ' A' ' 21' ' ' LYS . 26.2 m -63.0 -32.94 74.4 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.999 0.904 . . . . 1.1 108.605 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.12 56.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 111.438 -0.665 . . . . 1.12 111.438 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -68.37 148.94 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.8 1.8 . . . . 1.06 109.912 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -92.69 -131.18 0.13 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.524 -1.287 . . . . 3.49 107.524 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.832 ' HE ' HD21 ' A' ' 34' ' ' LEU . 73.9 ttt180 -139.86 122.32 16.15 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 103.982 -2.599 . . . . 2.78 103.982 173.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.744 ' O ' HG22 ' A' ' 35' ' ' VAL . 45.8 ptt85 -159.64 165.83 31.91 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 117.467 -1.693 . . . . 3.1 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -93.12 139.12 30.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.274 -0.891 . . . . 3.0 108.695 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.04 153.48 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.96 -1.087 . . . . 1.63 110.304 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' C ' HD22 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -86.3 167.7 14.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.955 0.883 . . . . 2.28 111.611 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.15 -24.84 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 115.999 -0.546 . . . . 1.41 110.234 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.512 HD12 ' OD1' ' A' ' 50' ' ' ASN . 63.7 mt -55.23 -30.87 60.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.207 -1.034 . . . . 1.25 108.207 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 98.7 m-70 -116.04 88.53 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.508 -1.293 . . . . 1.5 107.508 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.6 tp -118.91 129.67 55.31 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.285 -0.635 . . . . 1.56 109.285 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -143.14 90.41 7.4 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 106.368 -1.715 . . . . 2.28 106.368 176.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -90.22 153.54 4.64 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 121.557 1.504 . . . . 0.69 114.322 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 9' ' ' ILE . 63.5 p -111.68 166.71 10.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.333 -1.728 . . . . 0.88 106.333 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 8' ' ' ARG . 88.4 m-20 -84.21 11.49 8.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.047 -1.033 . . . . 2.57 110.664 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 8' ' ' ARG 0.317 44.6 tttm -91.34 124.6 35.65 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.185 -0.947 . . . . 2.9 111.389 -177.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -133.57 119.04 18.97 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 118.596 -1.242 . . . . 5.03 111.382 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 78' ' ' GLU . 31.8 pt -128.5 157.12 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.872 -1.158 . . . . 4.81 107.872 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -86.13 128.37 34.87 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 122.891 1.329 . . . . 2.14 111.928 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.963 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.78 164.07 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 115.11 -0.95 . . . . 1.72 109.933 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -96.39 139.98 31.71 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.842 -1.17 . . . . 2.59 107.842 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -67.24 138.87 57.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 116.056 -0.52 . . . . 3.48 111.064 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.8 21.43 61.55 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.52 -1.324 . . . . 0.64 112.998 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.04 21.74 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 120.294 2.047 . . . . 0.62 111.389 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 51.7 p -71.2 166.27 21.87 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.696 -1.594 . . . . 0.73 106.696 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 53.0 p30 -60.65 -40.55 92.45 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 116.328 -2.149 . . . . 2.02 110.683 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 97.1 mt-10 -63.23 -39.31 94.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 119.517 -1.989 . . . . 2.3 107.731 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.73 -35.71 81.93 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.773 -1.171 . . . . 1.96 108.09 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 36' ' ' THR . 71.1 t -64.09 -43.52 97.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.436 -1.306 . . . . 0.59 107.881 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.74 -44.25 97.27 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.014 -1.074 . . . . 0.79 109.428 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.48 -42.32 96.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.371 -1.456 . . . . 2.33 108.315 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.993 ' NZ ' HG11 ' A' ' 25' ' ' VAL . 10.1 mtmp? -62.63 -34.93 78.04 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.507 -0.877 . . . . 2.62 109.588 176.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.622 ' O ' ' OG ' ' A' ' 79' ' ' SER . 38.1 tp -59.24 -40.5 86.11 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.735 -1.186 . . . . 1.3 108.392 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.543 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -62.42 -34.38 76.64 Favored 'General case' 0 C--N 1.281 -2.373 0 O-C-N 120.175 -1.578 . . . . 1.7 108.135 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.482 ' HG2' HD12 ' A' ' 61' ' ' ILE . 48.8 tp10 -59.68 -36.97 77.52 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 105.589 -2.004 . . . . 2.29 105.589 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 95.8 p -71.11 -18.25 62.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.397 -1.705 . . . . 1.41 106.397 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 20.2 m120 61.6 35.02 17.45 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.123 -0.944 . . . . 1.53 111.065 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.58 HD13 ' OG ' ' A' ' 79' ' ' SER . 8.4 mp -74.55 -29.54 61.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.831 -0.543 . . . . 2.46 112.395 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 43.5 m -50.52 -33.09 20.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.122 -0.986 . . . . 2.54 110.856 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -147.42 -28.35 0.36 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 118.342 -1.343 . . . . 3.53 112.727 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -61.88 -48.57 79.89 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 114.94 -2.704 . . . . 3.06 105.606 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 62.2 mtt -88.09 -135.92 0.09 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.378 -1.737 . . . . 2.45 111.355 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.691 ' HG2' HG21 ' A' ' 41' ' ' ILE . 27.8 mtpt 62.81 29.67 16.67 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.521 -1.659 . . . . 1.49 106.521 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.493 1.68 0 CA-C-N 116.103 -0.498 . . . . 2.69 112.112 -179.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.578 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 95.2 mt-10 . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.281 -0.637 . . . . 4.72 109.281 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 61' ' ' ILE . 5.8 m -63.48 178.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.394 -1.335 . . . . 2.38 107.394 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 89.77 18.14 52.24 Favored Glycine 0 C--O 1.199 -2.042 0 C-N-CA 119.116 -1.516 . . . . 1.47 111.27 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 28.3 ptt-85 -137.53 176.02 9.08 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.147 -1.207 . . . . 3.56 108.275 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.779 HD12 ' NZ ' ' A' ' 59' ' ' LYS . 81.3 mt -104.81 146.98 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 123.171 1.462 . . . . 1.43 111.641 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -117.47 155.72 29.21 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 112.959 -1.928 . . . . 1.19 111.515 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 43.5 t -127.02 135.4 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 CA-C-N 115.437 -0.801 . . . . 0.95 111.144 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -87.96 139.05 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.296 -2.753 . . . . 3.12 110.189 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.32 120.12 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 118.834 -1.146 . . . . 1.69 110.659 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.634 ' HZ3' ' CE1' ' A' ' 53' ' ' HIS . 93.1 mttt -161.09 170.55 20.22 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.739 -1.578 . . . . 2.43 106.739 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.9 -178.63 51.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 106.142 -2.783 . . . . 2.26 106.142 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' O ' ' O ' ' A' ' 17' ' ' GLU . 84.7 mtt180 38.38 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 119.37 1.585 . . . . 4.93 111.332 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 35.27 110.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.905 0.86 . . . . 3.13 112.673 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.58 16.6 0.07 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.919 -1.113 . . . . 1.78 111.167 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.22 98.21 2.39 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.18 -1.968 . . . . 1.06 108.18 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -144.42 137.29 26.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.149 -1.207 . . . . 1.36 109.221 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.901 ' O ' HG21 ' A' ' 42' ' ' THR . 90.1 mttt -103.36 139.36 38.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 3.16 109.418 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.5 p -131.24 157.69 42.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.839 -1.144 . . . . 0.78 109.147 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 9' ' ' ILE . 42.9 t -105.17 135.18 44.33 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 N-CA-C 106.556 -1.646 . . . . 0.43 106.556 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 35' ' ' VAL . 68.8 mt -102.73 130.03 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.41 -0.916 . . . . 0.51 110.086 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -142.28 68.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.158 -1.417 . . . . 1.3 111.729 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 55.1 t0 164.97 148.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.116 -0.99 . . . . 1.56 108.542 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.1 tt -121.74 117.67 53.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.253 -2.499 . . . . 1.8 104.253 170.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.5 mt -97.64 -80.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.879 1.323 . . . . 0.77 109.653 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -106.18 161.26 14.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.105 -1.407 . . . . 2.4 107.845 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.14 -38.1 67.8 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 118.683 -1.207 . . . . 2.55 109.592 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.462 ' OD1' HD11 ' A' ' 51' ' ' ILE . 76.6 m-20 -96.25 0.3 50.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.357 . . . . 2.1 113.651 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -121.31 145.03 48.29 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.994 1.27 . . . . 1.6 113.091 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.91 161.98 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.926 -0.484 . . . . 0.49 110.064 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 35' ' ' VAL . 9.0 tt -101.36 133.9 45.25 Favored 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 108.122 -1.066 . . . . 0.93 108.122 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 24' ' ' ILE . 30.2 m -127.51 149.61 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.246 -0.909 . . . . 0.52 110.8 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -143.22 151.4 40.56 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.083 -1.047 . . . . 0.63 111.922 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.53 164.38 37.25 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.039 -2.025 . . . . 0.84 108.039 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -65.79 124.57 12.92 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-N 120.578 2.189 . . . . 0.99 109.56 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -60.37 -43.57 96.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.372 -1.455 . . . . 3.44 111.267 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.33 -37.43 87.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 2.27 113.729 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.594 HD13 ' HD3' ' A' ' 86' ' ' LYS . 85.2 mt -94.86 -71.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 114.751 1.389 . . . . 2.05 114.751 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.901 HG21 ' O ' ' A' ' 21' ' ' LYS . 28.5 m -70.17 -35.53 74.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.41 1.1 . . . . 1.1 109.635 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -18.17 47.03 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-N 115.136 -0.938 . . . . 1.12 112.316 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -92.26 124.04 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 CA-C-N 120.31 2.055 . . . . 1.06 107.582 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -88.98 -79.55 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.237 -1.764 . . . . 3.49 106.237 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.633 HH12 HG21 ' A' ' 72' ' ' VAL . 58.1 ttt85 -152.54 118.65 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.555 -1.276 . . . . 2.78 107.555 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' O ' HG22 ' A' ' 35' ' ' VAL . 10.6 ptm180 -156.13 163.17 39.96 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.353 -1.467 . . . . 3.1 109.838 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -95.39 138.21 33.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.147 -0.971 . . . . 3.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.64 150.62 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.6 -1.312 . . . . 1.63 110.908 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.802 HD21 HD12 ' A' ' 52' ' ' LEU . 43.7 p-10 -86.07 172.72 10.39 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.731 0.777 . . . . 2.28 111.646 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.462 HD11 ' OD1' ' A' ' 31' ' ' ASN . 90.3 mt -57.04 -29.04 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.742 -0.599 . . . . 1.41 110.769 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.802 HD12 HD21 ' A' ' 50' ' ' ASN . 77.4 mt -53.71 -29.03 37.36 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.124 -0.985 . . . . 1.25 109.083 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.634 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 61.8 m170 -115.96 88.61 2.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.257 -1.757 . . . . 1.5 106.257 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.8 tp -123.93 129.16 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 1.56 109.334 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 3.1 tp10 -152.37 94.89 3.18 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 107.584 -1.265 . . . . 2.28 107.584 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 72.6 Cg_endo -87.97 153.81 7.16 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 121.46 1.44 . . . . 0.69 112.541 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 9' ' ' ILE . 50.5 p -116.92 163.95 15.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.415 -0.958 . . . . 0.88 108.415 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 49.8 p30 -88.98 39.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.511 -0.743 . . . . 2.57 111.468 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.779 ' NZ ' HD12 ' A' ' 9' ' ' ILE . 15.2 mtpt -84.3 -166.65 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.007 -1.058 . . . . 2.9 111.805 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' ' O ' ' A' ' 7' ' ' GLY . 22.9 tttt -82.75 154.27 24.86 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.037 0.935 . . . . 5.03 108.988 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 6' ' ' VAL . 26.7 mm -116.42 117.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.987 -0.685 . . . . 4.81 109.77 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -173.39 85.94 0.05 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.983 -1.073 . . . . 2.14 113.464 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.979 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -131.59 159.32 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 120.23 -1.544 . . . . 1.72 109.153 176.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.1 mt-30 -63.41 -44.93 93.24 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 116.455 -2.098 . . . . 2.59 108.848 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 3.0 ttmp? 99.85 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 108.085 -1.08 . . . . 3.48 108.085 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 11.41 63.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.8 -1.72 . . . . 0.64 108.8 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.539 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . . . -56.98 149.44 18.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.662 -0.905 . . . . 0.62 112.36 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.4 p -65.23 164.4 13.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.661 -1.237 . . . . 0.73 107.661 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.58 -42.48 88.13 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.161 -1.587 . . . . 2.02 111.371 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.96 -39.56 95.03 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 117.269 -1.772 . . . . 2.3 108.747 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.9 -36.3 83.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.603 -0.839 . . . . 1.96 108.898 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.633 HG21 HH12 ' A' ' 46' ' ' ARG . 75.8 t -64.57 -42.81 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.59 109.844 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.16 -42.23 98.19 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.986 -1.086 . . . . 0.79 109.791 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.49 -43.39 97.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 2.33 110.176 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HZ1' ' HB3' ' A' ' 67' ' ' ALA . 37.5 mtmm -60.87 -31.67 71.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.763 -0.586 . . . . 2.62 110.637 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.64 ' O ' ' OG ' ' A' ' 79' ' ' SER . 36.4 tp -54.83 -37.48 66.21 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.51 -31.32 67.78 Favored 'General case' 0 C--N 1.277 -2.568 0 O-C-N 120.407 -1.433 . . . . 1.7 109.183 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.08 -35.64 69.63 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.305 -1.739 . . . . 2.29 106.305 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.64 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 57.6 p -66.57 -19.74 65.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.538 -1.282 . . . . 1.41 107.538 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 60.5 37.44 19.68 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 106.904 -1.517 . . . . 1.53 106.904 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.779 HD12 ' HB2' ' A' ' 85' ' ' MET . 13.9 tp -68.35 -30.42 69.37 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.454 -1.703 . . . . 2.46 111.413 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 38.9 m -43.28 -35.66 1.55 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.291 -0.881 . . . . 2.54 110.537 -175.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.79 -23.62 0.11 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.556 -1.658 . . . . 3.53 112.219 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -60.65 -48.01 83.67 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 116.404 -2.118 . . . . 3.06 107.417 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.779 ' HB2' HD12 ' A' ' 81' ' ' LEU . 84.7 mtp -84.25 -122.92 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 112.192 -2.276 . . . . 2.45 112.951 -174.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.672 ' HZ3' ' HG ' ' A' ' 81' ' ' LEU . 25.9 mttm 46.13 14.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.466 -0.939 . . . . 1.49 108.466 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.1 mt-10 . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 114.375 1.25 . . . . 2.69 114.375 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' OE1' ' CE ' ' A' ' 60' ' ' LYS . 95.4 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 122.024 0.916 . . . . 4.72 110.492 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -63.05 175.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.561 -0.904 . . . . 2.38 108.561 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 8' ' ' ARG . . . 75.55 -118.8 5.6 Favored Glycine 0 C--N 1.29 -2.023 0 C-N-CA 119.491 -1.338 . . . . 1.47 110.272 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.571 ' O ' ' O ' ' A' ' 7' ' ' GLY . 39.5 mtp180 39.8 -171.43 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.894 0 O-C-N 121.507 -0.996 . . . . 3.56 109.933 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.72 HD13 ' SD ' ' A' ' 85' ' ' MET . 16.0 tt -118.09 147.95 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 106.277 -1.749 . . . . 1.43 106.277 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 4.7 p -128.01 159.8 33.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.058 0.932 . . . . 1.19 111.95 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.16 145.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.961 -1.126 . . . . 0.95 107.961 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -89.95 137.16 32.57 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 119.516 -1.99 . . . . 3.12 109.512 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.96 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.254 -1.378 . . . . 1.69 111.754 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -165.76 160.17 16.89 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.144 -2.169 . . . . 2.43 105.144 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.89 178.94 51.17 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 117.667 -2.206 . . . . 2.26 109.095 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' GLU . 95.0 mtt-85 45.13 94.63 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.618 -0.931 . . . . 4.93 110.097 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 41.59 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.719 0.771 . . . . 3.13 112.877 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 178.6 8.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.376 -0.827 . . . . 1.78 111.725 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.95 115.1 4.69 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 107.618 -2.193 . . . . 1.06 107.618 178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -152.48 149.21 28.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.086 -1.243 . . . . 1.36 107.862 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 1.9 mptp? -94.93 141.77 28.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 3.16 110.516 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.0 p -139.57 158.8 43.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.78 110.313 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.01 135.68 52.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.476 -1.305 . . . . 0.43 107.476 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 35' ' ' VAL . 64.9 mt -94.49 133.78 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 C-N-CA 118.211 -1.395 . . . . 0.51 110.966 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -148.59 76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 118.442 -1.303 . . . . 1.3 111.422 176.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 47.1 t0 169.79 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.273 -1.517 . . . . 1.56 108.371 172.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 69.9 mt -119.44 121.88 67.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 103.411 -2.811 . . . . 1.8 103.411 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.9 mt -109.63 -38.82 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.941 -1.1 . . . . 0.77 109.927 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -164.69 173.93 11.32 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.962 -1.496 . . . . 2.4 106.962 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.93 -39.26 77.58 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.763 -1.175 . . . . 2.55 112.336 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -99.83 1.6 43.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.338 -1.476 . . . . 2.1 114.811 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -121.77 142.87 49.77 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.121 1.328 . . . . 1.6 111.814 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.7 162.42 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.44 -0.788 . . . . 0.49 109.411 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ASP . 13.3 tp -101.32 133.05 46.5 Favored 'General case' 0 N--CA 1.52 3.027 0 C-N-CA 118.894 -1.122 . . . . 0.93 109.163 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 24' ' ' ILE . 19.1 m -123.61 144.49 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.017 -1.073 . . . . 0.52 109.747 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.554 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.4 t -145.38 155.51 43.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.771 0.796 . . . . 0.63 112.293 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -155.34 164.51 32.01 Favored Glycine 0 N--CA 1.501 3.005 0 N-CA-C 107.168 -2.373 . . . . 0.84 107.168 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.71 115.6 3.02 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 119.145 1.472 . . . . 0.99 110.064 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.89 -34.9 72.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.76 0.79 . . . . 3.44 110.55 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.97 -40.96 99.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.635 -0.666 . . . . 2.27 112.683 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.659 HG21 ' HD3' ' A' ' 86' ' ' LYS . 81.6 mt -98.03 -78.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 2.05 112.767 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 m -61.34 -35.9 78.69 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.913 -1.117 . . . . 1.1 109.459 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.72 -3.82 57.64 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.658 -0.782 . . . . 1.12 112.112 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.5 m -90.73 131.68 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.497 -2.038 . . . . 1.06 105.497 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -94.15 -78.23 0.44 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.492 -1.283 . . . . 3.49 110.331 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -152.66 126.18 8.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.027 -1.842 . . . . 2.78 106.027 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -155.01 165.82 35.53 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.189 -1.569 . . . . 3.1 110.08 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -113.21 138.45 49.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.381 -0.824 . . . . 3.0 109.601 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 m -132.23 151.73 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 118.727 -1.189 . . . . 1.63 110.592 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.55 ' OD1' ' CE2' ' A' ' 32' ' ' PHE . 31.5 m-20 -87.3 163.25 16.94 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.268 -0.878 . . . . 2.28 108.717 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.3 mt -57.56 -24.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.02 -1.05 . . . . 1.41 111.062 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -55.2 -35.93 65.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.345 -1.472 . . . . 1.25 108.556 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -114.66 87.17 2.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.204 -1.036 . . . . 1.5 108.204 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.3 tp -128.5 127.85 43.23 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.655 -0.868 . . . . 1.56 108.655 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.34 87.09 39.19 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 107.314 -1.365 . . . . 2.28 107.314 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -92.17 147.95 3.04 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.107 1.872 . . . . 0.69 114.744 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 14.7 p -101.87 172.32 7.0 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.459 -1.312 . . . . 0.88 107.459 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 58' ' ' ASP . 50.3 p30 -83.1 16.37 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.088 0.947 . . . . 2.57 108.909 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HZ3' ' HB2' ' A' ' 79' ' ' SER 0.346 66.4 tttt -87.53 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.779 -0.823 . . . . 2.9 108.779 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' CE ' ' OE1' ' A' ' 5' ' ' GLU . 62.7 tttm -133.19 120.72 21.53 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.986 -1.086 . . . . 5.03 110.525 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -118.56 141.8 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.556 -1.646 . . . . 4.81 106.556 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.3 p30 -88.23 128.24 35.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.459 -1.4 . . . . 2.14 110.43 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.916 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -126.73 162.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.348 -0.845 . . . . 1.72 109.756 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -70.88 -107.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.092 -1.043 . . . . 2.59 108.308 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -177.35 119.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.802 -1.187 . . . . 3.48 109.663 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.88 20.61 70.23 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.227 -1.463 . . . . 0.64 110.855 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.56 147.19 6.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.981 -1.305 . . . . 0.62 111.316 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.82 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.0 p -66.64 163.37 19.06 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 107.737 -1.208 . . . . 0.73 107.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.9 -44.03 86.51 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 117.339 -1.744 . . . . 2.02 110.502 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.29 -39.58 94.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.092 -1.843 . . . . 2.3 109.404 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.87 -36.71 80.75 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.176 -1.01 . . . . 1.96 109.103 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 68' ' ' SER . 73.0 t -62.56 -41.63 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.591 -0.693 . . . . 0.59 110.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' HD13 ' A' ' 76' ' ' LEU . 97.2 mttt -58.65 -39.42 80.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.519 -0.872 . . . . 0.79 109.36 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.42 -40.79 87.86 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.221 -0.992 . . . . 2.33 111.217 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -60.51 -32.64 71.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.715 -1.241 . . . . 2.62 111.975 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' HA ' ' A' ' 73' ' ' LYS . 6.7 mp -58.62 -37.49 75.99 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 120.32 -1.488 . . . . 1.3 108.931 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 78.0 mm-40 -57.26 -32.67 66.83 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 116.957 -1.897 . . . . 1.7 107.353 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.98 -33.97 76.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.147 -1.797 . . . . 2.29 106.147 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 60.6 p -65.61 -26.92 68.05 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 105.74 -1.948 . . . . 1.41 105.74 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.9 m120 61.66 38.59 15.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.472 -1.677 . . . . 1.53 106.472 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 9' ' ' ILE . 13.5 tp -69.16 -29.56 67.61 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.059 -1.428 . . . . 2.46 108.609 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 m -42.55 -34.46 0.86 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.133 -0.94 . . . . 2.54 111.365 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -156.35 -14.91 0.1 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 117.949 -1.501 . . . . 3.53 111.818 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -61.49 -41.96 98.07 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 116.41 -2.116 . . . . 3.06 105.967 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.72 ' SD ' HD13 ' A' ' 9' ' ' ILE . 75.3 mtp -109.39 -120.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.958 -1.019 . . . . 2.45 112.76 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.659 ' HD3' HG21 ' A' ' 41' ' ' ILE . 90.5 mttt 57.74 33.36 23.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.53 -0.545 . . . . 1.49 109.53 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.297 -1.682 0 C-N-CA 118.677 -1.209 . . . . 2.69 109.067 178.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.682 ' O ' HG23 ' A' ' 6' ' ' VAL . 97.0 mt-10 . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.791 -0.818 . . . . 4.72 108.791 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 5' ' ' GLU . 57.4 t 111.12 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 106.782 -1.562 . . . . 2.38 106.782 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.914 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 89.42 9.33 67.06 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.366 -1.397 . . . . 1.47 110.398 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.599 HH21 ' N ' ' A' ' 5' ' ' GLU . 8.6 ptp180 -98.55 179.39 4.71 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.75 -1.441 . . . . 3.56 111.365 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 22' ' ' CYS . 70.0 mt -106.68 138.5 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.082 -2.192 . . . . 1.43 105.082 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 p -123.65 158.52 31.36 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.201 1.001 . . . . 1.19 113.128 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 21' ' ' LYS . 40.2 t -117.36 137.0 52.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.933 -1.506 . . . . 0.95 106.933 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 35' ' ' VAL . 16.7 mmtp -89.67 145.82 24.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 119.109 -2.245 . . . . 3.12 109.927 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.2 p -128.22 86.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 123.014 1.388 . . . . 1.69 112.664 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 tttt -139.06 144.14 38.66 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.615 -1.994 . . . . 2.43 105.615 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 179.65 53.06 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 117.795 -2.145 . . . . 2.26 109.373 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' GLU . 31.8 ttp180 53.2 91.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.799 -1.186 . . . . 4.93 107.799 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 84.3 tt0 45.1 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 120.99 0.424 . . . . 3.13 111.004 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.61 62.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 122.031 -0.418 . . . . 1.78 111.419 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.53 76.62 0.22 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 118.154 -1.974 . . . . 1.06 109.024 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.566 ' OG ' HG13 ' A' ' 44' ' ' VAL . 83.0 p -142.28 167.1 22.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.833 -0.804 . . . . 1.36 110.017 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 11' ' ' VAL . 66.3 mttm -86.9 152.56 22.34 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.806 1.289 . . . . 3.16 111.375 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 1.6 p -141.69 160.41 40.24 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.56 -1.2 . . . . 0.78 110.056 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.45 129.29 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 105.657 -1.979 . . . . 0.43 105.657 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 35' ' ' VAL . 69.2 mt -92.9 134.14 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.695 -1.253 . . . . 0.51 112.271 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG11 ' HZ2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -148.84 77.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.173 -1.411 . . . . 1.3 113.009 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 51.8 t0 169.08 148.75 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.361 -1.462 . . . . 1.56 110.051 172.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.545 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.9 tt -124.44 133.24 69.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 103.923 -2.621 . . . . 1.8 103.923 171.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.769 HG22 ' H ' ' A' ' 29' ' ' ASP . 21.5 mm -104.89 -122.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.271 -1.518 . . . . 0.77 110.423 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.769 ' H ' HG22 ' A' ' 28' ' ' ILE . 92.2 m-20 -61.69 -41.45 97.59 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 120.369 -0.532 . . . . 2.4 109.738 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 86.9 m-20 170.01 -58.47 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.559 1.143 . . . . 2.55 109.711 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -88.75 3.88 49.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.06 -1.025 . . . . 2.1 113.174 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.535 ' CD1' ' OD1' ' A' ' 50' ' ' ASN . 90.1 m-85 -110.94 144.29 40.25 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.094 -1.076 . . . . 1.6 108.094 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.06 161.11 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.235 -0.915 . . . . 0.49 108.883 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 35' ' ' VAL . 8.8 tt -106.82 131.96 53.32 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 118.698 -1.201 . . . . 0.93 108.974 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 12' ' ' LYS . 11.0 m -128.47 150.99 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 119.378 -0.929 . . . . 0.52 109.847 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -145.65 150.99 37.33 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.961 -1.096 . . . . 0.63 111.023 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -160.18 164.61 34.45 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.854 -2.099 . . . . 0.84 107.854 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' O ' ' OG1' ' A' ' 42' ' ' THR . 30.3 Cg_endo -69.11 101.46 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 CA-C-N 119.093 1.447 . . . . 0.99 109.874 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.32 -38.76 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 3.44 109.111 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.65 -36.55 67.18 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.681 -0.69 . . . . 2.27 110.755 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.734 HG21 ' HD3' ' A' ' 86' ' ' LYS . 22.9 mm -110.13 -40.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 119.065 -1.054 . . . . 2.05 111.1 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 38' ' ' PRO . 29.8 p -84.89 -31.29 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.225 -0.922 . . . . 1.1 112.292 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.98 -10.64 68.03 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.933 -1.267 . . . . 1.12 109.933 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 ' OG ' ' A' ' 20' ' ' SER . 9.8 m -103.0 128.46 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.913 -1.345 . . . . 1.06 107.972 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.72 ' H ' HH22 ' A' ' 47' ' ' ARG . 56.4 tttp -95.58 -81.59 0.4 Allowed 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.432 -1.307 . . . . 3.49 109.516 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 58.3 ttt85 -153.55 120.69 5.77 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.765 -1.198 . . . . 2.78 107.765 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.72 HH22 ' H ' ' A' ' 45' ' ' LYS . 9.4 ptp85 -156.86 168.45 27.41 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.709 -1.244 . . . . 3.1 109.999 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -110.76 140.42 45.18 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.429 -0.952 . . . . 3.0 108.429 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 53' ' ' HIS . 78.8 t -123.71 137.67 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 121.914 0.864 . . . . 1.63 112.069 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.535 ' OD1' ' CD1' ' A' ' 32' ' ' PHE . 36.3 m-20 -78.69 156.15 29.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.589 -1.263 . . . . 2.28 107.589 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.925 ' O ' HD23 ' A' ' 54' ' ' LEU . 28.5 mm -56.5 -27.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.495 -1.378 . . . . 1.41 109.301 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -54.23 -34.17 60.04 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 120.411 -1.431 . . . . 1.25 108.586 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.503 ' O ' HG11 ' A' ' 49' ' ' VAL . 77.9 m80 -115.72 93.29 4.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.198 -0.939 . . . . 1.5 108.958 176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.925 HD23 ' O ' ' A' ' 51' ' ' ILE . 1.7 pp -135.78 129.96 33.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.13 -1.606 . . . . 1.56 110.898 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -130.18 86.81 53.0 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 104.995 -2.224 . . . . 2.28 104.995 174.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' HD12 ' A' ' 54' ' ' LEU . 67.3 Cg_endo -91.52 157.41 3.61 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.283 2.655 . . . . 0.69 115.647 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.519 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 30.3 p -106.67 165.32 11.39 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.458 -0.942 . . . . 0.88 108.458 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -84.67 15.46 3.82 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.944 0.878 . . . . 2.57 108.849 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 45.8 mttp -88.53 141.91 28.14 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.19 -1.041 . . . . 2.9 108.19 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -135.69 129.21 32.35 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 5.03 110.545 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.914 HG22 ' O ' ' A' ' 7' ' ' GLY . 20.4 tt -125.18 148.03 29.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.925 -1.509 . . . . 4.81 106.925 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -84.86 119.95 25.91 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.472 -1.392 . . . . 2.14 108.281 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.523 HD13 ' HA2' ' A' ' 7' ' ' GLY . 30.6 pt -121.14 158.32 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.567 0.699 . . . . 1.72 111.848 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -86.76 0.35 54.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.732 . . . . 2.59 110.699 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 mttt 54.89 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.966 -1.084 . . . . 3.48 111.357 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.08 65.4 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.972 -1.109 . . . . 0.64 111.396 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.04 149.56 5.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.582 -1.54 . . . . 0.62 110.235 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.2 p -65.56 159.13 25.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.73 108.751 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.474 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 91.7 m-20 -57.12 -40.47 77.15 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.055 -1.028 . . . . 2.02 111.898 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.6 mp0 -63.03 -39.35 94.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 117.18 -1.808 . . . . 2.3 110.279 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.09 -38.15 82.02 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.685 -1.259 . . . . 1.96 109.357 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 68' ' ' SER . 69.0 t -64.24 -42.55 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.728 -0.608 . . . . 0.59 111.421 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -60.66 -42.27 96.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.009 -1.477 . . . . 0.79 109.763 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -60.98 -44.82 96.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 117.536 -1.665 . . . . 2.33 108.853 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HZ2' HG11 ' A' ' 25' ' ' VAL . 7.8 ttpm? -60.3 -36.26 77.47 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.514 -0.741 . . . . 2.62 111.347 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 81' ' ' LEU . 9.1 tt -53.83 -40.06 66.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.578 -0.849 . . . . 1.3 108.783 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.1 -33.68 67.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 117.843 -1.543 . . . . 1.7 107.732 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.67 ' OE1' HD11 ' A' ' 61' ' ' ILE . 84.5 tt0 -58.42 -34.08 70.39 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.042 -1.466 . . . . 2.29 107.042 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -61.56 -26.2 67.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.509 -1.663 . . . . 1.41 106.509 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 m120 71.63 43.85 0.55 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 122.684 1.231 . . . . 1.53 112.715 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -71.13 -22.37 62.08 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.277 -1.329 . . . . 2.46 109.517 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.6 ' CA ' ' HZ2' ' A' ' 86' ' ' LYS . 39.9 m -41.76 -37.8 1.31 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.785 -0.572 . . . . 2.54 109.774 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -168.82 -11.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.536 -1.353 . . . . 3.53 110.05 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -60.61 -44.05 96.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 123.559 1.647 . . . . 3.06 106.673 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.1 -127.09 0.16 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.836 -1.984 . . . . 2.45 111.548 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.734 ' HD3' HG21 ' A' ' 41' ' ' ILE . 23.5 mttt 52.72 21.76 2.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.74 -0.6 . . . . 1.49 112.155 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.489 1.514 0 C-N-CA 117.547 -1.661 . . . . 2.69 108.325 178.011 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 18.0 pt-20 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 108.256 -1.016 . . . . 4.72 108.256 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.412 HG21 ' HZ3' ' A' ' 65' ' ' LYS . 12.8 m -62.6 155.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.938 -1.134 . . . . 2.38 107.938 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 23.68 26.55 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.116 -1.516 . . . . 1.47 112.309 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.555 HH21 HD11 ' A' ' 54' ' ' LEU . 31.8 ptt-85 -123.62 170.59 10.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.173 -1.192 . . . . 3.56 110.842 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 57' ' ' THR . 13.9 mm -101.21 141.01 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.649 0.738 . . . . 1.43 109.713 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.595 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.56 156.02 28.8 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.817 1.294 . . . . 1.19 112.631 -176.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.446 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 42.0 t -120.65 138.32 51.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 106.536 -1.653 . . . . 0.95 106.536 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' ALA . 24.0 tttt -82.71 134.82 35.13 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 117.732 -3.105 . . . . 3.12 110.227 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.757 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.9 p -109.84 82.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.037 -1.065 . . . . 1.69 108.893 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 38.3 mtpt -155.66 164.84 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.498 -1.667 . . . . 2.43 106.498 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.5 165.82 43.0 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 116.908 -2.568 . . . . 2.26 107.045 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.587 ' O ' ' O ' ' A' ' 15' ' ' GLY . 93.1 mtt-85 55.73 134.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.087 -1.079 . . . . 4.93 108.087 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 48.75 20.4 0.33 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.615 -1.624 . . . . 3.13 106.615 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.513 ' N ' ' C ' ' A' ' 16' ' ' ARG . . . -56.97 -46.31 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.773 -1.103 . . . . 1.78 108.838 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.36 103.65 3.07 Favored Glycine 0 C--N 1.284 -2.307 0 N-CA-C 110.458 -1.057 . . . . 1.06 110.458 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 42' ' ' THR . 36.2 t -147.49 135.5 21.31 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.278 -1.379 . . . . 1.36 107.278 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.03 139.64 30.32 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.658 -1.217 . . . . 3.16 107.838 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -130.1 140.71 50.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.12 -0.632 . . . . 0.78 110.457 -177.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 9' ' ' ILE . 38.9 t -103.32 135.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.566 -2.383 . . . . 0.43 104.566 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.558 HG12 HG12 ' A' ' 35' ' ' VAL . 68.2 mt -103.14 132.29 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 119.246 -0.982 . . . . 0.51 110.826 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -151.43 72.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 118.409 -1.316 . . . . 1.3 111.693 175.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.8 t0 170.12 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.549 -1.345 . . . . 1.56 110.476 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.6 mt -120.51 127.74 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 104.345 -2.465 . . . . 1.8 104.345 171.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 17.8 mm -100.37 -104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 121.309 1.868 . . . . 0.77 110.988 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 56.1 t0 -64.19 -42.37 96.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.026 -1.046 . . . . 2.4 109.249 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.655 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 49.9 p30 164.0 -46.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.812 0.845 . . . . 2.55 109.291 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.655 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 79.7 m-20 -96.09 4.62 52.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.974 -1.079 . . . . 2.1 111.56 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 28' ' ' ILE . 96.7 m-85 -112.17 141.0 46.41 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.352 -0.842 . . . . 1.6 109.994 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.98 161.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.858 -0.526 . . . . 0.49 109.962 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.577 HD11 HH11 ' A' ' 46' ' ' ARG . 8.9 tt -100.9 132.45 46.29 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.69 -0.855 . . . . 0.93 108.69 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 24' ' ' ILE . 15.5 m -128.12 151.46 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 C-N-CA 119.234 -0.986 . . . . 0.52 110.564 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -146.01 152.59 39.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 0.63 111.104 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.0 154.38 25.14 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.692 -1.763 . . . . 0.84 108.692 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' O ' ' OG1' ' A' ' 42' ' ' THR . 6.2 Cg_exo -57.64 109.25 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 CA-C-N 119.978 1.889 . . . . 0.99 110.081 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.438 ' CE ' ' HZ1' ' A' ' 45' ' ' LYS . 34.9 tttp -56.64 -36.23 69.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.007 -1.058 . . . . 3.44 109.472 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.72 -38.58 69.94 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.192 -1.003 . . . . 2.27 109.626 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 86' ' ' LYS . 23.5 mm -114.32 -38.66 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.206 -0.998 . . . . 2.05 111.533 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' ' OG ' ' A' ' 20' ' ' SER . 80.6 p -81.19 -33.95 32.63 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.93 -1.106 . . . . 1.1 110.112 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.65 66.33 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.31 -0.716 . . . . 1.12 111.31 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 37' ' ' GLY . 15.2 m -103.38 133.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.48 -1.6 . . . . 1.06 109.832 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HZ1' ' CE ' ' A' ' 39' ' ' LYS . 63.5 mttp -86.11 -78.41 0.28 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.787 -1.821 . . . . 3.49 106.98 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.577 HH11 HD11 ' A' ' 34' ' ' LEU . 69.0 ttp85 -149.79 124.7 9.92 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.749 -2.315 . . . . 2.78 104.749 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 35' ' ' VAL . 46.8 ptt85 -155.55 166.38 33.71 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.827 -1.796 . . . . 3.1 109.912 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.441 HH12 HD12 ' A' ' 34' ' ' LEU . 77.3 mtt-85 -109.75 141.39 42.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.641 -0.824 . . . . 3.0 109.193 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.97 142.8 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 1.63 110.366 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.645 ' ND2' HD12 ' A' ' 52' ' ' LEU . 42.6 p-10 -86.45 167.33 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.769 . . . . 2.28 110.982 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.39 -26.59 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.689 -0.632 . . . . 1.41 111.061 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.645 HD12 ' ND2' ' A' ' 50' ' ' ASN . 66.5 mt -55.06 -33.0 62.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.967 -1.083 . . . . 1.25 110.371 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -121.76 90.43 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.383 -1.34 . . . . 1.5 107.383 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.555 HD11 HH21 ' A' ' 8' ' ' ARG . 27.0 tp -118.68 131.89 56.16 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.825 -0.547 . . . . 1.56 110.332 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 2.6 tt0 -131.33 89.6 40.63 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 104.707 -2.331 . . . . 2.28 104.707 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.461 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 93.3 Cg_endo -87.88 149.93 7.15 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.495 1.463 . . . . 0.69 114.293 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 9' ' ' ILE . 39.8 p -110.38 165.82 11.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.718 -1.215 . . . . 0.88 107.718 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.15 14.33 3.52 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.351 -0.843 . . . . 2.57 110.124 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -91.65 125.55 36.42 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.49 -0.756 . . . . 2.9 109.743 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -134.88 122.31 21.81 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.444 -0.785 . . . . 5.03 110.465 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.71 152.96 37.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.97 -1.122 . . . . 4.81 107.97 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 52.6 p30 -83.71 133.09 34.82 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.856 1.313 . . . . 2.14 110.406 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 25' ' ' VAL . 28.7 pt -125.24 158.71 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 115.031 -0.986 . . . . 1.72 112.006 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 59.7 tp60 -64.38 -48.95 73.51 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.546 -1.662 . . . . 2.59 109.378 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 15.2 ttmm 100.66 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.323 0.965 . . . . 3.48 110.781 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.97 63.75 Favored Glycine 0 N--CA 1.506 3.334 0 O-C-N 120.556 -1.34 . . . . 0.64 111.784 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 71' ' ' GLU . . . -56.88 152.87 11.94 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.991 -1.299 . . . . 0.62 112.832 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 72' ' ' VAL . 55.7 p -63.14 167.59 4.89 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 108.284 -1.006 . . . . 0.73 108.284 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.61 -45.65 88.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.916 -1.74 . . . . 2.02 112.749 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.32 -40.11 92.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 116.6 -2.04 . . . . 2.3 107.844 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.526 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 97.2 mt-10 -64.8 -36.07 83.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.844 -1.169 . . . . 1.96 107.844 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 68' ' ' SER . 73.2 t -64.79 -42.99 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.579 -0.849 . . . . 0.59 109.499 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.88 -41.65 92.02 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.362 -1.335 . . . . 0.79 107.619 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.22 -43.34 92.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.844 -1.169 . . . . 2.33 107.844 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 67' ' ' ALA . 57.6 mtmt -62.07 -34.18 75.79 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.596 -0.69 . . . . 2.62 110.754 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 23' ' ' VAL . 49.4 tp -55.75 -41.19 73.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.475 -1.391 . . . . 1.3 108.473 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -61.6 -33.94 74.78 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 119.297 -0.961 . . . . 1.7 109.063 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -38.48 81.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.212 -2.144 . . . . 2.29 105.212 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 81' ' ' LEU . 47.6 m -68.37 -29.4 68.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.338 -1.356 . . . . 1.41 107.338 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 29.1 m120 60.56 38.12 19.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.351 -2.092 . . . . 1.53 105.351 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 79' ' ' SER . 0.9 OUTLIER -96.95 -11.81 24.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.399 -0.819 . . . . 2.46 111.413 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 m -56.91 -39.72 74.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.306 -1.496 . . . . 2.54 110.098 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.582 ' HG3' ' HZ1' ' A' ' 86' ' ' LYS . 85.5 tt0 -156.09 -11.31 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.403 -1.319 . . . . 3.53 112.297 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 83' ' ' GLU . 70.7 t80 -58.7 -47.25 85.2 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 114.411 -2.915 . . . . 3.06 105.609 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.462 ' HG2' ' H ' ' A' ' 87' ' ' GLU . 48.7 ttm -90.73 -110.91 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.336 0.589 . . . . 2.45 112.034 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.663 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.4 mtmt 60.91 37.38 18.41 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.726 -1.213 . . . . 1.49 107.726 -175.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' H ' ' HG2' ' A' ' 85' ' ' MET . 97.5 mt-10 . . . . . 0 N--CA 1.495 1.806 0 C-N-CA 119.83 -0.748 . . . . 2.69 111.286 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HE ' ' A' ' 8' ' ' ARG . 95.5 mt-10 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 107.679 -1.23 . . . . 4.72 107.679 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.56 154.85 35.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.383 -2.08 . . . . 2.38 105.383 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . 90.26 8.81 65.99 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.517 -2.233 . . . . 1.47 107.517 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HB2' HD12 ' A' ' 24' ' ' ILE . 79.7 mtt180 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.977 -0.612 . . . . 3.56 109.503 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 57' ' ' THR . 24.9 mm -108.03 135.31 47.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.311 -2.107 . . . . 1.43 105.311 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.647 ' HB3' HD11 ' A' ' 24' ' ' ILE . 3.8 p -127.92 155.89 43.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.07 -1.019 . . . . 1.19 113.107 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 20' ' ' SER . 43.1 t -126.56 138.02 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 115.701 -0.681 . . . . 0.95 109.827 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -85.71 130.81 34.46 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 118.74 -2.475 . . . . 3.12 109.817 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -121.19 123.03 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 117.992 -1.483 . . . . 1.69 112.622 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.608 ' NZ ' ' CD2' ' A' ' 53' ' ' HIS . 49.8 mttm -146.29 153.52 40.65 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.475 -1.306 . . . . 2.43 107.475 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 16' ' ' ARG . . . -86.75 102.84 2.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.226 -2.349 . . . . 2.26 107.226 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 38.5 ttm180 118.44 124.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.936 -1.505 . . . . 4.93 106.936 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 18' ' ' ALA . 77.6 mm-40 73.06 -86.26 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 107.528 -1.286 . . . . 3.13 107.528 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.586 ' CB ' ' H ' ' A' ' 14' ' ' LYS . . . 8.19 113.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.07 0.938 . . . . 1.78 111.962 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.85 80.21 0.05 OUTLIER Glycine 0 C--N 1.292 -1.914 0 N-CA-C 103.66 -3.776 . . . . 1.06 103.66 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 11' ' ' VAL . 75.0 p -162.67 150.55 13.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 117.849 -1.54 . . . . 1.36 110.839 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -114.59 147.84 38.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.362 -0.607 . . . . 3.16 109.362 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 3.8 p -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.551 -0.718 . . . . 0.78 110.387 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG21 HD12 ' A' ' 76' ' ' LEU . 44.7 t -103.93 136.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 105.874 -1.899 . . . . 0.43 105.874 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' HB2' ' A' ' 8' ' ' ARG . 70.6 mt -94.43 129.25 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 123.642 1.687 . . . . 0.51 111.847 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 26' ' ' ASP . 2.6 t -105.18 -151.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 112.61 -2.086 . . . . 1.3 109.332 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.84 ' H ' HG12 ' A' ' 25' ' ' VAL 0.272 36.3 t0 -67.4 163.49 20.72 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.733 -0.667 . . . . 1.56 110.625 -172.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 27' ' ' ILE . 16.3 tt -113.82 125.42 71.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 122.429 1.109 . . . . 1.8 110.103 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 48' ' ' ARG . 61.7 mt -74.26 -37.45 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.934 0.873 . . . . 0.77 110.671 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 47.4 t0 -159.62 167.78 27.64 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.637 -0.875 . . . . 2.4 108.637 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.0 m-20 -57.14 -37.99 72.86 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.013 -1.075 . . . . 2.55 108.615 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -80.45 -31.43 37.46 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.099 -1.0 . . . . 2.1 112.464 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -113.27 143.25 44.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.514 -0.741 . . . . 1.6 112.71 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.42 156.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.562 -0.532 . . . . 0.49 109.562 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CZ ' ' A' ' 46' ' ' ARG . 6.7 tt -100.04 125.54 46.12 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 105.743 -1.947 . . . . 0.93 105.743 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.27 155.47 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 120.812 -1.18 . . . . 0.52 110.965 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -142.47 155.09 45.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.261 -0.899 . . . . 0.63 110.966 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.89 163.7 29.43 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.013 -2.035 . . . . 0.84 108.013 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.13 111.5 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.532 1.666 . . . . 0.99 110.05 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -58.66 -39.35 80.37 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.252 -0.905 . . . . 3.44 110.843 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.36 -39.78 94.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.415 0.895 . . . . 2.27 113.415 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 86' ' ' LYS . 20.5 mm -96.22 -76.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.037 . . . . 2.05 112.309 -177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -62.4 -34.87 77.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.667 -0.645 . . . . 1.1 110.311 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.95 -4.41 57.53 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.874 -0.89 . . . . 1.12 110.874 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.2 m -89.07 126.51 42.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.187 -2.153 . . . . 1.06 105.187 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -94.04 -78.86 0.43 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.676 -1.265 . . . . 3.49 110.241 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 1.0 HH12 HG21 ' A' ' 72' ' ' VAL . 56.3 ttt85 -150.8 124.25 8.97 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.658 -1.979 . . . . 2.78 105.658 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.62 163.18 40.61 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 117.438 -1.705 . . . . 3.1 110.846 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HG3' HD12 ' A' ' 28' ' ' ILE . 30.1 ttm180 -98.29 138.97 34.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.223 -1.029 . . . . 3.0 108.223 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.92 140.14 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-N 119.915 1.234 . . . . 1.63 109.817 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.76 ' ND2' HD12 ' A' ' 52' ' ' LEU . 44.0 p-10 -90.55 168.02 12.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.812 -0.555 . . . . 2.28 110.57 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.53 -27.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.246 -0.909 . . . . 1.41 110.549 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.76 HD12 ' ND2' ' A' ' 50' ' ' ASN . 73.0 mt -52.18 -33.2 39.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.25 109.666 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.608 ' CD2' ' NZ ' ' A' ' 14' ' ' LYS . 77.6 m80 -134.36 88.29 2.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.206 -1.405 . . . . 1.5 107.206 174.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.1 tp -124.49 132.24 53.48 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.648 -0.501 . . . . 1.56 109.648 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.49 89.0 32.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.481 -2.044 . . . . 2.28 105.481 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' HH11 ' A' ' 8' ' ' ARG . 74.0 Cg_endo -89.59 156.47 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.014 1.809 . . . . 0.69 112.701 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 9' ' ' ILE . 49.1 p -111.71 168.19 9.76 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.881 0.848 . . . . 0.88 108.748 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -81.95 18.44 1.32 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.794 0.807 . . . . 2.57 109.392 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 49.2 mttt -91.19 140.33 29.9 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 121.698 0.761 . . . . 2.9 112.386 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -136.87 122.62 19.9 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.942 -0.703 . . . . 5.03 109.472 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 71.7 mt -120.35 145.38 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.576 -0.898 . . . . 4.81 108.576 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -85.39 126.37 33.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.306 -1.497 . . . . 2.14 110.698 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -127.45 164.0 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 115.02 -0.991 . . . . 1.72 111.137 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 65' ' ' LYS . 95.6 mm-40 -84.27 1.49 44.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.763 -1.21 . . . . 2.59 109.679 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 64' ' ' GLN . 99.4 mttt 53.03 124.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.566 0.698 . . . . 3.48 112.07 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.04 70.63 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.574 -1.298 . . . . 0.64 110.183 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB1' ' CG ' ' A' ' 71' ' ' GLU . . . -54.08 146.64 14.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.015 -1.285 . . . . 0.62 111.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.0 p -67.16 164.4 18.16 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.878 -1.156 . . . . 0.73 107.878 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.28 -47.34 86.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.355 -1.465 . . . . 2.02 110.601 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -39.23 90.49 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.629 -1.628 . . . . 2.3 106.876 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.466 ' CG ' ' HB1' ' A' ' 67' ' ' ALA . 50.6 tp10 -64.72 -38.44 91.0 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.369 -0.832 . . . . 1.96 109.1 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.0 HG21 HH12 ' A' ' 46' ' ' ARG . 73.6 t -64.7 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.298 1.047 . . . . 0.59 109.697 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.8 -42.23 98.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.32 -1.352 . . . . 0.79 110.006 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -62.63 -42.89 99.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.998 -1.064 . . . . 2.33 112.821 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HZ3' HG13 ' A' ' 25' ' ' VAL . 18.1 ptmt -67.9 -27.53 66.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.902 -1.124 . . . . 2.62 109.593 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 53.9 tp -55.32 -39.33 69.83 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.326 -0.95 . . . . 1.3 108.75 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -29.37 66.83 Favored 'General case' 0 C--N 1.282 -2.328 0 O-C-N 121.043 -1.036 . . . . 1.7 109.349 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.51 -32.64 51.26 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.101 -0.999 . . . . 2.29 110.046 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.1 m -77.82 3.73 13.58 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 119.995 -1.691 . . . . 1.41 111.267 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 64.92 44.74 3.42 Favored 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 122.27 1.034 . . . . 1.53 112.485 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.714 HD22 ' H ' ' A' ' 81' ' ' LEU . 2.1 mm? -66.3 -24.95 66.63 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.484 -0.78 . . . . 2.46 110.398 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 m -42.51 -36.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.974 -1.079 . . . . 2.54 110.903 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -161.67 -18.83 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 119.574 -1.954 . . . . 3.53 111.029 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -60.49 -43.62 96.8 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 123.518 1.628 . . . . 3.06 108.049 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 81' ' ' LEU . 62.8 mtt -95.58 -123.95 0.11 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 112.91 -1.95 . . . . 2.45 111.972 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.642 ' HG2' HG21 ' A' ' 41' ' ' ILE . 14.8 mttm 56.45 29.53 15.46 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.867 0.691 . . . . 1.49 112.867 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 120.467 -1.396 . . . . 2.69 110.865 179.415 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 6' ' ' VAL . 95.3 mt-10 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 109.916 -0.401 . . . . 4.72 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG23 ' C ' ' A' ' 5' ' ' GLU . 3.1 t 94.95 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 CA-C-O 121.15 0.5 . . . . 2.38 111.162 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 83.26 27.83 38.76 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.172 -0.955 . . . . 1.47 110.991 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -149.01 -177.98 6.11 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.935 -1.333 . . . . 3.56 109.572 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.6 mt -99.78 140.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 124.031 1.872 . . . . 1.43 113.883 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.4 p -121.4 156.34 32.89 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.049 -2.341 . . . . 1.19 109.119 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.426 ' H ' ' HB3' ' A' ' 55' ' ' GLU . 42.5 t -124.77 136.29 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 108.668 -0.864 . . . . 0.95 108.668 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.585 ' CE ' HH21 ' A' ' 47' ' ' ARG . 36.2 mttp -91.17 125.49 35.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 118.987 -2.321 . . . . 3.12 110.851 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.2 124.29 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.635 -1.226 . . . . 1.69 109.583 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 24.0 mttm -146.66 156.14 42.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.532 -1.285 . . . . 2.43 107.532 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 16' ' ' ARG . . . -85.43 176.62 49.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 103.934 -3.666 . . . . 2.26 103.934 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 15' ' ' GLY . 37.0 mtm180 27.32 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.57 0 CA-C-N 120.049 1.924 . . . . 4.93 109.343 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 41.3 tp10 93.17 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 106.621 -1.622 . . . . 3.13 106.621 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 156.67 104.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.97 -0.456 . . . . 1.78 110.479 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.79 76.68 0.05 OUTLIER Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.634 -1.746 . . . . 1.06 110.645 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.2 m -155.64 135.8 13.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.394 -1.65 . . . . 1.36 109.928 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' O ' HG21 ' A' ' 42' ' ' THR . 67.8 mttm -98.35 145.83 26.3 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.409 -0.96 . . . . 3.16 108.409 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.1 p -134.61 162.58 31.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.346 0.593 . . . . 0.78 110.447 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.18 135.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.349 -2.093 . . . . 0.43 105.349 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.518 HG12 HG12 ' A' ' 35' ' ' VAL . 63.7 mt -97.31 132.17 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.694 -1.254 . . . . 0.51 110.37 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -143.78 70.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 C-N-CA 118.991 -1.084 . . . . 1.3 111.355 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 20.2 t70 165.83 148.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.505 -1.372 . . . . 1.56 109.582 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.98 115.45 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 103.815 -2.661 . . . . 1.8 103.815 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.3 mt -97.03 -81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.77 111.029 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -108.96 171.83 7.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.735 -1.12 . . . . 2.4 108.982 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' C ' HD22 ' A' ' 31' ' ' ASN . 92.3 m-20 -55.62 -40.19 71.78 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 118.497 -1.281 . . . . 2.55 109.51 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.443 HD22 ' C ' ' A' ' 30' ' ' ASP . 2.7 m120 -102.51 -0.96 31.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.635 -1.291 . . . . 2.1 113.82 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.04 141.14 48.99 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 120.935 1.698 . . . . 1.6 114.087 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.25 161.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.42 -0.955 . . . . 0.49 108.42 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.691 HD21 ' CG ' ' A' ' 46' ' ' ARG . 8.4 tt -99.46 136.04 39.98 Favored 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 108.215 -1.032 . . . . 0.93 108.215 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.7 m -128.09 150.43 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.258 -0.977 . . . . 0.52 111.944 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.662 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -143.07 155.05 44.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.472 0.654 . . . . 0.63 111.804 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.445 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -154.77 167.08 32.58 Favored Glycine 0 N--CA 1.506 3.361 0 N-CA-C 108.047 -2.021 . . . . 0.84 108.047 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.62 124.48 15.53 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 CA-C-N 119.037 1.418 . . . . 0.99 110.357 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' HZ3' ' HE2' ' A' ' 45' ' ' LYS . 23.5 mttt -60.51 -43.23 97.31 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.225 1.012 . . . . 3.44 110.869 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.87 -40.67 91.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.526 0.936 . . . . 2.27 113.526 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CD1' ' NZ ' ' A' ' 86' ' ' LYS . 81.6 mt -96.09 -76.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.325 -0.95 . . . . 2.05 113.145 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.62 HG21 ' O ' ' A' ' 21' ' ' LYS . 44.9 m -60.15 -36.6 77.89 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.354 -1.466 . . . . 1.1 109.035 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -6.65 63.46 Favored Glycine 0 C--N 1.293 -1.826 0 N-CA-C 110.249 -1.14 . . . . 1.12 110.249 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.5 m -91.64 131.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 119.267 1.533 . . . . 1.06 107.684 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HE2' ' HZ3' ' A' ' 39' ' ' LYS . 35.7 ttmt -89.16 -78.25 0.36 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.76 -1.176 . . . . 3.49 109.51 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.691 ' CG ' HD21 ' A' ' 34' ' ' LEU . 55.9 ttt180 -151.92 124.02 8.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 105.009 -2.219 . . . . 2.78 105.009 177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 38.1 ptt180 -158.8 166.96 30.7 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 119.385 -2.072 . . . . 3.1 110.191 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -96.23 143.38 27.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.112 -0.992 . . . . 3.0 111.435 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.93 143.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.595 -0.891 . . . . 1.63 108.595 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.663 ' ND2' HD12 ' A' ' 52' ' ' LEU . 41.7 p-10 -91.85 164.14 13.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.145 -0.972 . . . . 2.28 111.768 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.38 -24.75 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 115.814 -0.63 . . . . 1.41 111.341 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.663 HD12 ' ND2' ' A' ' 50' ' ' ASN . 60.9 mt -54.79 -31.4 58.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.954 -1.091 . . . . 1.25 109.557 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -118.15 92.33 3.8 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.09 -1.819 . . . . 1.5 106.09 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.487 HD23 ' HD3' ' A' ' 56' ' ' PRO . 9.1 tt -113.93 129.53 56.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.138 0.494 . . . . 1.56 109.722 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -140.84 93.87 8.25 Favored Pre-proline 0 N--CA 1.502 2.162 0 N-CA-C 107.743 -1.206 . . . . 2.28 107.743 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' HD23 ' A' ' 54' ' ' LEU . 94.2 Cg_endo -93.23 147.46 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.692 1.595 . . . . 0.69 114.307 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 p -120.26 161.86 20.39 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.823 -1.177 . . . . 0.88 107.823 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 54.6 p30 -78.66 135.61 37.25 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.334 -1.728 . . . . 2.57 106.334 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' H ' ' A' ' 60' ' ' LYS . 40.3 tttm -171.61 -174.57 1.41 Allowed 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 117.298 -1.761 . . . . 2.9 109.504 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.751 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 15.7 tttp -82.78 153.1 25.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.767 -1.197 . . . . 5.03 107.767 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.4 pt -138.0 82.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 114.609 1.337 . . . . 4.81 114.609 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -146.77 91.75 2.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.96 -1.087 . . . . 2.14 112.13 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.889 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.65 162.64 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.728 0.775 . . . . 1.72 109.364 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -72.32 -121.02 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.26 -2.126 . . . . 2.59 105.26 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -173.78 131.45 0.43 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.84 -1.163 . . . . 3.48 108.834 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.52 17.8 70.12 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.555 -1.783 . . . . 0.64 110.178 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.16 144.94 22.54 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.685 -1.48 . . . . 0.62 111.715 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.875 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.5 p -68.45 169.22 11.2 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 107.175 -1.417 . . . . 0.73 107.175 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 91.6 m-20 -59.15 -47.69 84.37 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.181 -2.199 . . . . 2.02 111.18 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.45 -41.79 98.65 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 116.936 -1.906 . . . . 2.3 108.332 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.91 -35.93 82.75 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.266 -0.974 . . . . 1.96 108.403 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 68' ' ' SER . 78.4 t -62.17 -40.12 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.73 0.776 . . . . 0.59 109.041 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 99.4 mttt -59.53 -40.66 87.93 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.701 -1.2 . . . . 0.79 108.775 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -60.31 -43.13 96.64 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 117.491 -1.684 . . . . 2.33 109.222 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.52 78.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.082 -1.011 . . . . 2.62 109.956 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.778 ' O ' HD11 ' A' ' 81' ' ' LEU . 9.4 tt -58.18 -42.98 87.23 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.956 . . . . 1.3 110.245 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.642 ' HA ' HD21 ' A' ' 81' ' ' LEU . 96.6 mt-10 -59.19 -31.15 68.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.183 -0.948 . . . . 1.7 108.715 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -52.57 -32.37 40.75 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.281 -1.748 . . . . 2.29 106.281 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.3 m -62.9 -18.41 62.98 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.783 -0.573 . . . . 1.41 111.668 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 70.4 50.35 0.4 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-O 123.257 1.503 . . . . 1.53 110.505 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.845 ' N ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.4 -28.22 69.1 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.544 -1.662 . . . . 2.46 112.362 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.354 -1.466 . . . . 2.54 112.988 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.39 -18.2 0.11 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 119.411 -2.055 . . . . 3.53 110.343 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.99 -38.58 86.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.699 1.238 . . . . 3.06 107.837 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.06 -125.95 0.22 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.477 -1.238 . . . . 2.45 111.004 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' NZ ' ' CD1' ' A' ' 41' ' ' ILE . 33.1 mttm 54.27 26.42 6.8 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.12 1.368 . . . . 1.49 114.369 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 . . . . . 0 N--CA 1.512 2.634 0 O-C-N 119.394 -2.066 . . . . 2.69 110.502 179.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 8' ' ' ARG . 94.6 mt-10 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 4.72 108.565 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 27' ' ' ILE . 23.7 t -100.39 142.69 15.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.549 -1.278 . . . . 2.38 107.549 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.475 ' HA3' ' H ' ' A' ' 62' ' ' ASP . . . 96.83 -3.4 62.64 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.492 -1.38 . . . . 1.47 110.329 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 5' ' ' GLU . 95.1 mtt180 -89.92 177.2 6.54 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.33 -1.1 . . . . 3.56 110.786 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.439 HD12 ' HD3' ' A' ' 59' ' ' LYS . 73.9 mt -95.9 137.34 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 106.569 -1.641 . . . . 1.43 106.569 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.8 p -127.79 158.62 37.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.515 -0.741 . . . . 1.19 110.441 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.08 132.22 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.467 -1.679 . . . . 0.95 106.467 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' NZ ' HG23 ' A' ' 49' ' ' VAL . 10.6 tptm -93.4 119.59 32.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.861 -1.774 . . . . 3.12 112.84 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.08 128.99 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.493 -1.299 . . . . 1.69 107.493 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -143.85 175.82 9.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.833 -0.803 . . . . 2.43 108.833 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -81.14 143.19 23.79 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.383 -1.865 . . . . 2.26 108.77 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 33.6 ttm180 49.6 87.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.19 -1.411 . . . . 4.93 107.19 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 48.9 tp10 112.62 152.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 105.92 -1.882 . . . . 3.13 105.92 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.95 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 112.662 0.616 . . . . 1.78 112.662 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.83 84.21 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.81 -1.662 . . . . 1.06 110.591 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.8 p -161.42 147.62 14.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.276 . . . . 1.36 108.798 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.826 ' O ' HG21 ' A' ' 42' ' ' THR . 97.1 mttt -96.63 147.77 23.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.161 -0.962 . . . . 3.16 108.707 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 4.9 p -143.93 162.81 35.18 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.228 -0.92 . . . . 0.78 110.396 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 76' ' ' LEU . 26.5 t -114.7 135.03 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 105.911 -1.885 . . . . 0.43 105.911 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 6' ' ' VAL . 66.5 mt -91.29 134.83 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.693 -1.203 . . . . 0.51 110.066 -175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 72' ' ' VAL . 13.1 m -156.78 76.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.464 1.653 . . . . 1.3 115.464 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 54.2 t0 171.63 150.89 0.05 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.094 -1.004 . . . . 1.56 109.249 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.793 HD11 HG21 ' A' ' 6' ' ' VAL . 26.4 mm -119.22 129.67 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.494 -2.039 . . . . 1.8 105.494 171.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.82 HG22 ' H ' ' A' ' 29' ' ' ASP . 88.6 mt -121.55 -117.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.816 -1.178 . . . . 0.77 109.552 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.82 ' H ' HG22 ' A' ' 28' ' ' ILE . 52.4 t0 -58.22 -35.23 71.37 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.082 -1.451 . . . . 2.4 107.082 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 91.9 m-20 121.98 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.119 -1.808 . . . . 2.55 106.119 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.59 4.7 53.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.437 -1.32 . . . . 2.1 107.437 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.69 148.48 52.48 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.541 -0.754 . . . . 1.6 109.736 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.29 161.11 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 108.12 -1.067 . . . . 0.49 108.12 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.654 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.3 tt -104.66 129.71 52.78 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 117.844 -1.542 . . . . 0.93 107.807 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 34' ' ' LEU . 7.4 m -125.7 154.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 118.815 -1.154 . . . . 0.52 110.708 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.732 HG21 ' CG1' ' A' ' 72' ' ' VAL . 10.5 t -140.61 156.88 46.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.63 112.109 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.47 163.54 31.65 Favored Glycine 0 N--CA 1.507 3.371 0 N-CA-C 107.523 -2.231 . . . . 0.84 107.523 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.24 122.82 12.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 CA-C-N 119.506 1.653 . . . . 0.99 110.78 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.6 -40.43 87.46 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.817 -0.552 . . . . 3.44 111.715 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.28 -43.11 95.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.15 1.167 . . . . 2.27 114.15 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.673 HG21 ' O ' ' A' ' 86' ' ' LYS . 15.8 mm -96.5 -71.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.32 -1.487 . . . . 2.05 114.016 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 21' ' ' LYS . 31.5 m -56.34 -37.06 69.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.723 -0.671 . . . . 1.1 111.002 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.83 7.52 47.45 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.31 -1.424 . . . . 1.12 110.03 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' HH21 ' A' ' 47' ' ' ARG . 18.2 m -122.08 162.62 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 105.527 -2.027 . . . . 1.06 105.527 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -139.16 -69.92 0.42 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.989 -1.115 . . . . 3.49 107.989 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.654 ' HG3' HD21 ' A' ' 34' ' ' LEU . 34.7 ttp180 -146.16 124.63 12.39 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 44' ' ' VAL . 18.9 ptp180 -155.17 168.06 28.29 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.876 -1.14 . . . . 3.1 109.543 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -116.62 143.6 45.42 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.662 -1.236 . . . . 3.0 107.662 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.453 HG23 ' NZ ' ' A' ' 12' ' ' LYS . 14.8 p -132.48 140.12 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.379 1.085 . . . . 1.63 111.365 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 44.6 t-20 -80.79 163.36 23.53 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.967 -1.015 . . . . 2.28 110.321 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 24.1 mm -59.2 -27.33 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 115.917 -0.583 . . . . 1.41 110.696 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.0 mt -54.55 -37.9 65.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.934 -1.104 . . . . 1.25 111.369 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.99 89.32 3.0 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.35 -1.34 . . . . 1.5 109.953 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.2 tp -118.83 128.82 54.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.928 -0.768 . . . . 1.56 108.928 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -135.26 85.88 31.99 Favored Pre-proline 0 N--CA 1.508 2.443 0 O-C-N 120.542 -1.348 . . . . 2.28 108.668 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -96.13 151.69 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.89 2.393 . . . . 0.69 115.512 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.461 ' OG1' ' NZ ' ' A' ' 59' ' ' LYS . 19.4 p -112.19 162.0 15.94 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 106.297 -1.742 . . . . 0.88 106.297 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.19 98.47 5.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.515 -1.99 . . . . 2.57 110.657 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' NZ ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -114.06 -164.63 0.94 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.416 1.103 . . . . 2.9 111.137 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -84.58 163.36 19.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.212 -1.774 . . . . 5.03 106.212 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 61' ' ' ILE . 13.7 tt -121.19 123.47 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.688 -1.258 . . . . 4.81 109.61 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 60.7 t0 -161.63 107.09 1.31 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.73 -0.606 . . . . 2.14 110.267 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -129.54 135.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.333 -1.728 . . . . 1.72 106.333 176.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.689 ' H ' ' HZ3' ' A' ' 75' ' ' LYS . 60.3 tp60 -64.78 -50.61 66.11 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 115.128 -2.629 . . . . 2.59 108.657 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 50.3 tttt 131.2 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 107.268 -1.382 . . . . 3.48 107.268 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.18 22.3 59.3 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.712 -1.355 . . . . 0.64 109.712 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -54.66 143.64 24.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.236 . . . . 0.62 112.436 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.6 p -71.08 163.91 26.65 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 109.059 -0.719 . . . . 0.73 109.059 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -54.97 -43.14 73.21 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.304 -1.498 . . . . 2.02 109.908 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -38.47 87.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 117.401 -1.72 . . . . 2.3 108.971 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 97.1 mt-10 -67.24 -37.38 83.43 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.557 -1.257 . . . . 1.96 108.581 177.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 36' ' ' THR . 67.2 t -63.7 -43.73 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 120.121 -0.632 . . . . 0.59 111.371 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.51 -42.05 91.33 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.103 -1.439 . . . . 0.79 108.322 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.99 -43.4 91.47 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 117.6 -1.64 . . . . 2.33 107.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.689 ' HZ3' ' H ' ' A' ' 64' ' ' GLN . 56.5 mtmt -60.26 -32.02 70.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 2.62 112.12 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.646 ' O ' ' OG ' ' A' ' 79' ' ' SER . 32.0 tp -52.8 -40.91 63.67 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.043 -1.661 . . . . 1.3 107.441 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -58.57 -34.46 71.08 Favored 'General case' 0 C--N 1.272 -2.776 0 C-N-CA 116.888 -1.925 . . . . 1.7 108.381 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.464 ' OE1' ' OD2' ' A' ' 62' ' ' ASP . 97.6 mt-10 -62.33 -33.47 74.76 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.888 -1.523 . . . . 2.29 106.888 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.646 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 83.7 p -65.34 -26.07 67.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.859 -2.274 . . . . 1.41 104.859 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.0 m120 63.12 42.15 7.47 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.743 0.783 . . . . 1.53 109.946 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 34.2 mt -92.11 3.73 54.67 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.685 -0.806 . . . . 2.46 111.35 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 m -46.61 -33.74 4.43 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.912 -1.118 . . . . 2.54 110.052 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -164.84 0.26 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.051 -1.031 . . . . 3.53 108.648 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -61.42 -43.86 98.14 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 103.176 -2.898 . . . . 3.06 103.176 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.592 ' CE ' ' HZ3' ' A' ' 21' ' ' LYS . 85.3 mmm -121.3 -120.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.281 -1.327 . . . . 2.45 110.388 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 41' ' ' ILE . 36.4 mtpt 64.97 39.45 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.152 -1.385 . . . . 1.49 109.878 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.471 0.653 . . . . 2.69 109.687 179.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.591 ' C ' HG12 ' A' ' 6' ' ' VAL . 58.3 mp0 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.931 -0.766 . . . . 4.72 108.931 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.591 HG12 ' C ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER 169.46 123.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.4 -0.963 . . . . 2.38 108.4 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 71.28 24.53 76.86 Favored Glycine 0 N--CA 1.502 3.1 0 C-N-CA 119.499 -1.334 . . . . 1.47 110.016 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 57' ' ' THR . 80.9 mtp180 -117.97 164.61 14.82 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.83 -0.806 . . . . 3.56 110.294 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.63 137.94 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 122.358 1.075 . . . . 1.43 109.448 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.85 156.69 27.96 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.994 -1.003 . . . . 1.19 111.554 -175.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 t -122.09 134.99 63.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 N-CA-C 105.979 -1.86 . . . . 0.95 105.979 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.43 130.05 38.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 119.202 -2.186 . . . . 3.12 111.443 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.89 120.46 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 118.197 -1.401 . . . . 1.69 110.409 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 91.1 mttt -146.59 152.71 39.36 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.664 -1.606 . . . . 2.43 106.664 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -85.29 174.1 48.73 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 105.333 -3.107 . . . . 2.26 105.333 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 15' ' ' GLY . 73.0 mtm180 34.68 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 CA-C-N 118.643 1.221 . . . . 4.93 107.756 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.699 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 82.6 tt0 89.71 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.364 -1.347 . . . . 3.13 107.364 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 153.59 106.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.78 0.324 . . . . 1.78 110.798 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.89 80.88 0.05 OUTLIER Glycine 0 C--N 1.297 -1.62 0 C-N-CA 118.906 -1.616 . . . . 1.06 109.835 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -156.71 141.76 17.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.399 -1.648 . . . . 1.36 110.346 176.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 42' ' ' THR . 68.5 mttm -93.62 148.38 22.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.383 -1.448 . . . . 3.16 107.725 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -137.02 142.95 42.5 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.249 -0.907 . . . . 0.78 112.634 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.82 137.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.228 -1.767 . . . . 0.43 106.228 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 35' ' ' VAL . 69.7 mt -100.43 131.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.465 -0.894 . . . . 0.51 111.706 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -143.84 72.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.145 -1.022 . . . . 1.3 109.966 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 56.9 t0 168.12 144.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.788 -1.195 . . . . 1.56 109.716 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.2 tt -124.0 124.42 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.331 -2.47 . . . . 1.8 104.331 170.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -99.56 -84.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.878 -1.139 . . . . 0.77 112.059 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 59.5 t0 -104.47 8.14 35.55 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.188 -0.671 . . . . 2.4 109.188 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 81.4 m-20 90.08 -26.86 0.05 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 124.043 0.937 . . . . 2.55 109.759 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 39.3 p-10 -103.09 -3.45 25.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 2.1 109.78 177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 95.9 m-85 -119.1 140.39 50.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.958 -1.127 . . . . 1.6 107.958 175.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.45 158.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.49 109.177 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.677 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.5 tt -103.53 135.88 44.29 Favored 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.026 -1.07 . . . . 0.93 108.333 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 24' ' ' ILE . 17.6 m -126.39 149.09 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.034 -1.066 . . . . 0.52 109.949 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.439 HG23 HD13 ' A' ' 76' ' ' LEU . 6.3 t -142.84 154.04 43.77 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.642 0.735 . . . . 0.63 111.236 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -156.54 160.14 30.01 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.698 -2.561 . . . . 0.84 106.698 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' HD21 ' A' ' 76' ' ' LEU . 17.2 Cg_exo -60.86 121.81 10.26 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 CA-C-N 120.629 2.215 . . . . 0.99 110.017 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -58.88 -36.57 74.86 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.522 1.153 . . . . 3.44 108.63 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.51 -38.86 91.58 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.511 -0.768 . . . . 2.27 112.373 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 86' ' ' LYS . 76.1 mt -96.5 -81.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.915 -1.116 . . . . 2.05 111.369 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 21' ' ' LYS . 53.5 m -63.03 -36.79 84.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.927 . . . . 1.1 111.067 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.73 -7.45 57.62 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 120.509 -0.853 . . . . 1.12 111.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.3 m -91.55 130.72 40.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 120.554 2.177 . . . . 1.06 105.929 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -92.38 -75.64 0.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.516 -1.273 . . . . 3.49 109.551 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.827 HH12 HG21 ' A' ' 72' ' ' VAL . 55.6 ttt85 -149.78 125.84 10.62 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.897 -1.89 . . . . 2.78 105.897 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -156.58 165.51 36.08 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 119.714 -1.866 . . . . 3.1 110.909 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -106.9 136.04 47.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.289 -0.882 . . . . 3.0 111.155 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 53' ' ' HIS . 62.7 t -124.88 136.74 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.033 -1.042 . . . . 1.63 110.674 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.24 167.62 16.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.331 -0.856 . . . . 2.28 109.474 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.5 mt -56.86 -26.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.231 -0.918 . . . . 1.41 111.375 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.88 -34.88 68.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.426 -1.421 . . . . 1.25 110.253 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.501 ' O ' HG11 ' A' ' 49' ' ' VAL . 98.6 m-70 -116.44 87.07 2.61 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.296 -0.962 . . . . 1.5 108.625 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 5' ' ' GLU . 30.7 tp -125.35 127.59 46.86 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.314 -0.866 . . . . 1.56 109.079 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -134.45 88.9 28.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.45 -1.315 . . . . 2.28 107.45 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -90.5 148.05 4.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.85 1.7 . . . . 0.69 114.866 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 30.4 p -117.1 165.46 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.99 -1.115 . . . . 0.88 107.99 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.85 137.0 53.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.264 -1.754 . . . . 2.57 106.264 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.32 -175.78 1.47 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.024 0.916 . . . . 2.9 110.127 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 7' ' ' GLY . 48.7 mmtm -86.61 163.15 17.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.781 -1.192 . . . . 5.03 107.781 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 61' ' ' ILE . 31.4 pt -130.89 87.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 123.595 1.664 . . . . 4.81 111.823 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.1 p30 -150.68 93.05 1.91 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 113.735 1.013 . . . . 2.14 113.735 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.1 pt -121.95 153.41 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.728 -1.233 . . . . 1.72 110.432 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 26.3 mt-30 -63.05 -42.34 99.69 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.477 -1.689 . . . . 2.59 109.216 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 34.4 mtmt 98.21 90.17 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.448 0.567 . . . . 3.48 110.037 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.11 8.47 60.21 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.893 -1.129 . . . . 0.64 111.66 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.81 148.47 10.12 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.822 -1.399 . . . . 0.62 112.158 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.815 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 p -65.49 165.71 11.65 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.616 -1.253 . . . . 0.73 107.616 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -59.33 -45.1 92.3 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 119.798 -1.814 . . . . 2.02 111.484 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.43 -39.72 95.25 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.089 -1.844 . . . . 2.3 108.777 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.99 -36.39 83.18 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.903 -1.119 . . . . 1.96 108.353 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.827 HG21 HH12 ' A' ' 46' ' ' ARG . 74.6 t -65.3 -42.59 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.768 . . . . 0.59 110.654 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.07 -41.95 93.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 118.716 -1.194 . . . . 0.79 109.666 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -59.23 -41.79 89.5 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 117.484 -1.686 . . . . 2.33 107.244 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -62.69 -34.92 78.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.63 -0.669 . . . . 2.62 110.704 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.56 HD21 ' HD3' ' A' ' 38' ' ' PRO . 50.3 tp -56.55 -41.38 76.75 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.812 -1.18 . . . . 1.3 108.983 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.27 -30.75 66.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.891 -0.781 . . . . 1.7 108.891 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' OD2' ' A' ' 62' ' ' ASP . 84.5 tt0 -53.62 -34.91 60.13 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.66 -1.237 . . . . 2.29 107.66 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.1 m -65.74 -18.31 65.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 1.41 109.907 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 71.16 51.13 0.28 Allowed 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.932 1.349 . . . . 1.53 111.551 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.5 mp -63.51 -28.59 70.06 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.265 -1.334 . . . . 2.46 112.153 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 39.8 m -44.88 -35.63 2.9 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.577 -1.327 . . . . 2.54 110.945 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -153.92 -19.06 0.14 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.046 -1.659 . . . . 3.53 110.268 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -61.99 -40.94 97.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.373 -1.454 . . . . 3.06 108.034 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . 87.7 mtp -103.65 -122.75 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.85 -1.068 . . . . 2.45 110.976 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 41' ' ' ILE . 28.6 mtpt 43.14 16.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.865 -0.522 . . . . 1.49 111.134 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.0 mt-10 . . . . . 0 C--N 1.301 -1.503 0 C-N-CA 118.566 -1.254 . . . . 2.69 108.923 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 5' ' ' GLU . 18.7 Cg_endo . . . . . 0 N--CA 1.496 1.629 0 CA-C-O 121.773 0.655 . . . . 3.54 111.335 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.69 -11.55 12.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.873 -0.517 . . . . 3.57 111.03 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.0 mt -65.75 -39.55 85.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.065 -1.454 . . . . 5.43 107.728 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' PRO . 95.5 mt-10 -127.17 151.3 48.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 115.756 -0.656 . . . . 4.72 110.66 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 7' ' ' GLY . 10.8 m -72.43 -153.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.081 -1.012 . . . . 2.38 108.972 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 79.91 37.72 21.63 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 120.722 -1.237 . . . . 1.47 111.187 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.76 HH21 HD11 ' A' ' 54' ' ' LEU . 29.1 ptt-85 -146.75 -177.93 5.91 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 120.92 -1.341 . . . . 3.56 108.789 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' CD ' ' A' ' 59' ' ' LYS . 61.4 mt -107.34 142.39 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.719 1.247 . . . . 1.43 112.213 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HB3' HD11 ' A' ' 24' ' ' ILE . 1.6 p -113.43 155.47 25.21 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.785 -1.552 . . . . 1.19 113.225 -175.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.7 138.82 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 CA-C-N 114.975 -1.011 . . . . 0.95 108.591 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 18' ' ' ALA . 63.1 tttm -86.16 126.93 34.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 118.682 -2.511 . . . . 3.12 110.826 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG21 ' CD ' ' A' ' 55' ' ' GLU . 40.5 t -118.71 126.61 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.62 -1.232 . . . . 1.69 111.498 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 51.9 tttp -170.94 172.42 5.54 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 105.221 -2.141 . . . . 2.43 105.221 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -86.1 178.23 49.44 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.167 -1.973 . . . . 2.26 108.167 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 17' ' ' GLU . 40.9 ttm180 40.07 99.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.598 -0.942 . . . . 4.93 111.291 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 33.3 109.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 113.441 0.904 . . . . 3.13 113.441 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 12' ' ' LYS . . . -171.75 16.37 0.01 OUTLIER 'General case' 0 C--O 1.192 -1.958 0 O-C-N 121.338 -0.851 . . . . 1.78 110.387 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.573 ' C ' HD12 ' A' ' 89' ' ' ILE . . . -95.05 110.53 4.03 Favored Glycine 0 N--CA 1.484 1.861 0 N-CA-C 107.564 -2.214 . . . . 1.06 107.564 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 89' ' ' ILE . 73.1 m -142.57 139.47 31.39 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.123 -1.436 . . . . 1.36 107.123 175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' HE3' ' H ' ' A' ' 86' ' ' LYS . 1.3 pttm -94.28 138.62 32.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.325 -1.484 . . . . 3.16 109.787 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.662 ' O ' HG23 ' A' ' 9' ' ' ILE . 3.2 p -142.1 157.96 44.29 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.531 -0.868 . . . . 0.78 111.274 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 76' ' ' LEU . 37.5 t -104.06 134.5 45.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.113 -1.81 . . . . 0.43 106.113 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 10' ' ' CYS . 69.9 mt -96.89 133.71 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.032 -1.043 . . . . 0.51 110.371 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 17.1 m -151.94 69.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 117.457 -1.697 . . . . 1.3 113.594 176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.6 t0 171.19 152.89 0.06 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.737 -1.227 . . . . 1.56 109.991 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.522 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.5 mt -117.66 127.57 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 103.038 -2.949 . . . . 1.8 103.038 171.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 29' ' ' ASP . 20.9 mm -99.75 -111.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.017 -1.677 . . . . 0.77 111.853 -175.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.582 ' O ' ' CG ' ' A' ' 30' ' ' ASP . 91.6 m-20 -62.71 -41.36 99.1 Favored 'General case' 0 C--O 1.201 -1.452 0 O-C-N 121.695 -0.628 . . . . 2.4 110.157 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.582 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 89.9 m-20 164.34 -50.33 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 C-N-CA 124.833 1.253 . . . . 2.55 109.353 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -95.07 4.85 53.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 2.1 111.922 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.84 147.22 42.33 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.068 -1.02 . . . . 1.6 110.337 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.98 162.15 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.676 -0.49 . . . . 0.49 109.676 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.06 HD11 ' HE ' ' A' ' 46' ' ' ARG . 8.2 tt -97.4 132.48 43.07 Favored 'General case' 0 N--CA 1.508 2.433 0 C-N-CA 119.361 -0.936 . . . . 0.93 108.643 177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' O ' ' A' ' 47' ' ' ARG . 22.2 m -127.71 150.72 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.777 -0.769 . . . . 0.52 110.556 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.747 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -144.03 155.12 43.88 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.974 -0.69 . . . . 0.63 112.15 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.535 ' HA3' HG23 ' A' ' 44' ' ' VAL . . . -152.55 169.08 31.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 108.132 -1.987 . . . . 0.84 108.132 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 21' ' ' LYS . 36.9 Cg_endo -70.39 110.35 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 CA-C-N 118.938 1.369 . . . . 0.99 109.322 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -58.82 -39.5 81.36 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.057 -1.027 . . . . 3.44 111.202 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.26 -40.22 96.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.941 -1.099 . . . . 2.27 112.47 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.458 HD13 ' HD3' ' A' ' 86' ' ' LYS . 82.8 mt -96.87 -77.83 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.419 -0.801 . . . . 2.05 112.874 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.4 m -61.89 -35.06 77.24 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.729 -1.232 . . . . 1.1 109.492 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.54 -10.97 56.47 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.653 -0.654 . . . . 1.12 111.797 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.535 HG23 ' HA3' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -91.1 128.33 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-N 119.93 1.865 . . . . 1.06 108.15 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -95.33 -75.57 0.52 Allowed 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 122.332 1.063 . . . . 3.49 110.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 1.06 ' HE ' HD11 ' A' ' 34' ' ' LEU . 65.2 ttt180 -148.7 125.44 11.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.301 -1.37 . . . . 2.78 107.301 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.712 ' O ' HG22 ' A' ' 35' ' ' VAL . 8.6 ptm180 -157.23 164.34 37.82 Favored 'General case' 0 C--N 1.29 -2.014 0 O-C-N 119.969 -1.707 . . . . 3.1 109.489 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -105.25 141.1 37.37 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.43 -0.793 . . . . 3.0 109.528 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -133.8 143.6 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.484 -0.76 . . . . 1.63 110.052 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 48.6 t-20 -80.87 154.24 27.19 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.669 0.747 . . . . 2.28 111.243 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 93.1 mt -58.36 -23.84 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.638 -0.664 . . . . 1.41 109.728 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 68.6 mt -53.26 -29.87 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 1.25 108.94 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -117.43 91.7 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.553 -1.647 . . . . 1.5 106.553 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.76 HD11 HH21 ' A' ' 8' ' ' ARG . 24.4 tp -113.82 130.38 56.47 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.684 -0.635 . . . . 1.56 110.548 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' CD ' HG21 ' A' ' 13' ' ' VAL . 14.7 tp10 -137.81 90.33 14.41 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 106.864 -1.532 . . . . 2.28 106.864 175.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.437 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 90.3 Cg_endo -90.26 148.13 4.46 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.629 1.553 . . . . 0.69 113.926 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.6 p -119.73 163.81 16.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.491 -0.929 . . . . 0.88 108.491 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.599 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 55.3 p30 -75.4 125.82 29.76 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.282 -1.747 . . . . 2.57 106.282 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.729 ' CD ' HD12 ' A' ' 9' ' ' ILE . 24.5 mttt -162.14 -173.03 3.46 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 123.083 1.42 . . . . 2.9 112.704 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' GLY . 25.3 tttt -81.48 150.88 28.08 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 113.722 -1.581 . . . . 5.03 111.231 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 61' ' ' ILE . 12.1 tt -120.6 120.16 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.503 0.668 . . . . 4.81 110.628 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -179.6 87.63 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 117.62 -1.181 . . . . 2.14 112.208 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 65' ' ' LYS . 15.6 mm -115.15 138.44 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.495 0 CA-C-N 123.543 2.883 . . . . 1.72 108.112 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.569 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.7 mt-30 -60.76 -41.28 95.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 115.166 -2.614 . . . . 2.59 106.282 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 59.3 tttt 114.11 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.139 -1.059 . . . . 3.48 108.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.494 2.51 0 O-C-N 119.849 -1.782 . . . . 0.64 111.539 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.76 144.8 17.23 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.201 -1.764 . . . . 0.62 112.225 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.8 p -69.89 167.02 18.26 Favored 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 108.152 -1.055 . . . . 0.73 108.152 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.534 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 93.0 m-20 -59.56 -47.35 85.88 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 119.585 -1.947 . . . . 2.02 112.088 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -41.1 98.3 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 117.003 -1.879 . . . . 2.3 108.022 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.8 -35.72 82.0 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.134 -1.061 . . . . 1.96 108.134 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 68' ' ' SER . 79.5 t -65.39 -42.82 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.226 -0.921 . . . . 0.59 110.094 177.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -60.68 -42.92 98.06 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 118.908 -1.117 . . . . 0.79 110.09 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -59.44 -38.19 80.08 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.182 -1.007 . . . . 2.33 109.072 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' NZ ' ' H ' ' A' ' 64' ' ' GLN . 11.8 mtpt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.882 -0.511 . . . . 2.62 110.169 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 36' ' ' THR . 88.4 mt -57.48 -37.68 73.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.662 -1.273 . . . . 1.3 108.641 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 97.1 mt-10 -58.65 -33.08 69.68 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 118.307 -1.357 . . . . 1.7 108.179 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.02 -35.68 75.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.145 -2.168 . . . . 2.29 105.145 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.701 ' OG ' HD11 ' A' ' 9' ' ' ILE . 31.1 m -70.01 -21.88 63.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.014 -0.539 . . . . 1.41 109.597 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 77' ' ' GLU . 74.4 m-20 66.83 46.7 1.62 Allowed 'General case' 0 N--CA 1.519 3.011 0 CA-C-O 122.229 1.014 . . . . 1.53 112.481 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.726 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.2 mp -65.52 -27.51 68.51 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 115.357 -0.838 . . . . 2.46 111.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.0 m -42.62 -33.59 0.74 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.965 -1.084 . . . . 2.54 111.29 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -157.66 -21.17 0.09 Allowed 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.009 -1.682 . . . . 3.53 110.952 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -60.59 -42.33 96.49 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 117.73 -1.588 . . . . 3.06 107.076 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.571 ' CE ' ' NZ ' ' A' ' 59' ' ' LYS . 62.3 mtt -94.82 -125.3 0.11 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.627 -1.624 . . . . 2.45 114.178 -176.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' HD3' HD13 ' A' ' 41' ' ' ILE . 17.2 mttm 52.99 31.42 10.96 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.631 -1.248 . . . . 1.49 107.631 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.2 mt-10 -62.71 -28.4 69.92 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 116.347 1.981 . . . . 2.69 116.347 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 28.8 mtpt 61.03 75.53 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 102.894 -3.002 . . . . 5.0 102.894 -175.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.573 HD12 ' C ' ' A' ' 19' ' ' GLY . 86.7 mt -58.39 -38.52 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 120.045 -0.662 . . . . 3.26 110.702 -174.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -115.99 140.0 49.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.546 -1.346 . . . . 4.47 107.994 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.08 -33.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.64 -1.245 . . . . 5.67 107.64 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -83.14 130.68 35.13 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 108.017 -1.105 . . . . 6.75 108.017 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.4 mmm -172.04 -58.37 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.657 -1.277 . . . . 9.5 112.018 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.27 -67.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.725 1.617 . . . . 7.68 115.846 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.3 p -93.38 -5.6 49.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.14 -0.975 . . . . 7.69 110.536 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.018 -0.991 . . . . 8.53 109.456 -179.015 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 N--CA 1.492 1.383 0 CA-C-O 121.576 0.573 . . . . 3.54 113.095 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.66 70.12 1.0 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.393 1.092 . . . . 3.57 108.646 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.578 HG21 ' HD2' ' A' ' 60' ' ' LYS . 73.3 mt -113.61 146.85 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 115.007 -0.997 . . . . 5.43 109.544 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.642 ' O ' ' O ' ' A' ' 6' ' ' VAL . 95.9 mt-10 -63.17 155.45 28.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.004 -1.06 . . . . 4.72 110.063 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.642 ' O ' ' O ' ' A' ' 5' ' ' GLU . 7.2 m -43.19 -149.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 122.269 1.033 . . . . 2.38 112.585 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.529 ' N ' HG23 ' A' ' 6' ' ' VAL . . . 79.35 21.81 66.4 Favored Glycine 0 N--CA 1.481 1.636 0 N-CA-C 106.721 -2.551 . . . . 1.47 106.721 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 57' ' ' THR . 71.1 mtp180 -128.74 170.43 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.431 -0.952 . . . . 3.56 108.431 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.703 ' O ' HG23 ' A' ' 57' ' ' THR . 82.8 mt -93.99 145.41 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.021 -1.05 . . . . 1.43 108.845 177.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.555 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 2.0 p -122.44 155.66 35.66 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.9 -1.045 . . . . 1.19 112.643 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 41.0 t -127.31 139.83 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 CA-C-N 115.625 -0.716 . . . . 0.95 110.158 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.562 ' O ' ' O ' ' A' ' 18' ' ' ALA . 22.7 tptm -81.1 137.52 35.97 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 118.03 -2.919 . . . . 3.12 111.685 -175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 13' ' ' VAL . 3.1 t -119.61 100.42 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-O 122.58 1.181 . . . . 1.69 109.476 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 31.6 mttm -157.02 169.08 25.63 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.153 -1.795 . . . . 2.43 106.153 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -82.84 178.83 53.15 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 117.353 -2.356 . . . . 2.26 107.305 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 15' ' ' GLY . 59.3 ttt85 49.35 106.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.172 -1.193 . . . . 4.93 111.01 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 48.33 53.55 11.73 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.996 0.903 . . . . 3.13 110.74 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.817 ' HB2' ' O ' ' A' ' 14' ' ' LYS . . . -67.88 -15.3 63.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.538 -1.351 . . . . 1.78 110.781 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.45 94.91 1.9 Allowed Glycine 0 C--N 1.285 -2.284 0 O-C-N 120.718 -1.239 . . . . 1.06 114.374 -172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.1 m -136.35 134.32 37.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.62 -1.992 . . . . 1.36 105.62 171.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.704 ' H ' HG21 ' A' ' 42' ' ' THR . 1.7 ptpt -100.53 136.84 39.78 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.622 -1.299 . . . . 3.16 111.455 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.555 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.2 p -137.5 159.57 41.58 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.772 0.796 . . . . 0.78 111.199 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 76' ' ' LEU . 41.1 t -111.12 136.27 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.056 -1.461 . . . . 0.43 107.056 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.657 HG12 HG12 ' A' ' 35' ' ' VAL . 62.7 mt -105.37 133.69 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.117 -0.989 . . . . 0.51 109.912 -177.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.993 HG11 ' NZ ' ' A' ' 75' ' ' LYS . 1.1 m -149.18 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.884 -1.126 . . . . 1.3 111.668 176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 6' ' ' VAL . 54.3 t0 172.14 137.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 1.56 109.183 173.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 5' ' ' GLU . 70.5 mt -118.78 113.82 42.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 104.177 -2.527 . . . . 1.8 104.177 171.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -97.05 -79.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.053 -1.03 . . . . 0.77 110.843 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 44.1 t0 -106.03 179.0 4.4 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.135 0.969 . . . . 2.4 108.871 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 91.8 m-20 -54.8 -38.51 67.39 Favored 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 118.969 -1.093 . . . . 2.55 108.81 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.54 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 33.6 p-10 -112.11 5.15 18.42 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 115.685 1.735 . . . . 2.1 115.685 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.54 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 89.3 m-85 -112.64 138.94 48.7 Favored 'General case' 0 N--CA 1.528 3.455 0 CA-C-N 121.696 2.044 . . . . 1.6 113.78 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 m -130.8 162.78 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 115.727 -0.67 . . . . 0.49 109.899 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.832 HD21 ' HE ' ' A' ' 46' ' ' ARG . 9.7 tt -100.28 135.61 41.44 Favored 'General case' 0 N--CA 1.518 2.939 0 O-C-N 121.272 -0.893 . . . . 0.93 108.829 176.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.3 m -126.75 150.5 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 C-N-CA 119.613 -0.835 . . . . 0.52 110.541 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.57 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.9 t -146.89 153.09 39.72 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.648 -0.821 . . . . 0.63 112.015 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.97 159.7 29.82 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.571 -2.212 . . . . 0.84 107.571 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.88 108.06 0.86 Allowed 'Trans proline' 0 C--N 1.303 -1.842 0 CA-C-N 119.156 1.478 . . . . 0.99 110.594 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -58.6 -39.21 79.79 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.174 0.988 . . . . 3.44 109.592 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.94 -38.99 93.25 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.43 -0.794 . . . . 2.27 112.251 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.691 HG21 ' HG2' ' A' ' 86' ' ' LYS . 26.8 mm -96.24 -78.54 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.028 . . . . 2.05 113.39 -176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.704 HG21 ' H ' ' A' ' 21' ' ' LYS . 26.2 m -63.0 -32.94 74.4 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.999 0.904 . . . . 1.1 108.605 -176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.9 -13.12 56.23 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 111.438 -0.665 . . . . 1.12 111.438 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -68.37 148.94 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 119.8 1.8 . . . . 1.06 109.912 -179.076 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -92.69 -131.18 0.13 Allowed 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.524 -1.287 . . . . 3.49 107.524 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.832 ' HE ' HD21 ' A' ' 34' ' ' LEU . 73.9 ttt180 -139.86 122.32 16.15 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 103.982 -2.599 . . . . 2.78 103.982 173.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.744 ' O ' HG22 ' A' ' 35' ' ' VAL . 45.8 ptt85 -159.64 165.83 31.91 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 117.467 -1.693 . . . . 3.1 110.576 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -93.12 139.12 30.91 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.274 -0.891 . . . . 3.0 108.695 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.04 153.48 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 120.96 -1.087 . . . . 1.63 110.304 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' C ' HD22 ' A' ' 50' ' ' ASN . 0.1 OUTLIER -86.3 167.7 14.56 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.955 0.883 . . . . 2.28 111.611 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.4 mt -58.15 -24.84 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 115.999 -0.546 . . . . 1.41 110.234 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.512 HD12 ' OD1' ' A' ' 50' ' ' ASN . 63.7 mt -55.23 -30.87 60.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.207 -1.034 . . . . 1.25 108.207 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' A' ' 14' ' ' LYS . 98.7 m-70 -116.04 88.53 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.508 -1.293 . . . . 1.5 107.508 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.6 tp -118.91 129.67 55.31 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.285 -0.635 . . . . 1.56 109.285 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -143.14 90.41 7.4 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 106.368 -1.715 . . . . 2.28 106.368 176.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -90.22 153.54 4.64 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 121.557 1.504 . . . . 0.69 114.322 -177.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 9' ' ' ILE . 63.5 p -111.68 166.71 10.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.333 -1.728 . . . . 0.88 106.333 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' HA ' HH21 ' A' ' 8' ' ' ARG . 88.4 m-20 -84.21 11.49 8.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.047 -1.033 . . . . 2.57 110.664 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 8' ' ' ARG 0.317 44.6 tttm -91.34 124.6 35.65 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.185 -0.947 . . . . 2.9 111.389 -177.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD2' HG21 ' A' ' 4' ' ' ILE . 65.0 tttm -133.57 119.04 18.97 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 118.596 -1.242 . . . . 5.03 111.382 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 78' ' ' GLU . 31.8 pt -128.5 157.12 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.872 -1.158 . . . . 4.81 107.872 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.538 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -86.13 128.37 34.87 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 122.891 1.329 . . . . 2.14 111.928 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.963 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.78 164.07 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 115.11 -0.95 . . . . 1.72 109.933 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -96.39 139.98 31.71 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.842 -1.17 . . . . 2.59 107.842 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -67.24 138.87 57.24 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 116.056 -0.52 . . . . 3.48 111.064 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.8 21.43 61.55 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.52 -1.324 . . . . 0.64 112.998 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.75 143.04 21.74 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 120.294 2.047 . . . . 0.62 111.389 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 51.7 p -71.2 166.27 21.87 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.696 -1.594 . . . . 0.73 106.696 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 70' ' ' GLU . 53.0 p30 -60.65 -40.55 92.45 Favored 'General case' 0 C--O 1.206 -1.222 0 C-N-CA 116.328 -2.149 . . . . 2.02 110.683 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 97.1 mt-10 -63.23 -39.31 94.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 119.517 -1.989 . . . . 2.3 107.731 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.73 -35.71 81.93 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.773 -1.171 . . . . 1.96 108.09 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.57 ' CG1' HG21 ' A' ' 36' ' ' THR . 71.1 t -64.09 -43.52 97.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 118.436 -1.306 . . . . 0.59 107.881 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.74 -44.25 97.27 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.014 -1.074 . . . . 0.79 109.428 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -60.48 -42.32 96.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.371 -1.456 . . . . 2.33 108.315 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.993 ' NZ ' HG11 ' A' ' 25' ' ' VAL . 10.1 mtmp? -62.63 -34.93 78.04 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.507 -0.877 . . . . 2.62 109.588 176.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.622 ' O ' ' OG ' ' A' ' 79' ' ' SER . 38.1 tp -59.24 -40.5 86.11 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 118.735 -1.186 . . . . 1.3 108.392 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.543 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -62.42 -34.38 76.64 Favored 'General case' 0 C--N 1.281 -2.373 0 O-C-N 120.175 -1.578 . . . . 1.7 108.135 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.482 ' HG2' HD12 ' A' ' 61' ' ' ILE . 48.8 tp10 -59.68 -36.97 77.52 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 105.589 -2.004 . . . . 2.29 105.589 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 95.8 p -71.11 -18.25 62.53 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.397 -1.705 . . . . 1.41 106.397 178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 20.2 m120 61.6 35.02 17.45 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 115.123 -0.944 . . . . 1.53 111.065 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.58 HD13 ' OG ' ' A' ' 79' ' ' SER . 8.4 mp -74.55 -29.54 61.4 Favored 'General case' 0 C--N 1.291 -1.976 0 O-C-N 121.831 -0.543 . . . . 2.46 112.395 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.444 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 43.5 m -50.52 -33.09 20.26 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.122 -0.986 . . . . 2.54 110.856 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -147.42 -28.35 0.36 Allowed 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 118.342 -1.343 . . . . 3.53 112.727 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -61.88 -48.57 79.89 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 114.94 -2.704 . . . . 3.06 105.606 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.445 ' O ' ' HB2' ' A' ' 86' ' ' LYS . 62.2 mtt -88.09 -135.92 0.09 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 113.378 -1.737 . . . . 2.45 111.355 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.691 ' HG2' HG21 ' A' ' 41' ' ' ILE . 27.8 mtpt 62.81 29.67 16.67 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.521 -1.659 . . . . 1.49 106.521 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.537 ' O ' ' O ' ' A' ' 88' ' ' LYS . 96.2 mt-10 -86.78 2.08 50.06 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 116.103 -0.498 . . . . 2.69 112.112 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 87' ' ' GLU . 27.6 mttt 56.86 117.34 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 119.562 1.073 . . . . 5.0 108.73 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.47 -39.36 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 119.94 -1.725 . . . . 3.26 108.708 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -95.45 132.92 40.0 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.722 -1.214 . . . . 4.47 107.722 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.68 128.8 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.348 -0.845 . . . . 5.67 110.383 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -129.44 143.32 50.79 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.085 0.945 . . . . 6.75 110.714 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.754 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -146.81 -45.58 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 107.576 -1.268 . . . . 9.5 107.576 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 93' ' ' MET . 25.5 Cg_exo -63.76 -171.96 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.208 0 C-N-CA 122.514 2.142 . . . . 7.68 110.354 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -59.75 -36.44 76.64 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.0 -1.063 . . . . 7.69 109.633 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.003 -1.061 . . . . 8.53 109.255 179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 14.9 Cg_endo . . . . . 0 N--CA 1.49 1.27 0 N-CA-C 112.937 0.322 . . . . 3.54 112.937 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 2' ' ' PRO . . . 62.08 175.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.269 -1.752 . . . . 3.57 106.269 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.402 ' CG2' ' NH2' ' A' ' 8' ' ' ARG . 71.4 mt -118.33 125.72 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.77 1.168 . . . . 5.43 109.349 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.578 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 95.2 mt-10 -126.93 149.02 50.01 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.281 -0.637 . . . . 4.72 109.281 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 61' ' ' ILE . 5.8 m -63.48 178.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.394 -1.335 . . . . 2.38 107.394 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 89.77 18.14 52.24 Favored Glycine 0 C--O 1.199 -2.042 0 C-N-CA 119.116 -1.516 . . . . 1.47 111.27 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.578 ' NH1' ' O ' ' A' ' 5' ' ' GLU . 28.3 ptt-85 -137.53 176.02 9.08 Favored 'General case' 0 C--N 1.291 -1.954 0 O-C-N 121.147 -1.207 . . . . 3.56 108.275 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.779 HD12 ' NZ ' ' A' ' 59' ' ' LYS . 81.3 mt -104.81 146.98 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-O 123.171 1.462 . . . . 1.43 111.641 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -117.47 155.72 29.21 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 112.959 -1.928 . . . . 1.19 111.515 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.535 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 43.5 t -127.02 135.4 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 CA-C-N 115.437 -0.801 . . . . 0.95 111.144 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -87.96 139.05 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.296 -2.753 . . . . 3.12 110.189 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.1 t -125.32 120.12 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 118.834 -1.146 . . . . 1.69 110.659 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.634 ' HZ3' ' CE1' ' A' ' 53' ' ' HIS . 93.1 mttt -161.09 170.55 20.22 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.739 -1.578 . . . . 2.43 106.739 176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.9 -178.63 51.8 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 106.142 -2.783 . . . . 2.26 106.142 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' O ' ' O ' ' A' ' 17' ' ' GLU . 84.7 mtt180 38.38 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 119.37 1.585 . . . . 4.93 111.332 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 35.27 110.18 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.905 0.86 . . . . 3.13 112.673 177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.58 16.6 0.07 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.919 -1.113 . . . . 1.78 111.167 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.22 98.21 2.39 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.18 -1.968 . . . . 1.06 108.18 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.7 m -144.42 137.29 26.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.149 -1.207 . . . . 1.36 109.221 175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.901 ' O ' HG21 ' A' ' 42' ' ' THR . 90.1 mttt -103.36 139.36 38.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 3.16 109.418 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.5 p -131.24 157.69 42.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.839 -1.144 . . . . 0.78 109.147 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.482 HG22 HG12 ' A' ' 9' ' ' ILE . 42.9 t -105.17 135.18 44.33 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 N-CA-C 106.556 -1.646 . . . . 0.43 106.556 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 35' ' ' VAL . 68.8 mt -102.73 130.03 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.41 -0.916 . . . . 0.51 110.086 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER -142.28 68.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 118.158 -1.417 . . . . 1.3 111.729 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 55.1 t0 164.97 148.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.116 -0.99 . . . . 1.56 108.542 172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.1 tt -121.74 117.67 53.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 104.253 -2.499 . . . . 1.8 104.253 170.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.5 mt -97.64 -80.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.879 1.323 . . . . 0.77 109.653 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -106.18 161.26 14.68 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.105 -1.407 . . . . 2.4 107.845 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.14 -38.1 67.8 Favored 'General case' 0 C--N 1.274 -2.695 0 C-N-CA 118.683 -1.207 . . . . 2.55 109.592 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.462 ' OD1' HD11 ' A' ' 51' ' ' ILE . 76.6 m-20 -96.25 0.3 50.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.357 . . . . 2.1 113.651 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -121.31 145.03 48.29 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-N 119.994 1.27 . . . . 1.6 113.091 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -131.91 161.98 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.926 -0.484 . . . . 0.49 110.064 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 35' ' ' VAL . 9.0 tt -101.36 133.9 45.25 Favored 'General case' 0 N--CA 1.516 2.842 0 N-CA-C 108.122 -1.066 . . . . 0.93 108.122 176.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.647 HG12 HG12 ' A' ' 24' ' ' ILE . 30.2 m -127.51 149.61 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.246 -0.909 . . . . 0.52 110.8 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 t -143.22 151.4 40.56 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.083 -1.047 . . . . 0.63 111.922 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.53 164.38 37.25 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 108.039 -2.025 . . . . 0.84 108.039 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -65.79 124.57 12.92 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 CA-C-N 120.578 2.189 . . . . 0.99 109.56 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -60.37 -43.57 96.44 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.372 -1.455 . . . . 3.44 111.267 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.33 -37.43 87.23 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.997 -1.064 . . . . 2.27 113.729 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.594 HD13 ' HD3' ' A' ' 86' ' ' LYS . 85.2 mt -94.86 -71.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 114.751 1.389 . . . . 2.05 114.751 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.901 HG21 ' O ' ' A' ' 21' ' ' LYS . 28.5 m -70.17 -35.53 74.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 122.41 1.1 . . . . 1.1 109.635 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.96 -18.17 47.03 Favored Glycine 0 N--CA 1.496 2.646 0 CA-C-N 115.136 -0.938 . . . . 1.12 112.316 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -92.26 124.04 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.454 0 CA-C-N 120.31 2.055 . . . . 1.06 107.582 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -88.98 -79.55 0.32 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.237 -1.764 . . . . 3.49 106.237 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.633 HH12 HG21 ' A' ' 72' ' ' VAL . 58.1 ttt85 -152.54 118.65 5.5 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.555 -1.276 . . . . 2.78 107.555 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' O ' HG22 ' A' ' 35' ' ' VAL . 10.6 ptm180 -156.13 163.17 39.96 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.353 -1.467 . . . . 3.1 109.838 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -95.39 138.21 33.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.147 -0.971 . . . . 3.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 m -130.64 150.62 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 120.6 -1.312 . . . . 1.63 110.908 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.802 HD21 HD12 ' A' ' 52' ' ' LEU . 43.7 p-10 -86.07 172.72 10.39 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.731 0.777 . . . . 2.28 111.646 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.462 HD11 ' OD1' ' A' ' 31' ' ' ASN . 90.3 mt -57.04 -29.04 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 O-C-N 121.742 -0.599 . . . . 1.41 110.769 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.802 HD12 HD21 ' A' ' 50' ' ' ASN . 77.4 mt -53.71 -29.03 37.36 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.124 -0.985 . . . . 1.25 109.083 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.634 ' CE1' ' HZ3' ' A' ' 14' ' ' LYS . 61.8 m170 -115.96 88.61 2.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.257 -1.757 . . . . 1.5 106.257 174.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.8 tp -123.93 129.16 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 1.56 109.334 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 3.1 tp10 -152.37 94.89 3.18 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 107.584 -1.265 . . . . 2.28 107.584 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.438 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 72.6 Cg_endo -87.97 153.81 7.16 Favored 'Trans proline' 0 C--N 1.299 -2.038 0 C-N-CA 121.46 1.44 . . . . 0.69 112.541 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 9' ' ' ILE . 50.5 p -116.92 163.95 15.42 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.415 -0.958 . . . . 0.88 108.415 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' C ' ' OD1' ' A' ' 58' ' ' ASP . 49.8 p30 -88.98 39.11 0.92 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.511 -0.743 . . . . 2.57 111.468 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.779 ' NZ ' HD12 ' A' ' 9' ' ' ILE . 15.2 mtpt -84.3 -166.65 1.5 Allowed 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.007 -1.058 . . . . 2.9 111.805 -176.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.606 ' O ' ' O ' ' A' ' 7' ' ' GLY . 22.9 tttt -82.75 154.27 24.86 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 124.037 0.935 . . . . 5.03 108.988 -178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 6' ' ' VAL . 26.7 mm -116.42 117.14 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 C-N-CA 119.987 -0.685 . . . . 4.81 109.77 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -173.39 85.94 0.05 Allowed 'General case' 0 N--CA 1.505 2.325 0 O-C-N 120.983 -1.073 . . . . 2.14 113.464 175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.979 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -131.59 159.32 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 O-C-N 120.23 -1.544 . . . . 1.72 109.153 176.005 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.568 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 94.1 mt-30 -63.41 -44.93 93.24 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 116.455 -2.098 . . . . 2.59 108.848 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 3.0 ttmp? 99.85 99.8 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 108.085 -1.08 . . . . 3.48 108.085 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 11.41 63.95 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 108.8 -1.72 . . . . 0.64 108.8 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.539 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . . . -56.98 149.44 18.91 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.662 -0.905 . . . . 0.62 112.36 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.4 p -65.23 164.4 13.39 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 107.661 -1.237 . . . . 0.73 107.661 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -58.58 -42.48 88.13 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.161 -1.587 . . . . 2.02 111.371 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.96 -39.56 95.03 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 117.269 -1.772 . . . . 2.3 108.747 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.9 -36.3 83.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.603 -0.839 . . . . 1.96 108.898 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.633 HG21 HH12 ' A' ' 46' ' ' ARG . 75.8 t -64.57 -42.81 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.285 -0.884 . . . . 0.59 109.844 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.16 -42.23 98.19 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.986 -1.086 . . . . 0.79 109.791 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -60.49 -43.39 97.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 2.33 110.176 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HZ1' ' HB3' ' A' ' 67' ' ' ALA . 37.5 mtmm -60.87 -31.67 71.13 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.763 -0.586 . . . . 2.62 110.637 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.64 ' O ' ' OG ' ' A' ' 79' ' ' SER . 36.4 tp -54.83 -37.48 66.21 Favored 'General case' 0 C--O 1.2 -1.551 0 N-CA-C 108.623 -0.88 . . . . 1.3 108.623 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.51 -31.32 67.78 Favored 'General case' 0 C--N 1.277 -2.568 0 O-C-N 120.407 -1.433 . . . . 1.7 109.183 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.08 -35.64 69.63 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 106.305 -1.739 . . . . 2.29 106.305 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.64 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 57.6 p -66.57 -19.74 65.85 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.538 -1.282 . . . . 1.41 107.538 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 60.5 37.44 19.68 Favored 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 106.904 -1.517 . . . . 1.53 106.904 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.779 HD12 ' HB2' ' A' ' 85' ' ' MET . 13.9 tp -68.35 -30.42 69.37 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.454 -1.703 . . . . 2.46 111.413 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 38.9 m -43.28 -35.66 1.55 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.291 -0.881 . . . . 2.54 110.537 -175.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.79 -23.62 0.11 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.556 -1.658 . . . . 3.53 112.219 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -60.65 -48.01 83.67 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 116.404 -2.118 . . . . 3.06 107.417 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.779 ' HB2' HD12 ' A' ' 81' ' ' LEU . 84.7 mtp -84.25 -122.92 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 112.192 -2.276 . . . . 2.45 112.951 -174.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.672 ' HZ3' ' HG ' ' A' ' 81' ' ' LEU . 25.9 mttm 46.13 14.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.466 -0.939 . . . . 1.49 108.466 -178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.556 ' O ' ' O ' ' A' ' 88' ' ' LYS . 97.1 mt-10 -68.31 -24.69 64.87 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.375 1.25 . . . . 2.69 114.375 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' O ' ' O ' ' A' ' 87' ' ' GLU . 91.5 mttt 57.08 143.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 120.139 1.336 . . . . 5.0 108.766 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' O ' HD12 ' A' ' 89' ' ' ILE . 1.3 pp -73.03 -8.79 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.052 -1.655 . . . . 3.26 108.402 -177.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.52 -157.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.356 -0.84 . . . . 4.47 109.998 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.01 127.93 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.205 -1.035 . . . . 5.67 108.205 176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' ' SD ' ' A' ' 93' ' ' MET . 81.9 mtp180 -133.34 134.76 44.2 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.799 -1.188 . . . . 6.75 113.358 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.564 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -155.83 -51.11 0.01 OUTLIER Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.156 -1.424 . . . . 9.5 107.156 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.564 ' CD ' ' H ' ' A' ' 93' ' ' MET . 17.9 Cg_exo -63.89 -22.87 68.68 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.914 1.743 . . . . 7.68 111.051 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 63.3 p -75.05 -24.53 58.26 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.298 0.57 . . . . 7.69 109.548 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 117.961 -1.018 . . . . 8.53 109.088 -179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ALA . 12.4 Cg_endo . . . . . 0 N--CA 1.492 1.394 0 N-CA-C 112.938 0.322 . . . . 3.54 112.938 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . 48.38 -171.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.591 -1.263 . . . . 3.57 107.591 -177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.476 HG21 HD21 ' A' ' 54' ' ' LEU . 69.6 mt -115.9 126.02 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.869 -1.144 . . . . 5.43 110.442 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.759 ' H ' HH11 ' A' ' 8' ' ' ARG . 95.4 mt-10 -108.8 154.98 21.31 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.024 0.916 . . . . 4.72 110.492 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.491 ' H ' HG13 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -63.05 175.49 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.561 -0.904 . . . . 2.38 108.561 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 8' ' ' ARG . . . 75.55 -118.8 5.6 Favored Glycine 0 C--N 1.29 -2.023 0 C-N-CA 119.491 -1.338 . . . . 1.47 110.272 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.759 HH11 ' H ' ' A' ' 5' ' ' GLU . 39.5 mtp180 39.8 -171.43 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.894 0 O-C-N 121.507 -0.996 . . . . 3.56 109.933 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.72 HD13 ' SD ' ' A' ' 85' ' ' MET . 16.0 tt -118.09 147.95 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.517 0 N-CA-C 106.277 -1.749 . . . . 1.43 106.277 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 4.7 p -128.01 159.8 33.91 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 122.058 0.932 . . . . 1.19 111.95 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.16 145.15 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.961 -1.126 . . . . 0.95 107.961 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.4 mttm -89.95 137.16 32.57 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 119.516 -1.99 . . . . 3.12 109.512 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.96 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.254 -1.378 . . . . 1.69 111.754 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -165.76 160.17 16.89 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 105.144 -2.169 . . . . 2.43 105.144 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.89 178.94 51.17 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 117.667 -2.206 . . . . 2.26 109.095 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' GLU . 95.0 mtt-85 45.13 94.63 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.618 -0.931 . . . . 4.93 110.097 -177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 16' ' ' ARG . 84.4 tt0 41.59 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.719 0.771 . . . . 3.13 112.877 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 178.6 8.34 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.376 -0.827 . . . . 1.78 111.725 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 1.006 ' H ' HD12 ' A' ' 89' ' ' ILE . . . -91.95 115.1 4.69 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 107.618 -2.193 . . . . 1.06 107.618 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -152.48 149.21 28.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.086 -1.243 . . . . 1.36 107.862 175.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 1.9 mptp? -94.93 141.77 28.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.583 -1.323 . . . . 3.16 110.516 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 5.0 p -139.57 158.8 43.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.542 0.687 . . . . 0.78 110.313 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.01 135.68 52.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.476 -1.305 . . . . 0.43 107.476 178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 HG12 ' A' ' 35' ' ' VAL . 64.9 mt -94.49 133.78 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.477 0 C-N-CA 118.211 -1.395 . . . . 0.51 110.966 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -148.59 76.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 118.442 -1.303 . . . . 1.3 111.422 176.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 34' ' ' LEU . 47.1 t0 169.79 148.22 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.273 -1.517 . . . . 1.56 108.371 172.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 69.9 mt -119.44 121.88 67.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 103.411 -2.811 . . . . 1.8 103.411 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 76.9 mt -109.63 -38.82 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.941 -1.1 . . . . 0.77 109.927 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -164.69 173.93 11.32 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.962 -1.496 . . . . 2.4 106.962 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.93 -39.26 77.58 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.763 -1.175 . . . . 2.55 112.336 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -99.83 1.6 43.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.338 -1.476 . . . . 2.1 114.811 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 81.0 m-85 -121.77 142.87 49.77 Favored 'General case' 0 N--CA 1.506 2.337 0 CA-C-N 120.121 1.328 . . . . 1.6 111.814 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.7 162.42 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.44 -0.788 . . . . 0.49 109.411 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 26' ' ' ASP . 13.3 tp -101.32 133.05 46.5 Favored 'General case' 0 N--CA 1.52 3.027 0 C-N-CA 118.894 -1.122 . . . . 0.93 109.163 176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 24' ' ' ILE . 19.1 m -123.61 144.49 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.017 -1.073 . . . . 0.52 109.747 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.554 HG21 ' CG1' ' A' ' 72' ' ' VAL . 6.4 t -145.38 155.51 43.21 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.771 0.796 . . . . 0.63 112.293 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -155.34 164.51 32.01 Favored Glycine 0 N--CA 1.501 3.005 0 N-CA-C 107.168 -2.373 . . . . 0.84 107.168 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.71 115.6 3.02 Favored 'Trans proline' 0 C--N 1.3 -1.989 0 CA-C-N 119.145 1.472 . . . . 0.99 110.064 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -58.89 -34.9 72.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.76 0.79 . . . . 3.44 110.55 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.97 -40.96 99.31 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.635 -0.666 . . . . 2.27 112.683 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.659 HG21 ' HD3' ' A' ' 86' ' ' LYS . 81.6 mt -98.03 -78.57 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 2.05 112.767 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.6 m -61.34 -35.9 78.69 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.913 -1.117 . . . . 1.1 109.459 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.72 -3.82 57.64 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.658 -0.782 . . . . 1.12 112.112 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.5 m -90.73 131.68 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 N-CA-C 105.497 -2.038 . . . . 1.06 105.497 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -94.15 -78.23 0.44 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.492 -1.283 . . . . 3.49 110.331 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -152.66 126.18 8.8 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.027 -1.842 . . . . 2.78 106.027 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -155.01 165.82 35.53 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 120.189 -1.569 . . . . 3.1 110.08 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -113.21 138.45 49.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.381 -0.824 . . . . 3.0 109.601 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.8 m -132.23 151.73 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 C-N-CA 118.727 -1.189 . . . . 1.63 110.592 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.55 ' OD1' ' CE2' ' A' ' 32' ' ' PHE . 31.5 m-20 -87.3 163.25 16.94 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.268 -0.878 . . . . 2.28 108.717 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.3 mt -57.56 -24.92 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.02 -1.05 . . . . 1.41 111.062 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.2 mt -55.2 -35.93 65.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.345 -1.472 . . . . 1.25 108.556 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -114.66 87.17 2.58 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.204 -1.036 . . . . 1.5 108.204 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.476 HD21 HG21 ' A' ' 4' ' ' ILE . 25.3 tp -128.5 127.85 43.23 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.655 -0.868 . . . . 1.56 108.655 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -133.34 87.09 39.19 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 107.314 -1.365 . . . . 2.28 107.314 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -92.17 147.95 3.04 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.107 1.872 . . . . 0.69 114.744 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.536 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 14.7 p -101.87 172.32 7.0 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.459 -1.312 . . . . 0.88 107.459 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 58' ' ' ASP . 50.3 p30 -83.1 16.37 2.41 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 122.088 0.947 . . . . 2.57 108.909 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HZ3' ' HB2' ' A' ' 79' ' ' SER 0.346 66.4 tttt -87.53 130.07 34.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.779 -0.823 . . . . 2.9 108.779 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' CE ' ' OE1' ' A' ' 5' ' ' GLU . 62.7 tttm -133.19 120.72 21.53 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 118.986 -1.086 . . . . 5.03 110.525 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.3 mm -118.56 141.8 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.556 -1.646 . . . . 4.81 106.556 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.558 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.3 p30 -88.23 128.24 35.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.459 -1.4 . . . . 2.14 110.43 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.916 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -126.73 162.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.348 -0.845 . . . . 1.72 109.756 -179.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -70.88 -107.8 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.092 -1.043 . . . . 2.59 108.308 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -177.35 119.25 0.11 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.802 -1.187 . . . . 3.48 109.663 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.88 20.61 70.23 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.227 -1.463 . . . . 0.64 110.855 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.56 147.19 6.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.981 -1.305 . . . . 0.62 111.316 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.82 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.0 p -66.64 163.37 19.06 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 107.737 -1.208 . . . . 0.73 107.737 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -57.9 -44.03 86.51 Favored 'General case' 0 C--O 1.203 -1.362 0 C-N-CA 117.339 -1.744 . . . . 2.02 110.502 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.29 -39.58 94.97 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 117.092 -1.843 . . . . 2.3 109.404 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.87 -36.71 80.75 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.176 -1.01 . . . . 1.96 109.103 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 68' ' ' SER . 73.0 t -62.56 -41.63 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.591 -0.693 . . . . 0.59 110.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' HD13 ' A' ' 76' ' ' LEU . 97.2 mttt -58.65 -39.42 80.54 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.519 -0.872 . . . . 0.79 109.36 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -59.42 -40.79 87.86 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.221 -0.992 . . . . 2.33 111.217 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.7 mptt -60.51 -32.64 71.65 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.715 -1.241 . . . . 2.62 111.975 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' HA ' ' A' ' 73' ' ' LYS . 6.7 mp -58.62 -37.49 75.99 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 120.32 -1.488 . . . . 1.3 108.931 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 78.0 mm-40 -57.26 -32.67 66.83 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 116.957 -1.897 . . . . 1.7 107.353 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.98 -33.97 76.93 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 106.147 -1.797 . . . . 2.29 106.147 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.638 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 60.6 p -65.61 -26.92 68.05 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 105.74 -1.948 . . . . 1.41 105.74 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.9 m120 61.66 38.59 15.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.472 -1.677 . . . . 1.53 106.472 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.505 HD13 HD11 ' A' ' 9' ' ' ILE . 13.5 tp -69.16 -29.56 67.61 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.059 -1.428 . . . . 2.46 108.609 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.2 m -42.55 -34.46 0.86 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.133 -0.94 . . . . 2.54 111.365 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -156.35 -14.91 0.1 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 117.949 -1.501 . . . . 3.53 111.818 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -61.49 -41.96 98.07 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 116.41 -2.116 . . . . 3.06 105.967 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.72 ' SD ' HD13 ' A' ' 9' ' ' ILE . 75.3 mtp -109.39 -120.4 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.958 -1.019 . . . . 2.45 112.76 -176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.659 ' HD3' HG21 ' A' ' 41' ' ' ILE . 90.5 mttt 57.74 33.36 23.14 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.53 -0.545 . . . . 1.49 109.53 -176.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.1 mt-10 -67.18 -37.65 84.07 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 118.677 -1.209 . . . . 2.69 109.067 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 43.5 mtpt 100.43 -137.68 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 106.811 -1.551 . . . . 5.0 106.811 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 1.006 HD12 ' H ' ' A' ' 19' ' ' GLY . 13.0 tt -110.39 -108.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 107.09 -1.448 . . . . 3.26 107.09 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.923 ' H ' HG23 ' A' ' 89' ' ' ILE . 18.2 mttp -138.3 130.7 28.98 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.366 -0.833 . . . . 4.47 110.273 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 91' ' ' ILE . 14.7 tt -129.85 129.82 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 107.866 -1.161 . . . . 5.67 107.866 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -136.41 133.67 36.95 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.004 1.275 . . . . 6.75 113.362 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.521 ' H ' ' HD2' ' A' ' 94' ' ' PRO . 2.8 mtm -157.96 -53.06 0.01 OUTLIER Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 106.977 -1.49 . . . . 9.5 106.977 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 93' ' ' MET . 23.0 Cg_exo -61.12 -22.14 73.76 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 121.447 1.431 . . . . 7.68 110.255 176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 52.9 p -74.58 -24.52 58.91 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.768 -0.827 . . . . 7.69 108.768 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.7 mt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.946 -1.026 . . . . 8.53 109.274 179.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.494 ' O ' ' C ' ' A' ' 3' ' ' ALA . 10.8 Cg_endo . . . . . 0 N--CA 1.491 1.373 0 CA-C-O 120.548 0.145 . . . . 3.54 112.398 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 2' ' ' PRO . . . 37.2 -124.68 0.2 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 107.726 -1.213 . . . . 3.57 107.726 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.1 mt -116.8 115.69 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.724 -1.19 . . . . 5.43 108.722 176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.869 ' H ' HH21 ' A' ' 8' ' ' ARG . 97.0 mt-10 -73.44 -36.37 65.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.023 -1.048 . . . . 4.72 108.791 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 5' ' ' GLU . 57.4 t 111.12 145.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 N-CA-C 106.782 -1.562 . . . . 2.38 106.782 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.914 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 89.42 9.33 67.06 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.366 -1.397 . . . . 1.47 110.398 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.869 HH21 ' H ' ' A' ' 5' ' ' GLU . 8.6 ptp180 -98.55 179.39 4.71 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.75 -1.441 . . . . 3.56 111.365 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 22' ' ' CYS . 70.0 mt -106.68 138.5 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 105.082 -2.192 . . . . 1.43 105.082 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 p -123.65 158.52 31.36 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 122.201 1.001 . . . . 1.19 113.128 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' A' ' 21' ' ' LYS . 40.2 t -117.36 137.0 52.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 106.933 -1.506 . . . . 0.95 106.933 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' NZ ' HG21 ' A' ' 35' ' ' VAL . 16.7 mmtp -89.67 145.82 24.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 119.109 -2.245 . . . . 3.12 109.927 -177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.2 p -128.22 86.75 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 123.014 1.388 . . . . 1.69 112.664 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 tttt -139.06 144.14 38.66 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.615 -1.994 . . . . 2.43 105.615 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 179.65 53.06 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 117.795 -2.145 . . . . 2.26 109.373 -176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' GLU . 31.8 ttp180 53.2 91.71 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.799 -1.186 . . . . 4.93 107.799 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 84.3 tt0 45.1 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 120.99 0.424 . . . . 3.13 111.004 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.61 62.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 122.031 -0.418 . . . . 1.78 111.419 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.53 76.62 0.22 Allowed Glycine 0 N--CA 1.483 1.811 0 C-N-CA 118.154 -1.974 . . . . 1.06 109.024 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.566 ' OG ' HG13 ' A' ' 44' ' ' VAL . 83.0 p -142.28 167.1 22.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.833 -0.804 . . . . 1.36 110.017 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.588 ' HG2' HG22 ' A' ' 11' ' ' VAL . 66.3 mttm -86.9 152.56 22.34 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.806 1.289 . . . . 3.16 111.375 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 1.6 p -141.69 160.41 40.24 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.56 -1.2 . . . . 0.78 110.056 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.4 t -111.45 129.29 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 105.657 -1.979 . . . . 0.43 105.657 175.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.509 HG12 HG12 ' A' ' 35' ' ' VAL . 69.2 mt -92.9 134.14 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.695 -1.253 . . . . 0.51 112.271 -174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG11 ' HZ2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -148.84 77.65 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.173 -1.411 . . . . 1.3 113.009 175.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 51.8 t0 169.08 148.75 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.361 -1.462 . . . . 1.56 110.051 172.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.545 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 14.9 tt -124.44 133.24 69.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 103.923 -2.621 . . . . 1.8 103.923 171.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.769 HG22 ' H ' ' A' ' 29' ' ' ASP . 21.5 mm -104.89 -122.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 120.271 -1.518 . . . . 0.77 110.423 -177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.769 ' H ' HG22 ' A' ' 28' ' ' ILE . 92.2 m-20 -61.69 -41.45 97.59 Favored 'General case' 0 C--O 1.202 -1.426 0 C-N-CA 120.369 -0.532 . . . . 2.4 109.738 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' CG ' ' O ' ' A' ' 29' ' ' ASP . 86.9 m-20 170.01 -58.47 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 124.559 1.143 . . . . 2.55 109.711 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -88.75 3.88 49.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.06 -1.025 . . . . 2.1 113.174 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.535 ' CD1' ' OD1' ' A' ' 50' ' ' ASN . 90.1 m-85 -110.94 144.29 40.25 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.094 -1.076 . . . . 1.6 108.094 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -131.06 161.11 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.235 -0.915 . . . . 0.49 108.883 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 35' ' ' VAL . 8.8 tt -106.82 131.96 53.32 Favored 'General case' 0 N--CA 1.526 3.359 0 C-N-CA 118.698 -1.201 . . . . 0.93 108.974 176.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.642 HG21 ' NZ ' ' A' ' 12' ' ' LYS . 11.0 m -128.47 150.99 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 119.378 -0.929 . . . . 0.52 109.847 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.0 t -145.65 150.99 37.33 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.961 -1.096 . . . . 0.63 111.023 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -160.18 164.61 34.45 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.854 -2.099 . . . . 0.84 107.854 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' O ' ' OG1' ' A' ' 42' ' ' THR . 30.3 Cg_endo -69.11 101.46 0.82 Allowed 'Trans proline' 0 C--N 1.303 -1.831 0 CA-C-N 119.093 1.447 . . . . 0.99 109.874 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.32 -38.76 69.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.933 -1.104 . . . . 3.44 109.111 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.65 -36.55 67.18 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.681 -0.69 . . . . 2.27 110.755 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.734 HG21 ' HD3' ' A' ' 86' ' ' LYS . 22.9 mm -110.13 -40.86 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 119.065 -1.054 . . . . 2.05 111.1 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 38' ' ' PRO . 29.8 p -84.89 -31.29 23.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.225 -0.922 . . . . 1.1 112.292 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.98 -10.64 68.03 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.933 -1.267 . . . . 1.12 109.933 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 ' OG ' ' A' ' 20' ' ' SER . 9.8 m -103.0 128.46 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.913 -1.345 . . . . 1.06 107.972 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.72 ' H ' HH22 ' A' ' 47' ' ' ARG . 56.4 tttp -95.58 -81.59 0.4 Allowed 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 118.432 -1.307 . . . . 3.49 109.516 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 58.3 ttt85 -153.55 120.69 5.77 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.765 -1.198 . . . . 2.78 107.765 178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.72 HH22 ' H ' ' A' ' 45' ' ' LYS . 9.4 ptp85 -156.86 168.45 27.41 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 120.709 -1.244 . . . . 3.1 109.999 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -110.76 140.42 45.18 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.429 -0.952 . . . . 3.0 108.429 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 53' ' ' HIS . 78.8 t -123.71 137.67 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 121.914 0.864 . . . . 1.63 112.069 -179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.535 ' OD1' ' CD1' ' A' ' 32' ' ' PHE . 36.3 m-20 -78.69 156.15 29.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.589 -1.263 . . . . 2.28 107.589 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.925 ' O ' HD23 ' A' ' 54' ' ' LEU . 28.5 mm -56.5 -27.02 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.495 -1.378 . . . . 1.41 109.301 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -54.23 -34.17 60.04 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 120.411 -1.431 . . . . 1.25 108.586 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.503 ' O ' HG11 ' A' ' 49' ' ' VAL . 77.9 m80 -115.72 93.29 4.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.198 -0.939 . . . . 1.5 108.958 176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.925 HD23 ' O ' ' A' ' 51' ' ' ILE . 1.7 pp -135.78 129.96 33.33 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.13 -1.606 . . . . 1.56 110.898 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -130.18 86.81 53.0 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 104.995 -2.224 . . . . 2.28 104.995 174.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.652 ' HD3' HD12 ' A' ' 54' ' ' LEU . 67.3 Cg_endo -91.52 157.41 3.61 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 123.283 2.655 . . . . 0.69 115.647 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.519 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 30.3 p -106.67 165.32 11.39 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.458 -0.942 . . . . 0.88 108.458 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -84.67 15.46 3.82 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.944 0.878 . . . . 2.57 108.849 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 45.8 mttp -88.53 141.91 28.14 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.19 -1.041 . . . . 2.9 108.19 -177.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -135.69 129.21 32.35 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.569 -0.707 . . . . 5.03 110.545 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.914 HG22 ' O ' ' A' ' 7' ' ' GLY . 20.4 tt -125.18 148.03 29.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.925 -1.509 . . . . 4.81 106.925 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -84.86 119.95 25.91 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.472 -1.392 . . . . 2.14 108.281 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.523 HD13 ' HA2' ' A' ' 7' ' ' GLY . 30.6 pt -121.14 158.32 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-O 121.567 0.699 . . . . 1.72 111.848 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -86.76 0.35 54.9 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.732 . . . . 2.59 110.699 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.1 mttt 54.89 102.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.966 -1.084 . . . . 3.48 111.357 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.05 6.08 65.4 Favored Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.972 -1.109 . . . . 0.64 111.396 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.04 149.56 5.03 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.582 -1.54 . . . . 0.62 110.235 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 72' ' ' VAL . 54.2 p -65.56 159.13 25.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 0.73 108.751 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.474 ' OD1' ' NH1' ' A' ' 46' ' ' ARG . 91.7 m-20 -57.12 -40.47 77.15 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.055 -1.028 . . . . 2.02 111.898 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.6 mp0 -63.03 -39.35 94.49 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 117.18 -1.808 . . . . 2.3 110.279 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.09 -38.15 82.02 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.685 -1.259 . . . . 1.96 109.357 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 68' ' ' SER . 69.0 t -64.24 -42.55 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.728 -0.608 . . . . 0.59 111.421 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -60.66 -42.27 96.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.009 -1.477 . . . . 0.79 109.763 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -60.98 -44.82 96.81 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 117.536 -1.665 . . . . 2.33 108.853 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HZ2' HG11 ' A' ' 25' ' ' VAL . 7.8 ttpm? -60.3 -36.26 77.47 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.514 -0.741 . . . . 2.62 111.347 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.466 HD21 ' HG ' ' A' ' 81' ' ' LEU . 9.1 tt -53.83 -40.06 66.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.578 -0.849 . . . . 1.3 108.783 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.1 -33.68 67.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 117.843 -1.543 . . . . 1.7 107.732 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.67 ' OE1' HD11 ' A' ' 61' ' ' ILE . 84.5 tt0 -58.42 -34.08 70.39 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.042 -1.466 . . . . 2.29 107.042 177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 m -61.56 -26.2 67.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 106.509 -1.663 . . . . 1.41 106.509 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 m120 71.63 43.85 0.55 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 122.684 1.231 . . . . 1.53 112.715 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -71.13 -22.37 62.08 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.277 -1.329 . . . . 2.46 109.517 174.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.6 ' CA ' ' HZ2' ' A' ' 86' ' ' LYS . 39.9 m -41.76 -37.8 1.31 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.785 -0.572 . . . . 2.54 109.774 -174.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -168.82 -11.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.536 -1.353 . . . . 3.53 110.05 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -60.61 -44.05 96.75 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 123.559 1.647 . . . . 3.06 106.673 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 63.5 mtt -98.1 -127.09 0.16 Allowed 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 112.836 -1.984 . . . . 2.45 111.548 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.734 ' HD3' HG21 ' A' ' 41' ' ' ILE . 23.5 mttt 52.72 21.76 2.02 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.74 -0.6 . . . . 1.49 112.155 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.1 mt-10 -68.17 -38.81 82.46 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 117.547 -1.661 . . . . 2.69 108.325 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' NZ ' ' O ' ' A' ' 41' ' ' ILE . 25.7 mttm 88.74 123.06 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 105.368 -2.086 . . . . 5.0 105.368 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.3 mm -59.02 -42.09 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.495 -1.378 . . . . 3.26 112.496 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -123.27 136.07 54.53 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 121.521 1.964 . . . . 4.47 109.862 179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 91' ' ' ILE . 42.2 pt -148.43 76.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 122.312 1.053 . . . . 5.67 110.956 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' CG ' ' N ' ' A' ' 93' ' ' MET . 30.1 ptt180 -64.12 -39.57 94.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.139 -1.601 . . . . 6.75 109.484 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.43 ' N ' ' CG ' ' A' ' 92' ' ' ARG . 39.8 mtt -146.85 88.48 5.95 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.422 -0.799 . . . . 9.5 109.452 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -54.25 -26.71 44.14 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 120.957 1.104 . . . . 7.68 110.235 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 m -62.36 -37.5 85.93 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.745 -0.835 . . . . 7.69 108.745 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.099 -0.953 . . . . 8.53 109.227 179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.491 1.327 0 CA-C-O 121.387 0.494 . . . . 3.54 112.3 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.79 146.17 42.68 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.881 0.848 . . . . 3.57 110.765 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.86 137.33 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.288 -1.005 . . . . 5.43 108.288 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 18.0 pt-20 -166.77 -177.08 3.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.648 -1.282 . . . . 4.72 108.256 176.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG21 ' HZ3' ' A' ' 65' ' ' LYS . 12.8 m -62.6 155.6 4.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.938 -1.134 . . . . 2.38 107.938 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.17 23.68 26.55 Favored Glycine 0 N--CA 1.484 1.875 0 C-N-CA 119.116 -1.516 . . . . 1.47 112.309 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.555 HH21 HD11 ' A' ' 54' ' ' LEU . 31.8 ptt-85 -123.62 170.59 10.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.173 -1.192 . . . . 3.56 110.842 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.678 ' O ' HG23 ' A' ' 57' ' ' THR . 13.9 mm -101.21 141.01 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 121.649 0.738 . . . . 1.43 109.713 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.595 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.56 156.02 28.8 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.817 1.294 . . . . 1.19 112.631 -176.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.446 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 42.0 t -120.65 138.32 51.53 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 N-CA-C 106.536 -1.653 . . . . 0.95 106.536 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' ALA . 24.0 tttt -82.71 134.82 35.13 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 117.732 -3.105 . . . . 3.12 110.227 -175.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.757 ' O ' HG13 ' A' ' 13' ' ' VAL . 8.9 p -109.84 82.24 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.037 -1.065 . . . . 1.69 108.893 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 38.3 mtpt -155.66 164.84 38.08 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.498 -1.667 . . . . 2.43 106.498 176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -83.5 165.82 43.0 Favored Glycine 0 N--CA 1.488 2.114 0 C-N-CA 116.908 -2.568 . . . . 2.26 107.045 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.587 ' O ' ' O ' ' A' ' 15' ' ' GLY . 93.1 mtt-85 55.73 134.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 108.087 -1.079 . . . . 4.93 108.087 -175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 48.75 20.4 0.33 Allowed 'General case' 0 N--CA 1.504 2.234 0 N-CA-C 106.615 -1.624 . . . . 3.13 106.615 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.513 ' N ' ' C ' ' A' ' 16' ' ' ARG . . . -56.97 -46.31 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.773 -1.103 . . . . 1.78 108.838 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -93.36 103.65 3.07 Favored Glycine 0 C--N 1.284 -2.307 0 N-CA-C 110.458 -1.057 . . . . 1.06 110.458 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 42' ' ' THR . 36.2 t -147.49 135.5 21.31 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.278 -1.379 . . . . 1.36 107.278 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.03 139.64 30.32 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.658 -1.217 . . . . 3.16 107.838 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.595 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -130.1 140.71 50.78 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 120.12 -0.632 . . . . 0.78 110.457 -177.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.57 HG22 HD12 ' A' ' 9' ' ' ILE . 38.9 t -103.32 135.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 104.566 -2.383 . . . . 0.43 104.566 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.558 HG12 HG12 ' A' ' 35' ' ' VAL . 68.2 mt -103.14 132.29 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 C-N-CA 119.246 -0.982 . . . . 0.51 110.826 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -151.43 72.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 118.409 -1.316 . . . . 1.3 111.693 175.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 50.8 t0 170.12 147.2 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.549 -1.345 . . . . 1.56 110.476 173.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 70.6 mt -120.51 127.74 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 104.345 -2.465 . . . . 1.8 104.345 171.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 32' ' ' PHE . 17.8 mm -100.37 -104.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 121.309 1.868 . . . . 0.77 110.988 -177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 56.1 t0 -64.19 -42.37 96.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.026 -1.046 . . . . 2.4 109.249 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.655 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 49.9 p30 164.0 -46.02 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.812 0.845 . . . . 2.55 109.291 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.655 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 79.7 m-20 -96.09 4.62 52.41 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.974 -1.079 . . . . 2.1 111.56 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.488 ' HB2' ' HB ' ' A' ' 28' ' ' ILE . 96.7 m-85 -112.17 141.0 46.41 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.352 -0.842 . . . . 1.6 109.994 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -129.98 161.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.858 -0.526 . . . . 0.49 109.962 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.577 HD11 HH11 ' A' ' 46' ' ' ARG . 8.9 tt -100.9 132.45 46.29 Favored 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 108.69 -0.855 . . . . 0.93 108.69 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 24' ' ' ILE . 15.5 m -128.12 151.46 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 C-N-CA 119.234 -0.986 . . . . 0.52 110.564 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -146.01 152.59 39.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 0.63 111.104 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -165.0 154.38 25.14 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.692 -1.763 . . . . 0.84 108.692 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' O ' ' OG1' ' A' ' 42' ' ' THR . 6.2 Cg_exo -57.64 109.25 0.45 Allowed 'Trans proline' 0 C--N 1.302 -1.919 0 CA-C-N 119.978 1.889 . . . . 0.99 110.081 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' CE ' ' HZ1' ' A' ' 45' ' ' LYS . 34.9 tttp -56.64 -36.23 69.25 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.007 -1.058 . . . . 3.44 109.472 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.72 -38.58 69.94 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 119.192 -1.003 . . . . 2.27 109.626 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.663 HG21 ' HB3' ' A' ' 86' ' ' LYS . 23.5 mm -114.32 -38.66 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.206 -0.998 . . . . 2.05 111.533 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.518 ' O ' ' OG ' ' A' ' 20' ' ' SER . 80.6 p -81.19 -33.95 32.63 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.93 -1.106 . . . . 1.1 110.112 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.42 -12.65 66.33 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.31 -0.716 . . . . 1.12 111.31 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 37' ' ' GLY . 15.2 m -103.38 133.19 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.48 -1.6 . . . . 1.06 109.832 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HZ1' ' CE ' ' A' ' 39' ' ' LYS . 63.5 mttp -86.11 -78.41 0.28 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 119.787 -1.821 . . . . 3.49 106.98 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.577 HH11 HD11 ' A' ' 34' ' ' LEU . 69.0 ttp85 -149.79 124.7 9.92 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 104.749 -2.315 . . . . 2.78 104.749 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' O ' HG22 ' A' ' 35' ' ' VAL . 46.8 ptt85 -155.55 166.38 33.71 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 119.827 -1.796 . . . . 3.1 109.912 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.441 HH12 HD12 ' A' ' 34' ' ' LEU . 77.3 mtt-85 -109.75 141.39 42.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.641 -0.824 . . . . 3.0 109.193 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.97 142.8 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 1.63 110.366 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.645 ' ND2' HD12 ' A' ' 52' ' ' LEU . 42.6 p-10 -86.45 167.33 14.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.469 -0.769 . . . . 2.28 110.982 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.1 mt -59.39 -26.59 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 121.689 -0.632 . . . . 1.41 111.061 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.645 HD12 ' ND2' ' A' ' 50' ' ' ASN . 66.5 mt -55.06 -33.0 62.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.967 -1.083 . . . . 1.25 110.371 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -121.76 90.43 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.383 -1.34 . . . . 1.5 107.383 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.555 HD11 HH21 ' A' ' 8' ' ' ARG . 27.0 tp -118.68 131.89 56.16 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.825 -0.547 . . . . 1.56 110.332 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 2.6 tt0 -131.33 89.6 40.63 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 104.707 -2.331 . . . . 2.28 104.707 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.461 ' HB3' ' HE ' ' A' ' 8' ' ' ARG . 93.3 Cg_endo -87.88 149.93 7.15 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.495 1.463 . . . . 0.69 114.293 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 9' ' ' ILE . 39.8 p -110.38 165.82 11.48 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.718 -1.215 . . . . 0.88 107.718 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -83.15 14.33 3.52 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.351 -0.843 . . . . 2.57 110.124 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -91.65 125.55 36.42 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.49 -0.756 . . . . 2.9 109.743 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.2 ttpt -134.88 122.31 21.81 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.444 -0.785 . . . . 5.03 110.465 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.0 tt -131.71 152.96 37.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 N-CA-C 107.97 -1.122 . . . . 4.81 107.97 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 52.6 p30 -83.71 133.09 34.82 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.856 1.313 . . . . 2.14 110.406 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 25' ' ' VAL . 28.7 pt -125.24 158.71 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 115.031 -0.986 . . . . 1.72 112.006 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.572 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 59.7 tp60 -64.38 -48.95 73.51 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 117.546 -1.662 . . . . 2.59 109.378 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 15.2 ttmm 100.66 98.27 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 119.323 0.965 . . . . 3.48 110.781 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.52 6.97 63.75 Favored Glycine 0 N--CA 1.506 3.334 0 O-C-N 120.556 -1.34 . . . . 0.64 111.784 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 71' ' ' GLU . . . -56.88 152.87 11.94 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 120.991 -1.299 . . . . 0.62 112.832 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 72' ' ' VAL . 55.7 p -63.14 167.59 4.89 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 108.284 -1.006 . . . . 0.73 108.284 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -58.61 -45.65 88.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 119.916 -1.74 . . . . 2.02 112.749 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.32 -40.11 92.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 116.6 -2.04 . . . . 2.3 107.844 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.526 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 97.2 mt-10 -64.8 -36.07 83.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.844 -1.169 . . . . 1.96 107.844 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 68' ' ' SER . 73.2 t -64.79 -42.99 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.579 -0.849 . . . . 0.59 109.499 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -59.88 -41.65 92.02 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.362 -1.335 . . . . 0.79 107.619 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.22 -43.34 92.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.844 -1.169 . . . . 2.33 107.844 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 67' ' ' ALA . 57.6 mtmt -62.07 -34.18 75.79 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.596 -0.69 . . . . 2.62 110.754 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 23' ' ' VAL . 49.4 tp -55.75 -41.19 73.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.475 -1.391 . . . . 1.3 108.473 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.586 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -61.6 -33.94 74.78 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 119.297 -0.961 . . . . 1.7 109.063 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -38.48 81.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.212 -2.144 . . . . 2.29 105.212 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.458 ' HB3' HD23 ' A' ' 81' ' ' LEU . 47.6 m -68.37 -29.4 68.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.338 -1.356 . . . . 1.41 107.338 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.586 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 29.1 m120 60.56 38.12 19.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 105.351 -2.092 . . . . 1.53 105.351 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 79' ' ' SER . 0.9 OUTLIER -96.95 -11.81 24.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.399 -0.819 . . . . 2.46 111.413 -178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 m -56.91 -39.72 74.95 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.306 -1.496 . . . . 2.54 110.098 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.582 ' HG3' ' HZ1' ' A' ' 86' ' ' LYS . 85.5 tt0 -156.09 -11.31 0.1 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.403 -1.319 . . . . 3.53 112.297 -174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 83' ' ' GLU . 70.7 t80 -58.7 -47.25 85.2 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 114.411 -2.915 . . . . 3.06 105.609 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.462 ' HG2' ' H ' ' A' ' 87' ' ' GLU . 48.7 ttm -90.73 -110.91 0.09 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.336 0.589 . . . . 2.45 112.034 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.663 ' HB3' HG21 ' A' ' 41' ' ' ILE . 10.4 mtmt 60.91 37.38 18.41 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.726 -1.213 . . . . 1.49 107.726 -175.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 97.5 mt-10 -67.57 -37.65 82.95 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.83 -0.748 . . . . 2.69 111.286 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 62.0 mttp 85.16 126.46 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 105.768 -1.938 . . . . 5.0 105.768 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.8 tt -61.3 -28.91 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 117.842 -1.543 . . . . 3.26 108.797 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -101.38 125.56 48.03 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 106.821 -1.548 . . . . 4.47 106.821 176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.839 HG23 HD21 ' A' ' 96' ' ' LEU . 70.1 mt -117.64 131.73 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.942 -1.099 . . . . 5.67 111.055 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.7 mmt-85 -60.16 152.26 24.93 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.145 -0.972 . . . . 6.75 108.792 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.482 ' SD ' ' C ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -57.04 -48.66 97.06 Favored Pre-proline 0 N--CA 1.489 1.51 0 CA-C-N 116.046 -0.525 . . . . 9.5 112.278 -177.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -87.39 -73.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 CA-C-N 120.457 1.199 . . . . 7.68 113.89 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.8 t -142.45 162.08 36.4 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.098 -1.001 . . . . 7.69 109.891 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.839 HD21 HG23 ' A' ' 91' ' ' ILE . 67.2 mt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.048 -0.977 . . . . 8.53 108.962 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.494 1.554 0 CA-C-O 121.545 0.56 . . . . 3.54 111.674 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.28 -101.88 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.099 -0.704 . . . . 3.57 109.099 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.1 mt -117.52 136.43 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 5.43 108.692 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HE ' ' A' ' 8' ' ' ARG . 95.5 mt-10 -131.69 148.15 52.56 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.679 -1.23 . . . . 4.72 107.679 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -135.56 154.85 35.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.383 -2.08 . . . . 2.38 105.383 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . 90.26 8.81 65.99 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 107.517 -2.233 . . . . 1.47 107.517 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HB2' HD12 ' A' ' 24' ' ' ILE . 79.7 mtt180 -67.15 157.72 32.99 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 114.977 -0.612 . . . . 3.56 109.503 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 57' ' ' THR . 24.9 mm -108.03 135.31 47.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.311 -2.107 . . . . 1.43 105.311 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.647 ' HB3' HD11 ' A' ' 24' ' ' ILE . 3.8 p -127.92 155.89 43.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.07 -1.019 . . . . 1.19 113.107 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 20' ' ' SER . 43.1 t -126.56 138.02 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 115.701 -0.681 . . . . 0.95 109.827 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -85.71 130.81 34.46 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 118.74 -2.475 . . . . 3.12 109.817 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -121.19 123.03 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 117.992 -1.483 . . . . 1.69 112.622 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.608 ' NZ ' ' CD2' ' A' ' 53' ' ' HIS . 49.8 mttm -146.29 153.52 40.65 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.475 -1.306 . . . . 2.43 107.475 175.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 16' ' ' ARG . . . -86.75 102.84 2.78 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.226 -2.349 . . . . 2.26 107.226 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 38.5 ttm180 118.44 124.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 106.936 -1.505 . . . . 4.93 106.936 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.571 ' O ' ' C ' ' A' ' 18' ' ' ALA . 77.6 mm-40 73.06 -86.26 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 107.528 -1.286 . . . . 3.13 107.528 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.586 ' CB ' ' H ' ' A' ' 14' ' ' LYS . . . 8.19 113.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 122.07 0.938 . . . . 1.78 111.962 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.85 80.21 0.05 OUTLIER Glycine 0 C--N 1.292 -1.914 0 N-CA-C 103.66 -3.776 . . . . 1.06 103.66 173.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 11' ' ' VAL . 75.0 p -162.67 150.55 13.94 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 117.849 -1.54 . . . . 1.36 110.839 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 1.2 ptpp? -114.59 147.84 38.92 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.362 -0.607 . . . . 3.16 109.362 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 3.8 p -142.32 160.87 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.551 -0.718 . . . . 0.78 110.387 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG21 HD12 ' A' ' 76' ' ' LEU . 44.7 t -103.93 136.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 105.874 -1.899 . . . . 0.43 105.874 177.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.75 HD12 ' HB2' ' A' ' 8' ' ' ARG . 70.6 mt -94.43 129.25 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 123.642 1.687 . . . . 0.51 111.847 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.84 HG12 ' H ' ' A' ' 26' ' ' ASP . 2.6 t -105.18 -151.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 CA-C-N 112.61 -2.086 . . . . 1.3 109.332 -176.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.84 ' H ' HG12 ' A' ' 25' ' ' VAL 0.272 36.3 t0 -67.4 163.49 20.72 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.733 -0.667 . . . . 1.56 110.625 -172.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 27' ' ' ILE . 16.3 tt -113.82 125.42 71.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-O 122.429 1.109 . . . . 1.8 110.103 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 48' ' ' ARG . 61.7 mt -74.26 -37.45 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.934 0.873 . . . . 0.77 110.671 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 47.4 t0 -159.62 167.78 27.64 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.637 -0.875 . . . . 2.4 108.637 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 91.0 m-20 -57.14 -37.99 72.86 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.013 -1.075 . . . . 2.55 108.615 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -80.45 -31.43 37.46 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.099 -1.0 . . . . 2.1 112.464 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -113.27 143.25 44.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.514 -0.741 . . . . 1.6 112.71 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -126.42 156.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.562 -0.532 . . . . 0.49 109.562 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.406 HD21 ' CZ ' ' A' ' 46' ' ' ARG . 6.7 tt -100.04 125.54 46.12 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 105.743 -1.947 . . . . 0.93 105.743 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.6 m -130.27 155.47 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.562 0 O-C-N 120.812 -1.18 . . . . 0.52 110.965 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.1 t -142.47 155.09 45.04 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.261 -0.899 . . . . 0.63 110.966 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.89 163.7 29.43 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.013 -2.035 . . . . 0.84 108.013 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.13 111.5 2.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.532 1.666 . . . . 0.99 110.05 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -58.66 -39.35 80.37 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.252 -0.905 . . . . 3.44 110.843 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.36 -39.78 94.26 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.415 0.895 . . . . 2.27 113.415 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.642 HG21 ' HG2' ' A' ' 86' ' ' LYS . 20.5 mm -96.22 -76.88 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.04 -1.037 . . . . 2.05 112.309 -177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -62.4 -34.87 77.58 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.667 -0.645 . . . . 1.1 110.311 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.95 -4.41 57.53 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.874 -0.89 . . . . 1.12 110.874 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 44' ' ' VAL . 1.2 m -89.07 126.51 42.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.187 -2.153 . . . . 1.06 105.187 176.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -94.04 -78.86 0.43 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.676 -1.265 . . . . 3.49 110.241 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 1.0 HH12 HG21 ' A' ' 72' ' ' VAL . 56.3 ttt85 -150.8 124.25 8.97 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 105.658 -1.979 . . . . 2.78 105.658 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.62 163.18 40.61 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 117.438 -1.705 . . . . 3.1 110.846 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HG3' HD12 ' A' ' 28' ' ' ILE . 30.1 ttm180 -98.29 138.97 34.77 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.223 -1.029 . . . . 3.0 108.223 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -131.92 140.14 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 CA-C-N 119.915 1.234 . . . . 1.63 109.817 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.76 ' ND2' HD12 ' A' ' 52' ' ' LEU . 44.0 p-10 -90.55 168.02 12.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.812 -0.555 . . . . 2.28 110.57 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.7 mt -58.53 -27.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.246 -0.909 . . . . 1.41 110.549 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.76 HD12 ' ND2' ' A' ' 50' ' ' ASN . 73.0 mt -52.18 -33.2 39.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 1.25 109.666 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.608 ' CD2' ' NZ ' ' A' ' 14' ' ' LYS . 77.6 m80 -134.36 88.29 2.44 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.206 -1.405 . . . . 1.5 107.206 174.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.1 tp -124.49 132.24 53.48 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.648 -0.501 . . . . 1.56 109.648 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.49 89.0 32.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.481 -2.044 . . . . 2.28 105.481 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HB2' HH11 ' A' ' 8' ' ' ARG . 74.0 Cg_endo -89.59 156.47 5.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.014 1.809 . . . . 0.69 112.701 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 9' ' ' ILE . 49.1 p -111.71 168.19 9.76 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.881 0.848 . . . . 0.88 108.748 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -81.95 18.44 1.32 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.794 0.807 . . . . 2.57 109.392 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 8' ' ' ARG . 49.2 mttt -91.19 140.33 29.9 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-O 121.698 0.761 . . . . 2.9 112.386 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -136.87 122.62 19.9 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.942 -0.703 . . . . 5.03 109.472 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 71.7 mt -120.35 145.38 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.576 -0.898 . . . . 4.81 108.576 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 55.3 p30 -85.39 126.37 33.71 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.306 -1.497 . . . . 2.14 110.698 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.778 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -127.45 164.0 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 115.02 -0.991 . . . . 1.72 111.137 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' O ' ' A' ' 65' ' ' LYS . 95.6 mm-40 -84.27 1.49 44.51 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.763 -1.21 . . . . 2.59 109.679 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 64' ' ' GLN . 99.4 mttt 53.03 124.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.566 0.698 . . . . 3.48 112.07 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.04 70.63 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.574 -1.298 . . . . 0.64 110.183 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' HB1' ' CG ' ' A' ' 71' ' ' GLU . . . -54.08 146.64 14.3 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.015 -1.285 . . . . 0.62 111.824 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.0 p -67.16 164.4 18.16 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.878 -1.156 . . . . 0.73 107.878 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.28 -47.34 86.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.355 -1.465 . . . . 2.02 110.601 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -39.23 90.49 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 117.629 -1.628 . . . . 2.3 106.876 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.466 ' CG ' ' HB1' ' A' ' 67' ' ' ALA . 50.6 tp10 -64.72 -38.44 91.0 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.369 -0.832 . . . . 1.96 109.1 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.0 HG21 HH12 ' A' ' 46' ' ' ARG . 73.6 t -64.7 -40.56 89.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 122.298 1.047 . . . . 0.59 109.697 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.8 -42.23 98.74 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 118.32 -1.352 . . . . 0.79 110.006 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -62.63 -42.89 99.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.998 -1.064 . . . . 2.33 112.821 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HZ3' HG13 ' A' ' 25' ' ' VAL . 18.1 ptmt -67.9 -27.53 66.72 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.902 -1.124 . . . . 2.62 109.593 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 53.9 tp -55.32 -39.33 69.83 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.326 -0.95 . . . . 1.3 108.75 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.82 -29.37 66.83 Favored 'General case' 0 C--N 1.282 -2.328 0 O-C-N 121.043 -1.036 . . . . 1.7 109.349 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -53.51 -32.64 51.26 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.101 -0.999 . . . . 2.29 110.046 -178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.1 m -77.82 3.73 13.58 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 119.995 -1.691 . . . . 1.41 111.267 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 64.92 44.74 3.42 Favored 'General case' 0 N--CA 1.513 2.7 0 CA-C-O 122.27 1.034 . . . . 1.53 112.485 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.714 HD22 ' H ' ' A' ' 81' ' ' LEU . 2.1 mm? -66.3 -24.95 66.63 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.484 -0.78 . . . . 2.46 110.398 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 m -42.51 -36.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.974 -1.079 . . . . 2.54 110.903 -174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -161.67 -18.83 0.05 OUTLIER 'General case' 0 C--N 1.297 -1.704 0 O-C-N 119.574 -1.954 . . . . 3.53 111.029 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -60.49 -43.62 96.8 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 123.518 1.628 . . . . 3.06 108.049 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.534 ' SD ' ' CD1' ' A' ' 81' ' ' LEU . 62.8 mtt -95.58 -123.95 0.11 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 112.91 -1.95 . . . . 2.45 111.972 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.642 ' HG2' HG21 ' A' ' 41' ' ' ILE . 14.8 mttm 56.45 29.53 15.46 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.867 0.691 . . . . 1.49 112.867 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' CG ' ' N ' ' A' ' 88' ' ' LYS . 17.6 pt-20 -150.17 -60.5 0.2 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.467 -1.396 . . . . 2.69 110.865 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' NZ ' HG21 ' A' ' 11' ' ' VAL . 44.4 tptt 45.69 -124.43 1.21 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.243 -1.536 . . . . 5.0 111.289 -176.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.52 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 83.7 mt -119.92 131.33 72.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-O 121.947 0.879 . . . . 3.26 110.306 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -130.92 149.14 52.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-O 122.343 1.068 . . . . 4.47 111.806 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.5 mm -108.31 142.21 21.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 107.825 -1.176 . . . . 5.67 107.825 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.7 mtt85 -127.18 138.81 53.21 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.121 0.962 . . . . 6.75 110.567 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.544 ' H ' ' HD2' ' A' ' 94' ' ' PRO . 2.2 ttt -166.32 -50.75 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 106.98 -1.489 . . . . 9.5 106.98 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' A' ' 93' ' ' MET . 23.8 Cg_exo -60.09 -28.0 86.07 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.612 1.541 . . . . 7.68 111.916 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 49.4 m -66.88 -38.71 86.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.924 -1.11 . . . . 7.69 108.331 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 49.9 mt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.098 -0.953 . . . . 8.53 109.334 -179.607 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo . . . . . 0 N--CA 1.496 1.647 0 CA-C-O 121.537 0.557 . . . . 3.54 112.067 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.65 69.88 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.587 -0.695 . . . . 3.57 109.633 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.45 HG21 HD12 ' A' ' 61' ' ' ILE . 72.0 mt -110.71 137.2 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 122.957 1.36 . . . . 5.43 112.147 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.613 ' C ' HG23 ' A' ' 6' ' ' VAL . 95.3 mt-10 -112.76 152.44 29.11 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.161 -1.381 . . . . 4.72 109.916 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG23 ' C ' ' A' ' 5' ' ' GLU . 3.1 t 94.95 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.57 0 CA-C-O 121.15 0.5 . . . . 2.38 111.162 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 83.26 27.83 38.76 Favored Glycine 0 N--CA 1.496 2.669 0 O-C-N 121.172 -0.955 . . . . 1.47 110.991 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' NH1' ' O ' ' A' ' 4' ' ' ILE . 12.7 ptm180 -149.01 -177.98 6.11 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 120.935 -1.333 . . . . 3.56 109.572 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.6 mt -99.78 140.93 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 124.031 1.872 . . . . 1.43 113.883 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.4 p -121.4 156.34 32.89 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.049 -2.341 . . . . 1.19 109.119 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.426 ' H ' ' HB3' ' A' ' 55' ' ' GLU . 42.5 t -124.77 136.29 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 108.668 -0.864 . . . . 0.95 108.668 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.585 ' CE ' HH21 ' A' ' 47' ' ' ARG . 36.2 mttp -91.17 125.49 35.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 118.987 -2.321 . . . . 3.12 110.851 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.2 124.29 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.635 -1.226 . . . . 1.69 109.583 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 24.0 mttm -146.66 156.14 42.97 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.532 -1.285 . . . . 2.43 107.532 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 16' ' ' ARG . . . -85.43 176.62 49.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 103.934 -3.666 . . . . 2.26 103.934 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.564 ' C ' ' O ' ' A' ' 15' ' ' GLY . 37.0 mtm180 27.32 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.57 0 CA-C-N 120.049 1.924 . . . . 4.93 109.343 -178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.709 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 41.3 tp10 93.17 132.55 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 106.621 -1.622 . . . . 3.13 106.621 -177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 156.67 104.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.97 -0.456 . . . . 1.78 110.479 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.79 76.68 0.05 OUTLIER Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.634 -1.746 . . . . 1.06 110.645 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.422 ' OG ' ' CE ' ' A' ' 90' ' ' LYS . 3.2 m -155.64 135.8 13.0 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.394 -1.65 . . . . 1.36 109.928 175.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' O ' HG21 ' A' ' 42' ' ' THR . 67.8 mttm -98.35 145.83 26.3 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.409 -0.96 . . . . 3.16 108.409 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 3.1 p -134.61 162.58 31.89 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.346 0.593 . . . . 0.78 110.447 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.18 135.33 54.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.349 -2.093 . . . . 0.43 105.349 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.518 HG12 HG12 ' A' ' 35' ' ' VAL . 63.7 mt -97.31 132.17 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.694 -1.254 . . . . 0.51 110.37 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.5 OUTLIER -143.78 70.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 C-N-CA 118.991 -1.084 . . . . 1.3 111.355 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 20.2 t70 165.83 148.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.505 -1.372 . . . . 1.56 109.582 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 71.4 mt -116.98 115.45 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 103.815 -2.661 . . . . 1.8 103.815 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.3 mt -97.03 -81.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.77 111.029 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -108.96 171.83 7.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.735 -1.12 . . . . 2.4 108.982 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' C ' HD22 ' A' ' 31' ' ' ASN . 92.3 m-20 -55.62 -40.19 71.78 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 118.497 -1.281 . . . . 2.55 109.51 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.443 HD22 ' C ' ' A' ' 30' ' ' ASP . 2.7 m120 -102.51 -0.96 31.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.635 -1.291 . . . . 2.1 113.82 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -119.04 141.14 48.99 Favored 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 120.935 1.698 . . . . 1.6 114.087 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.25 161.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.42 -0.955 . . . . 0.49 108.42 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD21 ' CG ' ' A' ' 46' ' ' ARG . 8.4 tt -99.46 136.04 39.98 Favored 'General case' 0 N--CA 1.515 2.79 0 N-CA-C 108.215 -1.032 . . . . 0.93 108.215 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 47' ' ' ARG . 24.7 m -128.09 150.43 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 119.258 -0.977 . . . . 0.52 111.944 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.662 HG21 ' CG1' ' A' ' 72' ' ' VAL . 7.0 t -143.07 155.05 44.54 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.472 0.654 . . . . 0.63 111.804 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.445 ' C ' HD11 ' A' ' 76' ' ' LEU . . . -154.77 167.08 32.58 Favored Glycine 0 N--CA 1.506 3.361 0 N-CA-C 108.047 -2.021 . . . . 0.84 108.047 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.62 124.48 15.53 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 CA-C-N 119.037 1.418 . . . . 0.99 110.357 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' HZ3' ' HE2' ' A' ' 45' ' ' LYS . 23.5 mttt -60.51 -43.23 97.31 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.225 1.012 . . . . 3.44 110.869 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.87 -40.67 91.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 113.526 0.936 . . . . 2.27 113.526 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CD1' ' NZ ' ' A' ' 86' ' ' LYS . 81.6 mt -96.09 -76.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.325 -0.95 . . . . 2.05 113.145 -175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.62 HG21 ' O ' ' A' ' 21' ' ' LYS . 44.9 m -60.15 -36.6 77.89 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.354 -1.466 . . . . 1.1 109.035 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.38 -6.65 63.46 Favored Glycine 0 C--N 1.293 -1.826 0 N-CA-C 110.249 -1.14 . . . . 1.12 110.249 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.5 m -91.64 131.32 39.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 119.267 1.533 . . . . 1.06 107.684 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.575 ' HE2' ' HZ3' ' A' ' 39' ' ' LYS . 35.7 ttmt -89.16 -78.25 0.36 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.76 -1.176 . . . . 3.49 109.51 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.691 ' CG ' HD21 ' A' ' 34' ' ' LEU . 55.9 ttt180 -151.92 124.02 8.14 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 105.009 -2.219 . . . . 2.78 105.009 177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.698 ' O ' HG22 ' A' ' 35' ' ' VAL . 38.1 ptt180 -158.8 166.96 30.7 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 119.385 -2.072 . . . . 3.1 110.191 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -96.23 143.38 27.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.112 -0.992 . . . . 3.0 111.435 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.93 143.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.595 -0.891 . . . . 1.63 108.595 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.663 ' ND2' HD12 ' A' ' 52' ' ' LEU . 41.7 p-10 -91.85 164.14 13.78 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.145 -0.972 . . . . 2.28 111.768 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 86.1 mt -60.38 -24.75 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-N 115.814 -0.63 . . . . 1.41 111.341 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.663 HD12 ' ND2' ' A' ' 50' ' ' ASN . 60.9 mt -54.79 -31.4 58.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.954 -1.091 . . . . 1.25 109.557 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -118.15 92.33 3.8 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.09 -1.819 . . . . 1.5 106.09 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.487 HD23 ' HD3' ' A' ' 56' ' ' PRO . 9.1 tt -113.93 129.53 56.59 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.138 0.494 . . . . 1.56 109.722 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 11' ' ' VAL . 0.6 OUTLIER -140.84 93.87 8.25 Favored Pre-proline 0 N--CA 1.502 2.162 0 N-CA-C 107.743 -1.206 . . . . 2.28 107.743 178.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.487 ' HD3' HD23 ' A' ' 54' ' ' LEU . 94.2 Cg_endo -93.23 147.46 2.39 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 121.692 1.595 . . . . 0.69 114.307 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 28.6 p -120.26 161.86 20.39 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.823 -1.177 . . . . 0.88 107.823 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 54.6 p30 -78.66 135.61 37.25 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.334 -1.728 . . . . 2.57 106.334 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HG2' ' H ' ' A' ' 60' ' ' LYS . 40.3 tttm -171.61 -174.57 1.41 Allowed 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 117.298 -1.761 . . . . 2.9 109.504 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.751 ' H ' ' HG2' ' A' ' 59' ' ' LYS . 15.7 tttp -82.78 153.1 25.41 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.767 -1.197 . . . . 5.03 107.767 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.45 HD12 HG21 ' A' ' 4' ' ' ILE . 12.4 pt -138.0 82.92 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 114.609 1.337 . . . . 4.81 114.609 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -146.77 91.75 2.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.96 -1.087 . . . . 2.14 112.13 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.889 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -130.65 162.64 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.728 0.775 . . . . 1.72 109.364 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -72.32 -121.02 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 105.26 -2.126 . . . . 2.59 105.26 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -173.78 131.45 0.43 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.84 -1.163 . . . . 3.48 108.834 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.52 17.8 70.12 Favored Glycine 0 N--CA 1.488 2.126 0 C-N-CA 118.555 -1.783 . . . . 0.64 110.178 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.16 144.94 22.54 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.685 -1.48 . . . . 0.62 111.715 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.875 ' O ' HG23 ' A' ' 72' ' ' VAL . 52.5 p -68.45 169.22 11.2 Favored 'General case' 0 N--CA 1.515 2.776 0 N-CA-C 107.175 -1.417 . . . . 0.73 107.175 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 91.6 m-20 -59.15 -47.69 84.37 Favored 'General case' 0 C--O 1.202 -1.436 0 O-C-N 119.181 -2.199 . . . . 2.02 111.18 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.45 -41.79 98.65 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 116.936 -1.906 . . . . 2.3 108.332 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -64.91 -35.93 82.75 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.266 -0.974 . . . . 1.96 108.403 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 68' ' ' SER . 78.4 t -62.17 -40.12 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.73 0.776 . . . . 0.59 109.041 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 99.4 mttt -59.53 -40.66 87.93 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.701 -1.2 . . . . 0.79 108.775 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -60.31 -43.13 96.64 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 117.491 -1.684 . . . . 2.33 109.222 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -34.52 78.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.082 -1.011 . . . . 2.62 109.956 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.778 ' O ' HD11 ' A' ' 81' ' ' LEU . 9.4 tt -58.18 -42.98 87.23 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.171 -0.956 . . . . 1.3 110.245 -177.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.642 ' HA ' HD21 ' A' ' 81' ' ' LEU . 96.6 mt-10 -59.19 -31.15 68.75 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.183 -0.948 . . . . 1.7 108.715 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -52.57 -32.37 40.75 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.281 -1.748 . . . . 2.29 106.281 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.3 m -62.9 -18.41 62.98 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.783 -0.573 . . . . 1.41 111.668 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.0 m120 70.4 50.35 0.4 Allowed 'General case' 0 N--CA 1.523 3.199 0 CA-C-O 123.257 1.503 . . . . 1.53 110.505 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.845 ' N ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -65.4 -28.22 69.1 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 113.544 -1.662 . . . . 2.46 112.362 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -42.0 -36.79 1.19 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.354 -1.466 . . . . 2.54 112.988 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -155.39 -18.2 0.11 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 119.411 -2.055 . . . . 3.53 110.343 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -60.99 -38.58 86.49 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.699 1.238 . . . . 3.06 107.837 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 85.4 mtp -104.06 -125.95 0.22 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.477 -1.238 . . . . 2.45 111.004 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' NZ ' ' CD1' ' A' ' 41' ' ' ILE . 33.1 mttm 54.27 26.42 6.8 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 125.12 1.368 . . . . 1.49 114.369 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -66.0 -38.7 89.14 Favored 'General case' 0 N--CA 1.512 2.634 0 O-C-N 119.394 -2.066 . . . . 2.69 110.502 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.974 ' NZ ' HD12 ' A' ' 91' ' ' ILE . 23.0 tttt 37.07 60.34 1.01 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 112.779 0.659 . . . . 5.0 112.779 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.811 HG23 HD12 ' A' ' 96' ' ' LEU . 86.4 mt -64.64 -34.09 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 O-C-N 119.456 -2.028 . . . . 3.26 107.846 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' CE ' ' OG ' ' A' ' 20' ' ' SER . 63.0 mttm -52.47 -29.78 26.52 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.927 -1.488 . . . . 4.47 109.773 -173.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.974 HD12 ' NZ ' ' A' ' 88' ' ' LYS . 19.7 tt -64.89 -23.52 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.302 -1.499 . . . . 5.67 109.652 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.711 ' HG3' HG23 ' A' ' 91' ' ' ILE . 98.0 mtt180 -125.92 147.07 49.59 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 122.37 1.081 . . . . 6.75 112.004 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.552 ' H ' ' CD ' ' A' ' 94' ' ' PRO . 1.7 ttm -131.25 -50.64 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.287 -0.87 . . . . 9.5 109.242 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 93' ' ' MET . 21.8 Cg_exo -61.37 -33.12 89.51 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 CA-C-N 119.998 1.035 . . . . 7.68 111.257 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 45.2 m -64.12 -39.37 93.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.726 -0.608 . . . . 7.69 109.385 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.811 HD12 HG23 ' A' ' 89' ' ' ILE . 62.1 mt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 117.989 -1.005 . . . . 8.53 109.172 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo . . . . . 0 N--CA 1.488 1.189 0 CA-C-O 121.809 0.671 . . . . 3.54 112.058 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.52 158.33 31.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.045 -1.465 . . . . 3.57 107.045 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.638 HG23 HD21 ' A' ' 54' ' ' LEU . 70.8 mt -110.04 132.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.705 -1.247 . . . . 5.43 108.681 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 8' ' ' ARG . 94.6 mt-10 -149.08 160.51 43.27 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.565 -0.902 . . . . 4.72 108.565 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.793 HG21 HD11 ' A' ' 27' ' ' ILE . 23.7 t -100.39 142.69 15.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.549 -1.278 . . . . 2.38 107.549 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' HA3' ' H ' ' A' ' 62' ' ' ASP . . . 96.83 -3.4 62.64 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.492 -1.38 . . . . 1.47 110.329 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 5' ' ' GLU . 95.1 mtt180 -89.92 177.2 6.54 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.33 -1.1 . . . . 3.56 110.786 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.439 HD12 ' HD3' ' A' ' 59' ' ' LYS . 73.9 mt -95.9 137.34 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 N-CA-C 106.569 -1.641 . . . . 1.43 106.569 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 1.8 p -127.79 158.62 37.2 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.515 -0.741 . . . . 1.19 110.441 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.08 132.22 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 106.467 -1.679 . . . . 0.95 106.467 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' NZ ' HG23 ' A' ' 49' ' ' VAL . 10.6 tptm -93.4 119.59 32.69 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.861 -1.774 . . . . 3.12 112.84 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.08 128.99 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 107.493 -1.299 . . . . 1.69 107.493 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -143.85 175.82 9.72 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.833 -0.803 . . . . 2.43 108.833 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -81.14 143.19 23.79 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 118.383 -1.865 . . . . 2.26 108.77 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.57 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 33.6 ttm180 49.6 87.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.19 -1.411 . . . . 4.93 107.19 -175.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.714 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 48.9 tp10 112.62 152.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 105.92 -1.882 . . . . 3.13 105.92 -177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 155.95 83.92 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.449 0 N-CA-C 112.662 0.616 . . . . 1.78 112.662 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.83 84.21 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.81 -1.662 . . . . 1.06 110.591 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.515 ' N ' HD12 ' A' ' 89' ' ' ILE . 79.8 p -161.42 147.62 14.23 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.276 . . . . 1.36 108.798 174.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.826 ' O ' HG21 ' A' ' 42' ' ' THR . 97.1 mttt -96.63 147.77 23.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.161 -0.962 . . . . 3.16 108.707 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 10' ' ' CYS . 4.9 p -143.93 162.81 35.18 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.228 -0.92 . . . . 0.78 110.396 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 76' ' ' LEU . 26.5 t -114.7 135.03 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 105.911 -1.885 . . . . 0.43 105.911 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.572 HG22 HG13 ' A' ' 6' ' ' VAL . 66.5 mt -91.29 134.83 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.693 -1.203 . . . . 0.51 110.066 -175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 72' ' ' VAL . 13.1 m -156.78 76.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 115.464 1.653 . . . . 1.3 115.464 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 54.2 t0 171.63 150.89 0.05 Allowed 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.094 -1.004 . . . . 1.56 109.249 171.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.793 HD11 HG21 ' A' ' 6' ' ' VAL . 26.4 mm -119.22 129.67 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.494 -2.039 . . . . 1.8 105.494 171.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.82 HG22 ' H ' ' A' ' 29' ' ' ASP . 88.6 mt -121.55 -117.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.816 -1.178 . . . . 0.77 109.552 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.82 ' H ' HG22 ' A' ' 28' ' ' ILE . 52.4 t0 -58.22 -35.23 71.37 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.082 -1.451 . . . . 2.4 107.082 177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 29' ' ' ASP . 91.9 m-20 121.98 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.119 -1.808 . . . . 2.55 106.119 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -94.59 4.7 53.51 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.437 -1.32 . . . . 2.1 107.437 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.69 148.48 52.48 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.541 -0.754 . . . . 1.6 109.736 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.29 161.11 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 N-CA-C 108.12 -1.067 . . . . 0.49 108.12 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.654 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.3 tt -104.66 129.71 52.78 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 117.844 -1.542 . . . . 0.93 107.807 176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 34' ' ' LEU . 7.4 m -125.7 154.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 118.815 -1.154 . . . . 0.52 110.708 -178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.732 HG21 ' CG1' ' A' ' 72' ' ' VAL . 10.5 t -140.61 156.88 46.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.63 112.109 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.47 163.54 31.65 Favored Glycine 0 N--CA 1.507 3.371 0 N-CA-C 107.523 -2.231 . . . . 0.84 107.523 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -59.24 122.82 12.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 CA-C-N 119.506 1.653 . . . . 0.99 110.78 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -59.6 -40.43 87.46 Favored 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.817 -0.552 . . . . 3.44 111.715 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.28 -43.11 95.82 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.15 1.167 . . . . 2.27 114.15 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.673 HG21 ' O ' ' A' ' 86' ' ' LYS . 15.8 mm -96.5 -71.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.32 -1.487 . . . . 2.05 114.016 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.826 HG21 ' O ' ' A' ' 21' ' ' LYS . 31.5 m -56.34 -37.06 69.49 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.723 -0.671 . . . . 1.1 111.002 -171.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.83 7.52 47.45 Favored Glycine 0 N--CA 1.489 2.22 0 C-N-CA 119.31 -1.424 . . . . 1.12 110.03 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' HA ' HH21 ' A' ' 47' ' ' ARG . 18.2 m -122.08 162.62 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 105.527 -2.027 . . . . 1.06 105.527 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -139.16 -69.92 0.42 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.989 -1.115 . . . . 3.49 107.989 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' HG3' HD21 ' A' ' 34' ' ' LEU . 34.7 ttp180 -146.16 124.63 12.39 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.435 HH21 ' HA ' ' A' ' 44' ' ' VAL . 18.9 ptp180 -155.17 168.06 28.29 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.876 -1.14 . . . . 3.1 109.543 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.7 mtm105 -116.62 143.6 45.42 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.662 -1.236 . . . . 3.0 107.662 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.453 HG23 ' NZ ' ' A' ' 12' ' ' LYS . 14.8 p -132.48 140.12 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 122.379 1.085 . . . . 1.63 111.365 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 51' ' ' ILE . 44.6 t-20 -80.79 163.36 23.53 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 114.967 -1.015 . . . . 2.28 110.321 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.447 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 24.1 mm -59.2 -27.33 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 115.917 -0.583 . . . . 1.41 110.696 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.0 mt -54.55 -37.9 65.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.934 -1.104 . . . . 1.25 111.369 -175.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.99 89.32 3.0 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 118.35 -1.34 . . . . 1.5 109.953 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.638 HD21 HG23 ' A' ' 4' ' ' ILE . 28.2 tp -118.83 128.82 54.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.928 -0.768 . . . . 1.56 108.928 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -135.26 85.88 31.99 Favored Pre-proline 0 N--CA 1.508 2.443 0 O-C-N 120.542 -1.348 . . . . 2.28 108.668 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -96.13 151.69 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.89 2.393 . . . . 0.69 115.512 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.461 ' OG1' ' NZ ' ' A' ' 59' ' ' LYS . 19.4 p -112.19 162.0 15.94 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 106.297 -1.742 . . . . 0.88 106.297 177.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -78.19 98.47 5.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 119.515 -1.99 . . . . 2.57 110.657 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' NZ ' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -114.06 -164.63 0.94 Allowed 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.416 1.103 . . . . 2.9 111.137 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -84.58 163.36 19.37 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.212 -1.774 . . . . 5.03 106.212 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 ' O ' HG23 ' A' ' 61' ' ' ILE . 13.7 tt -121.19 123.47 69.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.688 -1.258 . . . . 4.81 109.61 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' H ' ' HA3' ' A' ' 7' ' ' GLY . 60.7 t0 -161.63 107.09 1.31 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.73 -0.606 . . . . 2.14 110.267 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -129.54 135.38 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.333 -1.728 . . . . 1.72 106.333 176.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.689 ' H ' ' HZ3' ' A' ' 75' ' ' LYS . 60.3 tp60 -64.78 -50.61 66.11 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 115.128 -2.629 . . . . 2.59 108.657 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 64' ' ' GLN . 50.3 tttt 131.2 75.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 107.268 -1.382 . . . . 3.48 107.268 -177.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.18 22.3 59.3 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.712 -1.355 . . . . 0.64 109.712 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 64' ' ' GLN . . . -54.66 143.64 24.31 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.236 . . . . 0.62 112.436 -177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 72' ' ' VAL . 56.6 p -71.08 163.91 26.65 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 109.059 -0.719 . . . . 0.73 109.059 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -54.97 -43.14 73.21 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 120.304 -1.498 . . . . 2.02 109.908 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.44 -38.47 87.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 117.401 -1.72 . . . . 2.3 108.971 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.437 ' HB2' ' HB1' ' A' ' 67' ' ' ALA . 97.1 mt-10 -67.24 -37.38 83.43 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.557 -1.257 . . . . 1.96 108.581 177.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.732 ' CG1' HG21 ' A' ' 36' ' ' THR . 67.2 t -63.7 -43.73 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 120.121 -0.632 . . . . 0.59 111.371 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -59.51 -42.05 91.33 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.103 -1.439 . . . . 0.79 108.322 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.99 -43.4 91.47 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 117.6 -1.64 . . . . 2.33 107.389 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.689 ' HZ3' ' H ' ' A' ' 64' ' ' GLN . 56.5 mtmt -60.26 -32.02 70.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.388 -0.82 . . . . 2.62 112.12 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.646 ' O ' ' OG ' ' A' ' 79' ' ' SER . 32.0 tp -52.8 -40.91 63.67 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.043 -1.661 . . . . 1.3 107.441 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.54 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 97.2 mt-10 -58.57 -34.46 71.08 Favored 'General case' 0 C--N 1.272 -2.776 0 C-N-CA 116.888 -1.925 . . . . 1.7 108.381 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.464 ' OE1' ' OD2' ' A' ' 62' ' ' ASP . 97.6 mt-10 -62.33 -33.47 74.76 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.888 -1.523 . . . . 2.29 106.888 178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.646 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 83.7 p -65.34 -26.07 67.87 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.859 -2.274 . . . . 1.41 104.859 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 77' ' ' GLU . 17.0 m120 63.12 42.15 7.47 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.743 0.783 . . . . 1.53 109.946 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' A' ' 86' ' ' LYS . 34.2 mt -92.11 3.73 54.67 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.685 -0.806 . . . . 2.46 111.35 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 m -46.61 -33.74 4.43 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.912 -1.118 . . . . 2.54 110.052 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -164.84 0.26 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.051 -1.031 . . . . 3.53 108.648 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -61.42 -43.86 98.14 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 103.176 -2.898 . . . . 3.06 103.176 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.592 ' CE ' ' HZ3' ' A' ' 21' ' ' LYS . 85.3 mmm -121.3 -120.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.281 -1.327 . . . . 2.45 110.388 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 41' ' ' ILE . 36.4 mtpt 64.97 39.45 5.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 114.152 -1.385 . . . . 1.49 109.878 -176.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -98.28 172.28 7.67 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.471 0.653 . . . . 2.69 109.687 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -95.04 128.53 41.94 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.737 -1.209 . . . . 5.0 107.737 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 20' ' ' SER . 80.1 mt -68.36 -39.72 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.358 -1.464 . . . . 3.26 113.705 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 18' ' ' ALA . 22.8 mttt -128.71 139.21 52.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 121.357 1.89 . . . . 4.47 109.286 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.529 HD11 HD23 ' A' ' 96' ' ' LEU . 15.8 tt -125.66 134.15 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.572 -0.899 . . . . 5.67 108.572 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -126.38 147.22 49.8 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.87 -1.144 . . . . 6.75 109.274 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.43 ' SD ' ' C ' ' A' ' 93' ' ' MET . 2.3 tpt -54.65 -56.15 30.31 Favored Pre-proline 0 C--N 1.299 -1.601 0 C-N-CA 118.96 -1.096 . . . . 9.5 110.065 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -60.1 -40.14 63.34 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.488 1.21 . . . . 7.68 112.119 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -65.72 -39.12 90.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 7.69 108.192 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD23 HD11 ' A' ' 91' ' ' ILE . 29.3 tp . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.983 -1.008 . . . . 8.53 109.181 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 N--CA 1.492 1.433 0 CA-C-O 121.307 0.461 . . . . 3.54 112.513 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.66 -40.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.849 . . . . 3.57 109.511 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.5 mt -119.66 140.18 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 105.963 -1.866 . . . . 5.43 105.963 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.591 ' C ' HG12 ' A' ' 6' ' ' VAL . 58.3 mp0 -104.18 147.11 27.83 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 120.614 1.552 . . . . 4.72 108.931 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG12 ' C ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER 169.46 123.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.4 -0.963 . . . . 2.38 108.4 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 60' ' ' LYS . . . 71.28 24.53 76.86 Favored Glycine 0 N--CA 1.502 3.1 0 C-N-CA 119.499 -1.334 . . . . 1.47 110.016 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' NH2' ' O ' ' A' ' 57' ' ' THR . 80.9 mtp180 -117.97 164.61 14.82 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.83 -0.806 . . . . 3.56 110.294 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.63 137.94 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 122.358 1.075 . . . . 1.43 109.448 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.523 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -117.85 156.69 27.96 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.994 -1.003 . . . . 1.19 111.554 -175.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' A' ' 10' ' ' CYS . 43.5 t -122.09 134.99 63.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.386 0 N-CA-C 105.979 -1.86 . . . . 0.95 105.979 176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.43 130.05 38.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 119.202 -2.186 . . . . 3.12 111.443 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.2 t -120.89 120.46 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 118.197 -1.401 . . . . 1.69 110.409 177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 91.1 mttt -146.59 152.71 39.36 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.664 -1.606 . . . . 2.43 106.664 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 16' ' ' ARG . . . -85.29 174.1 48.73 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 105.333 -3.107 . . . . 2.26 105.333 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 15' ' ' GLY . 73.0 mtm180 34.68 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.43 0 CA-C-N 118.643 1.221 . . . . 4.93 107.756 -176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.699 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 82.6 tt0 89.71 132.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.364 -1.347 . . . . 3.13 107.364 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . 153.59 106.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 120.78 0.324 . . . . 1.78 110.798 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.89 80.88 0.05 OUTLIER Glycine 0 C--N 1.297 -1.62 0 C-N-CA 118.906 -1.616 . . . . 1.06 109.835 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -156.71 141.76 17.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.399 -1.648 . . . . 1.36 110.346 176.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' O ' HG21 ' A' ' 42' ' ' THR . 68.5 mttm -93.62 148.38 22.15 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.383 -1.448 . . . . 3.16 107.725 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' SG ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -137.02 142.95 42.5 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.249 -0.907 . . . . 0.78 112.634 -176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -104.82 137.86 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.228 -1.767 . . . . 0.43 106.228 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 35' ' ' VAL . 69.7 mt -100.43 131.73 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.465 -0.894 . . . . 0.51 111.706 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 0.2 OUTLIER -143.84 72.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 119.145 -1.022 . . . . 1.3 109.966 176.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 27' ' ' ILE . 56.9 t0 168.12 144.84 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.788 -1.195 . . . . 1.56 109.716 173.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 27' ' ' ILE . 14.2 tt -124.0 124.42 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.331 -2.47 . . . . 1.8 104.331 170.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -99.56 -84.98 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.878 -1.139 . . . . 0.77 112.059 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 59.5 t0 -104.47 8.14 35.55 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.188 -0.671 . . . . 2.4 109.188 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 29' ' ' ASP . 81.4 m-20 90.08 -26.86 0.05 Allowed 'General case' 0 N--CA 1.5 2.059 0 C-N-CA 124.043 0.937 . . . . 2.55 109.759 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' OD1' ' CD2' ' A' ' 32' ' ' PHE . 39.3 p-10 -103.09 -3.45 25.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 2.1 109.78 177.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.593 ' CD2' ' OD1' ' A' ' 31' ' ' ASN . 95.9 m-85 -119.1 140.39 50.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.958 -1.127 . . . . 1.6 107.958 175.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.45 158.61 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.37 -0.831 . . . . 0.49 109.177 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.677 HD21 ' HG3' ' A' ' 46' ' ' ARG . 8.5 tt -103.53 135.88 44.29 Favored 'General case' 0 N--CA 1.511 2.583 0 C-N-CA 119.026 -1.07 . . . . 0.93 108.333 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 24' ' ' ILE . 17.6 m -126.39 149.09 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.034 -1.066 . . . . 0.52 109.949 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.439 HG23 HD13 ' A' ' 76' ' ' LEU . 6.3 t -142.84 154.04 43.77 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-O 121.642 0.735 . . . . 0.63 111.236 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 44' ' ' VAL . . . -156.54 160.14 30.01 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 106.698 -2.561 . . . . 0.84 106.698 176.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD3' HD21 ' A' ' 76' ' ' LEU . 17.2 Cg_exo -60.86 121.81 10.26 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 CA-C-N 120.629 2.215 . . . . 0.99 110.017 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -58.88 -36.57 74.86 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.522 1.153 . . . . 3.44 108.63 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.51 -38.86 91.58 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.511 -0.768 . . . . 2.27 112.373 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' A' ' 86' ' ' LYS . 76.1 mt -96.5 -81.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.915 -1.116 . . . . 2.05 111.369 -177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 21' ' ' LYS . 53.5 m -63.03 -36.79 84.73 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.927 . . . . 1.1 111.067 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.73 -7.45 57.62 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 120.509 -0.853 . . . . 1.12 111.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 37' ' ' GLY . 27.3 m -91.55 130.72 40.27 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.216 0 CA-C-N 120.554 2.177 . . . . 1.06 105.929 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.9 tttt -92.38 -75.64 0.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 118.516 -1.273 . . . . 3.49 109.551 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.827 HH12 HG21 ' A' ' 72' ' ' VAL . 55.6 ttt85 -149.78 125.84 10.62 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.897 -1.89 . . . . 2.78 105.897 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -156.58 165.51 36.08 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 119.714 -1.866 . . . . 3.1 110.909 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -106.9 136.04 47.43 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.289 -0.882 . . . . 3.0 111.155 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 53' ' ' HIS . 62.7 t -124.88 136.74 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.033 -1.042 . . . . 1.63 110.674 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -84.24 167.62 16.47 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.331 -0.856 . . . . 2.28 109.474 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.5 mt -56.86 -26.95 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 121.231 -0.918 . . . . 1.41 111.375 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.7 mt -56.88 -34.88 68.29 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.426 -1.421 . . . . 1.25 110.253 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.501 ' O ' HG11 ' A' ' 49' ' ' VAL . 98.6 m-70 -116.44 87.07 2.61 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.296 -0.962 . . . . 1.5 108.625 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 5' ' ' GLU . 30.7 tp -125.35 127.59 46.86 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.314 -0.866 . . . . 1.56 109.079 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -134.45 88.9 28.36 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 107.45 -1.315 . . . . 2.28 107.45 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -90.5 148.05 4.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.85 1.7 . . . . 0.69 114.866 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' NH2' ' A' ' 8' ' ' ARG . 30.4 p -117.1 165.46 13.36 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.99 -1.115 . . . . 0.88 107.99 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -68.85 137.0 53.55 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 106.264 -1.754 . . . . 2.57 106.264 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.32 -175.78 1.47 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 122.024 0.916 . . . . 2.9 110.127 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 7' ' ' GLY . 48.7 mmtm -86.61 163.15 17.59 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.781 -1.192 . . . . 5.03 107.781 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 61' ' ' ILE . 31.4 pt -130.89 87.0 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 123.595 1.664 . . . . 4.81 111.823 176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 53.1 p30 -150.68 93.05 1.91 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 113.735 1.013 . . . . 2.14 113.735 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.1 pt -121.95 153.41 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.728 -1.233 . . . . 1.72 110.432 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 26.3 mt-30 -63.05 -42.34 99.69 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 117.477 -1.689 . . . . 2.59 109.216 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 64' ' ' GLN . 34.4 mtmt 98.21 90.17 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.802 0 CA-C-N 118.448 0.567 . . . . 3.48 110.037 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.11 8.47 60.21 Favored Glycine 0 N--CA 1.503 3.129 0 O-C-N 120.893 -1.129 . . . . 0.64 111.66 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.81 148.47 10.12 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.822 -1.399 . . . . 0.62 112.158 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.815 ' O ' HG23 ' A' ' 72' ' ' VAL . 53.7 p -65.49 165.71 11.65 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.616 -1.253 . . . . 0.73 107.616 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -59.33 -45.1 92.3 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 119.798 -1.814 . . . . 2.02 111.484 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.43 -39.72 95.25 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 117.089 -1.844 . . . . 2.3 108.777 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.99 -36.39 83.18 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 118.903 -1.119 . . . . 1.96 108.353 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.827 HG21 HH12 ' A' ' 46' ' ' ARG . 74.6 t -65.3 -42.59 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.472 -0.768 . . . . 0.59 110.654 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -60.07 -41.95 93.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 118.716 -1.194 . . . . 0.79 109.666 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -59.23 -41.79 89.5 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 117.484 -1.686 . . . . 2.33 107.244 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -62.69 -34.92 78.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.63 -0.669 . . . . 2.62 110.704 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.56 HD21 ' HD3' ' A' ' 38' ' ' PRO . 50.3 tp -56.55 -41.38 76.75 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.812 -1.18 . . . . 1.3 108.983 -177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.27 -30.75 66.84 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.891 -0.781 . . . . 1.7 108.891 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE2' ' OD2' ' A' ' 62' ' ' ASP . 84.5 tt0 -53.62 -34.91 60.13 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.66 -1.237 . . . . 2.29 107.66 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 63.1 m -65.74 -18.31 65.24 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.325 -0.859 . . . . 1.41 109.907 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 71.16 51.13 0.28 Allowed 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.932 1.349 . . . . 1.53 111.551 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.607 ' H ' HD12 ' A' ' 81' ' ' LEU . 6.5 mp -63.51 -28.59 70.06 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.265 -1.334 . . . . 2.46 112.153 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 81' ' ' LEU . 39.8 m -44.88 -35.63 2.9 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.577 -1.327 . . . . 2.54 110.945 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -153.92 -19.06 0.14 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.046 -1.659 . . . . 3.53 110.268 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -61.99 -40.94 97.33 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.373 -1.454 . . . . 3.06 108.034 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . 87.7 mtp -103.65 -122.75 0.2 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.85 -1.068 . . . . 2.45 110.976 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.653 ' HG2' HG21 ' A' ' 41' ' ' ILE . 28.6 mtpt 43.14 16.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.865 -0.522 . . . . 1.49 111.134 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' MET . 97.0 mt-10 -66.21 -35.61 80.89 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.566 -1.254 . . . . 2.69 108.923 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 33.8 mttp 72.76 124.88 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 104.657 -2.349 . . . . 5.0 104.657 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 mm -61.1 -44.51 98.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 118.35 -1.34 . . . . 3.26 111.669 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -130.46 136.64 49.21 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 121.316 1.871 . . . . 4.47 108.658 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 94' ' ' PRO . 71.2 mt -120.82 128.03 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.082 -1.081 . . . . 5.67 108.082 177.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.492 ' O ' ' SD ' ' A' ' 93' ' ' MET . 26.0 mmt85 -65.87 -40.64 91.82 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.4 -2.074 . . . . 6.75 105.4 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.593 ' N ' ' CD ' ' A' ' 94' ' ' PRO . 2.9 tpp 175.01 -43.83 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 CA-C-N 114.492 -1.231 . . . . 9.5 108.133 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 93' ' ' MET . 18.7 Cg_exo -66.35 179.38 2.04 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 124.156 3.237 . . . . 7.68 111.251 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 58.3 p -71.24 -10.94 60.59 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.221 -0.924 . . . . 7.69 109.74 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.914 -1.116 . . . . 8.53 109.175 -179.735 . . . . . . . . 0 0 . 1 stop_ save_